cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
122418,Homochlorcyclizine,212-699-1,848-53-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H400:38;H302:38;H335:38;H315:38;H410:38
122420,1-methoxy-5-methylphenazinium methyl sulphate,265-579-6,65162-13-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Carc. 2,Notified C&L,42,H351:41;H319:42;H315:42;H302:40;H335:2
122422,"Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C",410-880-1,,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H314:0;H302:0
122426,Sodium N-(6-chloropyrazinyl)sulphanilamidate,245-571-9,23307-72-4,Not Classified,Notified C&L,1,Not classified:1
122433,cis-hex-3-en-1-ol,213-192-8,928-96-1,Flam. Liq. 3;Eye Irrit. 2,REACH registration C&L,2059,H226:2044;H319:1665;H228:8;Not classified:6;H315:2;H412:1;H332:1;H335:1
122435,Allyl pentabromophenyl ether,222-610-8,3555-11-1,Aquatic Chronic 4,Notified C&L,38,H413:38
122437,2-ethyl-2-hydroxybutyronitrile,252-037-9,34451-66-6,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 1,Notified C&L,1,H331:1;H301:1;H410:1;H311:1;H318:1
122440,Dipentyl tartrate,243-724-4,20309-48-2,Eye Irrit. 2,Notified C&L,22,H319:22
122442,2-butenoic anhydride,210-807-1,623-68-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,75,H335:74;H315:74;H318:75;H400:47;H314:1;H290:1
122444,"Benzamide, N-(5-bromo-3-methyl-2-pyridinyl)-N-methyl-",610-202-6,446299-80-5,Not Classified,Notified C&L,1,Not classified:1
122447,Chrysanthemoyl chloride,238-229-5,14297-81-5,Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H314:1;H301:1
122448,"α,α-dichlorotoluene;benzylidene chloride;benzal chloride",202-709-2,98-87-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Carc. 2,Harmonised C&L,0,H331:0;H302:0;H335:0;H315:0;H351:0;H318:0
122450,"2,6-dimethylbenzothiazole",220-930-2,2941-71-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
122454,Chlorocyclopropane,230-988-0,7393-45-5,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H312:38;H315:38;H301:38;H335:38
122457,Sodium naphthalide,222-460-3,3481-12-7,Flam. Sol. 1;Aquatic Chronic 1,Notified C&L,2,H228:2;H410:2
122461,2-amino-4'-chlorobenzophenone,220-770-3,2894-51-1,Skin Sens. 1;Aquatic Acute 1,Notified C&L,39,H400:38;H317:38;H319:1;H315:1
122463,acetophenone,202-708-7,98-86-2,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H319:0;H302:0
122467,"2-methyl-1,3-dithiolane",227-038-2,5616-51-3,Not Classified,Notified C&L,89,Not classified:88;H226:1;H302:1
122468,Amersette,618-018-8,87435-35-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
122471,Oxetacaine,204-780-5,126-27-2,Acute Tox. 4,Notified C&L,39,H302:39
122475,trans-hex-3-en-1-ol,213-193-3,928-97-2,Flam. Liq. 3,Notified C&L,1448,H226:1448;H319:43
122479,Hexan-2-ol,210-971-4,626-93-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,160,H226:160;H319:152;H315:150;H335:150;H302:9
122482,Copper distearate,211-540-3,660-60-6,Not Classified,Notified C&L,3,Not classified:2;H410:1;H302:1
122483,"4-allyl-2,α-dimethoxyphenetole",269-268-6,68213-85-4,Not Classified,Notified C&L,88,Not classified:88
122492,"Iris pallida, ext.",289-955-4,90045-90-2,Flam. Liq. 3,Notified C&L,1439,H226:1286;Not classified:153
122494,N-propylpiperazinium dibromide,264-759-1,64262-23-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
122495,"(S)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodoisophthaldiamide",262-093-6,60166-93-0,,Notified C&L,2,Not classified:2
122497,"Benzenesulfonic acid, 4-amino-, diazotized, coupled with diazotized 4-nitrobenzenamine and resorcinol",290-690-1,90218-17-0,Eye Irrit. 2,REACH registration C&L,8,H319:5;Not classified:3
122504,3-(indol-3-yl)propionic acid,212-600-1,830-96-6,,Notified C&L,11,H319:9;H335:8;H315:9;Not classified:2;H302:2
122508,"Alkenes, C15-18 α-, sulfurized",267-023-8,67762-55-4,Aquatic Chronic 4,REACH registration C&L,27,H413:26;Not classified:1
122509,4-nitrophenyl phenyl ether,210-656-1,620-88-2,Eye Irrit. 2,Notified C&L,40,H319:39;H401:1;H411:1;H320:1
122513,urethane (INN);ethyl carbamate,200-123-1,51-79-6,Carc. 1B,Harmonised C&L,0,H350:0
122514,"N,N'-diphenylbenzamidine",219-872-0,2556-46-9,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
122515,2-thiazolidinylidenecyanamide,427-720-1,26364-65-8,Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H373:0;H302:0
122517,"Distillates (petroleum), thermal cracked naphtha and gas oil;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C",271-631-9,68603-00-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
122519,C.I. Direct Blue 293,604-273-2,142106-29-4,Not Classified,Notified C&L,4,Not classified:4
122521,Metronidazole,207-136-1,443-48-1,Muta. 2;Carc. 1B;Aquatic Chronic 3,REACH registration C&L,171,H341:92;H350:85;H412:15;H373:103;H351:58;H312:30;H332:31;H302:28;Not classified:3;H402:2;H360:1;H315:3;H318:3;H340:1;H361:2;H411:1;H301:1;H311:1
122526,"7-aminonaphthalene-1,3,6-trisulphonic acid",204-229-9,118-03-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,18,H319:4;H315:4;H314:10;H351:4;H411:4
122527,Methanedisulphonyl dichloride,227-350-9,5799-68-8,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H314:2;H290:1;H318:1
122531,"2-[ethyl[3-methyl-4-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl]amino]ethanol",286-875-1,85392-17-2,Eye Irrit. 2,Notified C&L,6,H319:4;Not classified:2
122533,"1,3'-Bipyridinium, 5'-[[4-[[4-[(1',2'-dihydro-6'-hydroxy-3,4'-dimethyl-2'-oxo[1,3'-bipyridinium]-5'-yl)azo]benzoyl]amino]phenyl]azo]-1',2'-dihydro-6'-hydroxy-3,4'-dimethyl-2'-oxo-, salt with 2-hydroxypropanoic acid (1:2)",278-130-4,75214-63-0,Aquatic Chronic 3,REACH registration C&L,42,H412:5;H315:1;H318:1;Not classified:37
122534,Ethylferrocene,215-056-3,1273-89-8,Acute Tox. 4;Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,2,H332:2;H302:2;H410:2;H360:2;H373:2
122537,"Tetrasodium 2-[[4-[[4-[[1-hydroxy-6-(phenylamino)-3-sulphonato-2-naphthyl]azo]-1-naphthyl]azo]-6-sulphonato-1-naphthyl]azo]benzene-1,4-disulphonate",219-708-8,2503-73-3,Aquatic Chronic 3,REACH registration C&L,18,H412:10;Not classified:8
122542,"6-[methyl(phenylsulphonyl)amino]hexanoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",248-107-3,26919-50-6,Eye Dam. 1,REACH registration C&L,3,H318:1;Not classified:2
122544,Methyl 4-oxopiperidine-3-carboxylate hydrochloride,275-526-9,71486-53-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
122545,"Cellulose, acetate propanoate",618-383-3,9004-39-1,Not Classified,Notified C&L,49,Not classified:49
122548,"Trisodium 4-[[2,4-dihydroxy-3-[(4-methoxyphenyl)azo]-5-[[4-[(4-nitro-2-sulphonatophenyl)amino]phenyl]azo]phenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",274-419-4,70210-23-0,Not Classified,Notified C&L,19,Not classified:19
122549,Methyl N-methylaminoacetate hydrochloride,236-853-2,13515-93-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,53,H319:12;H335:48;H315:52;H318:40;H302:39;Not classified:1
122550,"3-amino-5-hydroxynaphthalene-2,7-disulphonic acid",201-989-3,90-40-4,Eye Irrit. 2,REACH registration C&L,3,H319:3
122551,(4-METHOXYBENZYL)TRIPHENYLPHOSPHONIUM CHLORIDE,609-010-5,3462-97-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
122552,BERRYFLOR,412-930-8,,Not Classified,Notified C&L,37,Not classified:37
122555,Cloxacillin,200-514-7,61-72-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,35,H317:35;H334:35
122559,p-cyclohexylbenzaldehyde,248-582-7,27634-89-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H302:1;H312:1;H315:1;H335:1
122562,Trifluoroacetic [2H]acid,209-961-2,599-00-8,Skin Corr. 1A;Acute Tox. 4,Notified C&L,48,H314:48;H332:47;H312:4;H290:2;H412:5;H318:1;Not classified:1;H331:1
122563,"Glycerides, C4-22 mono- and di-, citrates, potassium salts",309-064-7,99811-73-1,Not Classified,Notified C&L,1,Not classified:1
122568,(2S)-tetrahydrofuran-2-carboxylic acid,618-003-6,87392-07-2,Acute Tox. 4;Skin Corr. 1B,Notified C&L,46,H314:46;H302:39;H318:2;H290:1
122570,Gallium trihydroxide,234-687-5,12023-99-3,Not Classified,Notified C&L,3,Not classified:2;H413:1
122571,2-(4-chlorobenzoyl)benzoic acid,201-615-9,85-56-3,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,113,H318:1;H317:1;H302:68;H319:112;H335:111;H315:112
122572,N-heptadecane,211-108-4,629-78-7,Asp. Tox. 1,REACH registration C&L,290,H304:282;H335:8;H336:8;Not classified:6;H315:4
122574,Deacetylforskolin from Coleus forskohlii,613-647-4,64657-20-1,Acute Tox. 4,Notified C&L,38,H312:38
122575,"Paraffin oils, sulfochlorinated, saponified",269-144-1,68188-18-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Repr. 2;Aquatic Chronic 3,REACH registration C&L,299,H319:269;H302:185;H315:270;H361:3;H412:122;Not classified:28;H318:4;H317:2;H400:1
122578,Bis(ethylenediamine)copper dihydroxide,238-597-7,14552-35-3,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
122579,"Ethanone, 1-(3-pyridinyl)-, oxime",611-872-2,5973-83-1,,Notified C&L,4,H319:4;H335:4;H315:4
122585,Carbazol-3-ylamine,228-946-1,6377-12-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
122586,"Alcohols, C16-18, ethoxylated",500-212-8,68439-49-6,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,2196,H400:857;H318:1708;H302:1836;H315:528;Not classified:171;H319:207;H411:116;H410:66;H412:52;H317:1
122588,"Iron, complexes with diazotized 3-amino-2-hydroxy-5-nitrobenzenesulfonic acid monosodium salt coupled with diazotized 2-amino-4-nitrophenol and resorcinol, sodium salts",280-008-0,82640-18-4,Aquatic Chronic 3,REACH registration C&L,63,H412:51;H319:35;H317:35;H334:35;Not classified:11
122589,"sodium 2-biphenylate;2-phenylphenol, sodium salt",205-055-6,132-27-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Harmonised C&L,0,H400:0;H302:0;H335:0;H315:0;H318:0
122590,"Benzene, polypropene derivs., sulfonated, calcium salts",616-278-7,75975-85-8,Eye Irrit. 2,Notified C&L,1891,H319:922;H317:969;Not classified:396;H318:126
122591,Trimethyloxonium hexachloroantimonate(1-),258-960-3,54075-76-2,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38,H411:38;H332:38;H302:38
122592,"Dihydro-3-(1-octenyl)furan-2,5-dione",231-828-2,7757-96-2,Not Classified,Notified C&L,36,Not classified:36
122594,Trihexadecyl citrate,224-931-9,4560-68-3,Aquatic Chronic 4,REACH registration C&L,3,H413:2;Not classified:1
122597,Iron oxide,215-721-8,1345-25-1,Not Classified,REACH registration C&L,377,Not classified:377
122602,Tetraamminedihydroxyplatinum(2+),253-823-4,38201-97-7,Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,93,H400:83;H318:84;H317:87;H410:83;H314:6;H290:6;H302:5
122604,"(octadec-9-enyl acetoacetato-O1',O3)dipropan-2-olatoaluminium",279-484-2,80481-35-2,Flam. Liq. 3;Skin Sens. 1,Notified C&L,28,H226:21;H317:20;Not classified:7;H319:1;H315:1;H335:1
122606,Dipotassium hexabromoiridate,242-827-1,19121-78-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
122608,Bromopentacarbonylrhenium,238-084-8,14220-21-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,43,H319:39;H331:42;H315:39;H301:42;H335:39;H311:38
122609,Selenium tetrabromide,232-181-9,7789-65-3,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:42;H331:42;H301:42;H410:42;H351:38;H311:38;H314:38;H373:42
122610,2-chlorobenzoxazole,210-414-5,615-18-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:42;H315:48;H302:48;H332:1;H312:1
122616,"POLY[OXY(METHYL-1,2-ETHANEDIYL)], α-HYDRO-ω-HYDROXY-, ESTERS WITH SUCCINIC ANHYDRIDE POLYISOBUTENYL DERIVS.",615-537-1,71820-32-1,Not Classified,Notified C&L,15,Not classified:9;H413:6
122617,flurochloridone (ISO); 3-chloro-4-(chloro­methyl)-1-[3-(trifluor­omethyl)phenyl]pyrro­lidin-2-one,262-661-3,61213-25-0,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H400:0;H302:0;H410:0;H317:0;H360:0
122619,"2,4,4-trimethylpentan-1-ol",240-403-0,16325-63-6,Flam. Liq. 3,Notified C&L,41,H226:38;Not classified:3
122620,"methyl 2,5-dichlorobenzoate",220-815-7,2905-69-3,Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H336:0;H302:0
122621,Dimethyldithioxodistannathiane,251-494-1,33397-79-4,Not Classified,Notified C&L,57,Not classified:56;H400:1;H302:1;H410:1;H317:1;H361:1;H373:1
122623,"2,5-Dibromo-3-methylpyridine",608-965-5,3430-18-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,100,H319:60;H335:59;H315:99;H301:40;H318:39;H332:5;H302:7;H312:5
122631,"2,2'-iminobis[4,6-diamino-1,3,5-triazine]",222-695-1,3576-88-3,Not Classified,REACH registration C&L,44,Not classified:43;H319:1;H335:1;H315:1
122633,Decyltrimethoxysilan,611-312-7,5575-48-4,Skin Irrit. 2,Notified C&L,45,H315:33;H319:18;H412:13;Not classified:12;H400:1;H410:1
122634,sodium salt of chloroacetic acid;sodium chloroacetate,223-498-3,3926-62-3,Acute Tox. 3;Skin Irrit. 2;Aquatic Acute 1,Harmonised C&L,0,H400:0;H315:0;H301:0
122639,2-methylenehexanal,213-978-0,1070-66-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H302:38;H312:38;H335:38;H226:38
122640,"3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, lithium sodium salt, compound with 2,2'-(methylimino)diethanol",280-829-4,83783-94-2,,Notified C&L,34,Not classified:34
122641,"Octahydro-4,4,7-trimethyl-3H-naphth[1,8a-b]oxiren-7-ol",272-448-7,68845-01-2,Not Classified,Notified C&L,113,Not classified:113
122642,"Linseed oil, polymer with isophthalic acid and pentaerythritol",614-199-2,67989-61-1,Not Classified,Notified C&L,27,Not classified:27
122646,"Butanoic acid, 3-(acetyloxy)-2-methyl-, ethyl ester",604-151-9,139564-43-5,Not Classified,Notified C&L,88,Not classified:88
122647,"1-Fluoro-3,5-dimethoxybenzene",610-795-1,52189-63-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
122648,Barium neodecanoate,259-509-3,55172-98-0,Eye Dam. 1,REACH registration C&L,123,H318:10;H332:30;H302:113;Not classified:5
122649,"oxasulfuron (ISO);oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate",604-430-5,144651-06-9,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H373:0;H410:0
122650,beta-hexabromocyclododecane,603-802-4,134237-51-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
122651,"Benzenesulfonic acid, mono-C10-13-alkyl derivs., compds. with ethanolamine",287-335-8,85480-55-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,83,H315:82;H412:62;H318:79;H302:71;H319:3;Not classified:1
122653,"reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane;trans-2-isobutyl-5-methyl 1,3-dioxane",426-130-1,166301-21-9,Skin Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H315:0;H412:0
122654,"Fatty acids, C8-21 and C8-21-unsatd., esters with sorbitan",306-636-8,97358-61-7,Not Classified,Notified C&L,1,Not classified:1
122657,methacrylonitrile;2-methyl-2-propene nitrile,204-817-5,126-98-7,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3,Harmonised C&L,0,H331:0;H301:0;H311:0;H317:0;H225:0
122659,"Hexahydro-1,3,5-triphenyl-1,3,5-triazine",202-097-7,91-78-1,,Notified C&L,6,H319:5;H335:4;H315:5;H302:1
122661,2-[[dichloro-di(propan-2-yloxy)phosphorylmethyl]-propan-2-yloxyphosphoryl]oxypropane,600-703-8,10596-22-2,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2,H319:1;H317:1;H302:1;Not classified:1
122662,Benzyl(decyl)dimethylammonium chloride,213-521-5,965-32-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
122663,"2,6,9,10-tetramethyl-1-oxaspiro[4.5]deca-3,6-diene",275-181-4,71078-31-4,Not Classified,Notified C&L,61,Not classified:61
122670,Methyl heptanoate,203-428-8,106-73-0,Skin Irrit. 2,Notified C&L,1448,H315:1407;H226:161;H319:40;H335:39;Not classified:1
122671,Titanium bis(hydrogen phosphate),237-402-2,13772-30-0,Not Classified,Notified C&L,26,Not classified:26
122672,Potassium selenate,232-214-7,7790-59-2,,Notified C&L,5,H400:5;H331:5;H301:5;H410:5;H373:5
122677,"Fatty acids, coco, compds. with triethanolamine",263-155-5,61790-64-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,12,H319:6;H315:6;Not classified:4;H314:2
122680,Triazine derivative,481-860-8,,Not Classified,Notified C&L,2,Not classified:2
122681,"4,4'-dibromobenzophenone",223-632-0,3988-03-2,,Notified C&L,6,H319:6;H335:6;H315:6
122683,"N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide",418-290-6,168612-06-4,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0
122687,Methyl propyl disulphide,218-551-2,2179-60-4,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1494,H319:1468;H335:1418;H315:1443;H332:1286;H226:520;H224:52;H330:1;H301:1;H311:1
122691,"Benzenamine, 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, N-Me derivatives, aluminosilicates",269-893-4,68389-48-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,2,H335:2;H315:2;H318:2
122693,"Amides, from 2-[(aminoethyl)amino]ethanol and low-boiling tall-oil fatty acids",274-333-7,70131-72-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,13,H319:13;H315:13
122694,"Amines, N,N'-ditallow alkyl[1,2-ethanediylbis(imino-3,1-propanediyl)]di-",295-969-1,92201-39-3,Acute Tox. 4;Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,37,H410:37;H400:37;H314:37;H302:37
122701,"dimethyl[[2,2'''-[1,3-propanediylbis(oxy-kO)]bis[3'',5,5''-tris(1,1-dimethylethyl)-5'-methyl[1,1':3',1''-terphenyl]-2'-olato-kO]](2-)]-zirconium",600-034-1,1001417-33-9,Flam. Sol. 1;Water-react. 1,REACH registration C&L,1,H228:1;H260:1
122702,tert-potassium decanoate,304-348-7,94248-74-5,Eye Irrit. 2,Notified C&L,1,H319:1
122703,"2,7-Naphthalenedisulfonic acid, 4-substituted-6-[[5-[(substituted-chloroheteromonocyclyl)substituted]-2-substituted-phenyl]azo]-3-[(2,5-disubstituted-phenyl)-azo]-5-hydroxy-, lithium sodium salt",415-420-3,,STOT RE 2,Notified C&L,1,H373:1
122704,2-ethylhex-2-enol,256-675-9,50639-00-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H226:38;H319:38;H315:38
122709,Tri[oxalato(2-)]dilanthanum,208-656-1,537-03-1,,Notified C&L,8,H312:5;H302:5;H411:3;H317:3
122714,"p-menthane-1,8-diyldiamine",201-287-7,80-52-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,94,H312:55;H314:94;H302:55;H331:39;H311:39;H301:39
122717,"N,N’-[cyclohexane-1,3-diylbis(methylene)]bis(2-methylpropan-1-imine)",619-764-7,173904-11-5,Skin Corr. 1C;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,47,H314:47;H317:47;H412:47
122718,Ginger Oil,616-904-9,8007-08-7,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,352,H304:351;H411:349;H317:351;H319:116;H315:116;H412:2;H335:1
122720,Potassium trifluorohydroxyborate(1-),237-637-0,13876-98-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
122724,Tiopronin,217-778-4,1953-02-2,Acute Tox. 4,Notified C&L,50,H302:50
122725,(4-fluorophenyl)boronic acid,605-778-0,1765-93-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:51;H335:50;H315:51;H302:45;H332:2;H312:2;H303:1
122730,4-chlorocinnamonitrile,249-025-0,28446-72-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H302:38;H312:38;H315:38;H335:38
122734,FULLMAP,434-010-5,,Flam. Sol. 1;Aquatic Chronic 4,Notified C&L,1,H228:1;H413:1
122735,"9,10,12,13,15,16-hexabromooctadecanoic acid",224-023-2,4167-08-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
122739,"Fatty acids, sunflower-oil, Me esters",272-900-3,68919-54-0,Not Classified,Notified C&L,29,Not classified:29
122742,"Isomerase, glucose phosphate",232-603-1,9001-41-6,Not Classified,Notified C&L,3,Not classified:3
122745,(2-Benzothiazolylthio)succinic acid,619-111-6,95154-01-1,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,18,H411:13;H317:18;H412:2
122754,Triethylammonium sulphate (2:1),219-269-2,2399-73-7,,Notified C&L,25,Not classified:25
122756,"4,4'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one]",222-530-3,3520-72-7,Not Classified,REACH registration C&L,618,Not classified:614;H413:3;H317:1
122761,"2-methyl-1,3-dioxolane",207-841-4,497-26-7,Flam. Liq. 2;Eye Irrit. 2,Notified C&L,81,H319:45;H225:81;Not classified:1;H335:1;H315:1
122764,"Distillates (petroleum), heavy catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-063-0,64741-61-3,Carc. 1B,Harmonised C&L,0,H350:0
122768,"1,3-dichloro-α-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)phenanthren-1-methanol hydrochloride",252-895-4,36167-63-2,Aquatic Chronic 4,Notified C&L,40,H413:39;H302:1
122769,"Oils, silver fir",617-003-3,8021-27-0,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,60,H304:60;H317:60;H410:60;H400:24
122772,"Residues, zinc smelting",273-824-3,69029-83-0,Skin Sens. 1;STOT SE 3;Carc. 1A;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,14,H400:13;H335:12;H410:14;H317:13;H360:13;H373:13;H350:13;H332:1;H302:2;H314:1;H315:1
122775,4-bromo-2-chloroanisole,256-672-2,50638-47-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
122776,"2-hexyl-1,3-dioxan-5-ol",216-961-6,1708-36-7,Not Classified,Notified C&L,112,Not classified:112
122778,Diamminediiodoplatinum,240-115-5,15978-93-5,Acute Tox. 2;Acute Tox. 1;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Muta. 1B;Carc. 1B;Repr. 1B,Notified C&L,1,H310:1;H319:1;H300:1;H334:1;H340:1;H317:1;H360:1;H350:1
122782,Xylometazoline hydrochloride,214-936-4,1218-35-5,Acute Tox. 3,Notified C&L,134,H301:134;H314:1;H330:1;H315:2;H411:2;H318:3;H412:1;H331:1;H311:1
122783,"8,13-diethyl-3,7,12,17,20-pentamethyl-21H,23H-porphine-2-propionic acid",237-719-6,13939-70-3,Not Classified,Notified C&L,1,Not classified:1
122786,Ethyl hydrogen glutarate,213-977-5,1070-62-8,,Notified C&L,5,H319:5;H315:5;H335:1
122790,4'-Methyl-4-(E)-pent-3-enyl-biphenyl,473-310-0,,Not Classified,REACH registration C&L,2,Not classified:2
122791,"Siloxanes and Silicones, Me methoxy, polymers with Me silsesquioxanes",614-229-4,68037-85-4,Flam. Liq. 3,Notified C&L,45,H226:45
122793,"Potassium N,N-dimethylglycinate",241-629-2,17647-86-8,Eye Dam. 1,REACH registration C&L,86,H318:84;H319:2;H315:2
122795,Methyl 2-bromo-2-methylpropionate,245-657-6,23426-63-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H226:41;H319:39;H315:41;H335:39;H317:2;H302:2;Not classified:1
122796,"Sodium hydrogen [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-)",270-876-9,68479-95-8,Not Classified,Notified C&L,22,Not classified:15;H411:6;H319:1
122799,N-cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine monohydrochloride,274-297-2,70059-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H317:1;H334:1
122800,α-cyclopropyl-α-(4-methoxyphenyl)-5-pyrimidylmethanol,235-814-7,12771-68-5,,Notified C&L,38,Not classified:38
122803,"Glycerides, C14-26",268-085-9,68002-72-2,Not Classified,Notified C&L,1,Not classified:1
122805,(Z)-4-decenal,244-514-5,21662-09-9,Not Classified,Notified C&L,315,Not classified:259;H319:43;H335:38;H315:43;H412:13
122807,"Fatty acids, vegetable-oil, esters with neopentyl glycol",268-225-9,68038-32-4,Not Classified,REACH registration C&L,17,Not classified:17
122808,"1-(2-Methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine",619-387-8,99011-02-6,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:41;H335:40;H315:42;H300:39;H301:2;Not classified:1;H336:1;H302:1
122809,Calcium 2-oxoglutarate,275-843-2,71686-01-6,Not Classified,Notified C&L,1,Not classified:1
122815,"Urs-12-en-23-oic acid, 3-(acetyloxy)-11-oxo-, (3α,4β)-",614-060-6,67416-61-9,Not Classified,Notified C&L,1,Not classified:1
122818,"Soybean oil, hydrated",272-212-3,68783-89-1,Not Classified,Notified C&L,1,Not classified:1
122822,"reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)",417-980-4,157321-59-0,Self-react. C;Carc. 2,Harmonised C&L,0,H242:0;H351:0
122824,Sodium hydrogen phosphonate,237-707-0,13933-52-3,Not Classified,Notified C&L,5,Not classified:3;H319:2;H315:2
122825,"pitch, coal tar, high-temp.,;[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]",266-028-2,65996-93-2,Muta. 1B;Carc. 1A;Repr. 1B,Harmonised C&L,0,H360:0;H340:0;H350:0
122827,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with butane-1,3-diol, 2,4'-diisocyanatodiphenylmethane, 1,1'-methylenebis(4-isocyanatobenzene) homopolymer, [(methylethylene)bis(oxy)]dipropanol and propane-1,2-diol",500-313-7,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,REACH registration C&L,37,H319:37;H332:37;H315:37;H335:37;H334:37;H351:37;H317:37;H373:37
122830,"Rose, Rosa canina, ext.",283-652-0,84696-47-9,Not Classified,Notified C&L,108,Not classified:106;H226:2;H319:1
122832,1-benzylcyclohexan-1-ol,217-740-7,1944-01-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,127,H335:127;H315:127;H318:127;H302:127
122833,"(±)-2-hydroxy-1,2-diphenylethan-1-one",209-441-5,579-44-2,Not Classified,Notified C&L,1,Not classified:1
122838,4-chloroquinoline,210-267-7,611-35-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
122840,"3-(2-ethylhexyloxy)propane-1,2-diol",408-080-2,70445-33-9,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H318:0;H412:0
122843,1-(4-hydroxy-3-methoxyphenyl)acetone,219-704-6,2503-46-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
122847,"Tricyclo[3.3.1.13,7]decane-1-acetic acid, α,α-dichloro-, methyl ester",615-200-9,709031-34-5,,Notified C&L,1,H312:1;H332:1;H302:1
122850,Isopropyl stearate,203-934-9,112-10-7,Aquatic Chronic 4,Notified C&L,75,H413:38;Not classified:37
122853,"Chromium, acetate hydroxy sulfate aluminum complexes",289-398-7,88272-68-8,Not Classified,Notified C&L,1,Not classified:1
122855,Trimagnesium bis(orthophosphate),231-824-0,7757-87-1,Not Classified,REACH registration C&L,18,Not classified:18
122864,"6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)vinyl]-1-methylquinolinium methyl sulphate",263-201-4,61791-77-3,Skin Sens. 1;Muta. 2;Aquatic Chronic 4,REACH registration C&L,2,H413:2;H341:2;H317:2
122867,"Benzene, mono-C10-13-alkyl derivs., distn. residues",284-660-7,84961-70-6,Not Classified,REACH registration C&L,179,Not classified:92;H304:87
122869,"2-(phenylmethylene)-1-Azabicyclo[2,2,2]octan-3-one",607-326-8,24123-89-5,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1
122873,"2,6,6-trimethylbicyclo[3.1.1]heptane-2-thiol",245-900-6,23832-18-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1456,H319:1456;H335:1447;H315:1456;H400:8;H410:8;H371:1;H317:1
122874,C.I. Acid Brown 365,613-301-2,63641-88-3,Not Classified,Notified C&L,1,Not classified:1
122879,D-methionine,206-483-6,348-67-4,Not Classified,Notified C&L,2,Not classified:2
122883,(4-bromophenoxy)acetic acid,217-530-5,1878-91-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
122890,"Hydroxylamine, O-(phenylmethyl)-",612-969-2,622-33-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H335:38;H315:38;H301:38;H314:5;H317:1
122892,"Formaldehyde, polymer with aniline, reaction products with maleic anhydride",500-064-4,28630-26-4,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,28,H319:27;H335:28;H315:27;H332:28
122893,"4-[N-[2,4-dibromo-6-[(cyclohexylmethylamino)methyl]phenyl]carbamoyl]-3-methoxyphenyl acetate monohydrochloride",259-110-4,54340-60-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
122894,Indium tribromide,236-692-8,13465-09-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:40;H335:41;H315:41;H314:7;H412:1;H318:1
122895,Sodium (±)-lactate,206-231-5,312-85-6,Not Classified,Notified C&L,25,Not classified:25
122899,"Larch, Larix europaea, ext.",294-466-4,91722-66-6,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,4,H400:3;H304:3;H410:3;H317:3;H226:4;H312:1;H332:1;H302:1
122902,"p-N,Nddiethylaniline",218-140-8,2052-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H335:38;H315:39;H311:4;H332:4;H302:4
122903,"Zinc O,O,O',O'-tetrakis(1,3-dimethylbutyl) bis(phosphorodithioate)",218-679-9,2215-35-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,458,H411:458;H315:457;H318:457;H319:1
122904,6-methoxy-2-methylbenzothiazole,220-931-8,2941-72-2,,Notified C&L,4,H319:4;H335:4;H315:4
122905,"3,4-dimethoxyphenylacetic acid",202-244-5,93-40-3,Not Classified,REACH registration C&L,50,Not classified:4;H319:46;H335:45;H315:7;H302:1
122907,Not known,617-605-6,84633-54-5,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,114,H413:66;H302:75;Not classified:39
122910,Polymer of allylamine hydrochloride,415-050-2,71550-12-4,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0
122911,Methyl thiocyanate,209-134-6,556-64-9,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,48,H319:42;H331:38;H335:42;H301:48;H311:40;H226:47;H330:6;H315:5;H318:1;H225:1
122912,Hexaammonium heptamolybdate,234-722-4,12027-67-7,Not Classified,REACH registration C&L,260,Not classified:231;H302:23;H319:18;H335:18;H315:18;H332:4;H312:4;H317:1;H412:1
122913,Hexafluorobenzene,206-876-2,392-56-3,Flam. Liq. 2,Notified C&L,75,H225:75;H319:8;H315:4;H335:2
122914,Niobium pentahydroxide,242-829-2,19132-56-0,Not Classified,Notified C&L,2,Not classified:2
122916,"5-nitro-2,4,6-triaminopyrimidine",213-742-7,1006-23-1,Skin Sens. 1,REACH registration C&L,126,H317:87;H319:39;H335:38;H315:39
122919,o-nitrobenzenesulphenyl chloride,231-644-2,7669-54-7,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,48,H314:48;H318:42;H290:1;H335:1
122920,"Glycerides, mixed acetyl and C16-18",308-835-5,98654-02-5,Not Classified,Notified C&L,7,Not classified:7
122921,"Sorbitan, octanoate (2:3)",295-118-4,91844-53-0,Not Classified,REACH registration C&L,3,Not classified:3
122922,Tribarium diphosphate,236-856-9,13517-08-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,39,H319:38;H315:38;H332:38;H302:38;Not classified:1
122923,Dipotassium tetracyanozincate,238-121-8,14244-62-3,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H310:38;H400:38;H330:38;H300:38;H410:38
122924,3-methoxy-2-nitrobenzoic acid,225-549-5,4920-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
122930,"2,5-dimethoxy-4-nitroaniline",228-640-8,6313-37-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H312:38;H332:38;H302:38;H331:1;H311:1;H301:1
122931,"(3β,5α)-stigmastan-3-ol",201-479-0,83-45-4,,Notified C&L,1,H319:1;H332:1;H302:1;H312:1;H315:1;H335:1
122934,"isobenzan (ISO);1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran",206-045-4,297-78-9,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1,Harmonised C&L,0,H310:0;H400:0;H300:0
122937,α-D-galactose 1-(dipotassium phosphate),242-783-3,19046-60-7,Not Classified,Notified C&L,1,Not classified:1
122943,"3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone",207-545-5,480-19-3,Carc. 2,Notified C&L,2,H351:1;Not classified:1
122944,"(Z)-2-butene-1,4-diol",228-085-1,6117-80-2,Acute Tox. 4;Skin Irrit. 2;STOT RE 2,REACH registration C&L,48,H315:47;H373:1;H302:46;H319:46;H335:45;H224:1;H226:1;Not classified:1
122951,Cinnamyl anthranilate,201-738-8,87-29-6,Not Classified,Notified C&L,88,Not classified:88
122952,Hydroxy(2-methylprop-2-enoato-O)zinc,264-202-2,63451-47-8,Skin Sens. 1B;Eye Irrit. 2A;Aquatic Acute 1,REACH registration C&L,2,H319:2;H400:2;H317:2
122953,α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane)),406-420-4,69430-40-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
122956,Butyl (S)-2-hydroxypropionate,252-036-3,34451-19-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,280,H335:75;H315:280;H318:120;H319:160
122958,"1,2,3,4-tetrahydro-1-naphthyl hydroperoxide",212-230-0,771-29-9,Org. Perox. D;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H242:0;H400:0;H302:0;H410:0;H314:0
122962,1H-pyrimidin-4-one,224-932-4,4562-27-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
122971,Dihydrogen bis(acetato-O)difluoroborate(1-),206-768-5,373-61-5,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;STOT RE 1,REACH registration C&L,170,H372:122;H332:122;H302:170;H314:170;H290:98;H318:83;H330:2;H335:1
122978,"1,2,4-Benzenetricarboxylic acid, mixed decyl and octyl triesters",290-754-9,90218-76-1,Not Classified,REACH registration C&L,25,Not classified:25
122979,"Fatty acids, C6-10",273-085-7,68937-74-6,Not Classified,Notified C&L,92,Not classified:55;H311:36;H314:37;H318:36
122980,Isopropyl hydroxyacetate,210-804-5,623-61-0,,Notified C&L,4,H319:4;H335:4;H315:4
122982,"(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride",401-500-5,118658-99-4,Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H350:0
122984,"Anthracene oil, anthracene paste, distn. lights;Anthracene Oil Fraction;[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290°C to 340°C (554°F to 644°F). It contains chiefly trinuclear aromatics and their dihydro derivatives.]",295-278-5,91995-17-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
122985,Methyl(purin-6-yl)amine,207-137-7,443-72-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
122986,1-O-α-D-glucopyranosyl-D-mannitol,244-122-4,20942-99-8,Not Classified,Notified C&L,1,Not classified:1
122989,"Disodium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cadmate(2-)",252-736-9,35803-35-1,Carc. 1A;Repr. 2;STOT SE 1;STOT RE 1,Notified C&L,1,H361:1;H372:1;H370:1;H350:1
122992,"4-[Trans-4-(trans-4-ethylcyclohexyl)-cyclohexyl]-2,6-difluorophenol",918-316-0,,Not Classified,Notified C&L,1,Not classified:1
122996,N-(3-fluorophenyl)acetamide,206-509-6,351-28-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,47,H319:47;H335:46;H315:47
122997,"4-(4,8-dimethylnona-3,7-dienyl)pyridine",253-954-7,38462-23-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1406,H319:1286;H317:1286;Not classified:120
123000,Potassium canrenoate,218-554-9,2181-04-6,Acute Tox. 4,Notified C&L,67,H302:67;H351:27;H312:16;H332:16;H362:9;H361:9;H373:2
123001,3-methylbutyl 2-methylbutyrate,248-581-1,27625-35-0,Not Classified,Notified C&L,159,Not classified:117;H319:42;H315:41;H335:3
123005,"Linseed oil, polymer with maleic anhydride and tung oil",614-409-2,68309-52-4,Not Classified,Notified C&L,6,Not classified:6
123009,Chlorsugar,451-520-3,,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1
123012,(E)-p-chlorocinnamic acid,213-373-1,940-62-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
123016,"4,4'-bipiperidine dihydrochloride",278-958-6,78619-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
123017,"tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate",400-430-2,,Skin Sens. 1,Harmonised C&L,0,H317:0
123018,Deslanoside,241-568-1,17598-65-1,Acute Tox. 2;Acute Tox. 2;STOT RE 2,Notified C&L,1,H330:1;H300:1;H373:1
123019,"Glycerides, C4-22 mono- and di-, citrates",309-063-1,99811-72-0,Not Classified,Notified C&L,48,Not classified:48
123020,PGMS-Salz,479-570-1,,Eye Irrit. 2B,Notified C&L,1,H320:1
123023,Pentadecan-1-ol,211-107-9,629-76-5,Not Classified,Notified C&L,562,Not classified:562
123026,2-formylphenoxyacetic acid,228-480-9,6280-80-4,,Notified C&L,5,H319:5;H335:5;H315:5;H302:1
123034,(Z)-1-(octadec-9-enylammonio)propane-3-ammonium diacetate,230-532-0,7173-67-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,3,H400:3;H315:3;H318:2;H302:3;H319:1
123035,"Benzenesulfonic acid, mono-C10-13-alkyl derivs., compds. with triethanolamine",287-336-3,85480-56-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,9,H315:8;H318:7;H302:2;Not classified:1;H319:1
123037,"Boric acid(H2B4O7), disodium salt, pentahydrate",601-808-1,12179-04-3,Eye Irrit. 2;Repr. 1B,Notified C&L,376,H360:376;H319:231;H318:1;H312:1;H330:1
123038,"N,N,N',N'-tetramethylmethylenediamine",200-124-7,51-80-9,Flam. Liq. 2;Skin Corr. 1B,REACH registration C&L,45,H314:44;H225:45;H332:1;H302:1;H312:1;H318:1
123039,Eucatropine hydrochloride,208-653-5,536-93-6,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,38,H310:38;H330:38;H300:38
123043,Flubendazole,250-624-4,31430-15-6,Repr. 2,Notified C&L,19,H361:13;Not classified:5;H302:2;H319:1;H335:1;H315:1
123046,"Disodium [6-[(2-anilino-1-naphthyl)azo]-2,4-dinitrophenolato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)]chromate(2-)",278-133-0,75214-65-2,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,48,H411:46;H317:4;H318:3;H319:1;Not classified:1;H412:1
123047,Delorazepam,220-771-9,2894-67-9,Acute Tox. 4,REACH registration C&L,197,H302:196;H332:1
123053,Sodium [N-[2-[bis(carboxymethyl)amino]ethyl]-N-(hydroxymethyl)glycinato(3-)]cuprate(1-),269-967-6,68391-62-8,Not Classified,Notified C&L,1,Not classified:1
123054,Bismuth trihydroxide,233-790-2,10361-43-0,Not Classified,REACH registration C&L,18,Not classified:12;H319:6;H335:6;H315:6;H302:1;H413:1
123058,Lithium formate,209-133-0,556-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,29,H319:27;H335:27;H315:27;Not classified:2
123059,2-amino-5-methylthiazole,423-800-5,7305-71-7,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H373:0;H302:0
123060,"[3,3'-bi-7H-benz[de]anthracene]-7,7'-dione",204-166-7,116-96-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H413:38;H319:38;H302:38
123061,2-[(2-aminoethyl)thio]ethanol,246-142-9,24304-84-5,Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H314:38;H302:38
123063,"Bis(2-ethylhexan-1-olato)bis(pentane-2,4-dionato-O,O')titanium",304-059-6,94233-27-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,25,H319:25;H335:3;H315:25;H336:17
123068,Phenylephrine hydrochloride,200-517-3,61-76-7,Acute Tox. 4;Skin Sens. 1B;Aquatic Acute 2,REACH registration C&L,360,H401:1;H317:138;H302:322;H312:99;H319:83;H335:49;H315:50;H411:36;H361:47;H371:36;Not classified:1;H301:1
123070,Sodium cholate,206-643-5,361-09-1,Aquatic Chronic 3,REACH registration C&L,14,H412:4;H319:6;H335:6;H315:6;Not classified:4
123072,"(2α,6α,11R*)-3-benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol hydrobromide",248-106-8,26918-40-1,Not Classified,REACH registration C&L,1,Not classified:1
123077,Methyl octacosanoate,259-754-6,55682-92-3,Not Classified,Notified C&L,1,Not classified:1
123079,"p-nitrobenzoic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",230-989-6,7394-38-9,Not Classified,REACH registration C&L,39,Not classified:39
123081,"Paraffin waxes and Hydrocarbon waxes, chloro, sulfochlorinated",269-145-7,68188-19-2,Skin Sens. 1,REACH registration C&L,75,H317:8;H319:67;H335:67;H315:67
123083,"m-mentha-1,3(8)-diene",404-150-1,17092-80-7,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
123084,m-phenoxyphenol,211-930-3,713-68-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43;H302:43;H312:4
123085,"2,3-dimethoxybenzoic acid",216-188-4,1521-38-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H302:1
123087,"[1,2,4]Triazolo[1,5-a]pyridine-6-carbonitrile, 8-[[2-(dibutylamino)-4-phenyl-5-thiazolyl]imino]-2-(1-ethylpentyl)-5,8-dihydro-7-methyl-5-oxo-",605-551-6,169324-83-8,Not Classified,Notified C&L,5,Not classified:5
123088,4-aminobutyric acid hydrochloride,227-724-1,5959-35-3,Eye Dam. 1,Notified C&L,38,H318:38
123089,"(RS)-3-[2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl]-7-hydroxy-4-methyl-1,5-diazabicyclo[4.4.0]deca-3,5-dien-2-one]",604-435-2,144689-94-1,Acute Tox. 3,Notified C&L,9,H301:9
123095,2-bromo-4-methylanisole,244-705-3,22002-45-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:39;H315:40;H332:1;H302:1;H312:1;H331:1;H311:1;H301:1
123099,2-p-toluoylbenzoic acid,201-614-3,85-55-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
123101,"Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-tallow acyl derivs., chlorides",271-993-8,68648-46-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H315:2;H318:2
123104,"Fatty acids, lanolin, iso-Pr esters",264-119-1,63393-93-1,Not Classified,REACH registration C&L,34,Not classified:32;H413:2
123107,"Fatty acids, C5-9, tetraesters with pentaerythritol",267-022-2,67762-53-2,Not Classified,REACH registration C&L,569,Not classified:513;H319:55;H315:55;H312:1;H331:1;H302:1
123110,4-(3-hydroxypropoxy)benzoic acid,918-767-3,46350-87-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 2;STOT SE 2,REACH registration C&L,2,H371:2;H341:2;H332:2;H302:2;H312:2
123113,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with 1-chloro-2,3-epoxypropane",500-215-4,68475-94-5,Skin Sens. 1;Repr. 1B;Aquatic Chronic 4,REACH registration C&L,165,H413:25;H360:12;H361:12;H317:107;H319:115;H315:151;H350:38;H335:52;H318:38;H412:2;H411:1
123114,"Phenol, 2-methoxy-, reaction products with 2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane, hydrogenated",275-062-7,70955-71-4,Aquatic Chronic 2,REACH registration C&L,137,H411:18;H317:92;H319:27;H315:2;H400:1;H410:1
123117,Imidazol-4-ylmethanol hydrochloride,251-150-0,32673-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
123120,"Gadolinium oxide sulfide (Gd2O2S), ytterbium-doped",271-829-5,68609-44-9,Not Classified,REACH registration C&L,2,Not classified:2
123126,Dipotassium trioxotellurate,232-213-1,7790-58-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:45;H335:42;H315:45;H301:49;H300:1
123127,Doxifluridine,221-440-1,3094-09-5,Not Classified,Notified C&L,6,Not classified:1;H319:2;H335:1;H315:2;H317:2;H360:2;H340:1;H350:1;H351:1;H411:1;H332:1;H226:1
123128,"Methyl (Z,Z)-8,8-dibutyl-3,6,10-trioxo-2,7,9-trioxa-8-stannatrideca-4,11-dien-13-oate",239-594-3,15546-11-9,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Muta. 2;Repr. 1B;STOT SE 1;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,3,H341:3;H370:3;H372:3;H302:3;H410:3;H318:3;H317:3;H360:3;H314:3
123131,titanium(4+) oxalate,403-260-7,31363-92-5,Eye Dam. 1,Harmonised C&L,0,H318:0
123132,Magnesium dihydrogen disulphite,237-403-8,13774-25-9,Met. Corr. 1;Eye Irrit. 2,REACH registration C&L,41,H319:2;H290:40;H314:38;Not classified:1
123136,"6-methoxy-2,6-dimethylheptan-1-al",263-545-5,62439-41-2,Skin Sens. 1,Notified C&L,1451,H317:1398;Not classified:53
123138,"2-ethyl-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol",242-243-7,18368-91-7,Not Classified,Notified C&L,122,Not classified:122
123139,"Sulfuric acid, mono-C14-16-alkyl esters, sodium salts",293-916-7,91648-54-3,,Notified C&L,1,H315:1;H318:1
123150,N-benzylaminodiacetic acid,223-631-5,3987-53-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,41,H319:41;H332:2;H302:2;H312:2;H315:41;H335:38
123153,4-(4'-Trifluoromethylphenyl)benzaldehyde,473-430-3,,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H315:1;H302:1
123154,"2-aminopurine-6,8-diol",227-035-6,5614-64-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
123156,"1,4-bis[(2-methylphenyl)amino]anthraquinone",229-792-8,6737-68-4,Not Classified,REACH registration C&L,54,Not classified:54
123157,2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane,417-420-9,156324-82-2,Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H411:0
123158,5-chloro-2-(4-chlorophenoxy)aniline,204-460-5,121-27-7,Eye Irrit. 2,Notified C&L,1,H319:1
123162,(2R-cis)-tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran,225-017-2,4610-11-1,Skin Irrit. 2;Eye Irrit. 2;Repr. 2,Notified C&L,526,H319:526;H361:407;H315:526;H412:119
123165,"silicon carbide fibres (with diameter < 3 μm, length > 5 μm and as­pect ratio ≥ 3:1)",206-991-8,409-21-2,Carc. 1B,Harmonised C&L,0,H350:0
123167,Sodium 4-cyclohexylbutyrate,263-286-8,61886-29-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
123168,"5,6-Diamino-1,3-dipropylpyrimidine-2 ,4(1H,3H)-dione hydrochloride (1:1)",608-735-4,324002-49-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
123169,Calcium decanoate,237-328-0,13747-30-3,Not Classified,Notified C&L,2,Not classified:2
123171,11-(heptylamino)undecanoic acid,271-487-7,68564-88-5,Skin Sens. 1,Notified C&L,1,H317:1
123175,"Disodium 1,5-dihydroxypentane-1,5-disulphonate",231-043-5,7420-89-5,Skin Sens. 1,REACH registration C&L,7,H315:4;H317:4;Not classified:2;H312:1
123178,"Fatty acids, vegetable-oil, calcium salts",268-086-4,68002-73-3,Not Classified,Notified C&L,40,Not classified:40
123180,Di-p-tolylamine,210-659-8,620-93-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,Not classified:2;H319:3;H335:2;H315:3;H332:1;H302:1;H312:1
123181,"formetanate hydrochloride;3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate",245-656-0,23422-53-9,Acute Tox. 2;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H330:0;H300:0;H410:0;H317:0
123184,"2-Propenoic acid, 2-methyl-, ethyl ester, homopolymer",618-365-5,9003-42-3,Not Classified,Notified C&L,65,Not classified:65
123186,"2,2'-[oxybis(methylene)]bisoxirane",218-802-6,2238-07-5,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,46,H311:39;H314:38;H330:41;H302:41;Not classified:5;H312:2;H315:3;H335:2;H318:3;H317:3;H412:1
123187,Carmine,215-724-4,1390-65-4,Not Classified,REACH registration C&L,275,Not classified:275
123195,4-ethylbenzoyl chloride,240-404-6,16331-45-6,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT SE 3,Notified C&L,97,H312:55;H335:55;H301:55;H318:93;H314:97
123196,"Bis(2-chloroethyl) 3,3'-[(2,5-dimethyl-p-phenylene)bis[iminocarbonyl(2-hydroxy-1,3-naphthylene)azo]]di-p-toluate",269-507-4,68259-05-2,Not Classified,REACH registration C&L,162,Not classified:162
123200,2-bromomalonaldehyde,430-470-6,2065-75-0,Acute Tox. 4;Eye Dam. 1,Harmonised C&L,0,H318:0;H302:0
123203,(1S)-1-NAPHTHYLETHYLAMINE,436-100-1,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H302:2;H312:2;H315:2;H335:2;H318:2;H317:2
123204,Silicon tetrabromide,232-182-4,7789-66-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,65,H314:61;H318:39;H332:22;H302:22;H312:22;H335:26;H319:4;H315:5
123207,"2(1H)-Naphthalenone, octahydro-5,5,8a-trimethyl-, (4aS,8aR)-",611-199-4,54808-90-1,,Notified C&L,1,H304:1;H315:1;H336:1;H373:1;H361:1;H225:1
123208,Cyclohexyl acetate,210-736-6,622-45-7,Flam. Liq. 3,Notified C&L,1700,H226:1697;H315:39;Not classified:2;H319:1;H331:1;H335:1;H336:1
123209,"Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;Baseoil - unspecified",297-857-8,93763-38-3,Carc. 1B,Harmonised C&L,0,H350:0
123211,Hymecromone,201-986-7,90-33-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,339,H319:339;H335:336;H315:339;H332:1;H302:1;H312:1
123215,3-isopropoxypropylamine,220-816-2,2906-12-9,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1A;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,131,H302:87;H335:87;H318:88;H317:87;H226:131;H314:131;H412:87
123217,"1,4-dihydro-3H-2-benzopyran-3-one",224-493-9,4385-35-7,Eye Irrit. 2,Notified C&L,195,H319:195;H335:38;H315:39
123223,alpha-hexabromocyclododecane,603-801-9,134237-50-6,Repr. 2;Lact.;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H362:38;H361:38;H400:38;H410:38
123225,"2-(phosphonooxy)acrylic acid, compound with cyclohexylamine (1:1)",234-084-7,10526-80-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
123227,Meclofenoxate hydrochloride,222-975-3,3685-84-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:38;H315:39;H302:40
123228,"2-ethoxy-2,6,6-trimethyl-9-methylenebicyclo[3.3.1]nonane",272-447-1,68845-00-1,Aquatic Chronic 2,REACH registration C&L,1430,H411:15;H319:1338;Not classified:77
123232,Isoprenaline hydrochloride,200-089-8,51-30-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
123236,(5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one,607-241-6,23513-14-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,68,H319:67;H335:66;H315:67;H301:40;H332:27;H302:26;H312:27
123243,"tert-Butyl ((7R,9R)-9-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl}-6,10-dioxasprio[4.5]dec-7yl)acetate",920-205-7,,Not Classified,REACH registration C&L,2,Not classified:2
123245,"1,3-diacetoxy-1,1,3,3-tetramethyldistannoxane",227-660-4,5926-79-4,,Notified C&L,4,H312:4;H332:4;H302:4
123246,S-3-t Butyl-5 hydroxymethyl-2-phenyloxazolidine,606-322-3,194861-99-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;STOT SE 3,REACH registration C&L,1,H302:1;H312:1;H315:1;H335:1;H317:1
123249,Isophthalohydrazide,220-425-7,2760-98-7,Not Classified,REACH registration C&L,51,Not classified:12;H319:39;H335:38;H315:39;H302:38
123250,"1,3-Propanediol, 2-ethyl-2-[(methoxymethoxy)methyl]-",607-139-1,22703-76-0,,Notified C&L,33,Not classified:33
123252,"Imidazolium compounds, 2-C7-18-alkyl-1-(2-carboxyethyl)-4,5-dihydro-3-(hydroxyethyl), hydroxides, sodium salts",273-535-2,68988-63-6,Eye Dam. 1,Notified C&L,1,H318:1
123254,Hydrogen sodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),270-875-3,68479-94-7,,Notified C&L,34,H400:16;H410:16;H319:13;H411:9;Not classified:5;H315:3
123255,Sodium hydrotri-sec-butylborate(1-),266-630-5,67276-04-4,Water-react. 1;Skin Corr. 1A;Eye Dam. 1,Notified C&L,121,H314:121;H260:121;H318:83;H335:38;H302:38
123256,"Naphthenic acids, magnesium salts",270-317-9,68424-71-5,,Notified C&L,5,H319:4;H335:4;H315:4;H226:1
123257,1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]piperidinium chloride,239-067-8,14984-68-0,Acute Tox. 4,Notified C&L,41,H302:41;H412:1;H319:1;H335:1;H315:1
123260,"1,3-bis(dimethylcarbamoyl)-imidazolium chloride",420-930-4,135756-61-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0;H302:0
123261,5-sulphoanthranilic acid,222-697-2,3577-63-7,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,5,H315:3;H302:1;Not classified:2;H319:2;H317:1
123262,Pyridine-4-carbonyl chloride,254-331-2,39178-35-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,47,H314:47;H318:40;H290:1
123263,"4,5-dihydroxy-1,3-dimethylimidazolidin-2-one",223-496-2,3923-79-3,Not Classified,Notified C&L,160,Not classified:122;H318:38
123266,Methyl 2-mercaptopropionate,258-856-8,53907-46-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H226:2;H319:2;H315:2;H335:2
123267,Dipotassium tetracyanoniccolate,238-082-7,14220-17-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H310:38;H400:38;H330:38;H300:38;H410:38
123269,"2,4-dinitrophenol",200-087-7,51-28-5,Acute Tox. 2;Acute Tox. 3;Acute Tox. 3;STOT RE 1;Aquatic Acute 1,Harmonised C&L,0,H400:0;H331:0;H372:0;H300:0;H311:0
123270,"Santalum yasi, ext.",296-847-0,93062-90-9,Not Classified,Notified C&L,1,Not classified:1
123271,"Glucosidase, α-",232-604-7,9001-42-7,Resp. Sens. 1,Notified C&L,7,H334:7
123276,3-aminopropane-1-sulphonic acid,222-977-4,3687-18-1,Not Classified,REACH registration C&L,53,Not classified:4;H319:49;H335:48;H315:49
123277,"2,2'-oxybis[[2H5]ethane]",220-235-4,2679-89-2,Flam. Liq. 1;Acute Tox. 4;STOT SE 3,Notified C&L,43,H336:43;H224:43;H302:43;Not classified:1
123278,3-(2-Dimethylamino-ethyl)-5-methylsulfamoylmethyl-1H-indole-2-carboxylic acid,604-919-3,153654-26-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
123282,Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate,414-590-6,125229-74-5,Aquatic Chronic 2,Harmonised C&L,0,H411:0
123283,"Phosphate rock and Phosphorite, calcined",266-029-8,65996-94-3,Not Classified,Notified C&L,84,Not classified:84
123287,Propineb,235-134-0,12071-83-9,,Notified C&L,42,Not classified:38;H312:4;H400:1;H373:1;H317:1
123288,"2,6,10-trimethylundeca-5,9-dienal",245-999-6,24048-13-3,Not Classified,Notified C&L,113,Not classified:113
123289,Cycloserine,200-688-4,68-41-7,Not Classified,Notified C&L,5,Not classified:4;H319:1;H332:1;H302:1;H335:1;H315:1
123290,2-Chloro-1-methyl-4-(methylsulfonyl)-benzene,465-910-6,1671-18-7,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,92,H411:92;H317:92;Not classified:3
123294,"2-bromo-1,3,4,5-tetrafluorobenzene",216-325-8,1559-86-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H226:38;H319:38;H315:38;H335:38
123296,"1,3,5-triazine-2,4,6-triamine 4-methylbenzenesulfonate (1:1)",605-959-4,182166-24-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H319:1;H335:1;H315:1
123297,p-tolylacetic acid,210-738-7,622-47-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
123299,Ethyl β-oxopyrazinepropionate,263-421-0,62124-77-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
123300,N-acetyl-L-tryptophan,214-935-9,1218-34-4,,Notified C&L,1,H302:1
123303,"5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt",418-380-5,168113-78-8,Eye Dam. 1,Harmonised C&L,0,H318:0
123304,"Phosphorothioic acid, O-[[]1-(4-chlorophenyl)-1H-pyrazol-4-yl] O-ethyl S-propyl ester",618-301-6,89784-60-1,Acute Tox. 3,Notified C&L,38,H301:38
123311,"Reaction mass of 1-Ethyl-6-hydroxy-5-(4-alkoxy-2-nitro-phenylazo)-4-alkyl-2-substituted-1,2-dihydro-pyridine- 3-carbonitrile and 6-Hydroxy-1-(3-isoalkoxy-alkyl)-5-(4-alkoxy-2-nitro-phenylazo)-4-alkyl-2-substituted-1,2- dihydropyridine-3-carbonitrile",419-330-5,,Not Classified,REACH registration C&L,1,Not classified:1
123315,Oxalyl dichloride,201-200-2,79-37-8,Water-react. 1;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,REACH registration C&L,411,H331:394;H301:205;H314:411;H260:291;H335:136;H318:161;H330:14;H302:9;Not classified:2;H420:3;H312:2;H290:2;H311:2;H332:2;H351:1
123323,"2-methylbuta-1,3-diene-1,4-diyl diacetate",273-419-1,68963-18-8,Flam. Liq. 3;Aquatic Chronic 4,Notified C&L,1,H413:1;H226:1
123325,Trifluoromethanesulfonic acid 2-fluoro-4-pentylphenyl ester,925-557-5,,Not Classified,Notified C&L,1,Not classified:1
123326,"2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;pyrethrin II",204-462-6,121-29-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H332:0;H302:0;H312:0;H410:0
123328,C.I. Acid Brown 289,602-002-2,12219-72-6,,Notified C&L,1,H319:1;H315:1
123329,"Hydrocarbons, C6-C10, n-alkanes, isoalkanes, > 5% n-hexane",920-191-2,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,1,H304:1;H315:1;H336:1;H373:1;H411:1;H361:1;H225:1
123334,"O,O-dibutyl hydrogen thiophosphate, compound with 1-octylamine (1:1)",300-947-2,93964-99-9,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,2,H315:2;H318:2;H317:2
123335,"Slags, lead smelting",273-825-9,69029-84-1,Carc. 1B;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,10,H362:10;H400:10;H372:10;H411:10;H360:10;H350:10
123338,"Soybean oil, deodorizer distillate",272-211-8,68783-88-0,Not Classified,REACH registration C&L,2,Not classified:2
123339,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with butane-1,3-diol, 2,4'-diisocyanatodiphenylmethane, [(methylethylene)bis(oxy)]dipropanol and propane-1,2-diol",500-312-1,123714-19-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,25,H317:25;H334:25
123340,"Hydrocarbons, C10-C12, isoalkanes, <2% aromatics",923-037-2,,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 2,REACH registration C&L,16,H304:16;H413:15;H226:16;H411:16
123342,"Tetraphenylphosphonium trihydrogen bis(o,o'-xynaphthalenediolato)",484-430-8,502157-73-5,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,2,H411:2;H318:2;H317:2;H302:2
123345,Yttrium trihydroxide,240-520-7,16469-22-0,Not Classified,Notified C&L,3,Not classified:3
123347,4-nitrobenzamidine hydrochloride,239-817-4,15723-90-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3;H332:1;H302:1;H312:1
123348,Tetraammineplatinum dichloride,237-706-5,13933-32-9,Met. Corr. 1;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,101,H319:17;H315:15;H290:10;H412:6;H317:85;H335:8;H334:2;H318:1
123349,"N,N-diethyl-m-phenetidine",217-469-4,1864-92-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
123353,"2-Cyclopentene-1-acetic acid, 3-(acetyloxy)-2-pentyl-, methyl ester",611-517-1,57374-49-9,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,10,H411:10;H317:10
123354,Abietic acid,208-178-3,514-10-3,Not Classified,Notified C&L,215,Not classified:131;H400:54;H319:84;H335:83;H315:84;H410:15;H413:1;H317:1
123356,"Poppy, Papaver rhoeas, ext.",283-651-5,84696-43-5,Flam. Liq. 3,Notified C&L,2,H226:2
123358,"2-Bromo-N,N-dimethylaniline",615-013-2,698-00-0,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H319:43;H400:38;H331:38;H301:38;H410:38;H351:38;H311:38;H373:38;H332:4;H302:4;H312:4;H315:5;H314:1
123360,2-mercapto-N-2-naphthylacetamide,202-245-0,93-42-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,38,H411:38;H335:38;H315:38;H318:38
123361,Indium chloride,236-693-3,13465-10-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H335:38;H315:38;H314:4
123364,Trisodium 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophenylazo)pyrazole-3-carboxylate,217-699-5,1934-21-0,Not Classified,REACH registration C&L,3629,Not classified:2524;H317:1103;H334:982;H411:1;H412:1;H361:1
123365,"Fatty acids, tall-oil, reaction products with pentaethylenehexamine",288-927-9,85940-40-5,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,90,H319:89;H411:88;H315:2;H317:1;H400:1;H318:1;H410:1
123366,6-amino-m-toluic acid,220-932-3,2941-78-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H335:49;H315:50
123369,Quinolin-4-ol,210-268-2,611-36-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
123372,"4-aminopyrazolo[3,4-d]pyrimidine",243-691-6,20289-44-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,40,H319:40;H331:38;H315:40;H301:40;H335:39;H311:38
123375,5-methoxybenzothiazole-2(3H)-thione,259-755-1,55690-60-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
123377,4-bromo-2-nitroanisole,251-642-5,33696-00-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:5;H335:4;H315:5
123391,"1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one, compound with 2,2,2-trichloroethane-1,1-diol (1:2)",207-546-0,480-30-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H302:1
123392,Lanthanum trihydroxide,238-510-2,14507-19-8,Not Classified,REACH registration C&L,52,Not classified:5;H314:43;H318:43;H319:4;H335:4;H315:4
123393,"Benzene, 1-iodo-4-pentyl-",617-654-3,85017-60-3,,Notified C&L,4,H319:4;H315:4
123395,"3,5,6-trimethylcyclohex-3-ene-1-carbaldehyde",266-810-3,67634-07-5,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,113,H319:113;H317:113;H412:113
123398,"3-hydroxy-2-methoxyestra-1,3,5(10)-trien-17-one",206-645-6,362-08-3,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H351:38;H400:38;H410:38
123400,4-(trans-4-Ethylcyclohexyl)benzoic Acid,618-034-5,87592-41-4,Acute Tox. 4,Notified C&L,2,Not classified:1;H302:1;H319:1;H315:1
123405,DL-2-(3-trifluoromethyl)phenylglycollic acid,206-484-1,349-10-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
123409,Lead molybdate,233-459-2,10190-55-3,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:42;H332:42;H302:42;H410:42;H360:42;H373:42
123412,Tin bis(tetrafluoroborate),237-487-6,13814-97-6,Met. Corr. 1;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,78,H319:74;H290:17;H317:17;H302:17;H315:57;H314:4
123413,1-methylethylene 2-ethylhexanoate,301-185-3,93981-97-6,Not Classified,Notified C&L,3,Not classified:3
123415,Indole-3-carboxylic acid,212-231-6,771-50-6,,Notified C&L,10,H319:9;H335:8;H315:9;H302:4;H312:2
123416,(p-iodophenoxy)acetic acid,217-531-0,1878-94-0,,Notified C&L,5,H319:5;H335:4;H315:5
123427,Chlorbufam,217-815-4,1967-16-4,Aquatic Chronic 2,Notified C&L,41,H411:38;Not classified:3
123428,"Silicic acid (H4SiO4), tetraethyl ester, reaction products with bis(acetyloxy)dibutylstannane",300-344-4,93925-42-9,Flam. Liq. 3;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT SE 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,33,H372:4;H370:4;H332:4;H302:4;H318:3;H226:31;H412:1;H319:29;H341:5;H315:2;H301:2;H411:2;H360:5;H400:1;H410:2;H317:1;H314:2;H413:1
123429,"Potassium sodium (R*,R*)-(±)-tartrate",205-698-2,147-79-5,Not Classified,Notified C&L,3,Not classified:3
123431,3-methylpiperidin-2-one,223-196-1,3768-43-2,,Notified C&L,2,H319:2;H332:2;H302:2;H312:2;H315:2;H335:2
123433,2-methyl-p-phenylenediamine sulphate,228-871-4,6369-59-1,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H312:0;H301:0;H411:0;H317:0
123435,2-bromobiphenyl,218-141-3,2052-07-5,Not Classified,REACH registration C&L,31,Not classified:2;H319:29;H335:29;H315:29;H410:26
123441,(4-methylphenoxy)acetic acid,213-374-7,940-64-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45;H302:2
123442,Nocodazole,250-626-5,31430-18-9,Muta. 2;Repr. 2,Notified C&L,45,H361:44;H341:44;H319:2;H332:1;H302:1;H312:1;H315:2;H335:2;H351:1;H360:1
123444,Magnesium sulphite,231-825-6,7757-88-2,Not Classified,Notified C&L,1,Not classified:1
123447,"Methyl 2,3,3-trifluoroacrylate",206-875-7,392-41-6,,Notified C&L,2,H319:2;H335:2;H315:2
123451,2-butoxyethyl acetate;butylglycol acetate,203-933-3,112-07-2,Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H312:0;H332:0
123452,Ammonium bis(2-ethylhexyl) phosphate,225-615-3,4971-47-5,Eye Dam. 1,Notified C&L,86,H318:84;Not classified:1;H302:1
123456,"Benzoic acid, 4-methoxy-, 1,1'-(1,6-hexanediyl) ester",609-608-6,390359-18-9,Not Classified,Notified C&L,3,Not classified:3
123457,"1,3-dihydro-6-methylfuro[3,4-c]pyridin-7-ol hydrochloride",213-741-1,1006-21-9,,Notified C&L,1,H302:1
123459,"4,6-dimethoxysalicylic acid",221-683-3,3187-19-7,,Notified C&L,5,H319:5;H335:5;H315:5
123461,α-fluorocinnamic acid,206-508-0,350-90-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
123464,"2-bromo-1,2-benzisothiazol-3(2H)-one 1,1-dioxide",252-737-4,35812-01-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
123467,"3-α,12-α-dihydroxy-5-β-cholan-24-oic acid",201-478-5,83-44-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:41;H335:40;H315:41;H302:48
123471,"7-methoxy-2,2-dimethylchromene",241-566-0,17598-02-6,Acute Tox. 4,Notified C&L,38,H302:38
123481,"N-amidino-3,5-diamino-6-chloropyrazinecarboxamide",926-801-3,,Not Classified,REACH registration C&L,1,Not classified:1
123494,"2,2-dichloroethane-1,1-diol",240-238-4,16086-14-9,Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H314:2;H318:2
123499,Hexadecanoic anhydride,210-805-0,623-65-4,Skin Corr. 1B,Notified C&L,63,H314:63;H290:21;H318:1
123500,"Lead alloy, base, Pb,Sn, dross",273-701-4,69011-60-5,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Carc. 1A;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,14,H362:14;H372:14;H400:14;H302:14;H411:14;H318:14;H317:14;H360:14;H350:14;H341:7;H331:7;H315:7
123501,"Polygonum aviculare, ext.",283-280-9,84604-04-6,Not Classified,Notified C&L,1,Not classified:1
123502,Tetramethylammonium fluoride tetrahydrate,206-769-0,373-68-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,63,H319:63;H332:40;H302:41;H312:40;H315:63;H335:40
123503,Sodium 3-[[4-[(2-ethoxy-5-methylphenyl)azo]-1-naphthyl]azo]benzenesulphonate,273-386-3,68959-00-2,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,62,H411:3;H315:3;H412:38;Not classified:19;H413:2
123505,"1,2,4-Benzenetricarboxylic acid, mixed hexyl and octyl triesters",290-755-4,90218-77-2,Not Classified,Notified C&L,1,Not classified:1
123510,Borated lecithin,414-430-5,,Not Classified,Notified C&L,442,Not classified:442
123514,"Aromatic hydrocarbons, C",295-279-0,91995-18-5,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
123515,2-(1-mercapto-1-methylethyl)-5-methylcyclohexan-1-one,253-953-1,38462-22-5,Skin Sens. 1,Notified C&L,1547,H317:1462;Not classified:40;H400:39;H301:39;H319:7;H335:5;H315:7;H351:1;H302:1
123524,Protirelin,246-143-4,24305-27-9,Acute Tox. 4,Notified C&L,17,H332:16;H360:1
123525,Chloro(3-chloropropyl)dimethylsilane,234-234-1,10605-40-0,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,41,H400:1;H302:1;H410:1;H318:2;H314:41;H226:1;H290:1
123526,2-(2-aminoethoxy)ethanol,213-195-4,929-06-6,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,952,H314:942;H318:738;H290:442;H312:48;H302:22;H371:20;H373:20;H315:1
123531,"Eucalyptus globulus, ext.",283-406-2,84625-32-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,2013,H304:1991;H315:385;H411:1806;H317:1992;H226:1983;Not classified:16;H400:1;H410:1;H319:4;H335:1;H228:1
123534,tert-butyllithium,209-831-5,594-19-4,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,71,H260:71;H314:71;H250:71;H318:1;H304:4;H336:4;H411:4
123535,2-Bromo-1-(3-chloro-phenyl)-ethanone,609-883-2,41011-01-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H335:38;H315:38;H314:2;H318:1
123536,Acetoxytri-tert-butoxysilane,241-875-0,17947-85-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,13,H314:13;H318:13
123539,(2-hydroxyethyl)ammonium hydrogen tartrate,241-567-6,17598-15-1,Not Classified,Notified C&L,1,Not classified:1
123540,"Benzenesulfonic acid, mono-C10-13-alkyl derivs., potassium salts",287-337-9,85480-57-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,40,H315:40;H318:40;H302:40
123541,"Glycerides, soya mono- and di-, 2,3-bis(acetyloxy)butanedioates",293-243-9,91052-81-2,Not Classified,Notified C&L,2,Not classified:2
123549,(S)-2-amino-N-(2-naphthyl)-3-phenylpropionamide,212-009-9,740-57-8,Carc. 1A,Notified C&L,1,H350:1
123551,"1,3,3-trimethyl-2-[(2-methyl-3H-indol-3-ylidene)ethylidene]indoline monohydrochloride",221-290-7,3056-93-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H312:38;H315:38;H335:38
123552,Indole-3-pyruvic acid monohydrate,206-874-1,392-12-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
123553,"Fatty acids, C5-9, hexaesters with dipentaerythritol",267-021-7,67762-52-1,Not Classified,REACH registration C&L,584,Not classified:472;H319:60;H315:60;H302:52
123555,"2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol (2E)-but-2-enedioate (2:1) (salt)",601-143-7,111974-69-7,Acute Tox. 4;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,2,H335:1;H412:1;H318:1;H302:2;H400:1
123556,Methapyrilene,202-099-8,91-80-5,Acute Tox. 3,Notified C&L,38,H301:38
123558,Tetrahydro-4-methyl-2H-pyran,225-207-5,4717-96-8,Flam. Liq. 2,REACH registration C&L,95,H225:95;H314:2;H318:4;H302:2;H315:2;H335:1
123560,2-hydroxyethyl salicylate,201-737-2,87-28-5,Acute Tox. 4,Notified C&L,48,H302:48;H411:1;Not classified:2;H335:1
123561,5-fluoro-1H-indole-3-acetic acid,207-138-2,443-73-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:41;H315:41
123562,"Trisodium [μ-[7-[[4'-[[6-benzamido-1-hydroxy-3-sulpho-2-naphthyl]azo]-3,3'-dihydroxy[1,1'-biphenyl]-4-yl]azo]-8-hydroxynaphthalene-1,6-disulphonato(7-)]]dicuprate(3-)",278-132-5,75214-64-1,Not Classified,Notified C&L,37,Not classified:37
123565,Sodium [N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxymethyl)glycinato(3-)]magnesate(1-),269-966-0,68391-61-7,Not Classified,Notified C&L,1,Not classified:1
123566,4-acetyl-1-(beta-D-ribofuranosyl)cytosine,223-195-6,3768-18-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:2;H332:2;H302:2
123568,5-methoxy-2-phenyl-4-benzopyrone,255-652-0,42079-78-7,,Notified C&L,4,H319:4;H335:4;H315:4
123569,"Hydrocarbons, C10-C13, n-alkanes, isoalkanes, cyclics, aromatics (2-25%)",919-164-8,,Asp. Tox. 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,12,H304:12;H372:12;H412:12
123572,Potassium metaphosphate,232-212-6,7790-53-6,Not Classified,Notified C&L,55,Not classified:55
123580,Toluidine,248-105-2,26915-12-8,,Notified C&L,33,Not classified:33
123581,Tetrahydro-α-pentylfurfuryl acetate,266-811-9,67634-08-6,Not Classified,Notified C&L,88,Not classified:88
123583,6-phenyluracil,236-393-2,13345-09-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H302:1;H312:1;H315:1;H335:1
123584,Bretylium tosilate,200-516-8,61-75-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
123586,Bupivacaine,218-553-3,2180-92-9,Acute Tox. 2;Acute Tox. 1;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2,Notified C&L,1,H310:1;H330:1;H300:1;H315:1;H318:1
123588,"2,2'-dithiodi(acetic) acid",208-019-8,505-73-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
123590,Sodium bis(2-ethylhexyl)dithiocarbamate,304-426-0,94266-20-3,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H317:1;H412:1
123592,"2,2'-diallyl-4,4'-sulfonyldiphenol",411-570-9,41481-66-7,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
123596,Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole- 5-carboxylate,604-434-7,144689-93-0,Not Classified,REACH registration C&L,5,Not classified:3;H319:1;H335:1;H315:1;H411:1;H317:1
123598,"Disodium hydrogen 4-[[5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-2-sulphonatophenyl]azo]-4,5-dihydro-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazole-3-carboxylate",238-599-8,14552-81-9,Not Classified,Notified C&L,1,Not classified:1
123602,2-chloropropionitrile,216-570-0,1617-17-0,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,39,H319:39;H331:39;H315:39;H301:39;H335:39;H311:39;H226:39
123603,Phenylbutazone calcium,274-335-8,70145-60-7,Acute Tox. 4,Notified C&L,2,H302:2
123604,"Dichloro(1,1-dimethylethyl)methylsilane",242-034-0,18147-18-7,,Notified C&L,1,H226:1;H314:1
123607,2-(4-chloro-3-nitrobenzoyl)benzoic acid,201-613-8,85-54-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
123608,Gadolinium telluride,235-294-1,12160-99-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
123610,"α-hydroxy-β,β-dimethyl-γ-butyrolactone",209-963-3,599-04-2,Eye Irrit. 2,REACH registration C&L,90,H319:89;H302:4;Not classified:1
123612,"Pentasodium 2-phosphonatobutane-1,2,4-tricarboxylate",266-595-6,67170-90-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
123615,"5-methyl-2-(1-methylbutyl)-5-propyl-1,3-dioxane",279-482-1,80480-24-6,Aquatic Chronic 2,REACH registration C&L,127,H411:2;H315:125;H412:125
123616,"4,4'-Isopropylidendiphenol, Polymer Mit 2,2-Bis(p-(2,3-Epoxypropoxy)Phenyl)Propan",607-500-3,25036-25-3,Skin Sens. 1,Notified C&L,1657,H317:1621;H319:1030;H315:539;H411:131;Not classified:36;H335:26;H332:1;H400:2;H412:1
123626,Dicyclohexylammonium nitrate,223-411-9,3882-06-2,Not Classified,Notified C&L,24,Not classified:24
123630,alfa-metil-6-metossi-N-[(1-idrossi)-butil]-2-naftaleneacetamide,619-411-7,99231-32-0,Acute Tox. 4,Notified C&L,1,H302:1
123633,"Fatty acids, C18-unsatd., dimers, hydrogenated, 2-ethylhexyl esters",500-214-9,68440-06-2,Not Classified,REACH registration C&L,25,Not classified:25
123636,"p-[4,5-dihydro-3-methyl-4-[[4-methyl-3-[(phenylamino)sulphonyl]phenyl]azo]-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid",247-224-7,25739-67-7,Not Classified,Notified C&L,2,Not classified:2
123637,"2-ethylhexyl 6,6-dibutyl-14-ethyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadeca-2,9-dienoate",239-595-9,15546-12-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H302:1;H312:1;H315:1;H373:1;H412:1
123639,"2-Propen-1-amine, N-2-propenyl-, hydrochloride",612-154-1,6147-66-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:39;H302:39
123640,"1',3'-dihydro-5'-methoxy-1',3',3'-trimethyl-6-nitrospiro[2H-1-benzopyran-2,2'-[2H]indole]",240-405-1,16331-96-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
123643,N-methylmethanesulfonamide,423-930-2,,Carc. 1B,Notified C&L,2,H350:1;Not classified:1
123644,Tertiarybutylphosphine,607-486-9,2501-94-2,Pyr. Liq. 1;Skin Corr. 1B;Acute Tox. 2,Notified C&L,39,H330:38;H314:38;H250:38;H319:1;H224:1;H304:1;H335:1;H315:1;H411:1;H361:1
123648,2-hydroxybenzimidazole,210-412-4,615-16-7,Acute Tox. 4,Notified C&L,35,H302:34;H319:3;H332:1;H312:1;H315:3;H335:3
123649,21-hydroxy-20-methylpregn-4-en-3-one,262-543-1,60966-36-1,Carc. 2;Repr. 1A;Lact.,REACH registration C&L,2,H351:2;H360:2;H362:2
123650,"Benzenesulfonic acid, 2-[(4-aminophenyl)amino]-5-nitro-, diazotized, coupled with diazotized 4-aminobenzenesulfonic acid, diazotized 4-nitrobenzenamine and Dyer's mulberry extract",305-546-6,94645-51-9,Not Classified,Notified C&L,1,Not classified:1
123652,S-methyl chlorothioformate,242-244-2,18369-83-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,38,H332:38;H302:38;H312:38;H226:38;H314:38
123653,chloromethyl propan-2-yl carbonate,439-370-7,35180-01-9,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,4,H411:2;H315:3;H317:2;H319:1;H332:1;H302:1;H312:1;H335:1;H226:1;H314:1
123654,Ethyl butyrate,203-306-4,105-54-4,Flam. Liq. 3;Eye Irrit. 2,REACH registration C&L,1945,H226:1938;H319:90;H315:53;H335:52;Not classified:6;H411:1;H312:1
123661,"2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-.sc.l.sc.-valinate",424-660-8,,Eye Dam. 1;Skin Sens. 1;STOT RE 2,Harmonised C&L,0,H317:0;H373:0;H318:0
123677,Methylheptenone,206-990-2,409-02-9,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2,Notified C&L,1585,H319:1583;H302:1321;H315:1325;H317:1350;H226:1556;Not classified:1
123678,"5,9-dimethyl-4,9-decadienal",272-446-6,68844-98-4,Not Classified,Notified C&L,52,Not classified:52
123679,Disodium (tetrapropenyl)succinate,301-848-7,94086-60-9,Skin Corr. 1B,Notified C&L,32,H314:25;H319:7;H315:7
123682,"2-isopropyl-N,2,3-trimethylbutyramide",256-974-4,51115-67-4,Acute Tox. 4,REACH registration C&L,1433,H302:1397;Not classified:36;H319:26;H332:4
123685,1-chloropropan-2-ol,204-819-6,127-00-4,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,69,H319:69;H332:63;H302:64;H315:69;H335:68;H226:69;H341:4;H330:4;H312:4;H331:2;H301:2;H311:1
123687,"fenarimol (ISO);2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol",262-095-7,60168-88-9,Lact.;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H362:0;H361:0;H411:0
123690,"Phenol, 4-[(4-amino-3-methylphenyl)amino]-, reaction products with sodium sulfide (Na2(Sx)), leuco derivatives",274-211-3,69900-21-6,Not Classified,Notified C&L,38,Not classified:38
123693,"4,4'-methylenediphenol",210-658-2,620-92-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,113,H319:88;H335:87;H315:88;H412:52;H411:14;H318:14;H317:15;Not classified:5
123696,"Distillates (petroleum), intermediate catalytic cracked;Cracked gasoil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-062-5,64741-60-2,Carc. 1B,Harmonised C&L,0,H350:0
123699,Ethyl diethoxyphosphinylformate,216-016-8,1474-78-8,Not Classified,REACH registration C&L,7,Not classified:2;H317:4;H319:1;H315:1
123702,"2,3,5,6-Tetrafluorobenzoic Acid",435-890-3,652-18-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
123703,"Bis[5-[[4-[benzylmethylamino]phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium] tetrachlorozincate(2-)",281-692-3,84012-52-2,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,14,H411:4;H318:13;H302:14;H412:10
123706,"Sodium 4-chloro-3-[4-[[2-(2,4-dichlorophenoxy)phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",282-076-7,84083-28-3,Not Classified,Notified C&L,18,Not classified:9;H315:8;H317:1;H334:1
123707,Dilutetium tricarbonate,227-586-2,5895-53-4,Not Classified,Notified C&L,6,Not classified:6
123708,Sucrose tristearate,248-731-6,27923-63-3,Not Classified,Notified C&L,32,Not classified:32
123710,"Propane-1,3-diylbis(diphenylphosphine)",229-791-2,6737-42-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,122,H319:122;H400:71;H302:71;H335:121;H315:122;H410:72;H317:71;Not classified:1;H413:1
123711,"Okadaic acid, sodium salt",606-670-6,209266-80-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Acute Tox. 3,Notified C&L,39,H331:39;H311:39;H315:39;H301:39
123713,"9,10-didehydro-6-methylergoline-8β-methanol",210-024-5,602-85-7,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H300:38;H331:1;H311:1;H301:1
123715,"3,5-dimethyl-4-hydroxybenzonitrile",619-915-7,4198-90-7,Acute Tox. 2;Eye Irrit. 2,Notified C&L,45,H319:45;H300:39;H335:5;H315:6;H302:5;H331:1;H301:1;H311:1
123717,O-benzyl-N-tert-butoxycarbonyl-L-threonine,239-304-5,15260-10-3,,Notified C&L,1,Not classified:1
123718,"3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctanesulphonic acid",248-580-6,27619-97-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT RE 2,REACH registration C&L,129,H314:54;H373:92;H318:126;H302:112
123719,"Hydroxamic acids, coco, potassium salts",297-858-3,93763-39-4,Not Classified,Notified C&L,51,Not classified:51
123720,C.I. Reactive Orange 96,618-589-3,90597-78-7,Not Classified,Notified C&L,1,Not classified:1
123721,"(4S)-(+)-4-PHENYL-1,3-OXAZOLIDIN-2-ONE",619-429-5,99395-88-7,Acute Tox. 4,Notified C&L,13,H302:11;H319:2;H335:2;H315:2
123723,"Fatty acids, coco, compds. with diethanolamine",263-153-4,61790-63-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,497,H319:451;H315:495;H302:447;H318:28;Not classified:2;H373:1
123727,Dodecairon strontium nonadecaoxide,234-685-4,12023-91-5,Not Classified,REACH registration C&L,64,Not classified:62;H319:2
123731,Hexadec-1-yne,211-106-3,629-74-3,Asp. Tox. 1,Notified C&L,1,H304:1
123733,"4-hydroxy-3,5-dimethoxyphenylacetic acid",224-494-4,4385-56-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,45,H319:45;H302:39;H335:5;H315:6
123745,Carbenoxolone disodium,231-044-0,7421-40-1,Eye Irrit. 2,Notified C&L,38,H319:38
123746,5-chloro-2-methoxybenzenediazonium,249-780-6,29684-42-2,Not Classified,Notified C&L,1,Not classified:1
123748,"N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine",435-010-8,26157-73-3,Muta. 2;Aquatic Chronic 3,Harmonised C&L,0,H341:0;H412:0
123750,2-(2-nonylphenoxy)ethanol; phosphoric acid,610-741-7,51811-79-1,Skin Corr. 1C,Notified C&L,456,H314:328;H318:242;H315:128;H413:31;H319:19;H412:5;H411:1;H400:1;H301:1
123755,"3,4,5-Trifluorphenol",619-451-5,99627-05-1,Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,45,H411:43;H314:45;H301:42;H312:6;H332:2;H302:2;H318:1;Not classified:1
123756,Miconazole,245-324-5,22916-47-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,257,H410:212;H400:212;H302:255;H413:39;Not classified:1;H361:1;H301:1;H317:1;H334:1
123757,"Epoxides, C10-12-alkyl, reaction products with diethanolamine",307-735-9,97721-88-5,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,28,H411:28;H314:28;H318:28
123758,Linalool oxide,215-723-9,1365-19-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1719,H319:1697;H302:1716;H315:430;Not classified:2;H312:1;H317:1
123759,2-(4-tert-butylbenzyl) propionaldehyde,201-289-8,80-54-6,Repr. 1B,Harmonised C&L,0,H360:0
123760,4-methoxysalicylic acid,218-801-0,2237-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
123761,"[2-[1,1-dimethyl-2-[(1-oxoallyl)oxy]ethyl]-5-ethyl-1,3-dioxan-5-yl]methyl acrylate",289-312-8,87320-05-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,25,H319:23;H335:13;H315:24;Not classified:1
123763,Cerium(3+) acetate,208-654-0,537-00-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,57,H400:4;H410:4;H319:40;H335:44;H315:45;Not classified:7;H318:6;H411:1
123767,"5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one",400-680-2,98181-47-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H332:0;H410:0
123772,2-methyl-2-nitropropan-1-ol,200-957-6,76-39-1,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,57,H319:57;H302:57;H412:56;H335:1;H315:1
123775,"amitraz (ISO);N,N-bis(2,4-xylyliminomethyl) methylamine",251-375-4,33089-61-1,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0;H317:0;H373:0
123780,"1-Azabicyclo[3.2.2]nonan-3-ol, 6-ethenyl-2-(4-quinolinyl)-, (1S,2S,3R,5S,6R)-",611-345-7,560119-44-0,Acute Tox. 4,Notified C&L,38,H302:38
123783,Hexadec-1-ene,211-105-8,629-73-2,Asp. Tox. 1,REACH registration C&L,849,H304:688;H319:91;Not classified:72;H335:20;H336:10
123790,Calcium glycinate (1:2),252-809-5,35947-07-0,Not Classified,REACH registration C&L,2,Not classified:2
123791,"3,5-Dimethoxybenzyl Bromide",618-071-7,877-88-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H314:39;H318:39;H290:1
123800,"2-Butyne-1,4-diol, reaction products with epichlorohydrin and sodium sulfite",272-538-6,68876-97-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,56,H319:56;H315:56
123804,"Tetrasodium 5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulphonato-1-naphthyl]azo]-2,5-dimethylphenyl]azo]naphthalene-1,3,6-trisulphonate",274-414-7,70210-17-2,Not Classified,Notified C&L,2,Not classified:2
123807,ETHOXYLATED NONYL PHENOL ACRYLATE,614-163-6,678991-31-6,Skin Irrit. 2;Skin Sens. 1,Notified C&L,67,H315:67;H317:47;H319:20
123811,Disodium silicate,239-476-1,15457-97-3,Not Classified,Notified C&L,1,Not classified:1
123812,4-fluoropropiophenone,207-255-9,456-03-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,48,H335:46;H315:48;H318:39;H302:39;H319:9
123813,Ethyl cyanoacetate,203-309-0,105-56-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,233,H312:55;H332:54;H302:52;Not classified:172;H319:6;H315:3;H331:1
123814,"Hydrocarbons, C4, 1,3-butadiene-free, polymd., triisobutylene fraction, hydrogenated",297-629-8,93685-81-5,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 4,REACH registration C&L,719,H304:683;H413:135;H226:682;Not classified:37;H315:2
123816,"9-chloro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-propionate",226-888-1,5534-18-9,,Notified C&L,1,H341:1;H302:1
123819,"1,2-Benzisoxazole-3-acetic Acid",610-430-6,4865-84-3,Acute Tox. 4,Notified C&L,40,H302:39;H319:2;H315:2;H335:1
123826,"2,3,6aα,9aα-tetrahydro-4-methoxycyclopenta[c]furo[2',3':4,5]furo[2,3-h]chromene-1,11-dione",214-603-3,1162-65-8,Acute Tox. 1;Acute Tox. 1;Acute Tox. 2;Muta. 1B;Carc. 1B,Notified C&L,43,H310:42;H330:43;H300:43;H340:39;H350:43;H360:1
123827,dimefox (ISO);tetramethylphosphorodiamidic fluoride,204-076-8,115-26-4,Acute Tox. 2;Acute Tox. 1,Harmonised C&L,0,H310:0;H300:0
123830,"2,4-dichloro-6-pyren-1-yl-1,3,5-triazine",221-754-9,3224-36-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H400:38;H335:38;H315:38;H301:38;H410:38
123831,"9,10-Anthracenedione, 4-[[4-(1,1-dimethylethyl)phenyl]amino]-5-hydroxy-1-[(1-methylethyl)amino]-",617-652-2,85011-89-8,Not Classified,Notified C&L,9,Not classified:9
123832,nickel di(acetate),206-761-7,373-02-4,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H372:0;H332:0;H302:0;H400:0;H334:0;H410:0;H317:0;H360:0;H350:0
123834,(Trimethylsilyl)diazomethane,605-915-4,18107-18-1,Acute Tox. 2;Carc. 1B;STOT SE 1,Notified C&L,43,H370:38;H330:38;H350:38;H331:5;H304:4;H315:5;H336:4;H373:5;H411:5;H361:4;H225:5
123838,Carbonylchlorobis(triphenylphosphine)rhodium,237-712-8,13938-94-8,,Notified C&L,7,H312:4;H332:4;H302:5;H319:2;H315:2;H335:1;H413:1
123839,2-methyl-1H-indole-3-carbaldehyde,226-512-6,5416-80-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41;H302:38
123840,"4,4'-bipyridinium dichloride",248-732-1,27926-72-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,39,H319:39;H331:38;H315:39;H301:38;H335:39;H311:38
123843,2-methylbutyl butyrate,256-973-9,51115-64-1,Flam. Liq. 3,Notified C&L,571,H226:398;Not classified:135;H319:39;H335:39;H315:39
123846,"vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped",407-350-7,,Eye Dam. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H411:0;H373:0;H318:0
123848,"Alkanes, C9-11-iso-",271-365-3,68551-16-6,Asp. Tox. 1,Notified C&L,183,H304:144;H336:56;H226:18;H225:14;Not classified:1;H335:1
123849,"N-[3-(dimethylamino)propyl]-3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctanesulphonamide N-oxide",279-481-6,80475-32-7,STOT RE 2;Aquatic Chronic 2,REACH registration C&L,50,H411:49;H373:2;Not classified:1
123850,Pyrrolnitrin,213-812-7,1018-71-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,127,H319:127;H335:127;H315:127
123853,"Gases (petroleum), catalytic cracked naphtha debutanizer;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",273-169-3,68952-76-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H340:0;H350:0;H220:0
123856,"4-Nonylphenol, branched, ethoxylated",500-315-8,127087-87-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,2133,H411:1328;H315:1424;H318:988;H319:988;H302:858;H400:162;H410:163;H361:181;H373:156;Not classified:100;H332:231;H312:68;H412:67;H335:12;H317:12;H371:1
123859,"3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol",605-757-6,175591-23-8,Not Classified,Notified C&L,2,Not classified:1;H361:1;H411:1;H302:1
123878,Mepiquat,604-881-8,15302-91-7,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,89,H412:89;H302:89
123887,"Octadecanoic acid, ester with 1,2,3-propanetriol",234-325-6,11099-07-3,Not Classified,Notified C&L,71,Not classified:71
123888,1-ethylazepan-2-one,606-384-1,19797-08-1,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,2,H332:2;H318:1;H302:2;H319:1;H312:1;H315:1
123891,Dimethyl methoxymalonate,225-697-0,5018-30-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
123894,"2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide",408-150-2,99141-89-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
123895,4-hydroxybutyl methacrylate,213-642-3,997-46-6,Not Classified,Notified C&L,1,Not classified:1
123899,Tetraethyl orthocarbonate,201-082-2,78-09-1,Flam. Liq. 3,REACH registration C&L,52,H226:51;H319:3;H315:3;H335:2;Not classified:1
123901,"2-bromo-1-(2,4-dimethoxyphenyl)ethan-1-one",262-542-6,60965-26-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:39;H335:39;H315:39;H314:5;H290:1;H318:1
123902,"Oxo[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]vanadium",237-700-2,13930-88-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:39;H335:43;H315:39;Not classified:1;H312:1;H332:1;H302:1
123907,m-bromobenzohydrazide,254-298-4,39115-96-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:42;H315:43;H312:1;H332:1;H302:1
123912,"4-tert-butyl-2,6-dinitrochlorobenzene",218-672-0,2213-81-2,Not Classified,REACH registration C&L,2,Not classified:2
123917,4-(dimethylamino)benzophenone,208-478-4,530-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
123918,"2-(3,6-dihydroxy-2,4,5,7-tetrabromoxanthen-9-yl)-benzoic acid",239-138-3,15086-94-9,Acute Tox. 4,Notified C&L,56,H302:37;Not classified:18;H317:1
123920,"Fatty acids, C12-18 and C18-unsatd., reaction products with triethanolamine",292-859-5,91001-85-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H319:4;H315:4;Not classified:2
123926,Ammonium manganese(3+) diphosphate,233-257-4,10101-66-3,Not Classified,REACH registration C&L,100,Not classified:100
123927,"2,2'-[(1-methylethylidene)bis(cyclohexane-4,1-diyloxymethylene)]bisoxirane, oligomeric reaction products with 3-aminopropyltriethoxysilane",921-623-2,,Not Classified,Notified C&L,1,Not classified:1
123928,"Tris[4,4'-thiobis[3-methyl-6-tert-butylphenol]]phosphite",252-983-2,36339-47-6,Not Classified,Notified C&L,5,Not classified:5
123929,Epithioethane,206-993-9,420-12-2,Flam. Liq. 2;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3,Notified C&L,40,H331:39;H301:40;H225:40;H318:39;H319:1;H330:1
123934,"4,8-dimethylnona-3,7-dien-2-ol",267-321-8,67845-50-5,Not Classified,Notified C&L,113,Not classified:113
123941,"Hydrogen trifluoromethoxyborate(1-), compound with methanol (1:1)",220-543-9,2802-68-8,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3;STOT SE 1;STOT RE 1,REACH registration C&L,89,H372:85;H331:85;H370:85;H302:85;H311:89;H318:85;H314:89;H301:4;H330:4
123947,"6 alpha-Fluoro-11 beta-hydroxy-16 alpha-methyl-21-valeryloxy-1,4-pregnadiene-3,20-dione",609-203-4,36130-02-6,Acute Tox. 3;Repr. 1A;STOT RE 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H360:1;H372:1;H301:1
123948,2-isopropyl-5-methylcyclohexyl 2-methylbut-2-enoate,267-144-6,67801-23-4,Not Classified,Notified C&L,88,Not classified:88
123954,Prostaglandins,234-237-8,11000-26-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
123965,"Phosphoric acid, di-C4-18-alkyl esters, ammonium salts",270-200-2,68412-62-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
123966,Tetranitromethane,208-094-7,509-14-8,Ox. Liq. 1;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3;Carc. 2,Notified C&L,38,H319:38;H330:38;H271:38;H315:38;H301:38;H335:38;H351:38
123968,4-methylhexan-3-ol,210-419-2,615-29-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H226:1;H319:1;H315:1;H335:1
123969,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 2,2'-[1,6-hexanediylbis(oxymethylene)]bis[oxirane]",609-160-1,356761-34-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H315:1;H317:1;H412:1
123971,"5,12-dihydronaphthacene",213-491-3,959-02-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
123973,"4,6-dimethyl-2H-pyran-2-one",211-618-7,675-09-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,148,H319:148;H302:148
123976,"Aluminoxanes, iso-Bu, branched, cyclic and linear",606-903-1,220326-29-4,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1A,Notified C&L,1,H260:1;H314:1;H250:1
123977,Tetrakis(triphenylphosphine)platinum,238-087-4,14221-02-4,,Notified C&L,6,H302:5;Not classified:1;H413:1;H319:1;H332:1;H312:1;H315:1
123979,"Amines, C10-14-branched and linear alkyl, bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]chromate(1-)",286-051-1,85186-67-0,Skin Sens. 1B;Repr. 1B;STOT RE 2,Notified C&L,83,H360:83;H373:83;H317:83
123986,1-nitro-3-(pentafluorosulfanyl)benzene,447-600-2,2613-26-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H319:1;H331:1;H315:1;H301:1;H311:1
123988,4-chloro-α-methylbenzyl alcohol,222-223-4,3391-10-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H319:40;H332:40;H302:44;H312:40;H315:40;H335:40
123990,2-(1-methylbutyl)phenol,201-736-7,87-26-3,Acute Tox. 3;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,38,H413:38;H301:38;H318:38
123991,N-methylpyrrole-2-carboxylic acid,230-217-8,6973-60-0,,Notified C&L,7,H319:7;H335:6;H315:7;H332:1;H302:1
123992,"Phenol, 4-(phenylamino)-, sulfurized, leuco deriv.",288-511-7,85736-99-8,Not Classified,REACH registration C&L,38,Not classified:38
123993,"Fatty acids, C16-18, compds. with diethanolamine",270-289-8,68424-29-3,Not Classified,Notified C&L,7,Not classified:4;H319:3;H315:3
123997,Copper dioleate,214-307-4,1120-44-1,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,3,H411:3;H319:3;H315:3;H317:3
123998,"Fatty acids, C6-12, sodium salts",267-020-1,67762-44-1,Not Classified,Notified C&L,6,Not classified:6
124003,"Trisodium [5-acetamido-4-hydroxy-3-[[2-hydroxy-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonato(5-)]cuprate(3-)",263-856-6,63105-49-7,Aquatic Chronic 2,REACH registration C&L,4,H411:4
124004,4-chloro-1-(4-chlorophenoxy)-2-nitrobenzene,205-176-4,135-12-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H302:38;H335:38;H315:38;H318:38
124010,Methyl-p-benzoquinone,209-056-2,553-97-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:53;H335:52;H315:53;H302:53;H317:4
124015,2-Deoxy-L-ribose,606-054-7,18546-37-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
124016,3-Bromo-4-fluorobenzyl Alcohol,616-500-2,77771-03-0,,Notified C&L,7,H319:7;H315:7;H335:2
124017,3-amino-2-naphthoic acid,227-726-2,5959-52-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:46;H335:45;H315:46;H302:47
124025,"N-acetylglycine, compound with 4,4'-(1-triazene-1,3-diyl)bis[benzenecarboxamidine] (2:1)",212-999-2,908-54-3,Not Classified,Notified C&L,2,Not classified:1;H319:1;H312:1;H335:1;H302:1
124026,"7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one",456-160-0,,,Notified C&L,1,H412:1
124034,N-octanenitrile,218-808-9,2243-27-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
124035,"4-chloro-3,5-dinitrobenzenesulphonic acid",201-868-5,88-91-5,Skin Sens. 1,Notified C&L,38,H317:38
124037,"2-Imidazolidinone, 4,5-dihydroxy-1,3-bis(hydroxymethyl)-, polymer with 2,2'-oxybis[ethanol]",605-210-1,160460-06-0,Not Classified,Notified C&L,1,Not classified:1
124039,"Octadecanoic acid, reaction products with triethylenetetramine, chloromethane-quaternized",291-716-4,90459-71-5,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:1;H318:1;H317:1;H410:1;H319:1
124040,"Oxirane, 2,2'-[1,2-ethanediylbis(oxymethylene)]bis[2-methyl-",609-475-4,3775-85-7,Not Classified,Notified C&L,1,Not classified:1
124041,"Cuprate(2-), [μ-[[3,3'-methylenebis[6-[[2,4-dihydroxy-5-[(4-sulfophenyl)azo]phenyl]azo]benzoato]](6-)]]di-, sodium",285-999-3,85186-16-9,Not Classified,Notified C&L,3,Not classified:3
124042,"Phosphocreatine, sodium salt",213-074-6,922-32-7,Not Classified,REACH registration C&L,44,Not classified:2;H319:42;H332:42;H302:42;H312:42;H315:42;H335:42
124043,Heptamethylsilanetriamine,223-199-8,3768-57-8,,Notified C&L,2,H226:2;H319:1;H315:1;H335:1
124044,"1,4-oxathiane",240-117-6,15980-15-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H226:44;H319:44;H315:39;H335:38
124045,(2-hydroxypropyl)ammonium decyl sulphate,244-238-5,21142-28-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H315:3;H318:2;H319:1;H412:1;H302:1
124046,"Ormenis multicaulis, ext.",296-034-0,92202-02-3,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1391,H304:1390;H411:1388;H317:1390;H226:104;H315:4;H400:2;H410:3
124048,5-benzyloxyindole,214-930-1,1215-59-4,,Notified C&L,9,H319:9;H335:8;H315:9;H228:1;H332:1;H302:1;H312:1
124052,4-bromo-α-ethylbenzyl alcohol,224-781-4,4489-22-9,Acute Tox. 4,Notified C&L,38,H302:38
124059,"4,4'-Methylenedianiline, oligomeric reaction products with 1-chloro-2,3-epoxypropane",500-062-3,28390-91-2,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,25,H411:17;H317:25;H341:8;H302:8;H312:8;H412:8
124061,Ethyl pent-4-en-1-oate,217-818-0,1968-40-7,,Notified C&L,5,H226:5
124064,Hydrazinium nitrate,236-690-7,13464-97-6,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H400:3;H331:3;H330:3;H301:3;H410:3;H311:3;H317:3;H350:3
124067,Potassium 4-chlorobenzenesulfonate,451-910-3,78135-07-6,Eye Dam. 1,Notified C&L,1,H318:1
124068,(4-methoxy-4-oxo-2-butenyl)triphenylphosphonium bromide,218-557-5,2181-98-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
124071,5-nitroindazole,226-451-5,5401-94-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:47;H335:45;H315:47;H302:43;H341:5;H242:1;H332:3;H312:3;H351:1;Not classified:1
124073,"Guanosine 5'-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid, tetralithium salt",305-606-1,94825-44-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
124077,"1-phenylpropane-1,2-dione",209-435-2,579-07-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,1441,H319:1439;H332:1374;H302:1414;H312:1374;H315:1440;H335:1439;H334:1374;H317:1374;H304:1;H225:1
124078,3-nitro-4-phenoxy-5-sulphamoylbenzoic acid,248-970-6,28328-53-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2
124079,C.I. Acid Blue 134,613-299-3,63641-86-1,Not Classified,Notified C&L,4,Not classified:4
124083,4-(p-aminoanilino)-3-nitrobenzenesulphonic acid,205-175-9,135-11-5,Not Classified,REACH registration C&L,1,Not classified:1
124087,"Acetic acid, (ethylenedinitrilo)tetra-, tetrasodium salt, dihydrate",600-485-4,10378-23-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,97,H318:49;H302:49;H319:46;H335:46;H315:46;H332:1;Not classified:1
124089,Quinoline-2-carbaldehyde,226-804-3,5470-96-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
124090,1-chloroundecane,219-596-0,2473-03-2,Eye Irrit. 2;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H336:1;H410:1;H351:1
124092,"Propanamide, 3-mercapto-N-octyl-",618-288-7,89614-32-4,Not Classified,Notified C&L,56,Not classified:56
124095,Ethyl 3-phenyloxirane-2-carboxylate,204-467-3,121-39-1,Skin Sens. 1B,REACH registration C&L,1593,H317:1587;H412:13;H319:6;H335:5;H315:6
124096,Potassium bis(2-ethylhexyl) phosphate,225-614-8,4971-46-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H319:24;H315:33;H318:11;Not classified:4
124097,"Sodium 1,4-didecyl sulphonatosuccinate",245-714-5,23524-64-3,Not Classified,Notified C&L,4,Not classified:4
124098,Pentamethylbenzoic acid,218-809-4,2243-32-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
124099,Dipotassium tetrakis(nitrito-N)palladate(2-),237-568-6,13844-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
124100,"Hexasodium 4-amino-3,6-bis[[4-[[4-chloro-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulphonatophenyl]azo]-5-hydroxynaphthalene-2,7-disulphonate",268-520-2,68110-31-6,Not Classified,Notified C&L,35,Not classified:25;H320:7;H319:3;H335:2;H334:2
124105,"Alcohols, C12-14, ethoxylated (12EO)",931-005-4,,Acute Tox. 4;Eye Dam. 1,Notified C&L,4,H318:4;H302:4
124106,"Soybean oil, maleated",272-000-0,68648-66-8,Not Classified,Notified C&L,4,Not classified:4
124107,Ethyl 3-oxohexanoate,221-835-9,3249-68-1,Not Classified,REACH registration C&L,102,Not classified:93;H302:8;H319:2;H335:2;H315:2;H312:1;H332:1
124108,"2,3-dichlorobuta-1,3-diene",216-721-0,1653-19-6,Flam. Liq. 2;Acute Tox. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,108,H319:20;H330:6;H304:6;H315:20;H301:7;H335:20;H411:20;H225:7;Not classified:88;H302:13;H331:1
124110,2-methylhexan-3-ol,210-508-6,617-29-8,Flam. Liq. 3,Notified C&L,39,H226:39
124113,Mercury monoxide,244-654-7,21908-53-2,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,77,H310:76;H400:76;H330:77;H300:77;H410:77;H373:77;Not classified:1;H361:1;H311:1
124118,"4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthyl)-1H-imidazolium dihydrogen phosphate",302-749-1,94133-85-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
124124,Indan-1-ylamine,252-158-7,34698-41-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:43;H315:45;H332:1;H302:1;H312:1
124125,2-acetoxy-m-toluic acid,224-499-1,4386-39-4,Acute Tox. 4,Notified C&L,38,H302:38
124126,"Silicones, monoorgano",924-722-9,63148-53-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
124127,"[2R[2R*(4R*,8R*)]]-3,4-dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol",200-201-5,54-28-4,Not Classified,Notified C&L,114,Not classified:114
124128,o-anisic acid,209-447-8,579-75-9,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,188,H319:187;H315:187;H335:6;Not classified:1
124129,Potassium naphthalene-1-acetate,239-220-9,15165-79-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
124133,"Phosphoric acid, C12-15-alkyl esters",270-201-8,68412-63-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,23,H315:19;H318:18;H314:2;Not classified:2;H319:1
124136,"3-(dodecylamino)propane-1,2-diol",212-482-1,821-91-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,441,H410:441;H400:441;H318:441;H302:441
124137,"Benzaldehyde, 2,3-dimethyl-",611-577-9,5779-93-1,,Notified C&L,1,H315:1
124139,Dobutamine hydrobromide,277-982-4,74753-15-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H312:2;H332:2;H302:2
124142,"2,3,4-trihydroxybenzophenone",214-540-1,1143-72-2,Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 1,REACH registration C&L,45,H315:45;H318:2;H317:2;H410:2;H319:43;H335:42
124144,Propiomazine,206-646-1,362-29-8,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H302:1
124145,"Glycerides, sunflower-oil mono- and di-, ethoxylated",605-883-1,180254-52-8,Not Classified,Notified C&L,1,Not classified:1
124149,Dipentaerythritol pentastearate,243-570-8,20190-00-5,Not Classified,Notified C&L,6,Not classified:6
124151,"Fatty acids, cottonseed-oil",269-656-5,68308-51-0,Not Classified,Notified C&L,1,Not classified:1
124152,5-bromopent-1-ene,214-281-4,1119-51-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,52,H226:52;H319:51;H315:51;H335:49;H302:1
124158,Pralidoxime iodide,202-349-6,94-63-3,Acute Tox. 4,Notified C&L,38,H302:38
124163,"Fatty acids, vegetable-oil, esters with 3,3'-oxybis[1,2-propanediol]",305-770-4,95009-42-0,Not Classified,Notified C&L,2,Not classified:2
124164,Sodium 3-nitrobenzoate,212-578-3,827-95-2,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,70,H228:58;H319:59;H335:59;H315:59;Not classified:6;H302:5
124166,"Benzenepropanol, α-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-2-(1-hydroxy-1-methylethyl)-, (αS)-",604-295-2,142569-70-8,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
124168,2-ethoxyethyl cyanoacetate,251-228-4,32804-77-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,11,H319:11;H332:11;H302:11;H312:11;H315:11
124169,Zinc bis(benzenesulphinate),246-148-1,24308-84-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,129,H319:113;H335:113;H315:112;Not classified:16;H412:2;H332:1;H302:1;H312:1
124170,"2,3-dihydroxybenzaldehyde",246-398-1,24677-78-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H302:1
124180,"2,3,5-trimethylanisole",243-843-1,20469-61-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:3;H335:3;H315:3
124181,Trimipramine hydrogen maleate,208-318-3,521-78-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,52,H319:40;H302:52;H335:40;H315:40;H361:41;H400:1;H372:1;H370:1;H410:2;H332:1;H312:1;H318:1;H317:1
124186,"Lithium, borate 12-hydroxyoctadecanoate complexes, basic",291-570-1,90431-46-2,Not Classified,Notified C&L,2,Not classified:2
124188,"1,1,2,3,3-pentamethyloctahydro-4H-inden-4-one",606-335-4,195379-87-4,Flam. Liq. 2,REACH registration C&L,2,H225:2
124189,6-nitrobenzothiazole,220-933-9,2942-06-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
124190,Ethyl 2-methylcrotonate,227-425-6,5837-78-5,Flam. Liq. 3,Notified C&L,1590,H226:1590
124191,L-Monomenthyl glutarate,606-919-9,220621-22-7,Eye Irrit. 2,Notified C&L,90,H319:90
124192,(chloromethyl)(methoxy)dimethylsilane,700-268-5,18143-33-4,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H226:38;H335:38;H315:38;H318:38;Not classified:1
124193,"Tetrasodium 4,4'-bis[[4-[bis(2-hydroxyethyl)amino]-6-(4-sulphonatoanilino)-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate]",240-521-2,16470-24-9,Not Classified,REACH registration C&L,341,Not classified:339;H319:2
124195,"Trisodium 4-hydroxy-3-[(2-sulphonatophenyl)azo]-5-[(2,5,6-trichloropyrimidin-4-yl)amino]naphthalene-2,7-disulphonate",239-892-3,15792-41-3,,Notified C&L,2,H317:2
124199,"Barium, C5-23-branched carboxylate octanoate complexes",281-908-6,84066-74-0,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,2,H413:2;H332:2;H302:2
124200,"reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)",411-710-9,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
124207,"6-fluoro-2,3-dihydro-4H-1-benzopyran-4-one",266-511-8,66892-34-0,,Notified C&L,5,H319:5;H335:5;H315:5
124213,"Rape oil, sulfonated, potassium salt",293-617-1,91081-15-1,Eye Irrit. 2,Notified C&L,1,H319:1
124215,Reactive deep green KE-4BD,612-760-6,61931-49-5,Eye Irrit. 2,Notified C&L,38,H319:38
124217,Glycerol propoxylate triglycidyl ether,609-366-1,37237-76-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,103,H319:103;H315:103;H317:103;H335:39;H334:39
124218,"reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid;ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate",432-190-1,182176-52-9,Acute Tox. 4;Eye Dam. 1;STOT RE 2,Harmonised C&L,0,H373:0;H318:0;H302:0
124219,C.I. Reactive Red 152,615-673-1,71872-80-5,Not Classified,Notified C&L,1,Not classified:1
124220,"Oxidase, glucose",232-601-0,9001-37-0,Resp. Sens. 1,REACH registration C&L,273,H334:188;Not classified:85;H332:4;H302:4
124225,Methyl hexanoate,203-425-1,106-70-7,Flam. Liq. 3,REACH registration C&L,1767,H226:1765;H319:55;H315:55;H335:55;Not classified:1;H411:1
124226,Propyne,200-828-4,74-99-7,Flam. Gas 1;Press. Gas (Liq.);STOT SE 3,REACH registration C&L,275,H335:113;H280:275;H220:271;H341:9;H336:14;H373:5;H224:4
124228,"7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",614-262-4,68077-26-9,Aquatic Chronic 3,Notified C&L,16,H412:9;H319:5;H335:4;H315:5;H410:1;H413:1
124234,2-hydroxy-2-methylpropionamide,235-890-1,13027-88-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:1
124239,Bifenazate,604-709-1,149877-41-8,Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,57,H319:38;H400:57;H317:56;H373:18;H410:18
124242,"{[1,1'-biphenyl]-2-yl}dicyclohexylphosphane",480-030-2,,Aquatic Chronic 4,Notified C&L,2,H413:2;H319:1;H335:1;H315:1
124243,"Alkanes, C8-10-iso-",271-364-8,68551-15-5,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,17,H304:9;H336:9;H411:9;H225:10;Not classified:6;H371:2;H400:2;H332:2;H226:1;H373:2
124244,"2-Propenoic acid, butyl ester, homopolymer RN: 9003-49-0",618-366-0,9003-49-0,Not Classified,Notified C&L,117,Not classified:116;H315:1
124248,"2,6,6-trimethoxy-2-vinyltetrahydropyran",230-983-3,7392-19-0,Flam. Liq. 3;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,297,H226:297;H319:13;H412:15;H304:1;H315:1;H411:1;H317:1
124250,"1,3-dibromotetrafluorobenzene",216-326-3,1559-87-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
124251,Tetrahydro-1-methyl-1H-pyrimidine-2-thione,246-238-0,24421-05-4,Acute Tox. 3,Notified C&L,38,H301:38
124252,"Manganese, borate neodecanoate complexes",270-502-4,68442-99-9,Acute Tox. 4;Skin Irrit. 2,Notified C&L,2,H315:2;H302:2
124255,"3-methoxyandrosta-3,5-dien-17-one",260-591-8,57144-06-6,Carc. 2;Repr. 1A;Lact.,REACH registration C&L,2,H351:1;H360:1;H362:1;H341:1;H302:1
124256,"Disodium 5-[[2,4-dihydroxy-3-[(4-nitrophenyl)azo]phenyl]azo]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonate",289-012-7,85959-21-3,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H412:1
124257,"Gas oils, paraffinic;Gasoil - unspecified;[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 °C to 330 °C (374 °F to 594 °F).]",300-227-8,93924-33-5,Carc. 1B,Harmonised C&L,0,H350:0
124260,"4,4'-carbonylbis[2-({[3-(triethoxysilyl)propyl]amino}carbonyl)benzoic acid]",419-190-5,,Eye Irrit. 2,Notified C&L,1,H319:1
124263,Indan-5-sulphonamide,252-432-6,35203-93-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
124265,"Phosphoric acid, C16-18-branched and linear alkyl esters, sodium salts",307-079-3,97489-37-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
124268,(Z)-7-decenal,244-512-4,21661-97-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H226:38;H319:43;H315:43;H335:43
124270,Ethyl 6-bromohexanoate,247-085-2,25542-62-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H226:41;H319:46;H315:46;H335:43
124272,"(2,2-diethoxyethyl)benzene",228-642-9,6314-97-2,Not Classified,Notified C&L,88,Not classified:88
124279,"Bis[[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthyl]methylene]cyclohexa-2,5-dien-1-ylidene]diethylammonium] dicopper(1+) hexa(cyano-C)ferrate(4-)",279-935-3,82338-76-9,Eye Irrit. 2,REACH registration C&L,97,H319:2;H400:88;H318:86;H410:89;Not classified:6
124283,Hexahydrocyclopenta[c]pyrrol-2(1H)-amine monohydrochloride,261-131-9,58108-05-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44,H319:43;H335:43;H315:43;H302:2;Not classified:1
124284,"9-Octadecenoic acid (Z)-, sulfonated",273-538-9,68988-76-1,Acute Tox. 4;Skin Corr. 1A,Notified C&L,1,H314:1;H302:1
124286,"2,4-dimethoxybenzonitrile",223-886-2,4107-65-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H332:42;H302:42;H312:42;H315:43;H335:42;H331:1;H301:1;H311:1
124287,"Butanedioic acid, sulfo-, C-C16-18 alkyl ester, monosodium salt",273-536-8,68988-68-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,70,H315:66;H318:33;H319:33;H335:33;Not classified:4
124290,"5-methoxy-N,N-dimethyl-1H-indole-3-ethylamine",213-813-2,1019-45-0,Acute Tox. 4,Notified C&L,39,H332:39;H314:1;H317:1
124292,"1-Azabicyclo[3.2.2]nonan-3-ol, 6-ethenyl-2-(4-quinolinyl)-, (1S,2R,3S,5S,6R)-",611-346-2,560119-45-1,Acute Tox. 4,Notified C&L,38,H302:38
124295,"1,4,7,10,13,16,19,22-octaoxacyclotetracosane",251-374-9,33089-37-1,Eye Irrit. 2,Notified C&L,1,H319:1
124297,"Reaction products of diazotised 2-amin-6-nitrophenol-4-sulphonic Acid and 2-Amino-4-nitrophenol-6-sulfonic Acid, coupled with a mixture of 6-Amino-4-hydroxy-2-naphthalenesulfonic Acid and Acetylated 6-Amino-4-hydroxy-2-naphthalenesulfonic Acid, subsequently metallized with Chromium (III) Basic Sulfate and Acetic Acid, and at the end diazotised and coupled with p-Cresol, sodium salts",405-750-6,,Not Classified,REACH registration C&L,33,Not classified:33
124300,Methoxyflurane,200-956-0,76-38-0,,Notified C&L,6,H226:6;H319:6;H341:5;H315:1;H335:1
124302,2-methylbutyl salicylate,256-972-3,51115-63-0,Not Classified,Notified C&L,131,Not classified:78;H411:52;H302:49;H319:1;H315:1;H317:1
124305,Vanadium oxide,234-326-1,11099-11-9,Not Classified,Notified C&L,34,Not classified:33;H319:1;H335:1;H332:1;H302:1
124308,"flubenzimine (ISO);N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline",253-703-1,37893-02-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H400:0;H410:0
124309,trichloroethylene;trichloroethene,201-167-4,79-01-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Carc. 1B;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H341:0;H315:0;H336:0;H350:0;H412:0
124314,"Oils, marine, oleins",297-110-6,93334-35-1,Not Classified,Notified C&L,1,Not classified:1
124317,Titanium trichloride,231-728-9,7705-07-9,Pyr. Sol. 1;Self-heat. 2;Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,200,H252:11;H301:11;H250:192;H318:149;H314:200;H290:12;H330:83;H335:86;H317:83
124320,Benoxaprofen,257-069-7,51234-28-7,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,38,H413:38;H301:38
124321,"Hydrocarbons, C4, 1,3-butadiene-free, polymd., tetraisobutylene fraction, hydrogenated",297-628-2,93685-80-4,Asp. Tox. 1;Acute Tox. 4,REACH registration C&L,188,H304:188;H332:184;H315:2
124323,α-chloro-4-fluoroacetophenone,207-256-4,456-04-2,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;Aquatic Chronic 1,REACH registration C&L,134,H330:86;H301:89;H410:86;H318:86;H317:86;H314:95;H319:40;H335:39;H315:40;H331:2;H400:1
124324,1-aminobutyl oleate,275-691-7,71607-50-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
124330,Bis(neodecanoyloxy)dioctylstannane,269-595-4,68299-15-0,STOT SE 2,REACH registration C&L,338,H371:10;H413:299;H373:298;H411:14;H361:14;H372:27;H370:13;Not classified:2
124331,Diethylcarbamazine dihydrogen citrate,216-696-6,1642-54-2,Acute Tox. 4;Acute Tox. 2,Notified C&L,39,H330:39;H302:39
124332,pilocarpine,202-128-4,92-13-7,Acute Tox. 2;Acute Tox. 2,Harmonised C&L,0,H330:0;H300:0
124333,"1,3-diethyl-2-thiourea",203-308-5,105-55-5,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;STOT RE 1,REACH registration C&L,280,H372:52;H302:231;H312:54;H318:187;H317:211;H412:54;H335:128;H351:151;Not classified:30;H319:22;H315:22;H301:20
124338,"reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide",442-280-0,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
124339,C8-C26 branched and linear hydrocarbons – Distillates,481-740-5,848301-67-7,Asp. Tox. 1,REACH registration C&L,454,H304:454
124340,Octafluorocyclobutane,204-075-2,115-25-3,Press. Gas (Comp.),REACH registration C&L,148,H280:101;H411:47;H319:2;H335:2
124342,1-methyl-β-carbolin-7-ol hydrochloride monohydrate,254-980-1,40580-83-4,Eye Irrit. 2,Notified C&L,38,H319:38
124343,"Isononanoic acid, compound with 2,2'-iminodiethanol (1:1)",304-176-2,94247-01-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:1;H315:2;H302:1;H318:1;Not classified:1
124344,Hexacarbonylmolybdenum,237-713-3,13939-06-5,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,70,H310:66;H330:70;H300:70;H413:2;H319:2;H315:2
124348,"2-chloro-3-(dimethylamino)-N,N-dimethylprop-2-en-1-iminium hexafluorophosphate",619-785-1,249561-98-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2,H319:2;H317:2;H302:2
124349,"Cuprate(2-), [μ-[[3,3'-[methylenebis[(4,6-dihydroxy-3,1-phenylene)azo]]bis[4-hydroxy-5-nitrobenzenesulfonato]](6-)]]di-, sodium",285-998-8,85186-15-8,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,19,H319:16;H411:9;H317:12;H334:3;Not classified:3
124350,benzyl chloroformate,207-925-0,501-53-1,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H314:0;H410:0
124355,"Alcohols, C12-15, ethoxylated, sulfates, sodium salts",500-314-2,125301-92-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,53,H315:51;H318:48;H412:36;H319:3;Not classified:2
124356,[[4-[[2-(4-cyclohexylphenoxy)ethyl]ethylamino]-2-methylphenyl]methylene]malononitrile,258-964-5,54079-53-7,Not Classified,REACH registration C&L,16,Not classified:16
124361,Dimolybdenum trizinc nonaoxide,245-322-4,22914-58-5,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,82,H411:2;H400:2;H410:46;Not classified:34
124364,"Alkanes, C10-13-iso-",271-366-9,68551-17-7,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 2,REACH registration C&L,1726,H304:1719;H226:122;H411:88;H413:1407;H315:80;H336:65;H335:4;Not classified:3
124365,lithium bis(trifluoromethylsulfonyl)imide,415-300-0,90076-65-6,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H301:0;H311:0;H314:0;H373:0;H412:0
124369,"Phosphoric acid, C16-18-alkyl esters, compds. with diethanolamine",291-881-2,90506-22-2,Not Classified,Notified C&L,1,Not classified:1
124374,"Titanium, diethylene glycol ethylene glycol triisopropanolamine complexes",272-249-5,68784-47-4,Not Classified,REACH registration C&L,68,Not classified:1;H319:67;H315:67
124375,"Butanedioic acid, 2,3-bis(benzoyloxy)-, (2R,3R)-, compd. with (2S,3aS,6aS)-phenylmethyl octahydrocyclopenta[b]pyrrole-2-carboxylate (1:1) (9CI)",600-479-1,103728-95-6,Aquatic Chronic 3,REACH registration C&L,2,H412:2
124376,"Ammonium hydrogen 9,10-dihydroxysebacate",283-850-7,84753-04-8,Eye Dam. 1,Notified C&L,105,H318:105
124377,Monophosphothiamine,208-536-9,532-40-1,Skin Sens. 1,REACH registration C&L,5,H317:4;Not classified:1
124379,Chloropyrazine,238-517-0,14508-49-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H226:48;H319:49;H315:48;H335:48
124380,"2-Butyne-1,4-diol, reaction products with epichlorohydrin",272-537-0,68876-96-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
124385,"2,3-difluoro-1-propoxy-4-[4-(trans-4-propylcyclohexyl)-1-cyclohexen-1-yl]-benzene",600-065-0,1003218-40-3,Not Classified,REACH registration C&L,1,Not classified:1
124391,Broxyquinoline,208-317-8,521-74-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
124394,"Silane, (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)trimethoxy-",617-434-7,83048-65-1,Skin Corr. 1B,Notified C&L,86,H314:64;H319:22;H335:21;H315:22;H332:1;H302:1;H312:1
124396,tetraethyl silicate,201-083-8,78-10-4,Flam. Liq. 3;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H226:0;H319:0;H335:0;H332:0
124404,Potassium hydrogen 2-oxoglutarate,213-641-8,997-43-3,Not Classified,Notified C&L,2,Not classified:2
124405,(2-hydroxyethyl)ammonium nitrate,244-005-8,20748-72-5,Not Classified,REACH registration C&L,91,Not classified:85;H319:6;H302:4
124406,"9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-propionate",226-887-6,5534-13-4,Repr. 1B;Aquatic Chronic 3,REACH registration C&L,5,H360:5;H412:4;H373:1
124407,"2,2-difluoro-1,3-benzodioxole-5-carboxylic acid methyl ester",616-458-5,773873-95-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,13,H319:2;H335:2;H315:2;Not classified:11
124408,"1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid",618-911-2,93106-60-6,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,Notified C&L,103,H334:54;H317:54;H302:92;H400:36;H372:35;H410:37;H361:35;Not classified:6;H411:4;H319:2;H312:2;H373:1;H412:1
124413,propane,200-827-9,74-98-6,Press. Gas;Flam. Gas 1,Harmonised C&L,0,Not classified:0;H220:0
124415,3-ethyl-5-[(3-methylthiazolidin-2-ylidene)ethylidene]rhodanine,248-733-7,27930-87-6,Not Classified,Notified C&L,1,Not classified:1
124416,4-methoxyphenyl isocyanate,226-513-1,5416-93-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,46,H312:40;H314:40;H332:45;H302:45;H319:6;H315:6;H335:6;H334:5;H331:1;H301:1
124418,N-benzyloxycarbonyl-β-alanine,218-967-4,2304-94-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:39;H302:39
124419,"Tetrasodium [5-[[4-chloro-6-(4-sulphoanilino)-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(2-hydroxy-5-sulphophenyl)azo]naphthalene-2,7-disulphonato(6-)]cuprate(4-)",278-134-6,75214-66-3,Not Classified,Notified C&L,31,Not classified:31
124420,N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide,216-014-7,1474-02-8,Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,1,H301:1;H412:1
124421,"5-methyl-3-(1,1,3,3-tetramethylbutyl)pyrocatechol",218-671-5,2213-68-5,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H413:38;H335:38;H315:38;H318:38
124423,"thiamethoxam (ISO);3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine",428-650-4,153719-23-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H302:0
124424,Sodium glucoheptonate,250-480-2,31138-65-5,Not Classified,REACH registration C&L,194,Not classified:119;H319:75;H315:26;H332:1;H302:1;H312:1;H335:1
124425,"Alcohols, C6-10, EO/PO~",614-868-9,68987-81-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,759,H315:560;H318:491;Not classified:102;H302:64;H319:89;H335:56;H412:1
124426,Chloramphenicol palmitate,208-477-9,530-43-8,Carc. 2,Notified C&L,43,H351:42;H319:1;H315:1
124428,"1,3,5-trimethyl-1,1,3,5,5-pentaphenyltrisiloxane",222-222-9,3390-61-2,Not Classified,REACH registration C&L,65,Not classified:27;H319:38
124431,Tetraboron manganese heptaoxide,235-446-7,12228-91-0,Not Classified,Notified C&L,8,Not classified:8
124432,"Acetamide, N-(2,4-dinitrophenyl)-, reaction products with phthalic anhydride and sodium sulfide (Na2(Sx)), leuco derivatives",288-512-2,85737-01-5,Not Classified,Notified C&L,31,Not classified:31
124438,Ethyl anthranilate,201-735-1,87-25-2,Not Classified,Notified C&L,307,Not classified:260;H319:47;H315:47;H335:7
124440,"Phosphoric acid, 2-methylpropyl ester, ammonium salt",292-410-3,90605-12-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;Not classified:1
124444,Menglytate,209-448-3,579-94-2,,Notified C&L,1,H332:1;H302:1
124445,Ethyl isopropyl sulphide,225-917-5,5145-99-3,Flam. Liq. 2,Notified C&L,2,H225:2;H319:1;H315:1
124449,"Phenol, polymer with 3a,4,7,7a-tetrahydro-4,7-methano-1H-indene",608-479-3,30420-31-6,Acute Tox. 4;Acute Tox. 3;Repr. 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H361:1;H312:1;H331:1
124450,cyanamide;carbamonitril,206-992-3,420-04-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H301:0;H351:0;H311:0;H317:0;H318:0;H361:0;H314:0;H373:0;H412:0
124458,"4-Butyl-4''-ethyl-2'-fluor-1,1':4',1''-terphenyl",617-357-9,825633-75-8,Not Classified,REACH registration C&L,1,Not classified:1
124461,"Amines, C10-14-branched and linear alkyl, bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]chromate(1-)",286-050-6,85186-66-9,Skin Sens. 1B;Repr. 1B;STOT RE 2,Notified C&L,83,H360:83;H373:83;H317:83
124463,3-[(2-methylpropyl)amino]propanenitrile,604-310-2,14278-96-7,Acute Tox. 4;Skin Corr. 1B;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H335:1;H314:1
124466,Gelsemine,208-095-2,509-15-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,40,H310:38;H330:39;H300:39;H331:1;H301:1
124471,"Butanedioic acid, di-C8-10-alkyl esters",290-831-7,90268-30-7,Not Classified,Notified C&L,1,Not classified:1
124472,Heptamethylphenylcyclotetrasiloxane,233-931-8,10448-09-6,Repr. 1B;Aquatic Chronic 4,Notified C&L,56,H413:56;H360:56
124474,Vasopressin,234-236-2,11000-17-2,Not Classified,Notified C&L,1,Not classified:1
124477,"Trichlorotris[1,1'-thiobis[butane]]rhodium",259-633-8,55425-73-5,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,87,H413:83;H302:83;Not classified:4
124479,N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine monohydrochloride,256-023-3,42965-91-3,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,5,H413:5;H319:5;H317:5;H302:5
124482,o-phenylenediamine dihydrochloride,210-418-7,615-28-1,Acute Tox. 3;Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Muta. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H341:0;H400:0;H332:0;H312:0;H301:0;H410:0;H351:0;H317:0
124490,Phthaloyl dichloride,201-869-0,88-95-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1;STOT SE 3,REACH registration C&L,241,H312:38;H335:87;H334:7;H317:7;H314:240;H318:86;Not classified:1;H302:2;H290:1;H331:1
124492,methyl isothiocyanate,209-132-5,556-61-6,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H331:0;H301:0;H410:0;H317:0;H314:0
124493,"1,3,5-Triazin-2-amine, 4-methoxy-6-(trifluoromethyl)-",610-962-9,5311-05-7,Acute Tox. 4;Repr. 2,REACH registration C&L,34,H361:34;H302:34
124497,"1,7,7-trimethyl-3-(phenylmethylene)bicyclo[2.2.1]heptan-2-one",239-139-9,15087-24-8,Repr. 2,Notified C&L,374,H361:309;Not classified:65
124499,salts of benzidine [,252-984-8,36341-27-2,Acute Tox. 4;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H350:0;H302:0
124501,"1,4-diisooctyl sulphosuccinate",249-782-7,29699-21-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,28,H315:28;H318:28
124504,Tetradec-1-ene,214-306-9,1120-36-1,Asp. Tox. 1,REACH registration C&L,969,H304:861;H315:235;H411:25;Not classified:20;H319:6;H335:5
124510,1-aminopropan-2-ol hydrochloride,231-948-5,7780-04-3,Not Classified,Notified C&L,1,Not classified:1
124511,"4-[4-trans-(3,4-Difluorophenyl)-cyclohexyl]-cyclohexanone",604-593-2,147622-85-3,Not Classified,REACH registration C&L,2,Not classified:2
124512,"Fatty acids, lanolin, 2-octyldodecenyl esters",305-853-5,95193-42-3,Not Classified,Notified C&L,49,Not classified:49
124513,Methyl o-sulphamoylbenzoate,260-903-2,57683-71-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
124515,N-tert-butyl-3-methylpicolinamide,406-720-5,32998-95-1,Aquatic Chronic 3,Harmonised C&L,0,H412:0
124516,"1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, polymer with 2-methyloxirane",614-579-8,68541-39-9,Not Classified,Notified C&L,59,Not classified:59
124521,2-bromo-p-xylene,209-055-7,553-94-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H332:1;H302:1;H227:1
124524,"1-[2-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium acetate",261-871-2,59709-07-8,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,4,H319:4;H411:4;H302:4
124531,"Hydrogen [4-[4-(diethylamino)-2',4'-disulphonatobenzhydrylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium",204-165-1,116-95-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;Not classified:1
124532,"1-Propanone, 3-(methylamino)-1-(2-thienyl)-, hydrochloride (1:1)",613-619-1,645411-16-1,Acute Tox. 4;Skin Corr. 1A;Aquatic Chronic 3,Notified C&L,1,H314:1;H412:1;H302:1
124534,Trimethylsulphonium iodide,218-555-4,2181-42-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
124535,"2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate",444-250-2,144111-81-9,Self-react. C;Aquatic Chronic 2,Harmonised C&L,0,H242:0;H411:0
124538,"6-hydroxy-5-[(2-methoxy-4-nitrophenyl)azo]-2-methyl-1H-benz[de]isoquinoline-1,3(2H)-dione",255-770-2,42357-98-2,Not Classified,Notified C&L,9,Not classified:9
124540,Lithium hydroxyacetate,254-570-2,39663-84-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,26,H319:26;H302:26;H335:26;H315:26;H412:26
124541,1-chloro-4-(methylthio)benzene,204-600-5,123-09-1,Acute Tox. 4,Notified C&L,44,H302:43;H319:2;H315:2;H335:1
124543,n-butyl propionate,209-669-5,590-01-2,Flam. Liq. 3,Harmonised C&L,0,H226:0
124544,4-hydroxy-6-methylpyran-4-one,211-619-2,675-10-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
124551,6-aminohexanamide,206-762-2,373-04-6,Not Classified,Notified C&L,22,Not classified:22
124554,"(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarbonyl chloride",224-780-9,4489-14-9,Acute Tox. 3;Skin Corr. 1B,Notified C&L,2,H314:2;H301:2;H411:1;H318:1
124555,"3,4,5,6,7,8-hexahydro-2H-1-benzopyran-2-one",211-851-4,700-82-3,Skin Sens. 1,Notified C&L,233,H317:233
124558,1-(Trimethylsilyl)-1-pentyne,605-977-2,18270-17-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H319:39;H315:39;H335:38
124559,"Nitriles, C14-18",268-080-1,68002-66-4,Aquatic Acute 1,Notified C&L,31,H400:31
124562,"Olive oil, reaction products with sorbitol",296-033-5,92202-01-2,Not Classified,Notified C&L,5,Not classified:5
124563,"3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol",401-110-5,87113-78-8,Aquatic Chronic 3,Harmonised C&L,0,H412:0
124566,"1-bromo-2,3,5,6-tetrafluorobenzene",216-327-9,1559-88-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H226:47;H319:47;H315:47;H335:45
124567,"5-[[2,4-dihydroxy-3-[(4-nitrophenyl)azo]phenyl]azo]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonic acid",289-013-2,85959-22-4,Not Classified,Notified C&L,2,Not classified:2
124570,Octadec-2-enylsuccinic acid,268-159-0,68015-93-0,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,23,H413:23;H318:23;H317:1;H315:22
124577,2-ethoxybenzonitrile,613-895-3,6609-57-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H319:46;H332:45;H302:46;H312:45;H315:46;H335:45;H331:1;H301:1;H311:1;H412:1
124579,"3-(2-Bromo-4,5-dimethoxyphenyl)propanenitrile",609-105-1,35249-62-8,Not Classified,REACH registration C&L,3,Not classified:2;H312:1;H332:1;H302:1
124580,Carbachol,200-127-3,51-83-2,Acute Tox. 2,Notified C&L,200,H300:200
124585,8-Bromooctanoic Acid,605-788-5,17696-11-6,Skin Corr. 1B,Notified C&L,47,H314:47;H318:2;H290:1
124586,"2',3'-isopropylideneuridine",206-647-7,362-43-6,Skin Sens. 1,REACH registration C&L,5,H317:4;Not classified:1
124588,Diisononylnaphthalene,264-290-2,63512-64-1,,Notified C&L,2,Not classified:2
124589,9-acridone,209-434-7,578-95-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
124597,Diisopropyl (cyanomethyl)phosphonate,244-511-9,21658-95-7,,Notified C&L,4,H311:4;H314:4;H301:4;H330:4
124598,Green MGi 2168 (notification presscake),472-080-9,,Aquatic Chronic 3,Notified C&L,37,H413:37
124603,2-isopropyl-4-(N-methyl)aminomethylthiazole,414-800-6,154212-60-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H302:0;H312:0;H315:0;H411:0;H318:0
124604,"4-amino-2,5-xylenol",221-449-0,3096-71-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,128,H319:128;H332:127;H302:127;H312:127;H315:128;H335:127
124606,"Licorice, Glycyrrhiza foetida, ext., calcium salts",309-069-4,99811-78-6,Not Classified,Notified C&L,1,Not classified:1
124609,Magnesium dilaurate,223-727-7,4040-48-6,Not Classified,Notified C&L,8,Not classified:8
124611,Bis(phenethylammonium) sulphate,226-805-9,5471-08-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H302:38;H312:38;H315:38;H335:38
124612,"(3S,5R)-4-chloro-[5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)furan-3-yl]methylbenzenesulfonate",436-150-2,,Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H400:3;H372:3;H301:2;H410:3;H300:1
124613,1-benzyl-4-piperidone,222-782-4,3612-20-2,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,58,H317:12;H302:13;H319:46;H335:44;H315:46;Not classified:2
124614,"4,4'-ISOPROPYLIDENEDIPHENOL-CARBONYLCHLORIDE COND",607-838-1,25971-63-5,,Notified C&L,89,Not classified:68;H319:21;H315:21
124615,"2,5,9-trimethyl-4,9-decadienal",251-227-9,32803-39-7,Not Classified,Notified C&L,88,Not classified:88
124619,2-hydroxyvaleric acid,210-509-1,617-31-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H315:1;H318:1
124623,"2,6-dimethyl-1,3-dioxan-4-yl acetate",212-579-9,828-00-2,Skin Sens. 1A,Notified C&L,217,H317:98;H319:130;H302:92;H315:130;H335:90;H351:90;H226:90;H332:42;Not classified:29
124626,"Ganoderma lucidum, ext.",607-059-7,223751-82-4,Not Classified,Notified C&L,1,Not classified:1
124627,"mono-, and di-(sec-hexadecyl)naphthalene",930-936-3,,Not Classified,Notified C&L,1,Not classified:1
124635,Methylcyclohexanol,247-152-6,25639-42-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,99,H226:39;H332:67;H302:41;Not classified:31;H315:1;H336:1
124637,hydroxylammonium nitrate,236-691-2,13465-08-2,Expl. 1.1;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H319:0;H400:0;H302:0;H315:0;H351:0;H201:0;H311:0;H317:0;H373:0
124641,Coenzyme A,201-619-0,85-61-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H319:90;H335:90;H315:90;Not classified:1
124646,2-phenoxybutyryl chloride,255-513-4,41717-60-6,Skin Corr. 1B;STOT SE 3,Notified C&L,34,H335:33;H314:33;H319:1;H315:1;H332:1
124647,"Poly(oxy-1,2-ethanediyl), .alpha.-(1-oxohexadecyl)-.omega.-[(1- oxohexadecyl)oxy]- (3-EO)",608-762-1,32628-06-1,Not Classified,Notified C&L,102,Not classified:80;H319:22
124651,Octadecyl benzoate,234-169-9,10578-34-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H315:1;H412:1
124655,"2-amino-5-trifluoromethyl-1,3,4-thiadiazole",233-930-2,10444-89-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;H312:2;H332:2;H302:2
124657,"Fatty acids, lanolin, zinc salts",270-435-0,68440-10-8,Aquatic Chronic 4,Notified C&L,1,H413:1
124659,trimethyl borate,204-468-9,121-43-7,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0,H226:0;H312:0
124660,"5-nitrobenzene-1,2-dicarbonitrile",250-748-9,31643-49-9,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,46,H319:46;H302:46;H335:42;H315:43;H332:1
124663,"1,7-dichloro-1,1,3,3,5,5,7,7-octamethyltetrasiloxane",219-597-6,2474-02-4,Skin Corr. 1B,Notified C&L,156,H314:156;H335:1;H290:1;H318:1
124669,5-Acetyl-2-fluorobenzeneboronic acid,617-952-3,870777-29-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
124670,methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate,421-220-7,144740-59-0,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
124671,"4,4'-bis[[1-[[(2-methylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-2,2'-disulphonic acid",279-222-7,79665-34-2,Not Classified,Notified C&L,1,Not classified:1
124672,C.I. Reactive Red 237,605-148-5,158453-73-7,Not Classified,Notified C&L,1,Not classified:1
124674,"Hexanedioic acid, polymer with 1,4-butanediol and 1,1'-methylenebis[4-isocyanatobenzene]",607-922-8,26375-23-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;STOT RE 2,Notified C&L,49,H319:47;H332:30;H315:47;H335:47;H334:47;H317:47;H373:30;H351:17;Not classified:2
124677,3-(iodomethyl)heptane,216-720-5,1653-16-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
124679,Marjoram Oil,616-955-7,8015-01-8,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,32,H304:30;H411:30;H315:30;H317:30;Not classified:2;H319:1;H226:1
124680,"1,3,3-trimethyl-2-[(methylphenylhydrazono)methyl]-3H-indolium hydrogen sulphate",265-459-3,65121-73-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,2,H318:2;H302:2
124682,Tungsten diboride,235-445-1,12228-69-2,Not Classified,Notified C&L,1,Not classified:1
124695,6-aminohexanonitrile,219-409-2,2432-74-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:29;H335:29;H315:29;H302:52;H314:23;H332:23;H318:1
124697,C.I. Acid Brown 432,601-618-9,119509-50-1,Not Classified,Notified C&L,38,Not classified:38
124698,"Chestnut, C. sativa, ext.",283-619-0,84695-99-8,Not Classified,REACH registration C&L,29,Not classified:1;H226:28;H319:1
124702,Oxalohydrazide,213-640-2,996-98-5,,Notified C&L,5,H319:5;H335:4;H315:5
124703,"Disodium 5-(acetylamino)-3-[(4-dodecylphenyl)azo]-4-hydroxynaphthalene-2,7-disulphonate",239-893-9,15792-43-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,460,H400:444;H410:445;Not classified:15
124704,"coumatetralyl (ISO);4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin",227-424-0,5836-29-3,Acute Tox. 2;Acute Tox. 3;Acute Tox. 2;STOT RE 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H372:0;H300:0;H330:0;H410:0;H311:0;H360:0
124705,(Chloromethyl)trimethoxysilane,611-813-0,5926-26-1,Flam. Liq. 2,Notified C&L,41,H225:39;H315:2;H318:1;H302:2;H226:2;H319:1;H332:1;H335:1
124710,"3,5-dimethoxybenzamide",241-257-0,17213-58-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39;H302:39
124712,5-iodoanthranil acid,226-205-7,5326-47-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48
124714,DL-carnitine hydrochloride,207-309-1,461-05-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,57,H319:49;H335:47;H315:49;Not classified:8
124717,"Dehydrogenase, glucose 6-phosphate",232-602-6,9001-40-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:39;H315:39;H334:1
124723,"4-(4-chlorophenyl)dihydro-2H-pyran-2,6(3H)-dione",258-858-9,53911-68-5,Acute Tox. 4,REACH registration C&L,4,H302:3;Not classified:1;H319:1;H332:1;H312:1;H315:1;H335:1
124725,"Methacrylic acid, monoester with propane-1,2-diol",248-666-3,27813-02-1,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1262,H319:1191;H317:1220;H341:48;H315:47;H318:11;Not classified:11;H335:3
124727,Chromium picolinate,604-524-6,14639-25-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:42;H335:42;H315:42;H312:3;H332:3;H302:5
124731,"Glycerides, tallow mono-",263-035-2,61789-13-7,Not Classified,Notified C&L,28,Not classified:28
124733,"1-acetyl-1H-indole-2,3-dione",209-368-9,574-17-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
124734,4-(1-oxo-2-propenyl)-morpholine,418-140-1,5117-12-4,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2,Harmonised C&L,0,H317:0;H373:0;H318:0;H302:0
124735,N-(2-hydroxyethyl)acetoacetamide,246-149-7,24309-97-5,Not Classified,Notified C&L,11,Not classified:11
124738,3-acetyl-3-chlorodihydrofuran-2(3H)-one,221-050-1,2986-00-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H315:1;H318:1
124748,Carbazamidine phosphate,246-237-5,24413-21-6,Acute Tox. 4,REACH registration C&L,2,H302:2
124750,7-nitro-1H-indazole,220-934-4,2942-42-9,Acute Tox. 3;Eye Irrit. 2;Carc. 2;Repr. 1B,Notified C&L,45,H351:39;H360:39;H319:44;H301:39;H335:4;H315:5;H341:5;H332:1;H302:1;H312:1
124751,"Fatty acids, tall-oil, dimers, compds. with ethoxylated tallow alkylamines",614-810-2,68920-32-1,,Notified C&L,33,H411:33;H315:33;H318:33
124753,"Vaccinium macrocarpon, ext.",294-875-8,91770-88-6,Not Classified,Notified C&L,129,Not classified:102;H226:26;H319:1;H318:1
124755,Phenyltoloxamine,202-127-9,92-12-6,Acute Tox. 4,REACH registration C&L,4,H302:4;H319:1;H315:1
124761,1-propyl-1H-imidazole,252-431-0,35203-44-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
124762,"Foots oil (petroleum), clay-treated;[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C",300-226-2,93924-32-4,Press. Gas;Flam. Gas 1;Carc. 1B,Harmonised C&L,0,Not classified:0;H340:0;H350:0;H220:0
124766,1-ethylpiperidine-2-methylamine,253-664-0,37782-46-0,Flam. Liq. 4;Skin Corr. 1C,Notified C&L,1,H314:1;H227:1
124769,"Disodium 4,4'-bis[(6-anilino-4-chloro-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate",253-358-7,37138-23-1,Not Classified,Notified C&L,1,Not classified:1
124772,"2(1H)-Naphthalenone, octahydro-5,5,8a-trimethyl-, (4aR,8aS)-rel-",607-344-6,24222-51-3,,Notified C&L,1,H304:1;H315:1;H336:1;H373:1;H361:1;H225:1
124773,"2,5-diisopropylphenol",252-807-4,35946-91-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
124775,2-methyltetrahydrofuran-3-one,221-685-4,3188-00-9,Flam. Liq. 3,Notified C&L,1608,H226:1608;H302:46;H319:2;H315:2;H335:1
124776,"Hexane-1,2,6-triol",203-424-6,106-69-4,Not Classified,REACH registration C&L,8,Not classified:8
124780,Iron trichloride,231-729-4,7705-08-0,Met. Corr. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2725,H315:567;H290:229;H318:569;H302:2643;H317:119;H314:2151;H412:2067;H301:19;H411:14;Not classified:7;H319:1;H335:2
124781,"Rape oil, esters with d-sorbitol",293-616-6,91081-14-0,Not Classified,Notified C&L,34,Not classified:34
124782,"2-Hexadecen-1-ol, 3,7,11,15-tetramethyl-",616-221-6,7541-49-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,118,H319:40;H400:2;H315:117;H410:2;H317:2;H413:77;H335:38;Not classified:1
124784,"1,2,3,6,-tetrahydro-N-(2-hydroxyethyl)phthalimide",239-477-7,15458-48-7,Not Classified,REACH registration C&L,2,Not classified:2
124785,"2',3-dimethyl[1,1'-biphenyl]-4-amine hydrochloride",261-132-4,58109-32-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H319:38;H400:38;H302:38;H335:38;H315:38
124790,Perfluorooctane,206-199-2,307-34-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,25,H319:24;H335:24;H315:24;Not classified:1
124795,2-Azabicyclo[2.2.1]hept-5-en-3-one,610-480-9,49805-30-3,Acute Tox. 4;Skin Sens. 1,Notified C&L,39,H317:39;H302:39
124796,"Butanoic acid, 4-amino-4-oxosulfo-, N-tallow alkyl derivs., disodium salts",273-537-3,68988-69-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,219,H319:112;H315:112;Not classified:107;H318:36;H412:36
124799,"Chromium, acetate oxalate complexes",296-725-7,93028-33-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H302:1;H312:1;H315:1;H335:1
124802,"1H-Indole-2-carboxaldehyde, 2,3-dihydro-2-hydroxy-1,3,3-trimethyl-, (4-methoxyphenyl)methylhydrazone",617-207-2,81241-99-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,9,H318:9;H302:9
124803,"reaction mass of: pentasodium 2-{}{4-{}{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}}-benzene-1,4-disulfonate;pentasodium 2-{}{4-{}{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}}-benzene-1,4-disulfonate",421-160-1,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
124807,"1,1,2,2,3,3,4,4,5,6-decafluoro-5,6-bis(trifluoromethyl)cyclohexane",206-195-0,306-98-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H226:38;H319:38;H315:38;H335:38
124809,"Zinc sulfide (ZnS), copper and manganese-doped",271-599-6,68585-91-1,Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1,Notified C&L,2,H410:1;H400:1;H317:1;H334:1;Not classified:1
124815,Hexadecyl acetate,211-103-7,629-70-9,Not Classified,REACH registration C&L,192,Not classified:192
124818,"3-[(6-deoxy-α-L-mannopyranosyl)oxy]-1,8-dihydroxy-6-methylanthraquinone",208-316-2,521-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H335:38;H315:38;H302:2
124825,"3,5-bis(6-isocyanatohexyl)-2H-1,3,5-oxadiazine-2,4,6(3H,5H)-trione",256-676-4,50639-37-7,Skin Sens. 1;Acute Tox. 3;STOT SE 3,Notified C&L,25,H335:25;H331:25;H317:25
124829,"diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate",422-670-7,150202-11-2,Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H400:0;H301:0;H410:0;H361:0;H373:0
124830,16-Cyano Palmitic Acid Methyl Ester,604-787-7,151276-57-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H315:1;H332:1;H302:1
124832,strophantin-K,234-239-9,11005-63-3,Acute Tox. 3;Acute Tox. 3;STOT RE 2,Harmonised C&L,0,H331:0;H301:0;H373:0
124834,Bromochloromethane,200-826-3,74-97-5,Skin Corr. 1B;Ozone 1,REACH registration C&L,55,H314:7;H420:43;H332:45;H335:44;H315:44;H318:39;H312:3;Not classified:1;H319:1;H059:1
124839,Fluorodifen,239-474-0,15457-05-3,Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1,Notified C&L,41,H319:38;H400:38;H332:38;H315:3
124840,"(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one",418-530-1,79200-56-9,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0;H302:0
124846,C.I. Solvent Blue 79,613-622-8,64553-79-3,Not Classified,Notified C&L,1,Not classified:1
124847,3-MERCAPTOHEXANOL,440-730-0,51755-83-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1423,H319:1311;H315:1311;Not classified:110;H411:2;H302:3;H335:1
124855,Aluminium dihydrogen triphosphate,237-714-9,13939-25-8,Eye Irrit. 2,REACH registration C&L,126,H319:109;Not classified:14;H411:7;H400:7;H335:1
124856,"2,6-dimethylhept-5-enal",203-427-2,106-72-9,Skin Sens. 1B,REACH registration C&L,1773,H317:66;H226:1641;H319:43;H335:42;H315:43;Not classified:29
124857,Bis(benzonitrile)palladium chloride,238-085-3,14220-64-5,,Notified C&L,8,H311:6;H301:6;H330:4;H312:2;H332:2;H302:2;H413:2;H319:2;H331:2;H315:2
124858,"Glycerides, tall-oil mono-",263-034-7,61789-12-6,Not Classified,REACH registration C&L,446,Not classified:446
124860,"Cement, purification of copper electrolyte",922-642-9,,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1;Carc. 1A;Repr. 1A;STOT SE 2;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,1,H371:1;H372:1;H331:1;H301:1;H334:1;H411:1;H317:1;H360:1;H373:1;H350:1;H401:1
124863,"Guanidine, N-cyano-,polymer with formaldehyde",607-967-3,26591-12-8,,Notified C&L,40,Not classified:33;H412:3;H302:4
124864,"Propanenitrile, 3-[[4-[2-(2,6-dibromo-4-nitrophenyl)diazenyl]phenyl]ethylamino]-",602-862-9,12270-45-0,Not Classified,Notified C&L,3,Not classified:3
124865,NATACTONE,417-300-6,,Not Classified,Notified C&L,24,Not classified:24
124867,"4-bromo-2,6-difluorobenzoic acid",457-940-3,183065-68-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
124869,"ε-Caprolactone, oligomers, ester with 2-hydroxyethyl methacrylate",500-317-9,128152-19-2,Not Classified,Notified C&L,197,Not classified:177;H319:20;H315:20;H317:20
124871,"1,2-dimethylnaphthalene",209-364-7,573-98-8,Not Classified,Notified C&L,3,Not classified:3
124872,"Fatty acids, C16 and C18-unsatd., triesters with trimethylolpropane",270-287-7,68424-27-1,Not Classified,REACH registration C&L,103,Not classified:103
124876,"1,2,4,5-tetraisopropylbenzene",211-227-1,635-11-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
124882,"Alkanes, C10-14-iso-",271-367-4,68551-18-8,Not Classified,Notified C&L,2,Not classified:2
124885,2-ethylhexyl laurate,243-697-9,20292-08-4,Not Classified,REACH registration C&L,94,Not classified:94
124886,"Sodium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzene-1-sulphonamidato(2-)]chromate(1-)",276-558-6,72275-69-5,Aquatic Chronic 2,REACH registration C&L,18,H411:7;Not classified:9;H317:2;H410:2;H319:1;H335:1;H315:1;H412:1
124887,"4-hydroxy-3,5-dinitrobenzoic acid",213-814-8,1019-52-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
124888,Yttrium oxide sulfide,234-327-7,11099-13-1,,Notified C&L,1,Not classified:1
124889,Dilithium oxalate,209-054-1,553-91-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,64,H312:64;H302:64
124891,Zirconium dihydride,231-727-3,7704-99-6,Flam. Sol. 1,REACH registration C&L,70,H228:45;H319:42;H335:42;H315:42;H260:25
124893,"Kunzea ambigua, ext.",307-193-3,97553-36-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,4,H304:3;H315:3;H410:2;H317:3;H226:3;Not classified:1
124894,Disuccinimido sulphonylbis(ethylenecarbonate),260-904-8,57683-72-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
124897,"N'-[(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)sulfonyl]pyridine-4-carbohydrazide",606-923-0,220654-99-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
124899,3-Phenyl-2-propyn-1-ol,604-740-0,1504-58-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
124900,"5-ethyl-3,4-dihydro-4,4-diphenyl-2H-pyrrole",258-342-3,53067-74-6,Acute Tox. 4;Skin Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H302:38;H335:38;H315:38;H410:38
124908,"Fatty acids, C16-18, monoesters with sorbitol",292-979-8,91031-74-2,Not Classified,Notified C&L,1,Not classified:1
124909,"Distillates (coal), liq. solvent extn., primary;[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30°C to 300°C (86°F to 572°F). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C",302-688-0,94114-52-0,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
124910,"2'-hydroxy-4',5'-dimethylacetophenone",253-035-0,36436-65-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
124911,"2-amino-8-bromo-1,7-dihydro-6H-purin-6-one",221-320-9,3066-84-0,Acute Tox. 3;Skin Sens. 1,Notified C&L,38,H301:38;H317:38
124913,Dipotassium tetrathionate,237-702-3,13932-13-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:38;H335:38;H315:38;Not classified:2
124914,pentaerythritol tetranitrate; pentaerythrite tetranitrate;P.E.T.N.;[>20 % phlegmatiser],201-084-3,78-11-5,,,0,H200:0
124915,4-(chloromethyl)benzoic acid,216-697-1,1642-81-5,Skin Corr. 1B;Resp. Sens. 1,Notified C&L,45,H314:45;H334:38;H318:2
124917,"Benzene, (trans-4-butylcyclohexyl)-",612-102-8,61203-95-0,Not Classified,Notified C&L,1,Not classified:1
124925,"N,N'-di-2-naphthyl-p-phenylenediamine",202-249-2,93-46-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,538,H319:524;H315:510;H317:448;H413:9;Not classified:5
124931,C.I. Solvent Violet 36,612-812-8,61951-89-1,Not Classified,Notified C&L,57,Not classified:57
124932,Diethyl cyanidophosphate,220-936-5,2942-58-7,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Acute Tox. 2,Notified C&L,50,H310:43;H330:43;H314:44;H300:49;H318:2;H331:1;H301:1;H311:1
124933,"Sodium bis[4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-N,N-dimethylbenzene-1-sulphonamidato(2-)]chromate(1-)",278-137-2,75214-69-6,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1
124934,"N,N-diethyl-N',N'-dimethylethylenediamine",204-601-0,123-10-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38;H302:38
124935,"2,2,3,3-tetrafluoropropan-1-ol",200-955-5,76-37-9,Flam. Liq. 3;Eye Irrit. 2;Acute Tox. 3,REACH registration C&L,85,H226:85;H319:57;H331:50;H332:33;H315:7;H335:6;Not classified:2;H318:1;H301:1
124937,cyclooct-4-en-1-yl methyl carbonate,401-620-8,87731-18-8,Skin Sens. 1,Harmonised C&L,0,H317:0
124939,N-phenyl-p-toluidine,210-655-6,620-84-8,,Notified C&L,5,H319:5;H312:4;H315:5;H302:4
124940,"(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride",432-360-3,105813-13-6,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H317:0;H302:0
124942,"1,2-dichloro-1,1,2,2-tetramethyldisilane",224-400-1,4342-61-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,63,H226:63;H314:63;H290:1;H318:2;H312:1
124953,"Cyclohexanamine, 2-(phenylmethoxy)-, (1R,2R)-rel-",619-352-7,98454-43-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,84,H411:83;H314:83;H318:84;H302:83;H335:1;H315:1
124956,"2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide",418-060-5,118020-93-2,Aquatic Chronic 4,Harmonised C&L,0,H413:0
124960,Octadecyl 2-ethylhexanoate,261-620-7,59130-70-0,Not Classified,Notified C&L,213,Not classified:213
124963,Allyloxytrimethylsilane,242-031-4,18146-00-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:42;H315:43;H225:44;H314:1
124965,Tris(1-phenylethyl)phenol,247-155-2,25640-71-5,Not Classified,Notified C&L,29,Not classified:29
124966,L-ornithine 2-oxoglutarate (2:1),225-914-9,5144-42-3,Not Classified,Notified C&L,2,Not classified:2
124967,"Hexamethylene diisocyanate, oligomers",500-060-2,28182-81-2,Skin Sens. 1,Notified C&L,1230,H317:1214;H332:341;H335:374;H412:73;H315:150;H319:155;H334:112;H331:30;Not classified:11;H318:2;H330:6;H413:1;H411:1;H302:1
124968,"Slags, chromium-manufg., aluminothermic",282-216-7,84144-94-5,Not Classified,Notified C&L,1,Not classified:1
124972,"2-ethyl-6-hydroxy-5-[(2-methoxy-4-nitrophenyl)azo]-1H-benz[de]isoquinoline-1,3(2H)-dione",255-771-8,42358-36-1,Not Classified,Notified C&L,9,Not classified:9
124974,2-methoxy-3-methylpyrazine,220-651-6,2847-30-5,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1632,H226:1632;H302:1630;H335:41;H315:48;H318:39;H319:9;H317:1
124979,"4,9-epoxycevane-3β,4α,12,14,16β,17,20-heptol 3-veratrate",200-758-4,71-62-5,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Repr. 2,Notified C&L,129,H310:129;H319:129;H300:129;H330:129;H315:129;H335:129;H361:128
124981,"Malic acid, compound with 2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine (2:1)",257-780-2,52239-63-1,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,3,H410:3;H302:3;H400:2
124982,(2S)-3-(tert-butoxy)-2-{[(tert-butoxy)carbonyl]amino}propanoic acid,604-015-9,13734-38-8,,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
124983,2-bromotoluene,202-421-7,95-46-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H335:48;H315:49;H302:49;H411:1;H227:1
124985,"Disodium 4-[(2-amino-4-hydroxyphenyl)azo]-5-hydroxynaphthalene-2,7-disulphonate, mono[(p-nitrophenyl)azo] mono[(2-hydroxy-3,5-dinitrophenyl)azo] derivative",283-039-8,84522-43-0,Eye Irrit. 2,REACH registration C&L,37,H319:2;H412:32;Not classified:3
124988,2-(methylthio)benzothiazole,210-417-1,615-22-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:40;H335:39;H315:40;Not classified:3;H332:1;H302:1;H312:1
124995,3-methylcyclohexanone,209-710-7,591-24-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,122,H226:122;H319:81;H315:81;H335:80;H312:1;H332:1;H302:1;H336:1
124996,3-phenylpropionic acid,207-924-5,501-52-0,Not Classified,REACH registration C&L,250,Not classified:241;H319:11;H335:7;H315:11
124997,1-fluorohexane,206-763-8,373-14-8,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,40,H319:39;H331:39;H315:39;H301:40;H335:39;H311:40;H226:39;H225:1;H330:1
125001,Oxolamine,213-493-4,959-14-8,Not Classified,REACH registration C&L,1,Not classified:1
125003,"Solvate of (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol with 2-butyne-1, 4-diol (1:1)",619-496-0,960404-59-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2,H319:1;H317:2;H302:2;H335:1;H318:1;H373:1;H412:1
125005,2(2-Amino-ethoxy)-2'chloro-diethylsulfone Hydrochloride,619-328-6,98231-71-1,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H314:1;H318:1;H317:1
125013,"Phosphoric acid, 2-methylpropyl ester, potassium salt",292-411-9,90605-13-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:1
125015,Ethyl 4-hydroxy-7-trifluoromethyl-3-quinolinecarboxylate,206-871-5,391-02-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
125016,"2,4-dimethyl-1,3-dioxolane",222-221-3,3390-12-3,Flam. Liq. 2,Notified C&L,1401,H225:1401;H319:104;H335:104;H315:104
125019,Ethyl o-toluate,201-734-6,87-24-1,Eye Dam. 1,Notified C&L,38,H318:38
125021,"16,23-dihydronaphth[2',3':6,7]indolo[2,3-c]dinaphtho[2,3-a:2'3'-i]carbazole-5,10,15,17,22,24-hexone",219-599-7,2475-33-4,Skin Sens. 1,REACH registration C&L,34,H317:22;Not classified:7;H319:4;H318:1
125022,N-ethylpropylamine,243-573-4,20193-20-8,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,163,H332:156;H302:157;H335:156;H311:156;H318:86;H314:163;H225:163
125025,"N-[2-Nitro-4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-4-methoxy-benzamide",616-053-3,74149-73-8,,,0,No data
125028,"2',4'-dichloropropiophenone",253-700-5,37885-41-9,Acute Tox. 4,Notified C&L,132,H302:127;H319:5;H335:4;H315:5
125039,Niobium dioxide,234-809-7,12034-59-2,Not Classified,REACH registration C&L,65,Not classified:3;H319:62;H335:62;H315:62;H413:19
125045,"[1R-(1α,3α,4α,5β)]-3-[[3-(3,4-dihydroxyphenyl)-1-oxoallyl]oxy]-1,4,5-trihydroxycyclohexanecarboxylic acid",212-997-1,906-33-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,10,H319:10;H335:10;H315:10
125046,"(1RS, 2SR) (+/-) Methyl trans 2,6,6,-trimethyl-3-cyclohexene-1-carboxylate",453-570-1,,Aquatic Chronic 3,REACH registration C&L,28,H412:28
125047,Methyl N-[4-[(2-bromo-6-chloro-4-nitrophenyl)azo]phenyl]-N-(3-methoxy-3-oxopropyl)-β-alaninate,261-874-9,59709-38-5,Not Classified,REACH registration C&L,36,Not classified:36
125054,"thionazin (ISO);O,O-diethyl O-pyrazin-2-yl phosphorothioate",206-049-6,297-97-2,Acute Tox. 2;Acute Tox. 1,Harmonised C&L,0,H310:0;H300:0
125055,Sodium N-(6-methoxypyridazin-3-yl)sulphanilamidate,219-928-4,2577-32-4,,Notified C&L,2,H302:1;Not classified:1
125058,"Benzenesulfonic acid, mono-C16-24-alkyl derivs., calcium salts, overbased",615-049-9,70024-71-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
125059,Ethyl quinine carbonate,201-500-3,83-75-0,,Notified C&L,1,H317:1;H302:1
125060,N-[(4-chlorophenyl)methyl]pyridin-2-amine,245-283-3,22881-33-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H332:1;H302:1;H312:1;H315:1;H335:1
125062,"1-butyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile",254-296-3,39108-47-9,Eye Irrit. 2,REACH registration C&L,85,H319:85
125064,o-chlorotoluene-α-thiol,254-602-5,39718-00-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H331:5;H302:4;H301:1;H311:1
125066,2-ethylhexyl (2S)-2-hydroxypropanoate,606-097-1,186817-80-1,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3,REACH registration C&L,304,H319:304;H335:5;H315:304;H317:117;H318:156
125067,"2-(azidomethyl)-1,3-difluorobenzene",927-936-0,106308-60-5,Flam. Liq. 3;Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2;Aquatic Chronic 2,Notified C&L,1,H228:1;H319:1;H332:1;H302:1;H315:1;H335:1;H411:1;H317:1;H226:1;H361:1
125068,"Formaldehyde, reaction products with piperazine, epichlorohydrin-quaternized",291-323-8,90387-50-1,Not Classified,Notified C&L,1,Not classified:1
125070,5-bromocytosine,218-806-8,2240-25-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,39,H302:39;H335:39;H315:39;H318:39;H317:39
125071,α-[2-(dimethylamino)-1-methylethyl]-α-phenylphenethyl alcohol hydrochloride,218-674-1,2214-28-0,Acute Tox. 3;Aquatic Acute 1,Notified C&L,38,H400:38;H301:38
125073,Tetrakis[μ-(acetato-O:O')]dirhodium,240-084-8,15956-28-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H319:4;H315:5
125076,"Phenol, 2,6-difluoro-4-[(trans,trans)-4'-propyl[1,1'-bicyclohexyl]-4-yl]-",604-490-2,145767-70-0,Not Classified,Notified C&L,1,Not classified:1
125082,"2-mercaptopurine-6,8-diol",240-119-7,15986-31-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38;H302:38
125084,Famprofazone,245-284-9,22881-35-2,Acute Tox. 4,Notified C&L,38,H302:38
125088,(2-acetoxyethyl)trimethylammonium,200-128-9,51-84-3,Not Classified,Notified C&L,1,Not classified:1
125090,Tris(2-ethylhexyl) phosphite,206-111-2,301-13-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
125093,(Z)-3-hexenyl 2-methylcrotonate,267-554-5,67883-79-8,Not Classified,Notified C&L,168,Not classified:124;H315:43;H411:1
125100,trans-hex-2-en-1-ol,213-191-2,928-95-0,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,1657,H314:3;H318:3;H226:1621;H319:1467;H317:1363;H315:100;H335:99;Not classified:32;H332:1;H302:1;H312:1
125102,2-anilino-2-methylpropiononitrile,218-559-6,2182-38-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
125103,Methyl 3-phenanthryl ketone,218-020-5,2039-76-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H332:1;H302:1;H312:1;H315:1;H335:1
125106,"Licorice, Glycyrrhiza echinata, ext., calcium salts",309-068-9,99811-77-5,Not Classified,Notified C&L,1,Not classified:1
125108,Hydroflumethiazide,205-173-8,135-09-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39,H317:39;H334:39
125110,"3,5-dimethoxybenzoyl chloride",241-256-5,17213-57-9,Skin Corr. 1B,Notified C&L,43,H314:43;H290:1;H318:1
125113,Calcium 2-propylvalerate,251-521-7,33433-82-8,,Notified C&L,1,H360:1;H319:1;H315:1;H302:1
125117,"2,3,4,5-Tetrafluoro-6-nitro-benzoic acid",605-418-2,16583-08-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
125118,trizinc bis(orthophosphate),231-944-3,7779-90-0,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
125119,"Benzenebutanoic acid, 4-[(4-methoxybenzoyl)amino]-β-methyl-3-nitro-γ-oxo-, methyl ester",616-052-8,74149-72-7,,Notified C&L,1,H413:1;H317:1
125122,"5,7-dibromo-2-(5,7-dibromo-1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,2-dihydro-3H-indol-3-one",219-598-1,2475-31-2,Not Classified,Notified C&L,19,Not classified:19
125124,"6'-butoxy-3,3'-azopyridine-2,6-diyldiamine",210-506-5,617-19-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
125125,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine, 1,3-benzenedimethanamine and 2-(chloromethyl)oxirane",606-731-7,212580-83-1,Not Classified,Notified C&L,77,Not classified:77
125127,"Oligomeric reaction products of 4,4'-propane-2,2-diyldiphenol and 2-methyloxirane and 2-(chloromethyl)oxirane",460-230-6,,Skin Sens. 1B;Muta. 2;Aquatic Chronic 2;Skin Sens. 1B;Muta. 2;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H341:1;H317:1
125129,"1,10-phenanthroline-4,7-diol",223-493-6,3922-40-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:43
125134,"Orthoboric acid, lead(2+) salt",252-594-8,35498-15-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,Not classified:1;H400:1;H332:1;H302:1;H410:1;H360:1;H373:1
125136,"Chirata, ext.",292-344-5,90604-50-5,Flam. Liq. 2,Notified C&L,1286,H225:1286
125138,1-ethylpiperidin-4-one,222-781-9,3612-18-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1;H227:1
125141,2-ethylcyclopentan-1-one,225-612-7,4971-18-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
125143,5-bromo-2-fluorotoluene,257-202-9,51437-00-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
125144,2-acetamido-5-aminobenzenesulphonic acid,230-214-1,6973-05-3,Not Classified,REACH registration C&L,1,Not classified:1
125146,"2,6-diethylaniline",209-445-7,579-66-8,Acute Tox. 4,Harmonised C&L,0,H302:0
125147,1-(p-chlorophenyl)cyclopropanecarboxylic acid,277-105-5,72934-37-3,,Notified C&L,8,H319:8;H335:7;H315:8;H302:2;H332:1
125148,[[(phosphonomethyl)imino]bis[hexamethylenenitrilobis(methylene)]]tetrakisphosphonic acid,252-156-6,34690-00-1,Met. Corr. 1;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,59,H315:2;H290:4;H318:7;H314:45;Not classified:12;H371:1;H373:1;H402:1;H412:1
125151,Cholest-5-en-3β-yl (Z)-octadec-9-en-1-yl carbonate,241-179-7,17110-51-9,Not Classified,Notified C&L,2,Not classified:2
125154,"6,6'-di-tert-butyl-4,4'-butylidenedi-m-cresol",201-618-5,85-60-9,Not Classified,REACH registration C&L,319,Not classified:128;H410:71;H412:43;H413:42;H319:76;H335:41;H315:44;H373:33
125157,"Boronic acid, [6-(benzoylmethylamino)-5-methyl-3-pyridinyl]-",610-203-1,446299-81-6,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H411:2;H317:3
125158,"5-[[2,4-dihydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]phenyl]azo]-4-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonic acid",289-014-8,85959-23-5,Not Classified,Notified C&L,1,Not classified:1
125160,"1-(α,α,α-trifluoro-m-tolyl)acetone",244-652-6,21906-39-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
125167,o-xylene,202-422-2,95-47-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Harmonised C&L,0,H226:0;H312:0;H315:0;H332:0
125170,"Gases (petroleum, light steam-cracked, butadiene conc.;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]",273-265-5,68955-28-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H340:0;H350:0;H220:0
125177,"1,9-dichlorononane",212-484-2,821-99-8,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,41,H400:2;H410:2;H319:39;H335:38;H315:39;H411:1
125181,"Potassium 2,4,5-trichlorophenoxyacetate",253-667-7,37785-57-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
125182,4-(1-methylpropyl)-2-nitrophenol,222-611-3,3555-18-8,Acute Tox. 4,Notified C&L,38,H302:38
125184,"44-(nonylphenoxy)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontanol",260-678-0,57321-10-5,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,25,H412:25;H302:25
125186,"Dimethyl cyclohexane-1,4-dicarboxylate",202-347-5,94-60-0,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,91,H319:55;H412:2;Not classified:36;H335:1;H315:1
125187,"1,1,1-trifluoroethane",206-996-5,420-46-2,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,191,H221:17;H280:166;H220:150;H224:23;H312:1
125194,"Glycerides, tallow mono-, di- and tri-, hydrogenated",269-658-6,68308-54-3,Not Classified,Notified C&L,166,Not classified:166
125196,[No public or meaningful name is available],639-933-9,119299-01-3,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,33,H411:33;H314:33
125198,"1,4-bis[(2-bromo-4,6-dimethylphenyl)amino]anthraquinone",241-948-7,18038-99-8,Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H302:1
125200,"chlorfenac (ISO);2,3,6-trichlorophenylacetic acid",201-599-3,85-34-7,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
125201,"3,4-dichlorobenzaldehyde",228-520-5,6287-38-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,50,H314:47;H318:39;H319:3;H315:3;H412:3
125203,"Phosphoric acid, 2-methylpropyl ester, compd. with 2,2',2''-nitrilotris[ethanol]",300-049-0,93919-64-3,Not Classified,Notified C&L,1,Not classified:1
125206,Glipentide,251-226-3,32797-92-5,Skin Sens. 1;Muta. 2;Repr. 2,Notified C&L,1,H361:1;H341:1;H317:1
125208,Sodium bis[N-[7-hydroxy-8-[[2-hydroxy-5-sulphamoylphenyl]azo]-1-naphthyl]acetamidato(2-)]chromate(1-),246-146-0,24305-97-3,Not Classified,Notified C&L,2055,Not classified:2051;H319:2;H412:2
125212,Iron oxide black,235-442-5,12227-89-3,Not Classified,Notified C&L,368,Not classified:361;H332:3;H251:3;H252:1
125218,Melaleuca Tea Tree Oil,617-013-8,8022-72-8,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Repr. 2;Aquatic Chronic 2,Notified C&L,12,H319:11;H302:11;H304:10;H315:11;H336:10;H411:10;H317:10;H361:10;Not classified:1;H334:1
125221,"7-hydroxy-3H-phenoxazin-3-one, sodium salt",252-310-2,34994-50-8,Skin Irrit. 2;STOT SE 3,Notified C&L,154,H335:154;H315:154;H319:38
125222,1-Piperidinecarbonyl chloride,604-129-9,13939-69-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H314:39;H318:38
125224,p-(2-naphthylamino)phenol,202-248-7,93-45-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,39,H319:38;H332:38;H312:38;H315:38;H335:38;H351:38;H411:1
125226,"Fusel oil, distn. residues",281-997-1,84082-50-8,Flam. Liq. 3;Acute Tox. 4;STOT SE 3,Notified C&L,83,H226:58;H335:56;H332:57;H302:25;H225:1;H315:1;H318:1;H317:1;H412:1
125227,2-methoxybenzylamine,229-941-7,6850-57-3,Skin Corr. 1B,Notified C&L,46,H314:46;H318:3;H413:1;H302:1;H312:1
125228,"reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine",414-340-6,,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Acute Tox. 4;STOT SE 2;Aquatic Chronic 3,Harmonised C&L,0,H371:0;H332:0;H302:0;H312:0;H317:0;H318:0;H226:0;H412:0
125230,(2S)-pentan-2-ol,700-266-4,26184-62-3,Flam. Liq. 3;Acute Tox. 4;STOT SE 3,Notified C&L,123,H226:123;H335:123;H332:122;H319:2;H315:2
125232,"1H-2-Benzopyrano[6',5',4':10,5,6]anthra[2,1,9-def]isoquinoline-1,3,8,10(9H)-tetrone, 9-methyl-",615-137-7,70654-96-5,,Notified C&L,31,H413:31
125234,(3-(Formylamino)propyl)dimethylammonioacetate,480-680-7,,Not Classified,REACH registration C&L,1,Not classified:1
125235,Cyclopentanethiol,216-841-3,1679-07-8,Flam. Liq. 3,Notified C&L,44,H226:44
125237,4-CHLORO-2-FLUOROBENZYL BROMIDE,615-694-6,71916-82-0,,Notified C&L,9,H314:9;H312:1;H332:1;H302:1;H290:1;H318:2
125239,nickel(II) trifluoroacetate,240-235-8,16083-14-0,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H400:0;H341:0;H372:0;H334:0;H410:0;H317:0;H360:0;H350:0
125241,"Benzenesulfonic acid, dodecyl-, compd. with (Z)-.alpha.,.alpha.'-[(9-octadecenylimino)di-2,1-ethanediyl]bis[.omega.-hydroxypoly(oxy-1,2-ethanediyl)]",613-939-1,66467-20-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,17,H315:17;H318:17;H302:17;H411:1
125244,"Fatty acids, palm-oil",270-438-7,68440-15-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,48,H319:34;H315:34;Not classified:14
125245,Vitamin A,234-328-2,11103-57-4,Not Classified,Notified C&L,1,Not classified:1
125246,4-chloro-N-(3-methoxypropyl)-3-nitrobenzenesulphonamide,273-416-5,68959-43-3,Eye Irrit. 2;STOT SE 3,Notified C&L,2039,H319:2039;H335:2039;H412:2039
125248,"Hexamethylene diisocyanate, oligomers, reaction products with N-(3-trimethoxysilyl)propylbutylamine and Bis-(Trimethoxysilylpropyl)amine",926-191-9,,Skin Sens. 1B,REACH registration C&L,85,H317:85
125255,(cyano-C)diethylaluminium,227-359-8,5804-85-3,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1,Notified C&L,38,H310:38;H330:38;H400:38;H300:38
125256,"13-ethyl-3-methoxygona-2,5(10)-dien-17β-ol",238-513-9,14507-49-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H400:4;H410:4
125259,Vanillin,204-465-2,121-33-5,Eye Irrit. 2,REACH registration C&L,2405,H319:1787;H317:342;H302:222;Not classified:101;H315:18;H332:6;H335:3;H303:1;H412:2;H400:1;H341:1;H361:1
125261,"Rape oil, reaction products with diethylenetriamine",293-615-0,91081-13-9,Skin Sens. 1B,REACH registration C&L,25,H317:24;H319:22;H315:22;Not classified:1
125262,4-(4-hydroxyphenyl)butan-2-one,226-806-4,5471-51-2,Not Classified,REACH registration C&L,2004,Not classified:1395;H302:610;H312:6;H319:1;H315:1
125263,"Barium 4-(1,1-dimethylethyl)benzoate",233-490-1,10196-68-6,Acute Tox. 4,Notified C&L,128,H302:127;H332:43;H312:40;H411:42;H361:41;H373:41;Not classified:1;H360:2;H372:2;H319:1;H371:1
125267,substituted alkylalkanoate,,,Not Classified,Notified C&L,1,Not classified:1
125268,"(2,4-dioxo-1,3-benzoxazin-7-yl) ethyl carbonate",605-404-6,16535-55-0,Eye Irrit. 2,REACH registration C&L,1,H319:1
125269,cis-2-bromovinyl ethyl ether,245-712-4,23521-49-5,Flam. Liq. 3,Notified C&L,43,H226:43;H302:4
125272,"[1,1'-Bicyclohexyl]-4-carboxaldehyde, 4'-butyl-, (trans,trans)-",603-498-3,131610-58-7,Skin Sens. 1,REACH registration C&L,2,H317:2
125274,"Naphthalene-1,2-diol",209-365-2,574-00-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
125286,4-(chloromethyl)-2-nitrotoluene,283-154-3,84540-59-0,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H314:38;H318:38
125289,Carbasalate calcium,227-273-0,5749-67-7,,Notified C&L,2,H335:1;H315:1;H302:2
125290,N-[2-[(4-amino-m-tolyl)ethylamino]ethyl]methanesulphonamide,202-124-2,92-09-1,Acute Tox. 3;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H400:2;H301:2;H410:3;H318:3;H317:3;Not classified:1;H302:1;H373:1;H314:1;H290:1
125292,Dimethylditetradecylammonium bromide,268-474-3,68105-02-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
125293,Dicesium pentachloronitrosylosmate(2-),245-124-8,22615-69-6,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H317:1
125294,"(1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl(2S)-2-methylbutanoate",700-442-0,73573-88-3,Not Classified,Notified C&L,2,Not classified:1;H362:1;H351:1;H317:1;H360:1;H373:1;H412:1
125295,1-methyl-2-phenoxyethylamine,252-434-7,35205-54-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H335:3;H315:3;H332:1;H302:1;H312:1;H318:1
125298,4-ethoxyphenylthiourea,212-912-8,880-29-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
125300,"2,3-dichlorobenzoyl chloride",220-811-5,2905-60-4,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H410:38;H400:38;H314:44;H302:38;H290:1;H318:1
125303,"Foots oil (petroleum), acid-treated;[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C",300-225-7,93924-31-3,Press. Gas;Flam. Gas 1;Carc. 1B,Harmonised C&L,0,Not classified:0;H340:0;H350:0;H220:0
125305,"1,2-dimethylcyclohexane",209-509-4,583-57-3,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,51,H304:51;H225:51;H315:8;H336:12;H411:8
125307,Tin phosphide,246-848-7,25324-56-5,,Notified C&L,4,H332:4;H302:4
125309,"2-Methyl-4-(1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine",605-264-6,161696-76-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,130,H319:129;H335:129;H315:129;H318:1;H301:1;H317:1
125310,"1,3-diisopropyl-2-thiourea",221-051-7,2986-17-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,40,H331:38;H311:38;H301:38;H302:1;H319:1;H335:1;H315:1
125312,2-iodo-5-nitrotoluene,226-204-1,5326-38-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
125314,"cis-4-cyclohexene-1,2-dicarboximide",248-667-9,27813-21-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
125320,5-[1-methyl-1-[4-(oxiranylmethoxy)phenyl]ethyl]-2-(oxiranylmethoxy)benzyl alcohol,221-688-0,3188-83-8,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,20,H411:20;H317:20
125324,"2-Bromo-4,5,6-trifluoroaniline",602-692-5,122375-82-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H319:40;H332:40;H302:40;H312:40;H315:40;H335:40
125329,Undecafluorohexanoic acid,206-196-6,307-24-4,Skin Corr. 1B,Notified C&L,44,H314:44;H335:3;H290:1;H318:1;H311:1;H301:1;H330:1
125331,"2,2-Difluoro-1,3-dimethylimidazolidine",606-909-4,220405-40-3,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,41,H226:41;H314:41;H301:1;H318:1
125338,"1,2,3,4,7,7-hexachlorobicyclo[2.2.1]hepta-2,5-diene",222-220-8,3389-71-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
125339,"[R(R*,R*)]-2,3-dimethoxy-N,N,N'N'-tetramethylbutane-1,4-diamine",247-795-2,26549-22-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
125340,1-(4-tert-butylphenyl)piperazine,268-473-8,68104-61-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H311:1;H314:1;H301:1
125341,"Zinc sulfide (ZnS), copper and lead-doped",271-598-0,68585-90-0,Acute Tox. 4;Acute Tox. 4;Repr. 1A;Aquatic Acute 1,Notified C&L,1,H400:1;H332:1;H302:1;H410:1;H360:1
125344,Eisen(II)-sulfat,603-840-1,13463-43-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,60,H319:60;H400:39;H302:60;H315:60;H410:39;H317:13;H335:4
125347,"Eschscholtzia californica, ext.",289-837-2,90028-46-9,Flam. Liq. 3,Notified C&L,3,H226:3
125348,Dipiperidinomethane,212-911-2,880-09-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
125349,2-[(o-nitrophenyl)azo]acetoacetanilide,223-884-1,4106-67-6,Not Classified,Notified C&L,69,Not classified:69
125350,4-chloro-3-(trifluoromethyl)benzaldehyde,251-940-5,34328-46-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
125351,Barium 2-cyanoethyl phosphate,225-696-5,5015-38-3,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:38;H331:1;H301:1
125352,Titanium dihydride,231-726-8,7704-98-5,Flam. Sol. 1,REACH registration C&L,106,H228:106
125355,(2-acetylthio)ethyltrimethylammonium perchlorate,282-585-4,84255-37-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
125358,"Distillates (coal tar), high-temperature, heavy oils",310-231-1,140203-21-0,Skin Irrit. 2;Skin Sens. 1;Muta. 1B;Carc. 1A;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H315:2;H410:2;H340:2;H317:2;H360:2;H350:2
125365,"1,2-dibromobenzene",209-507-3,583-53-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:40;H315:45;H411:4
125372,4-Bromo-2-chloro-1-fluorobenzene,612-037-5,60811-21-4,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H410:42;H400:42;H315:43;H302:42;H319:1;H335:1
125379,Mercury chloride,231-430-9,7546-30-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H310:2;H400:1;H330:2;H300:2;H410:2;H373:2
125382,3-hydroxy-3-ethylbutanone,204-073-1,115-22-0,Flam. Liq. 3,Notified C&L,44,H226:44
125391,Tetrakis(triphenylphosphine)palladium,238-086-9,14221-01-3,Aquatic Chronic 4,REACH registration C&L,132,H413:90;H317:84;H302:126;H312:4;H332:5;H319:2;H315:2;H335:2;Not classified:1;H351:1
125400,"Glycerides, fish-oil mono- and di-",309-182-9,100085-41-4,Not Classified,Notified C&L,111,Not classified:111
125401,"Tar acids, cresylic, Ph phosphates",273-168-8,68952-35-2,Not Classified,Notified C&L,15,Not classified:15
125402,"1,4-bis[chloro(difluoro)methyl]benzene",700-265-9,2629-68-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
125403,"Fatty acids, C6-12, compds. with diethanolamine",270-288-2,68424-28-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
125409,Sodium 2-chloroethanesulphonate,239-508-4,15484-44-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
125416,"1,8-dihydroxy-3-methoxy-6-methylanthraquinone",208-315-7,521-61-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H335:42;H315:42;H302:1
125418,Sodium (5or8)-[(4-hydroxy-2-methylphenyl)azo]-(8or5)-(phenylazo)naphthalene-2-sulphonate,268-229-0,68039-07-6,Not Classified,Notified C&L,1,Not classified:1
125419,Sodium benzoate,208-534-8,532-32-1,Eye Irrit. 2A,REACH registration C&L,2874,H319:1031;Not classified:1833;H317:8;H302:2;H315:1;H280:1
125423,Dimethyl oxalate,209-053-6,553-90-2,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,79,H314:18;H318:14;H302:23;H319:60;H315:60;H335:1;Not classified:1
125425,"Litsea citrata, ext.",307-194-9,97553-37-2,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,28,H304:28;H411:28;H315:28;H317:28
125430,2-ethoxybenzaldehyde,210-349-2,613-69-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
125431,Ditridecyl phosphonate,253-034-5,36432-46-9,Not Classified,Notified C&L,1,Not classified:1
125433,Pentagastrin,226-889-7,5534-95-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
125434,bromoethane;ethyl bromide,200-825-8,74-96-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Carc. 2,Harmonised C&L,0,H351:0;H225:0;H332:0;H302:0
125435,"1-(4-hydroxyphenyl)-1H-pyrrole-2,5-dione",230-750-6,7300-91-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H301:1
125438,Tetrakis(2-ethylbutyl) orthosilicate,201-085-9,78-13-7,Skin Sens. 1B,REACH registration C&L,2,H317:1;Not classified:1
125440,"1-hexyl-1,2-dicarbadodecaborane(12)",244-003-7,20740-05-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H315:1
125441,1-amino-4-hydroxyanthraquinone,204-163-0,116-85-8,,Notified C&L,14,H341:14
125445,"3-Ethyl-4-methyl-2-oxo-2,5-dihydropyrrole-1-carboxylic acid phenethylamide",925-067-1,,Skin Sens. 1;Carc. 2;Aquatic Chronic 4,REACH registration C&L,2,H351:2;H413:2;H317:2
125447,"Octadecanoic acid, reaction products with diethylenetriamine and urea",605-227-4,160799-07-5,Not Classified,Notified C&L,1,Not classified:1
125450,Anisaldehyde,204-602-6,123-11-5,Aquatic Chronic 3,REACH registration C&L,3929,H412:34;Not classified:2301;H302:1592;H312:1;H314:2;H331:1;H319:7;H335:5;H315:8;H318:3;H317:4;H372:1;H336:1;H373:1;H340:1;H360:1;H226:1;H225:1
125451,3-aminophenol,209-711-2,591-27-5,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H332:0;H302:0
125453,2-chloronicotinic acid,220-937-0,2942-59-8,Not Classified,REACH registration C&L,30,Not classified:13;H319:18;H335:16;H315:18;H302:1;H341:1
125460,N-(3β-hydroxyolean-12-en-28-oyl)-L-lysyl-L-threonyl-L-threonyl-L-lysyl-L-Serine,921-112-4,,Acute Tox. 5;Skin Mild Irrit. 3;Skin Sens. 1B;Eye Irrit. 2B,Notified C&L,1,H317:1;H320:1;H316:1;H303:1
125461,3-morpholinopropiophenone hydrochloride,213-815-3,1020-16-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
125462,Dicyclohexyl oxalate,210-654-0,620-82-6,Aquatic Acute 1,Notified C&L,38,H400:38
125468,(2S)-2-butoxybutan-1-ol,607-637-9,25190-06-1,Aquatic Chronic 3,Notified C&L,440,H412:154;H319:179;Not classified:107;H335:52;H315:52
125470,2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride,411-110-7,136213-74-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
125477,"2-Naphthalenol, 1-[[4-(phenylazo)phenyl]azo]-, ar',ar''-Me derivs.",274-972-1,70879-65-1,Acute Tox. 4,REACH registration C&L,61,H302:1;Not classified:56;H351:4;H413:3;H341:4;H317:4
125480,"3,7-dimethylnon-6-en-1-yn-3-ol",246-061-9,24173-47-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H411:1;H319:2;H315:2;H410:1
125481,4-amino-1-naphthol hydrochloride,227-727-8,5959-56-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:44;H315:45
125486,"2-Propenoic acid, methyl ester, reaction products with mixed O,O-bis(branched and linear pentyl and iso-Bu) phosphorodithioates",300-340-2,93925-38-3,Not Classified,REACH registration C&L,2,Not classified:2
125487,3-(2-(Diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile,616-395-3,76823-93-3,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
125488,"(R*,S*)-3-mercaptobutan-2-ol",253-701-0,37887-04-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1440,H319:1430;H335:1440;H315:1430;H226:51
125491,Trimethyloxonium tetrafluoroborate(1-),206-994-4,420-37-1,Skin Corr. 1B,Notified C&L,50,H314:50;H318:5;H302:2
125492,Niobium oxide,234-808-1,12034-57-0,Ox. Sol. 2,REACH registration C&L,217,H272:1;H319:216;H335:216;H315:216
125493,"Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",308-713-1,98219-46-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
125495,"Phenol, propoxylated",500-061-8,28212-40-0,Not Classified,Notified C&L,1,Not classified:1
125499,"9-[4-(chlorosulphonyl)-2-sulphonatophenyl]-3,6-bis(diethylamino)xanthylium",263-735-8,62796-29-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,155,H319:155;H335:155;H315:155;H302:116
125500,Naphazoline nitrate,225-915-4,5144-52-5,Acute Tox. 4,Notified C&L,43,H302:43
125501,"Slags, ferromolybdenum-manufg., silicothermic",282-217-2,84144-95-6,Not Classified,REACH registration C&L,6,Not classified:6
125503,Silver(1+) pentafluoropropionate,208-093-1,509-09-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38;H302:38
125507,2-(triphenylphosphoranylidene)succinic anhydride,212-998-7,906-65-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
125508,1-(dichloromethyl)-4-fluorobenzene,207-258-5,456-19-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 3,Notified C&L,39,H332:39;H302:39;H312:38;H335:38;H314:39;H341:1;H318:1
125509,"1,1,5,5,5-hexamethyl-3,3-bis[(trimethylsilyl)oxy]trisiloxane",222-613-4,3555-47-3,Not Classified,REACH registration C&L,287,Not classified:59;H319:204;H335:203;H315:204;H413:24
125511,"N-(2,6-difluorophenyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide",619-383-6,98967-40-9,Aquatic Chronic 1,REACH registration C&L,253,H410:212;H400:249;H332:38;Not classified:3
125514,N-[4-(methoxymethyl)piperidin-4-yl]-N-phenylpropionamide hydrochloride,282-425-3,84196-16-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H302:2;H319:1
125517,Butanedione dioxime,202-420-1,95-45-4,Flam. Sol. 2;Acute Tox. 3,Notified C&L,56,H228:48;H301:47;H302:3;H319:1;H312:1;Not classified:2
125518,"9-fluoro-11β,17-dihydroxy-6α-methylpregna-1,4-diene-3,20-dione 17-acetate",223-270-3,3801-06-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,3,H361:3;H319:2;H335:2;H315:2;H373:1;H318:1
125521,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecanesulphonic acid",254-295-8,39108-34-4,Acute Tox. 4;Eye Dam. 1;STOT RE 2,Notified C&L,56,H373:55;H318:55;H302:56;H335:1;H314:1
125522,Carrot seed oil,616-965-1,8015-88-1,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,126,H304:63;H226:101;H411:62;H317:63;H315:26;H412:1
125524,"Fatty acids, C16-18 and C18-unsatd., branched and linear, butyl esters",441-620-5,,Not Classified,REACH registration C&L,2,Not classified:2
125527,Benzothiazol-2-ylhydrazine,210-416-6,615-21-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,44,H319:43;H315:43;H301:40;H335:4;H302:4;H331:1;H311:1
125528,"1,3-dimethoxypropan-2-ol",801-583-1,623-69-8,,Notified C&L,2,H226:2;H336:1
125529,3-iodpropene;allyl iodide,209-130-4,556-56-9,Flam. Liq. 2;Skin Corr. 1B,Harmonised C&L,0,H314:0;H225:0
125530,"lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide",411-690-1,111337-53-2,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H314:0;H317:0;H302:0
125535,Fencamfamin hydrochloride,218-805-2,2240-14-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,194,H331:194;H311:194;H301:194
125540,Aluminium triphenolate,239-137-8,15086-27-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
125542,"(2R)-2-[(2R,3S,6R)-6-[[(2S,4R,5R,7R,9R,10R)- 2-[(2R,5S)-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-Hydroxy- 6-(hydroxymethyl)-3,5-dimethyl-2-tetrahydropyranyl]-3-methyl- 2-tetrahydrofuranyl]-5-methyl-2-tetrahydrofuranyl]-9-methoxy- 2,4,10-trimethyl-1,6-dioxaspiro[4.5]decan-7-yl]methyl]-3-methyl- 2-tetrahydropyranyl]propanoic acid sodium salt",608-231-4,28643-80-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:41;H335:41;H315:41;H301:42
125544,"N-acetyl-L-cysteine, compound with [R-(R*,R*)]-2-[(dichloroacetyl)amino]-3-hydroxy-3-[4-mesylphenyl]propyl glycinate (1:1)",243-572-9,20192-91-0,Not Classified,Notified C&L,1,Not classified:1
125550,"N-[2-Amino-4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-4-methoxy-benzamide",616-054-9,74149-74-9,Not Classified,Notified C&L,1,Not classified:1
125557,"Juniper, Juniperus mexicana, ext., epoxidized",309-066-8,99811-75-3,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H319:1;H411:1;H317:1
125559,Bis(1-phenylethyl)phenol,247-154-7,25640-70-4,Not Classified,Notified C&L,84,Not classified:84
125562,"Trisodium 5-[[4-chloro-6-(methylphenylamino)-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",274-417-3,70210-20-7,Skin Sens. 1B,REACH registration C&L,17,H317:7;Not classified:10;H319:1;H315:1
125570,Bis(2-hydroxyethyl)ammonium toluene-p-sulphonate,257-781-8,52243-33-1,,Notified C&L,1,Not classified:1
125572,1-[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium acetate,261-873-3,59709-10-3,Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,130,H400:7;H318:129;H317:7;H410:7;H412:123;H302:33;H315:2;H319:1
125573,2-phenoxypropionic acid,213-370-5,940-31-8,,Notified C&L,9,H319:6;H335:5;H315:6;Not classified:3
125574,"1,4-dichlorobutan-2-ol",219-339-2,2419-74-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H332:1;H302:1;H312:1;H315:1
125579,"Phosphoric acid, C13-15-branched and linear alkyl esters, compds. with triethanolamine",297-781-5,93762-65-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
125585,"Benzenesulfonic acid, 4-dodecyl-, cerium(4+) salt, basic",282-500-0,84238-45-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,9,H411:2;H315:2;H318:2;Not classified:5;H413:2
125587,Octamethylenediamine,206-764-3,373-44-4,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,132,H314:132;H318:87;H317:93;H302:94
125588,"(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone",201-501-9,83-79-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H400:0;H335:0;H315:0;H301:0;H410:0
125589,Octan-3-ol,209-667-4,589-98-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1549,H319:1412;H315:1422;Not classified:98;H335:38;H412:13
125591,"(3S)-1,3,4-Trihydroxy-2-butanone",443-800-9,,Not Classified,REACH registration C&L,17,Not classified:17
125595,"Fatty acids, C14-18 and C16-18-unsatd.",266-930-6,67701-06-8,Not Classified,REACH registration C&L,411,Not classified:410;H319:1
125597,"Benzenesulfonic acid, hydroxy-, polymer with formaldehyde, phenol and urea, sodium salt",600-378-2,102980-04-1,Aquatic Chronic 3,Notified C&L,139,H412:83;Not classified:34;H319:22
125598,1-(2-methoxyphenyl)ethan-1-one,209-446-2,579-74-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:39;H315:1
125601,p-chloro-α-[2-(dimethylamino)-1-methylethyl]-α-methylphenethyl alcohol hydrochloride,214-931-7,1215-83-4,Acute Tox. 4,Notified C&L,5,H302:5
125602,S-methyl butanethioate,219-407-1,2432-51-1,Flam. Liq. 3,Notified C&L,1649,H226:1649;H319:44;H315:44;H335:43
125604,3-(triethoxysilyl)propyl methacrylate,244-239-0,21142-29-0,Not Classified,REACH registration C&L,31,Not classified:28;H319:3;H315:3;H335:1
125606,"Disodium 7-[[2,4-dihydroxy-5-[[4-[(4-sulphonatophenyl)azo]phenyl]azo]phenyl]azo]-4-hydroxynaphthalene-2-sulphonate",289-015-3,85959-24-6,Not Classified,Notified C&L,1,Not classified:1
125611,"21-Acetoxy-6 alpha-fluoro-16 alpha-methyl-4-pregnene-3,20-dione",603-033-4,1251-28-1,Aquatic Chronic 1,Notified C&L,1,H410:1
125612,3-CARBOXYPHENYLBORONIC ACID,607-734-6,25487-66-5,,Notified C&L,12,H319:11;H335:10;H315:11;H312:1;H332:1;H302:1
125614,"4-hydroxynaphthalene-2,7-disulphonic acid",209-432-6,578-85-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:1
125617,"Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2β,3β,4β,5α,12β,19α)-",218-558-0,2182-14-1,Muta. 2,Notified C&L,40,H341:39;H332:1;H302:1
125619,"3,5-Difluorobenzaldehyde",608-701-9,32085-88-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H226:43;H319:49;H315:49;H335:48;H228:5
125620,"oxydemeton-methyl;S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate",206-110-7,301-12-2,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0,H311:0;H400:0;H301:0
125623,Undec-1-ene,212-483-7,821-95-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H319:44;H332:44;H302:44;H335:43;H315:44;Not classified:3
125625,Aluminum Zirconium Pentachlorohydrex Gly,603-096-8,125913-22-6,Not Classified,Notified C&L,1,Not classified:1
125628,reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate,435-960-3,,Skin Sens. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H350:0;H340:0;H317:0
125629,"Licorice, Glycyrrhiza asperrima, ext., calcium salts",309-067-3,99811-76-4,Not Classified,Notified C&L,1,Not classified:1
125630,"Fatty acids, soya",269-657-0,68308-53-2,Not Classified,Notified C&L,70,Not classified:70
125631,Lithiumbis(trimethylsilyl)amide,223-725-6,4039-32-1,Flam. Sol. 1;Self-heat. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,174,H228:84;H251:6;H314:174;H318:90;H332:84;H302:83;H312:84;H412:84;H336:5;H373:5;H411:5;H225:5
125638,"8,8-diethoxy-2,6-dimethyloctan-2-ol",231-945-9,7779-94-4,Not Classified,Notified C&L,120,Not classified:120
125641,N-(2-Nitrophenyl)phosphoric triamide,618-024-0,874819-71-3,Repr. 1A;Aquatic Chronic 3,Notified C&L,2,H360:1;H412:1;H319:1;H332:1;H302:1;H312:1;H315:1;H335:1
125646,"Raphanus niger, ext.",296-843-9,93062-87-4,Not Classified,Notified C&L,1,Not classified:1
125653,"Phosphoric acid, 2-methylpropyl ester, compd. with 2,2'-iminobis[ethanol]",300-048-5,93919-63-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
125654,Cloridarol,222-780-3,3611-72-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
125655,Ethyl β-alaninate hydrochloride,210-507-0,617-27-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
125656,"1,1-dimethylpiperidinium chloride;mepiquat chloride",246-147-6,24307-26-4,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
125658,"Fatty acids, C18-unsatd., dimers, mixed esters with decanoic acid, octanoic acid and trimethylolpropane",605-693-9,173832-39-8,Not Classified,Notified C&L,6,Not classified:6
125659,6-amino-1-methyl-5-nitrosouracil,230-213-6,6972-78-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
125666,"Resin acids and Rosin acids, barium salts",269-142-0,68188-14-7,Self-heat. 1;Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,215,H319:2;H332:124;H302:206;H251:2;H317:4;Not classified:7;H228:1;H316:1;H320:1
125669,2-amino-2-phenylbutyrate sodium,302-748-6,94133-84-3,Not Classified,REACH registration C&L,5,Not classified:4;H228:1;H341:1;H332:1;H302:1;H315:1
125672,"1-Tetradecanol, phosphate, compd. with 2-aminoethanol",308-608-0,98143-43-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
125677,1-(3-fluorophenyl)piperazine,223-271-9,3801-89-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H332:1;H302:2;H312:1;H315:1;H335:1;H412:1
125678,"1-Octene, polymer with ethene",607-890-5,26221-73-8,Not Classified,Notified C&L,123,Not classified:123
125680,"Distillates (petroleum), light thermal cracked, debutanized arom.;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]",273-266-0,68955-29-3,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
125682,Diethyl (3-thienyl)malonate,253-666-1,37784-67-1,,Notified C&L,1,H319:1;H335:1;H315:1;H318:1
125683,cis-hex-2-en-1-ol,213-190-7,928-94-9,Not Classified,Notified C&L,132,Not classified:88;H226:44;H319:39
125687,"salts of 4,4'-bi-o-toluidine;salts of 3,3'-dimethylbenzidine;salts of o-tolidine",277-985-0,74753-18-7,Acute Tox. 4;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H350:0;H302:0
125691,"Naphtha (petroleum), light steam-cracked, thermally treated;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",308-714-7,98219-47-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
125697,Piperine,202-348-0,94-62-2,Acute Tox. 3,Notified C&L,1771,H301:1713;H302:57;H361:4;H411:4;H319:2;H315:2;H335:1
125705,"3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-ol",267-140-4,67801-20-1,Aquatic Chronic 2,REACH registration C&L,1688,H411:1501;Not classified:187
125706,Vanillic acid,204-466-8,121-34-6,Not Classified,REACH registration C&L,196,Not classified:98;H319:98;H335:97;H315:98
125711,"Eucalyptus camaldulensis, ext.",307-648-6,97675-74-6,Not Classified,Notified C&L,216,Not classified:184;H304:32;H315:32;H411:32;H317:32;H226:32
125717,"1-Pyrrolidinecarboxylic acid, 3-(1-methylethyl)-2-oxo-5-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]-, 1,1-dimethylethyl ester, (3S,5S)-",618-951-0,934841-17-5,Not Classified,Notified C&L,116,Not classified:116
125720,"1-Naphthalenemethanamine, .alpha.-methyl-",608-829-5,3309-13-5,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,87,H411:83;H314:87;H301:87;H318:83;H311:4
125721,"2-ethylhexanoic acid, manganese salt",240-085-3,15956-58-8,Eye Irrit. 2;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,489,H319:322;H361:144;H411:99;H373:144;H335:177;H315:323;H317:176;H302:75;H312:24;Not classified:21;H400:1;H332:2;H410:1
125727,"ethyl 5-hydroxy-1,2-dimethyl-1H-indole-3-carboxylate",605-026-1,15574-49-9,Not Classified,REACH registration C&L,6,Not classified:4;H410:1;H400:1;H302:2;H319:1;H335:1;H315:1;H412:1
125730,Dichloroacetaldehyde,201-169-5,79-02-7,Not Classified,Notified C&L,2,Not classified:1;H310:1;H400:1;H330:1;H335:1;H301:1;H351:1;H318:1;H314:1
125734,"Glycoproteins, bovine-whey",281-998-7,84082-51-9,Not Classified,Notified C&L,1,Not classified:1
125735,"2,6-dimethylcyclohexylamine",229-942-2,6850-63-1,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3,Notified C&L,85,H331:85;H301:85;H318:85;H226:85;H314:85;H412:2
125737,8-(trifluoromethyl)quinolin-4-ol,245-879-3,23779-96-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
125739,"2H-Pyran-4-ol, tetrahydro-4-methyl-2-propyl-, 4-acetate",603-508-6,131766-73-9,Skin Irrit. 2,Notified C&L,35,H315:25;H317:10
125744,(4-(methylthio)phenyl)boronic acid,619-361-6,98546-51-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,99,H319:98;H335:97;H315:98;H312:1;H332:1;H302:2
125750,"3-ethylthiopropane-1,2-diol",262-419-7,60763-78-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
125751,"1,3-Butadiene, 2-methyl-, homopolymer, chlorinated",614-502-8,68441-58-7,Not Classified,Notified C&L,2,Not classified:2
125752,2-pyridone hydrazone dihydrochloride,263-541-3,62437-99-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H302:38;H312:38;H315:38;H335:38
125758,"1,1'-Bicyclohexyl, 4-ethyl-4'-pentyl-, (trans,trans)-",619-231-9,96624-43-0,Not Classified,Notified C&L,1,Not classified:1
125766,2-[[4-[(2-cyano-3-nitrophenyl)azo]-m-tolyl](2-acetoxyethyl)amino]ethyl acetate,266-510-2,66882-16-4,Not Classified,Notified C&L,39,Not classified:29;H412:9;H317:1
125768,Potassium hydroxyoctaoxodizincatedichromate(1-),234-329-8,11103-86-9,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 2;STOT SE 3;Muta. 2;Carc. 1A;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,63,H341:21;H330:5;H400:62;H302:63;H335:5;H410:62;H317:63;H361:5;H350:63;H319:16;H315:16;H334:16;H373:16;H340:3
125772,"13-ethyl-3-methoxy-18,19-dinor-17α-pregna-2,5(10)-dien-20-yn-17-ol",238-514-4,14507-51-8,Carc. 2;Repr. 1A;Lact.,Notified C&L,1,H351:1;H360:1;H362:1
125775,Phenethyl 2-ethylbutyrate,228-643-4,6315-04-4,Aquatic Chronic 2,Notified C&L,258,H411:258
125777,4-bromo-3-nitrotoluene,226-203-6,5326-34-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:6;H312:5;H332:1
125783,Zirconium tetrapropanolate,245-711-9,23519-77-9,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,179,H332:3;H315:29;H336:29;H318:29;H226:34;H319:149;H225:1
125784,"Benzene, (trans-4-pentylcyclohexyl)-",612-103-3,61203-96-1,Not Classified,Notified C&L,1,Not classified:1
125785,"6-methoxy-N2-methylpyridine-2,3-diamine dihydrochloride",280-622-9,83732-72-3,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,59,H400:2;H302:59;H410:2;H318:15;H317:52;H319:37;H332:37;H335:37
125786,5'-guanylic acid,201-598-8,85-32-5,Not Classified,Notified C&L,15,Not classified:15
125789,"2-ethoxy-1,2-diphenylethan-1-one",209-366-8,574-09-4,Skin Sens. 1;Aquatic Acute 1,Notified C&L,43,H400:43;H317:38;H410:5
125790,"Tetraammonium hydrogen 2-phosphonobutane-1,2,4-tricarboxylate",298-278-3,93803-05-5,,Notified C&L,33,Not classified:33
125792,2-Methoxy-6-methylphenol,608-297-4,2896-67-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
125793,(3-methylphenoxy)acetic acid,216-698-7,1643-15-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42;H302:38
125795,4-(chloromethyl)phenyltrimethoxysilane,246-235-4,24413-04-5,,Notified C&L,5,H314:4;H319:1;H335:1;H315:1
125799,1-bromo-2-iodobenzene,209-508-9,583-55-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,56,H319:54;H335:47;H315:56
125801,1-benzyl-4-phenyl-piperidin-4-carboxylic acid ethyl ester,444-700-8,,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1
125802,"Extract residues (coal), benzole fraction acid;Light Oil Extract Residues, low boiling;[An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]",298-725-2,93821-38-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
125803,Lithium palmitate,243-842-6,20466-33-5,Not Classified,Notified C&L,7,Not classified:7
125807,"Phosphoric acid, mono(C8-18 and C18-unsatd. branched and linear alkyl) esters, potassium salts",291-960-1,90506-93-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1
125811,"Tetrasodium 4,4'-bis[[4-[(2-hydroxyethyl)amino]-6-(m-sulphonatoanilino)-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate",240-400-4,16324-27-9,Not Classified,REACH registration C&L,5,Not classified:5
125813,"(RS,SR)-N-[2-Hydroxy-5- [1-hydroxy-2-[1-(4-methoxyphenyl)propan- 2-ylamino]ethyl] phenyl]formamid",615-991-0,73573-87-2,Repr. 2;Lact.,Notified C&L,13,H362:9;H361:10;H372:4;H370:3;H332:3;H412:4;H330:1
125817,"(5α,6β)-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan",255-511-3,41714-53-8,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1,Notified C&L,1,H331:1;H301:1;H317:1;H334:1
125819,"2,6,10-trimethylundeca-5,9-dienal",258-966-6,54082-68-7,Not Classified,Notified C&L,145,Not classified:145
125826,(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol,428-010-4,82413-20-5,Skin Sens. 1;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H400:0;H410:0;H351:0;H317:0;H360:0
125827,4-[(2-chloroethyl)ethylamino]-o-tolualdehyde,202-125-8,92-10-4,Skin Sens. 1,Notified C&L,38,H317:38
125832,"2,5-dichlorobenzoyl chloride",220-812-0,2905-61-5,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H314:2;H290:1;H318:1
125835,"methyl (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoate",604-568-6,147118-40-9,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,6,H317:2;H302:2;Not classified:3;H413:1
125836,3-ethyl-1-methyl-1H-Imidazolium salt with N-cyanocyanamide (1:1),609-330-5,370865-89-7,Skin Sens. 1B,REACH registration C&L,132,H317:86;H319:46;H335:41;H315:46;H302:45;H301:1
125844,2-cyanoethyl acrylate,203-426-7,106-71-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,15,H319:15;H335:14;H315:15;H332:1;H312:1;H301:2;H311:1
125846,"1,1,4,4-tetramethylbutane-1,4-diyl bis(2-ethylperoxyhexanoate)",235-935-5,13052-09-0,Org. Perox. C,REACH registration C&L,21,H242:21
125847,Chloromethoxyethane,221-687-5,3188-13-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Carc. 2,Notified C&L,42,H319:40;H332:40;H302:40;H312:40;H351:40;H225:42;H341:2;H331:2;H301:2;H311:2;H318:2;H314:2
125848,(R)-(+)-3-Aminoquinuclidine Dihydrochloride,602-940-2,123536-14-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:40;H315:40;H312:1;H332:1;H302:1
125851,2-(Dicyclohexylphosphino)-2'-methylbiphenyl,607-557-4,251320-86-2,,Notified C&L,7,H319:7;H335:6;H315:7;H317:1
125852,Disodium [orthosilicato(4-)-O]oxozirconate(2-),234-727-1,12027-83-7,Not Classified,Notified C&L,6,Not classified:6
125853,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chlorosulfonyl derivs., reaction products with sodium sulfide",291-008-5,90295-17-3,Not Classified,Notified C&L,37,Not classified:37
125854,"Benzene, C10-12-alkyl derivs., distn. residues",273-539-4,68988-79-4,Not Classified,Notified C&L,113,Not classified:105;H413:8;H319:8
125857,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctan-1-ol",206-197-1,307-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
125858,"[S(R*,R*)]-2,3-dimethoxy-N,N,N',N'-tetramethylbutane-1,4-diamine",247-794-7,26549-21-3,Skin Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H315:39;H319:1
125859,Trisodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)][6-hydroxy-5-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)]chromate(3-),263-320-1,61916-42-5,Eye Dam. 1;STOT SE 3,Notified C&L,13,H335:11;H318:13;H412:2
125867,Dialuminium barium tetraoxide,234-445-9,12004-04-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H332:43;H302:43
125868,"5-propyl-1,3-benzodioxole",202-344-9,94-58-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,130,H400:1;H319:1;H315:1;H410:1;Not classified:91;H351:38
125878,Pyruvaldehyde,201-164-8,78-98-8,Met. Corr. 1;Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Muta. 2,REACH registration C&L,249,H341:91;H302:249;H318:87;H317:87;H290:86;H319:158;H335:119;H315:119;H225:1
125879,Dialuminium tris[4-hydroxy-3-[(4-sulphonato-1-naphthyl)azo]naphthalenesulphonate],281-848-0,84041-67-8,Not Classified,REACH registration C&L,41,Not classified:41
125880,N-[5-chloro-2-[(2-nitrophenyl)thio]phenyl]formamide,299-120-6,93856-86-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2;H317:2
125881,"α,α-dicyclopropyl-4-fluorobenzyl alcohol",263-615-5,62586-96-3,Eye Irrit. 2,Notified C&L,38,H319:38
125886,"Octahydro-1,1,2,3,3-pentamethyl-1H-indene",251-648-8,33704-60-8,Not Classified,Notified C&L,88,Not classified:88
125888,"2-Hexenoic acid, (3Z)-3-hexen-1-yl ester, (2E)-",610-995-9,53398-87-1,Not Classified,Notified C&L,1,Not classified:1
125890,Strontium molybdate,236-730-3,13470-04-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H319:38;H331:38;H315:38;H301:38;H335:38;H311:38
125895,"Benzenamine, 2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-",600-380-3,103015-84-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H410:156;H319:156;H400:156;H302:156
125899,Pentadecan-8-ol,216-726-8,1653-35-6,Aquatic Chronic 4,Notified C&L,38,H413:38
125900,4-butoxyaniline,224-402-2,4344-55-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H319:44;H332:38;H302:43;H312:38;H315:44;H335:43;H330:1;H301:1;H311:1
125901,5-hydroxy-2-hydroxymethyl-4-pyrone,207-922-4,501-30-4,Not Classified,Notified C&L,78,Not classified:68;H351:10
125906,"4-methoxybenzyl (6R,7R)-7-amino-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride (1:1)",601-254-0,113479-65-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,3,H319:3;H335:3;H315:3;H334:3;H317:3
125907,"4-amino-2,3-xylenol",221-446-4,3096-69-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
125909,Tetradecanol,204-000-3,112-72-1,Not Classified,REACH registration C&L,2120,Not classified:310;H319:1023;H410:636;H411:259;H400:279;H412:552;H302:52;H312:52;H335:52;H336:52;H318:52;H225:52;H315:684
125910,Tripotassium hexafluoroaluminate,237-409-0,13775-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:44;H335:41;H315:41;H373:2;Not classified:2;H362:3;H411:2;H372:5;H332:5;H412:3;H302:2
125911,4-chlorobutyl veratrate,410-950-1,69788-75-6,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
125913,3-(Bromomethyl)-2-chloro-4-(methylsulfonyl) benzoic acid,475-670-4,,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1,H319:1;H317:1;H302:1
125914,Disamarium tricarbonate,227-581-5,5895-47-6,Not Classified,Notified C&L,6,Not classified:6
125915,"ethyl-2-chloro-2,2-diphenylacetate",406-580-5,52460-86-3,Skin Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H315:0;H412:0
125916,"Fatty acids, C16-18 and C18-unsatd.",266-932-7,67701-08-0,Not Classified,Notified C&L,334,Not classified:329;H319:5;H315:5
125919,{1-[1-(4-Fluoro-benzyl)-1H-benzoimidazol-2-yl]-piperidin-4-yl}-methyl-ammonium; chloride,919-585-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H312:2;H332:2;H302:2
125920,2-methoxythiophene,240-863-2,16839-97-7,Flam. Liq. 3,Notified C&L,44,H226:44;H312:1;H332:1;H302:1
125921,Collagens,232-697-4,9007-34-5,Not Classified,Notified C&L,145,Not classified:145
125922,"Hexahydro-1,3,5-tris(3-methoxypropyl)-1,3,5-triazine",223-563-6,3960-05-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,12,H319:12;H335:12;H315:12;H302:12
125923,"Dibutyl pyridine-2,6-dicarboxylate",255-519-7,41727-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
125924,"Fatty acids, C6-10, compds. with triethanolamine",286-239-3,85203-47-0,Not Classified,Notified C&L,1,Not classified:1
125925,Hexafluoroantimonic acid hexahydrate,615-716-4,72121-43-8,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,40,H411:39;H332:39;H302:39;H331:1;H311:1;H314:1;H301:1
125927,Sodium isodecyl sulphate,269-598-0,68299-17-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,35,H315:35;H318:35;H302:1
125929,"(4R,6R)-4-Hydroxy-2,2,6-trimethylcyclohexanone / 60046-50-6",700-052-0,60046-50-6,Not Classified,REACH registration C&L,1,Not classified:1
125931,Metixene,225-610-6,4969-02-2,,Notified C&L,1,H410:1;H302:1
125932,"1,1,1-trichloroethane;methyl chloroform",200-756-3,71-55-6,Acute Tox. 4;Ozone 1,Harmonised C&L,0,H420:0;H332:0
125938,"5-[[4-(diethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium methyl sulphate",245-718-7,23532-28-7,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H302:1
125946,"3-(isopropylamino)propane-1,2-diol",229-255-8,6452-57-9,,Notified C&L,4,H302:1;H314:1;H318:1;H319:2;H315:2;H335:1
125947,"Honeycomb, ext.",307-191-2,97553-34-9,Not Classified,Notified C&L,1,Not classified:1
125948,"2,3-Quinoxalinedione, 1,4-dihydro-6-methoxy-",608-679-0,31910-18-6,Not Classified,Notified C&L,31,Not classified:31
125950,3-allyl-5-(1-methylpyridin-2(1H)-ylidene)rhodanine,251-943-1,34330-15-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
125953,"(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene",444-480-3,,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
125954,constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside,419-640-0,68784-14-5,Acute Tox. 4,Harmonised C&L,0,H302:0
125956,"Naphthalenesulfonic acid, dinonyl-, barium salt, basic, overbased",306-092-1,96041-58-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:39;H302:39;H319:12;H315:12
125960,tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate),430-630-5,10596-22-2,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0;H302:0
125961,"Oils, sardine",297-115-3,93334-41-9,Not Classified,Notified C&L,1,Not classified:1
125964,"Fatty acids, coco, reaction products with isopropanolamine",270-431-9,68440-05-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H315:2;H318:1;H319:1;H335:1
125966,"1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium hydroxide",306-751-3,97403-89-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2,H319:2;H302:2
125969,Aminophenazone,200-365-8,58-15-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:49;H335:49;H315:49;H301:53;H302:2;H312:3;H332:1
125973,4-amino-3-chlorobenzoic acid,219-630-4,2486-71-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:41;H335:40;H315:41;H302:39;Not classified:1
125975,"Propanenitrile, 3-[[4-[2-(4-nitrophenyl)diazenyl]phenyl](phenylmethyl)amino]-",429-530-4,,Not Classified,REACH registration C&L,48,Not classified:48
125976,"3,5-di-tert-butylpyrocatechol",213-816-9,1020-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
125980,"Caraway, ext.",288-921-6,85940-31-4,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1426,H400:1385;H302:1292;H304:1422;H315:1423;H410:1421;H317:1424;H226:1423;H312:132;H319:1;H411:1
125984,Alminoprofen,254-604-6,39718-89-3,Not Classified,Notified C&L,1,Not classified:1
125988,"2-chloro-N-(2,4-dimethylphenyl)acetamide",254-294-2,39106-10-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H315:1;H318:1;H302:1
125989,Pentamethonium bromide,208-771-7,541-20-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
125990,"Glycerides, coco mono-, ethoxylated",613-896-9,66105-29-1,Not Classified,Notified C&L,5,Not classified:5
125992,Ethyl 4-methyloxazole-5-carboxylate,243-848-9,20485-39-6,Eye Irrit. 2,REACH registration C&L,3,H319:3;H335:2;H315:2
125995,2-(2H-benzotriazol-2-yl)-4-(tert-butyl)-6-(sec-butyl)phenol,253-037-1,36437-37-3,STOT RE 2;Aquatic Chronic 4,Notified C&L,172,H413:172;H373:153;H319:1
126001,"(2R,3R)-Dimethyl-2,3-O-isopropylidene tartrate",609-324-2,37031-29-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
126003,4-[2-[(phenylmethyl)amino]propyl]- Phenol,608-112-7,27566-05-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
126005,C.I. Acid Yellow 219,615-515-1,71819-57-3,,Notified C&L,2,Not classified:2
126006,Tetrakis(isobutyl)-μ-oxodialuminium,213-646-5,998-00-5,,Notified C&L,39,Not classified:38;H225:1;H304:1;H336:1;H411:1;H314:1;H260:1
126008,3-Methoxyperfluoro(2-methylpentane),603-554-7,132182-92-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;Not classified:1
126009,"gon-5-ene-3,17-dione, 13-ethyl-11-hydroxy-, cyclic bis(1,2-ethanediylacetal), (11beta)-",620-090-0,59017-10-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,1,H332:1;H302:1;H312:1;H351:1;H361:1
126010,"Tetrakis(2-ethylhexanoic) acid, tetraanhydride with silicic acid",267-853-0,67939-81-5,,Notified C&L,4,H361:4;H225:4
126013,Indan-4-ol,216-691-9,1641-41-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
126017,IUPAC name has not been assignet yet.,923-617-5,,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Notified C&L,1,H310:1;H330:1;H300:1
126020,"Amides, coco, N-[2-[(2-hydroxyethyl)amino]ethyl]",269-651-8,68308-43-0,Eye Dam. 1;Repr. 1B;Aquatic Chronic 2,Notified C&L,6,H360:6;H411:6;H318:6
126021,"Methyl 2-(3,5-dioxo-4-phenyl-2-furylidene)-2-phenylacetate",208-314-1,521-52-8,Acute Tox. 4,Notified C&L,2,H302:2
126022,"Hydrogen 7-phenylsulphonato-5-[(4-sulphonatophenyl)aminobenzo[a]phenazinium, sodium salt",247-157-3,25641-18-3,,Notified C&L,5,H319:5;H335:5;H315:5
126025,N-(1-methylundecyl)acrylamide,236-301-0,13288-50-1,Acute Tox. 4,Notified C&L,1,H302:1
126026,Bromomethyl 2-naphthyl ketone,210-348-7,613-54-7,Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:39;H335:39;H314:44;H290:1;H318:1
126028,Tetramethylammonium formate,261-622-8,59138-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,60,H319:60;H335:60;H315:60
126029,Dichromium tris(sulphate),233-253-2,10101-53-8,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2152,H302:18;H411:5;H318:6;H317:16;H314:7;H290:4;Not classified:2133;H319:11;H332:11;H315:12;H335:4;H312:1;H400:1;H410:1
126032,N-methylheptylamine,252-987-4,36343-05-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38,H226:38;H314:38
126034,Chloropropylate,227-421-4,5836-10-2,Eye Dam. 1,Notified C&L,41,H318:38;Not classified:3
126036,"GAMMA-CYCLODEXTRINE, 6A,6B,6C,6D,6E,6F,6G,6H-OCTABROMO-6A,6B,6C,6D,6E,6F,6G,6H-OCTADEOXY-",611-044-0,53784-84-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H400:4;H410:4
126037,Ethyl (E)hex-3-enoate,247-798-9,26553-46-8,Flam. Liq. 3,Notified C&L,1424,H226:1287;Not classified:137
126044,"2,6-dimethylocta-2,4,6-triene",211-614-5,673-84-7,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1595,H319:1555;H302:1594;H304:1555;H315:1555;H411:1290;H317:1291;H226:1291;H412:1;H400:1;H410:1
126045,5-Hexyn-1-ol,618-884-7,928-90-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:46;H315:47
126046,"2',5'-dimethoxypropiophenone",227-357-7,5803-30-5,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38,H319:38;H301:38
126047,3-(trifluoromethoxy)aniline,216-256-3,1535-73-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H319:46;H332:46;H302:46;H312:46;H315:46;H335:39;H373:5
126048,"3,4,5-trimethoxybenzylic alcohol",223-331-4,3840-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
126055,"3'-Cytidylic acid, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, mono(2-chlorophenyl) ester, compd. with N,N-diethylethanamine (1:1)",286-752-2,85381-24-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H302:38;H312:38;H315:38;H335:38
126062,3-chloro-4-methylbenzylamine,267-929-3,67952-93-6,Skin Corr. 1B,Notified C&L,2,H314:2;H318:1
126067,"Alcohols, C16-22, ethoxylated",614-941-5,69227-20-9,Not Classified,Notified C&L,36,Not classified:30;H411:6;H400:6;H318:6
126068,diphenylamine,204-539-4,122-39-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H331:0;H301:0;H410:0;H311:0;H373:0
126069,"9-Octadecenoic acid (Z)-, sulfonated, sodium salts",270-506-6,68443-05-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
126075,"3,4-dimethoxyaniline",228-647-6,6315-89-5,Acute Tox. 4,Notified C&L,56,H302:56;H312:13;H311:4;H373:4;H332:7;H319:3;H315:3;H335:2
126076,Reaction mass of (R)-(-)-1-methoxy-2-propylamine and (S)-(+)-1-methoxy-2-propylamine,609-333-1,37143-54-7,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,64,H412:64;H314:64;H225:64;H302:64;H402:2;H318:2
126078,(3H)-benzofuran-2-one,209-052-0,553-86-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,107,H319:107;H315:107;H317:70
126082,Tripotassium vanadium tetraoxide,238-220-6,14293-78-8,,Notified C&L,6,H319:5;H335:5;H315:5;H332:5;H314:1;H302:1
126084,"Glycerides, fish-oil",309-181-3,100085-40-3,Not Classified,Notified C&L,156,Not classified:156
126089,Phenethyl salicylate,201-732-5,87-22-9,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1660,H411:1620;H315:43;H317:52;H319:39;H335:38;Not classified:1
126093,4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonic acid,209-362-6,573-89-7,Not Classified,Notified C&L,2,Not classified:2
126095,Hexapotassium [nitrilotris(methylene)]trisphosphonate,254-983-8,40588-62-3,Not Classified,Notified C&L,4,Not classified:4
126096,"Disodium 5,7-dinitro-8-oxidonaphthalene-2-sulphonate",212-690-2,846-70-8,,Notified C&L,77,Not classified:40;H373:36;H317:37
126097,(Z)-3-methylpent-2-ene,213-078-8,922-62-3,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,61,H304:61;H225:61
126098,"[R-(R*,S*)]-dodecyldimethyl(α-methylphenacyl)ammonium bromide",260-596-5,57155-63-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
126099,"2-chloro-1,3,5-trinitrobenzene",201-864-3,88-88-0,Expl. 1.1;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H310:0;H400:0;H330:0;H300:0;H410:0;H201:0
126100,"2,3,6-trimethyl-p-anisaldehyde",259-117-2,54344-92-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,5,H319:5;H335:4;H315:5
126101,Spectinomycin sulphate,245-578-7,23312-56-3,,Notified C&L,2,H319:2;H335:2;H315:1;H334:1;H317:1
126106,"3,9-diethyl-3,6,9-triazaundecane",204-603-1,123-12-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H314:1
126107,Diethyl 3-hydroxyglutarate,250-992-6,32328-03-3,Not Classified,Notified C&L,1,Not classified:1
126108,Hydroxytoluic acid,201-473-8,83-40-9,Eye Dam. 1,REACH registration C&L,134,H318:134;H302:132;H335:46;H315:47
126110,Dichloroisobutylmethylsilane,241-942-4,18028-96-1,,Notified C&L,4,H314:4
126112,1-amino-2-bromo-4-hydroxyanthraquinone,204-160-4,116-82-5,Skin Sens. 1,Notified C&L,2,H317:2
126114,Dimethylamine sulphate (2:1),253-660-9,37773-96-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:2
126117,Dipotassium oxalate,209-506-8,583-52-8,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,159,H319:42;H312:158;H302:158;H335:1;H315:1
126118,"reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)",430-930-6,122886-55-9,Aquatic Chronic 4,Harmonised C&L,0,H413:0
126119,"4,4'-ethylenedipyridine",225-543-2,4916-57-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
126120,1-methyl-2-phenylindole,222-618-1,3558-24-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
126121,"4-methylpyridazine-3,6-diol",227-276-7,5754-18-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:39
126124,3-(D-gluconoylamino)propyl(2-hydroxyethyl)dimethylammonium chloride,257-440-3,51812-80-7,Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,10,H402:2;H412:2;Not classified:8
126125,"1,4,10,13-pentaoxacyclopentadecane",251-379-6,33100-27-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,50,H319:49;H315:47;H302:50;H335:7;H332:1
126128,"Disodium 3,3'-(1,3,8,10-tetrahydro-1,3,8,10-tetraoxoanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-2,9-diyl)bis[6-aminobenzenesulphonate]",299-201-6,93857-65-9,Not Classified,Notified C&L,31,Not classified:31
126129,2-methylbutane-2-thiol,216-843-4,1679-09-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,185,H319:152;H335:151;H315:151;H302:38;H225:72;H317:33
126130,L-lysine,200-294-2,56-87-1,Not Classified,Notified C&L,117,Not classified:115;H319:2;H335:2;H315:2;H302:1
126132,Metamfepramone,239-384-1,15351-09-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
126133,"Benzoic acid, 5-[(4-aminophenyl)azo]-2-hydroxy-, reaction products with 3-[(4-amino-3-methoxyphenyl)azo]benzenesulfonic acid and carbonic dichloride, sodium salts",232-339-7,8005-52-5,Skin Sens. 1B,REACH registration C&L,16,H317:2;Not classified:14
126134,"2,3-dimethylhex-2-ene",230-452-6,7145-20-2,Flam. Liq. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H319:38;H225:38;H317:38
126135,"3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide",247-081-0,25535-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,161,H319:161;H335:161;H315:161;H341:40
126139,"Quaternary ammonium compounds, benzyl-C10-21-alkyldimethyl, chlorides",293-523-0,91080-30-7,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,59,H400:59;H314:59;H318:59;H302:59
126141,Diheptyl sulphide,211-101-6,629-65-2,Aquatic Chronic 4,Notified C&L,38,H413:38
126142,"Fatty acids, C8-22, reaction products with poly-C2-3-alkylenepolyamines and ethanolamines",281-995-0,84082-48-4,Skin Corr. 1A;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1,H314:1;H317:1;H410:1
126149,"4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ol",207-470-8,473-67-6,Not Classified,Notified C&L,88,Not classified:88
126153,"monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex",400-720-9,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
126155,"Thiocyanic acid, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester",607-977-8,26650-09-9,Not Classified,REACH registration C&L,1,Not classified:1
126158,2-fluoro-5-nitrotoluene,207-251-7,455-88-9,Not Classified,REACH registration C&L,47,Not classified:2;H319:45;H332:45;H302:45;H312:45;H315:45;H335:44
126160,2-methoxy-4-nitrophenol,221-839-0,3251-56-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
126164,[(2-methylphenyl)methyl]triphenylphosphonium chloride,264-112-3,63368-36-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42;H302:4
126172,"3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid",407-990-7,141915-64-2,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0
126180,N-acetyl-β-D-glucosamine,231-368-2,7512-17-6,Not Classified,Notified C&L,47,Not classified:47
126181,"6-methoxy-1,2,3,4-tetrahydronaphthalen-2-one",219-592-9,2472-22-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
126187,Trichloro(ethyl)silane,204-072-6,115-21-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 3,REACH registration C&L,85,H331:81;H314:85;H225:85;H302:85;H318:16;H335:2;H290:1;H332:1
126188,3-isobutylpyridine,238-003-6,14159-61-6,Not Classified,Notified C&L,93,Not classified:88;H319:5;H335:5;H315:5
126192,N-chloroacetyl-L-tyrosine,214-544-3,1145-56-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
126193,POLYOXYETHYLENE LAURYL ETHER PHOSPHATE,609-689-8,39464-66-9,Not Classified,Notified C&L,48,Not classified:37;H400:3;H314:7;H302:3;H318:4;H319:1;H315:4;H290:1
126194,"Licorice, Glycyrrhiza glabra, ext., ammonium salt",310-008-9,102110-11-2,Not Classified,Notified C&L,2,Not classified:2
126196,4-dimethylaminoazobenzene,200-455-7,60-11-7,Acute Tox. 3;Carc. 2,Notified C&L,51,H351:48;H301:51;H317:3;Not classified:1;H341:2;H319:1;H335:1;H315:1
126198,"Distillates (petroleum), petroleum residues vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]",273-263-4,68955-27-1,Carc. 1B,Harmonised C&L,0,H350:0
126199,[No public or meaningful name is available],642-383-2,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,25,H319:25;H317:25
126205,Methoxypropyl acetate,283-152-2,84540-57-8,Flam. Liq. 3,Notified C&L,6,H226:6;H360:3;H319:3
126207,2-acetoxyethyl stearate,245-122-7,22613-51-0,Not Classified,Notified C&L,2,Not classified:2
126208,Aluminium citrate,250-484-4,31142-56-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2,Notified C&L,38,H319:38;H315:38;H373:38;H302:38
126211,Furfuryl isovalerate,237-171-8,13678-60-9,Not Classified,Notified C&L,88,Not classified:88
126212,4-hydroxy-8-(trifluoromethyl)quinoline-3-carboxylic acid,245-878-8,23779-95-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
126213,2-chloromethylbenzimidazole,225-452-8,4857-04-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:45;H315:45;H302:40
126214,1-(chloromethyl)-4-(methylthio)benzene,212-870-0,874-87-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,44,H314:44;H318:38;H319:1
126217,"1,1-dimethoxy-3,7-dimethylocta-2,6-diene",231-434-0,7549-37-3,Not Classified,Notified C&L,1601,Not classified:1561;H317:40;H319:1;H315:1
126219,2-Chloromethyl-4-(3-methoxypropoxy)-3-methylpyridine hydrochloride,604-893-3,153259-31-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,3,H319:2;H335:2;H315:2;H350:1;H318:1;H302:1
126220,2-hydroxyiminoacetophenone,208-539-5,532-54-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,77,H312:72;H332:39;H302:77;H319:1;H315:1
126221,Neodymium,231-109-3,7440-00-8,Not Classified,REACH registration C&L,360,Not classified:261;H228:56;H251:51;H319:91;H315:91;H335:40;H260:4;H252:4;H250:4;H413:1;H317:1;H334:1
126222,"2,3,5,6-tetrafluoroanisole",219-037-0,2324-98-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H226:44;H319:45;H315:45;H335:44
126231,"2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide",402-260-4,54942-74-4,Aquatic Chronic 4,Harmonised C&L,0,H413:0
126233,"2-(3,6-dihydroxy-2,4,5,7-tetraiodoxanthen-9-yl)benzoic acid, aluminium salt",235-440-4,12227-78-0,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,80,H319:3;H412:3;Not classified:77
126245,"Castor oil, polymer with ethylene oxide, maleic anhydride and rosin, bisulfited, sodium salt",606-062-0,185765-78-0,Not Classified,Notified C&L,39,Not classified:39
126248,"3-diazo-3,4-dihydro-4-oxonaphthalene-1-sulphonic acid",243-965-5,20680-48-2,Self-react. D;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H242:38;H319:38;H335:38;H315:38
126251,oxalonitrile;cyanogen,207-306-5,460-19-5,Press. Gas;Flam. Gas 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,Not classified:0;H400:0;H331:0;H220:0;H410:0
126252,"3,4-Dihydroxy-5-benzaldehyde",601-421-8,116313-85-0,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,5,H318:3;H317:3;H302:3;H335:1;H315:1;Not classified:1
126253,Methylbutan-1-ol,256-810-1,50858-14-5,,Notified C&L,898,H226:898;H319:898;H315:898;H335:898
126256,Tetrabutylphosphonium chloride,218-964-8,2304-30-5,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,42,H330:41;H302:41;H311:2;H411:2;H318:2;H317:2;H314:42;H401:2;H310:39;H413:1
126258,Methoxycyclododecane,221-053-8,2986-54-1,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,288,H400:252;H315:80;H317:81;H410:288
126264,3-methyl-5-phenylpentanenitrile,258-969-2,54089-83-7,Acute Tox. 4,Notified C&L,1547,H302:1547;H315:4
126269,"Sodium 4-[4-[[3-(anilinosulphonyl)phenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-2,5-dichlorobenzenesulphonate",239-896-5,15792-51-5,Not Classified,Notified C&L,1,Not classified:1
126271,(R)-(-)-Oxirane-2-methanol 3-nitrobenzenesulfonate,601-353-9,115314-17-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:39;H315:40;H228:2;H341:3
126274,"Fatty acids, C12-18 and C18-unsatd., reaction products with diethylenetriamine",292-855-3,91001-82-0,Not Classified,Notified C&L,16,Not classified:8;H314:6;H317:6;H410:6;H315:2;H318:2
126275,"Quaternary ammonium compounds, (C12-16-branched and linear alkyl)ethyldimethyl, Et sulfates",287-657-9,85566-47-8,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1,Notified C&L,76,H400:58;H302:76;H410:55;H318:73;H314:76
126278,"Cardamom, ext.",288-922-1,85940-32-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1552,H304:1359;H315:1466;H411:1548;H317:1550;H226:1509;H319:174;H224:52;H314:1;H225:1;H341:1;H351:1;H335:1;H318:1;H312:1;H350:1
126280,"4-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)butan-2-one",243-847-3,20483-36-7,Not Classified,Notified C&L,88,Not classified:88
126282,"Propanenitrile, 3-amino-, N-coco alkyl derivs.",272-244-8,68784-40-7,Skin Corr. 1B;Aquatic Chronic 1,REACH registration C&L,34,H314:34;H410:34
126283,4-(methoxycarbonyl)pyridine-2-carboxylic acid,842-339-4,24195-03-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:2
126286,2-Thiopheneboronic Acid (contains varying amounts of Anhydride),612-186-6,6165-68-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48;H302:40;H332:1;H312:1
126289,"Alcohols, C9-11-branched",271-360-6,68551-08-6,Aquatic Chronic 3,REACH registration C&L,46,H412:2;H319:36;H411:36;Not classified:8
126295,Nitrosium tetrafluoroborate,238-679-2,14635-75-7,Skin Corr. 1B,Notified C&L,45,H314:45;H318:1
126297,Decyl dihydrogen phosphate,223-491-5,3921-30-0,Skin Corr. 1B,Notified C&L,4,H314:3;Not classified:1
126302,(±)-2′-Hydroxy-5′-[(1RS)-1-hydroxy-2-[[(1RS)-2-(4-methoxyphenyl)-1-methylethyl]-amino]ethyl]formanilide fumarate (2:1),610-119-5,43229-80-7,Acute Tox. 4;Carc. 2;Repr. 2;STOT SE 1;STOT RE 1,Notified C&L,70,H372:43;H370:67;H332:39;H351:36;H361:64;H300:26;H373:26;H412:31;H330:3;H362:1;H312:1;H302:1;H331:1
126304,Magnesium neodecanoate,260-742-8,57453-97-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,11,H315:6;H318:6;Not classified:5
126310,"1,6-dibromohexane",211-067-2,629-03-8,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,123,H411:14;H317:64;H302:17;Not classified:52;H300:49;H315:5;H319:4;H335:3;H331:1;H311:1;H301:2;H412:1
126320,α-styryl p-anisyl ketone,213-495-5,959-23-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
126321,Vinpocetine,256-028-0,42971-09-5,Acute Tox. 4,Notified C&L,47,H302:47;H332:1
126324,m-terphenyl,202-122-1,92-06-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,47,H400:40;H319:44;H335:43;H315:44;Not classified:3;H410:1
126325,Sodium 4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate,211-199-0,633-96-5,STOT RE 1;Aquatic Chronic 3,REACH registration C&L,2441,H372:102;H412:120;Not classified:2213;H319:109;H335:94;H315:96
126326,"1,4-Diisocyanatobutane",610-246-6,4538-37-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,64,H319:64;H332:39;H302:39;H312:39;H315:64;H335:64;H330:25;H334:25;H317:25
126327,"2,2'-[(4-fluoro-3-nitrophenyl)imino]bisethanol",249-787-4,29705-38-2,Muta. 2;Carc. 2;STOT RE 2,Notified C&L,2,H351:1;H341:1;H373:1;H302:1
126330,cobalt di(acetate),200-755-8,71-48-7,Skin Sens. 1;Resp. Sens. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1B;Repr. 1B,Harmonised C&L,0,H400:0;H341:0;H410:0;H334:0;H317:0;H360:0;H350:0
126332,"Residues (coal), liq. solvent extn.;[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]",302-681-2,94114-46-2,Carc. 1B,Harmonised C&L,0,H350:0
126336,2-chlorotoluene,202-424-3,95-49-8,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H332:0
126339,"N,N'-(iminodipropane-1,3-diyl)distearamide",237-799-2,13998-73-7,Not Classified,Notified C&L,37,Not classified:37
126340,3-Methoxyacrylonitrile,612-045-9,60838-50-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,51,H319:51;H332:51;H302:51;H312:51;H315:51;H335:50
126347,3-hydroxy-N-2-naphthyl-2-naphthamide,205-208-7,135-64-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
126348,Bis(2-butoxyethyl) ether,204-001-9,112-73-2,Not Classified,REACH registration C&L,207,Not classified:196;H319:6;H335:5;H315:4;H226:4;H316:1;H361:1;H373:1
126351,"Ethanone, 1-(4-phenylcyclohexyl)-, trans-",606-698-9,21060-31-1,Not Classified,Notified C&L,1,Not classified:1
126353,"Fatty acids, C16 and C18-unsatd.",266-931-1,67701-07-9,Not Classified,Notified C&L,37,Not classified:37
126354,"Alcohols (C12 - 15 Ln saturated) ethoxylate, sulphonate, sodium salt",601-784-2,121546-77-8,Skin Irrit. 2,Notified C&L,194,H315:194;H319:21
126358,[(tolyloxy)methyl]oxirane;cresyl glycidyl ether,247-711-4,26447-14-3,Skin Irrit. 2;Skin Sens. 1;Muta. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H341:0;H315:0;H317:0
126359,"Cyclotetrasiloxane, octamethyl-, reaction products with silica",271-514-2,68583-49-3,Not Classified,Notified C&L,12,Not classified:12
126360,"1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)",604-093-4,138786-67-1,Acute Tox. 4,Notified C&L,57,H302:56;H319:10;H335:9;H315:10;H351:11;H412:2;H336:2;H362:1;H341:1;H317:1;H360:1;H413:2;H350:1
126365,PRÄPARAT FFU 641,421-990-4,,Not Classified,Notified C&L,1,Not classified:1
126367,Calcium fluoride,232-188-7,7789-75-5,Not Classified,REACH registration C&L,905,Not classified:445;H319:459;H335:459;H315:459;H332:1;H302:1
126372,(Z)-but-2-enedioic acid;N-[2-(dimethylamino)ethyl]-5-(dithiolan-3-yl)pentanamide,922-363-2,,Skin Mild Irrit. 3;Eye Irrit. 2B,Notified C&L,1,H316:1;H320:1
126375,"Sodium 2,2,2-trifluoroethanolate",206-998-6,420-87-1,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Repr. 1B,REACH registration C&L,2,H319:2;H332:2;H312:2;H315:2;H360:2;H226:2
126381,"Fumaric acid, magnesium salt",231-724-7,7704-71-4,Not Classified,Notified C&L,3,Not classified:3
126382,Dibutyldiphenylstannane,229-256-3,6452-61-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H319:38;H400:38;H331:38;H315:38;H301:38;H335:38;H311:38
126385,Etofibrate,250-743-1,31637-97-5,Not Classified,Notified C&L,1,Not classified:1
126387,Nepheline syenite,609-369-8,37244-96-5,Not Classified,Notified C&L,125,Not classified:74;H335:51
126391,"Oils, palm, oleins",297-114-8,93334-39-5,Not Classified,Notified C&L,1,Not classified:1
126392,Lactonitrile,201-163-2,78-97-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;Carc. 2;Repr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,180,H310:122;H400:84;H330:84;H300:84;H351:1;H360:1;H373:1;H412:84;Not classified:55;H301:41;H332:38
126395,"Amines, C18-22-tert-alkyl, compds. with tungstic acid (H2WO4)",270-507-1,68443-09-4,,Notified C&L,1,Not classified:1
126405,"2-(2-bromophenyl)-5-phenyl-1,3,4-oxadiazole",280-945-5,83817-43-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H301:38
126407,Camphoric anhydride,200-952-9,76-32-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H302:38
126408,Pentadecan-2-ol,216-725-2,1653-34-5,Eye Irrit. 2,Notified C&L,38,H319:38
126410,"2,3-dimethyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenal",276-097-0,71850-78-7,Not Classified,Notified C&L,88,Not classified:88
126411,"2,2,4,4,6,6,8,8-octamethylcyclotetrasilazane",213-817-4,1020-84-4,Acute Tox. 3,Notified C&L,44,H301:44;H314:5;H318:1;H319:1;H335:1;H315:1
126412,3-pentadecylphenol,207-921-9,501-24-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H319:40;H332:39;H302:39;H312:39;H315:40;H335:39;H317:2
126417,"Fatty acids, C8-18 and C18-unsatd., potassium salts",266-933-2,67701-09-1,,Notified C&L,118,H319:111;H315:39;Not classified:7;H411:1;H335:1
126418,"Phenol, 4-(trans-4-methylcyclohexyl)-",601-448-5,116794-13-9,Not Classified,Notified C&L,1,Not classified:1
126421,2-aminofluoren-9-one,221-445-9,3096-57-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
126422,Tributylmethylammoniummethylsulfate,454-210-6,13106-24-6,Eye Irrit. 2A,REACH registration C&L,84,H319:84
126423,2-methyl-1-(methylamino)propan-2-ol,614-091-5,67622-86-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
126424,"2,7-Naphthalenedisulfonic acid, 4-amino-6-[2-[5-[(4,6-difluoro-2-pyrimidinyl)amino]-2-sulfophenyl]diazenyl]-5-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:?)",606-642-3,208246-36-0,Not Classified,Notified C&L,37,Not classified:37
126427,"Fatty acids, tall-oil, reaction products with triethylenetetramine",272-905-0,68919-79-9,Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,138,H319:88;H317:88;H412:82;Not classified:37;H318:13;H411:4;H315:10;H400:3;H410:3
126428,trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II),407-110-1,480445-87-2,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H318:0
126429,Medroxyprogesterone acetate,200-757-9,71-58-9,Carc. 2,Notified C&L,225,H351:223;H360:91;H332:30;H302:31;H312:31;H413:28;H362:26;H319:3;H315:3;H335:3;H340:3;Not classified:1;H361:2;H341:1;H334:1;H317:1
126433,n-hexyllithium,404-950-0,21369-64-2,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1A,Harmonised C&L,0,H260:0;H314:0;H250:0
126434,S186260,470-880-2,,Skin Sens. 1B,Notified C&L,1,H317:1
126436,3-ethyl-2-[3-(3-ethyl-3H-benzoxazol-2-ylidene)prop-1-enyl]benzoxazolium iodide,212-996-6,905-96-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:39;H315:41
126440,"17-(2-bromoacetyl)-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",606-543-5,20380-17-0,Skin Sens. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H361:1;H400:1;H317:1;H410:1
126455,"(E)-1,4,5,6-tetrahydro-1-methyl-2-[2-(3-methyl-2-thienyl)vinyl]pyrimidinediylium hydrogen citrate",274-028-9,69525-81-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H332:38;H302:38
126457,"1,1-bis(4-hydroxyphenyl)-1-phenylethane",433-130-5,1571-75-1,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
126458,"Fatty acids, coco, reaction products with diethanolamine",270-430-3,68440-04-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,483,H319:447;H315:448;H411:36;H314:34;H318:30;Not classified:1;H335:2
126461,"(1-methylethyl)-1,1'-biphenyl",247-156-8,25640-78-2,Asp. Tox. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,443,H319:2;H400:2;H304:443;H410:2;H411:443
126462,"safrole;5-allyl-1,3-benzodioxole",202-345-4,94-59-7,Acute Tox. 4;Muta. 2;Carc. 1B,Harmonised C&L,0,H341:0;H350:0;H302:0
126463,Nonan-2-ol,211-065-1,628-99-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,200,H319:198;H315:198;Not classified:2
126466,"1,3-bis(2-ethylhexyl)cyclohexane",283-854-9,84753-08-2,Not Classified,Notified C&L,22,Not classified:22
126473,Pyrimethamine,200-364-2,58-14-0,Acute Tox. 4,Notified C&L,132,H302:131;H319:1;H371:2;H315:1;H301:1;H411:5;H361:2;H341:1;H401:1;H373:1
126474,"4-Hydroxybenzaldehyde, polymer with 1-chloro-2,3-epoxypropane and 6-tert-butyl-3-cresol",500-318-4,130262-42-9,Not Classified,Notified C&L,1,Not classified:1
126475,"Fatty acids, C12-20 and C12-20-unsatd., reaction products with diethylenetriamine",292-856-9,91001-83-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H319:1;H315:1
126476,"p,p'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis[azo(2-acetyl-1-oxoethylene)imino]]bis(benzenesulphonic) acid, potassium salt",282-111-6,84100-30-1,Not Classified,Notified C&L,7,Not classified:7
126483,"4-bromo-3,5-dimethyl-1H-pyrazole-1-methanol",303-795-5,94230-83-8,Acute Tox. 4,Notified C&L,38,H302:38
126486,"Dibenz[b,e]oxepin-11(6H)-one",224-820-5,4504-87-4,Not Classified,REACH registration C&L,3,Not classified:2;H302:1
126487,"poly(oxy-1,2-ethanediyl),alpha-((2-ethylhexyl)oxy)hydroxyphosphinyl)-omega-hydroxy-,monosodium salt",601-442-2,116671-29-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
126489,Decamethonium bromide,208-772-2,541-22-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39;H301:39
126492,"Capsicum frutescens, ext.",288-920-0,85940-30-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1415,H319:1288;H315:1364;H318:78;H302:77;Not classified:49;H334:1;H317:1
126494,"1,3-Dichloro-2-fluorobenzene",607-128-1,2268-05-5,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,133,H228:127;H319:133;H335:132;H315:133;H226:1
126495,[(difluoromethyl)thio]benzene,216-255-8,1535-67-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H226:2;H319:2;H315:2;H335:1
126498,"2,2'-[(octahydro-4,7-methano-1H-indenediyl)bis(methyleneoxymethylene)]dioxirane",256-895-5,50985-55-2,Muta. 2,Notified C&L,14,H341:13;Not classified:1
126499,"Benzene, 1-(dimethoxymethyl)-4-(1,1-dimethylethyl)-",608-932-5,3395-82-2,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,83,H412:83;H302:83
126500,"3,3'-[[2,2-bis[(allyloxy)methyl]-1,3-propanediyl]bis(oxy)]dipropene",216-010-5,1471-18-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
126501,3-bromo-3-methyl-2-[(2-nitrophenyl)thio]-3H-indole,248-737-9,27933-36-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
126507,"Oestr-5(10)-ene-3,17-dione",223-564-1,3962-66-1,Acute Tox. 4;Repr. 1B;Aquatic Chronic 4,Notified C&L,2,H413:1;H360:2;H302:1;H362:1;H400:1;H410:1;H351:1
126516,"(2-Chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoic acid)",619-779-9,120100-77-8,Skin Sens. 1,Notified C&L,65,H317:65
126517,Copper methacrylate,243-211-5,19662-59-0,,Notified C&L,5,H319:5;H335:5;H315:5;H317:4
126519,N-[2-(1-piperazinyl)ethyl]ethylenediamine,245-992-8,24028-46-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1,Notified C&L,118,H302:83;H311:83;H318:83;H317:83;H314:85;Not classified:33
126520,Thallium triarsenide,281-902-3,84057-85-2,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H330:38;H300:38;H410:38;H373:38
126526,"N,N,N',N'-tetramethylnaphthalene-1,8-diamine",244-001-6,20734-58-1,Acute Tox. 4,Notified C&L,125,H302:93;H319:45;H335:44;H315:45;H301:32;H314:2;H318:1
126535,4-anilinophenol,204-538-9,122-37-2,Not Classified,REACH registration C&L,136,Not classified:43;H318:78;H312:37;H315:41;H335:40;H319:15;H400:14;H410:14;H302:6;H317:1
126537,"1,4-anhydro-D-glucitol 6-dodecanoate",227-729-9,5959-89-7,Not Classified,Notified C&L,1,Not classified:1
126540,Benzylidene(ethyl)amine,229-948-5,6852-54-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
126550,1-bromo-2-naphthol,209-363-1,573-97-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H302:45
126553,"4-trans-ethyl-4'-trans-propyl-[1,1'-bicyclohexyl]",619-230-3,96624-41-8,Not Classified,REACH registration C&L,1,Not classified:1
126556,"1,3,6-Naphthalenetrisulfonic acid, 7-[2-[2-[(aminocarbonyl)amino]-4-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]diazenyl]-, sodium salt (1:4)",616-960-4,80156-97-4,Not Classified,Notified C&L,3,Not classified:3
126561,3-methylpent-2-ene,213-077-2,922-61-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H335:38;H315:38;H225:42;H304:1
126564,Bis(2-hydroxyethyl)ammonium dihydrogen citrate,260-597-0,57155-85-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H319:6;H315:6
126565,3-methylisoxazole-5-carboxylic acid,225-454-9,4857-42-5,,Notified C&L,161,H319:160;H331:157;H315:160;H301:157;H335:159;H311:157;H332:1;H302:1;H312:1
126567,Calcium isooctadecanoate,261-999-9,59963-30-3,Not Classified,REACH registration C&L,5,Not classified:5
126569,"2,4,6-trinitrophenol;picric acid",201-865-9,88-89-1,Expl. 1.1;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0,H331:0;H201:0;H311:0;H301:0
126570,"Fatty acids, fish-oil, sulfated-sulfonated, ammonium salts",307-489-2,97659-82-0,Not Classified,Notified C&L,1,Not classified:1
126571,"1,2-Ethanediamine, N1-(2-aminoethyl)-, polymer with 2-methyloxirane",608-352-2,29380-50-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,60,H319:59;H315:59;Not classified:1
126578,"(6S,7S)-7-Amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",435-680-1,,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
126581,"Glycerides, tallow mono-, hydrogenated",263-031-0,61789-09-1,Not Classified,Notified C&L,3,Not classified:3
126582,2-hydroxy-2-methylpropiophenone,231-272-0,7473-98-5,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,921,H412:247;H302:910;H410:222;H400:287;H317:48;Not classified:8;H312:1;H332:2;H319:1;H411:2
126583,(2-methoxyethyl)benzene,222-619-7,3558-60-9,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1582,H319:38;H315:37;H412:37;Not classified:1525;H226:28;H302:2;H335:1
126584,"N-chloroacetyl-D,L-alanine",214-721-5,1190-32-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
126586,D-erythrose,209-505-2,583-50-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
126592,"Fatty acids, C16-18 and C18-unsatd., sodium salts",270-286-1,68424-26-0,Not Classified,Notified C&L,33,Not classified:33
126593,"Cadmium, dross",273-707-7,69011-69-4,Acute Tox. 4;Acute Tox. 2;Muta. 2;Carc. 1B;Repr. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H341:3;H330:3;H372:3;H302:2;H400:3;H410:3;H361:3;H350:3;H314:1
126596,"2,4-dichloroanisole",209-051-5,553-82-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
126597,"Fatty acids, soya, iso-Pr esters",305-857-7,95193-46-7,Not Classified,REACH registration C&L,15,Not classified:15
126598,Huntite (CaMg3(CO3)4),606-340-1,19569-21-2,Not Classified,Notified C&L,1,Not classified:1
126601,"Quaternary ammonium compounds, benzyl-C16-22-alkyldimethyl, chlorides",293-524-6,91080-31-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1;H302:1
126605,"8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane",424-030-2,62406-73-9,Skin Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H315:0;H412:0
126607,"2H-Imidazo[4,5-b]pyridine-2-thione, 1,3-dihydro-5-methoxy-",601-278-1,113713-60-3,,Notified C&L,4,H319:4;H335:4;H315:4
126609,"2,2-di(tetrahydrofuryl)propane",700-263-8,89686-69-1,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,85,H319:45;H317:46;H302:85;H226:38;H312:1;H332:1;H411:1;H318:1
126612,"1,2,3,5,6,7-hexahydro-1,1,2,3,3-pentamethyl-4H-inden-4-one",251-649-3,33704-61-9,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1545,H411:1540;H319:1424;H315:1424;H317:1424;H373:111;Not classified:7
126613,Cobalt wolframate,233-254-8,10101-58-3,,Notified C&L,4,H317:4;H302:4
126614,"Glycerides, C8-21 and C8-21-unsatd. mono- and di-, 2-(acetyloxy)-3-hydroxybutanedioates 2,3-bis(acetyloxy)butanedioates",309-180-8,100085-39-0,Not Classified,Notified C&L,10,Not classified:10
126619,nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate,413-670-8,103969-79-5,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0
126621,"(1S,2R)-(-)-1-Amino-2-hydroxyindane",603-144-8,126456-43-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,206,H319:201;H335:200;H315:201;H314:5
126625,"C16-18 and C18 (unsaturated) alkylamine, ethoxylated",614-345-5,68155-40-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,9,H400:5;H314:5;H318:8;H302:8;H410:4;H315:4
126626,6-methoxy-1H-indole,221-689-6,3189-13-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:41;H315:42
126628,Polyethersiloxane,614-827-5,68938-54-5,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,973,H411:790;H332:730;H312:206;H315:249;H318:211;Not classified:145;H319:38;H335:43
126629,"2,6-dichlorobenzaldehyde",201-472-2,83-38-5,Skin Corr. 1B,Notified C&L,48,H314:45;H411:3;H319:3;H335:3;H315:3;H318:1
126630,"1,2-Ethanediamine, N-(2-aminoethyl)-, N-mono- and di-C8-18-alkyl derivs.",282-198-0,84144-78-5,Acute Tox. 4;Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,7,H410:7;H400:7;H314:7;H302:7
126631,2-aminoadipic acid,208-809-2,542-32-5,Skin Sens. 1,Notified C&L,38,H317:38
126636,Cystine,200-296-3,56-89-3,Not Classified,REACH registration C&L,175,Not classified:172;H319:3;H335:3;H315:3
126638,Fluxofenim,618-167-9,88485-37-4,,Notified C&L,194,H410:156;H312:194;H302:194;H400:38;H330:38;H315:38
126645,"Chondroitin, hydrogen sulfate",232-696-9,9007-28-7,Not Classified,Notified C&L,11,Not classified:7;H332:4;H317:4;H334:4
126647,"Methyl 3-[4-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy]-m-tolyl]propionate",240-527-5,16472-09-6,Not Classified,Notified C&L,9,Not classified:9
126648,3-Methylamino-1-(thiophen-2-yl)-propan-1-on-hydrochlorid,927-428-9,,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,Not classified:1;H411:1;H302:1
126652,"Bis(5-oxo-DL-prolinato-N1,O2)zinc",268-475-9,68107-75-5,Not Classified,Notified C&L,13,Not classified:13
126654,2-phenylethanol,200-456-2,60-12-8,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,2631,H319:2590;H302:2132;H312:70;H315:145;H311:131;H318:37;H331:8;H335:8;H373:8;H226:2;H332:4;Not classified:2;H317:1
126655,"1,5(or1,8)-bis[(4-methylphenyl)amino]anthraquinone",232-338-1,8005-40-1,Not Classified,Notified C&L,17,Not classified:17
126657,(R)-S-(2-amino-2-carboxyethyl)-L-homocysteine,200-295-8,56-88-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
126659,2-(methylthio)-1H-pyrimidin-4-one,227-274-6,5751-20-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H335:39;H315:39;H318:39;H302:39
126661,"2,2-dimethylpropanethiol",216-842-9,1679-08-9,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H335:1;H315:1;H318:1;H225:1
126663,"Trisodium 2-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-5-sulphonatonaphthyl]azo]-2,5-dimethylphenyl]azo]benzene-1,4-disulphonate",274-410-5,70210-13-8,Skin Sens. 1A;STOT RE 2,REACH registration C&L,43,H373:3;H317:36;H319:32;Not classified:7
126665,"N-(4-bromo-2,5-dimethylphenyl)acetamide",604-002-8,13711-31-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
126666,"Fatty acids, C16-18, calcium salts",286-484-6,85251-71-4,Not Classified,REACH registration C&L,166,Not classified:166
126670,2-methylvaleraldehyde,204-605-2,123-15-9,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,1527,H319:1527;H315:1527;H402:2;H317:85;H225:241;H412:202;H335:52
126671,"1,6-Octadiene, 7-methyl-3-methylene-, acetylated",270-162-7,68412-04-4,Not Classified,Notified C&L,233,Not classified:223;H411:10;H315:10;H317:10
126672,Disodium titanate,234-802-9,12034-34-3,Not Classified,REACH registration C&L,89,Not classified:35;H314:24;H319:30;H315:30
126679,3-(indol-3-yl)lactic acid,217-347-0,1821-52-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
126681,potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide,406-650-5,97888-41-0,Eye Dam. 1,Harmonised C&L,0,H318:0
126686,"N,N-dimethylnonanamide",612-975-5,6225-08-7,Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,2,H319:2;H315:2
126690,"2,4'-dichlorobenzophenone",201-596-7,85-29-0,,Notified C&L,37,Not classified:33;H319:4;H335:4;H315:4
126692,"L-Aspartic acid, N,N'-1,2-ethanediylbis-, sodium salt (1:3)",605-842-8,178949-82-1,Not Classified,Notified C&L,62,Not classified:62
126694,nickel dipotassium bis(sulfate),237-563-9,13842-46-1,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H372:0;H332:0;H302:0;H400:0;H334:0;H410:0;H317:0;H360:0;H350:0
126699,"Glycerides, castor-oil mono-, hydrogenated",297-624-0,93685-76-8,Not Classified,Notified C&L,2,Not classified:2
126701,"8-ammonio-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinolinium maleate",251-223-7,32795-47-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H302:38
126704,3-chloro-p-anisic acid,253-708-9,37908-96-6,Acute Tox. 3;Aquatic Acute 1,Notified C&L,44,H400:38;H301:38;H319:6;H335:5;H315:6
126708,"Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane",413-720-9,117933-89-8,,Notified C&L,1569,H410:1569;H400:246;H373:271;H302:1
126711,3-ethylpent-1-ene,223-723-5,4038-04-4,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,46,H304:46;H225:46;H336:8
126715,"N-(2-(dimethylamino)ethoxy)ethyl)-N-methyl-1,3-propanediamine",470-720-1,189253-72-3,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,REACH registration C&L,14,H314:14;H317:14;H302:14;H318:8
126716,"2-Oxetanone, 3-C12-16-alkyl-4-C13-17-alkylidene derivs.",284-932-5,84989-41-3,Not Classified,REACH registration C&L,114,Not classified:114
126719,"2,2,2-trichloroethanol",204-071-0,115-20-8,Acute Tox. 4;Eye Dam. 1;STOT SE 3,Notified C&L,48,H336:45;H318:48;H302:48;H315:5;Not classified:2;H314:1
126722,"Vanilla tahitensis, ext.",303-413-7,94167-14-3,Skin Sens. 1,Notified C&L,141,H317:116;H226:25;H318:25
126723,"4,4-diethoxybutylamine",228-753-2,6346-09-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:38;H335:38;H315:38;H314:10;H318:3;H227:1
126728,"Hydrocarbons, C14-C18, n-alkanes, isoalkanes, cyclics, aromatics (2-30 %)",920-360-0,,Asp. Tox. 1,REACH registration C&L,516,H304:516
126730,Sodium N-(5-methylisoxazol-3-yl)sulphanilamidate,224-939-2,4563-84-2,Not Classified,Notified C&L,1,Not classified:1
126735,p-(benzyloxy)nitrobenzene,214-545-9,1145-76-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
126738,"2,2'-[thiobis(methylene)]bisfuran",237-172-3,13678-67-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1443,H319:1432;H335:1431;H315:1432;H302:1286;Not classified:11
126740,Ethyl N-hydroxyacetimidate,234-165-7,10576-12-2,Flam. Liq. 3;Skin Corr. 1;Eye Irrit. 2,REACH registration C&L,48,H226:42;H319:10;H314:3;H335:5;H315:7
126743,"trans-α,α,4-trimethylcyclohexanemethanol",225-844-9,5114-00-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
126747,2-chloro-1H-benzimidazole,225-453-3,4857-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,138,H319:137;H335:136;H315:137;Not classified:1
126748,p-methoxybenzyl propionate,231-433-5,7549-33-9,Not Classified,Notified C&L,135,Not classified:125;H412:10
126751,"Alcohols, C12-16, ethoxylated",500-478-5,161025-21-4,Eye Dam. 1;Aquatic Acute 1,Notified C&L,3,H400:1;H318:2;H302:1;H319:1
126755,"2-(α,α,α-tribromomethyl)quinoline",210-347-1,613-53-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
126757,"Benzoxazole, 2,2'-(1,2-ethenediyl)bis[5-methyl-",602-366-2,12224-12-3,Not Classified,Notified C&L,1,Not classified:1
126759,"Benzoic acid, 4-hydroxy- ester with alcohols C18-22-alkyl (even numbered)",606-441-0,201305-16-0,Not Classified,REACH registration C&L,2,Not classified:2
126763,"(3R,5R)-tert-Butyl 7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate",603-817-6,134395-00-9,Aquatic Chronic 4,REACH registration C&L,1,H413:1
126768,"Hydrocarbons, C11-C12, n-alkanes, <2% aromatics",928-282-9,,Asp. Tox. 1,Notified C&L,1,H304:1
126769,"Fatty acids, C4-24, esters with sorbitan",306-520-7,97281-21-5,Not Classified,Notified C&L,7,Not classified:7
126774,Dichloromethylbenzene,249-854-8,29797-40-8,Skin Irrit. 2;Aquatic Chronic 1,REACH registration C&L,22,H315:22;H410:2;H411:20
126780,"5-(chloromethyl)-1,2,3-trimethoxybenzene",223-330-9,3840-30-0,Skin Corr. 1B,Notified C&L,38,H314:38
126782,5-acetamido-2-methoxybenzenesulphonyl chloride,227-358-2,5804-73-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H314:2;H318:1
126783,4-[2-(6-methoxy-2-naphthyl)-1-thioxoethyl]morpholine,258-348-6,53077-21-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H335:38;H315:38;H318:38
126785,"1,2-diphenyl-1H-indole",242-311-6,18434-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
126786,Bis(tetrabutylammonium) sulphate,219-593-4,2472-88-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:38;H315:42
126789,"4-(chlorophenylmethyl)-1,1'-biphenyl",231-369-8,7515-73-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H413:38;H319:38;H315:38
126790,"[2S-(2α,4β,5α)]-[tetrahydro-4-hydroxy-5-tetramethylfurfuryl]trimethylammonium chloride",218-963-2,2303-35-7,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,38,H310:38;H330:38;H300:38
126791,Ethylenebis[triphenylphosphonium] dibromide,216-182-1,1519-45-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
126794,o-cresol,202-423-8,95-48-7,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0,H311:0;H314:0;H301:0
126801,"Hexahydrogen tris[(ethyl)[4-[[4-[ethyl(3-sulphonatobenzyl)amino]phenyl](2-sulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene](3-sulphonatobenzyl)ammonium], dialuminium salt",239-897-0,15792-67-3,Not Classified,Notified C&L,98,Not classified:98
126802,"1,3-Propanediol, 2,2'-[oxybis(methylene)]bis[2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-",610-139-4,4376-78-7,Not Classified,Notified C&L,20,Not classified:20
126811,Methyl 4-(Bromomethyl)benzoate,607-335-7,2417-72-3,Acute Tox. 3;Skin Corr. 1B;Resp. Sens. 1,Notified C&L,47,H314:47;H301:39;H334:39;H317:1;H302:2;H290:1;H318:2
126814,p-methoxybenzonitrile,212-871-6,874-90-8,Not Classified,Notified C&L,139,Not classified:90;H302:47;H319:8;H332:8;H312:8;H315:8;H335:7;H331:1;H301:1;H311:1
126817,2-(2-chlorophenoxy)ethanol,239-501-6,15480-00-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H319:42;H332:38;H302:42;H312:42;H315:42;H335:38
126820,"4,4'-oxybis[dodecylbenzenesulphonic] acid",274-218-1,69929-03-9,Skin Corr. 1B,Notified C&L,1,H314:1
126829,"pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate",436-920-8,172399-10-9,Eye Dam. 1,Harmonised C&L,0,H318:0
126833,"1,1'-{2-(2,4-difluorophenyl)-2-[(trimethylsilyl)oxy]propane-1,3-diyl}bis(1H-1,2,4-triazole)",928-141-1,,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H315:2;H411:2;H317:2;H373:2;H401:2
126835,"2,7-Naphthalenedisulfonic acid, 4-amino-6-[2-[4-[[[4-[2-(2,4-diaminophenyl)diazenyl]phenyl]amino]sulfonyl]phenyl]diazenyl]-5-hydroxy-3-[2-(4-nitrophenyl)diazenyl]-, potassium sodium salt (1:?:?)",601-187-7,112484-44-3,,Notified C&L,83,Not classified:83
126836,Isobutylphenol,250-509-9,31195-95-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,88,H319:88;H315:88
126837,calcium hydride,232-189-2,7789-78-8,Water-react. 1,Harmonised C&L,0,H260:0
126839,Octanamide,211-066-7,629-01-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
126842,trisodium;chromium(3+);7-nitro-3-oxido-4-[(2-oxidonaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate,612-556-7,61847-77-6,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,11,H319:8;H411:8;H317:8;Not classified:3
126843,"3,3-dimethylbutyraldehyde",221-054-3,2987-16-8,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H319:54;H335:53;H315:54;H225:54
126847,Potassium methyl terephthalate,256-027-5,42967-55-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
126849,Fluorotrimethylsilane,206-997-0,420-56-4,Flam. Liq. 1;Press. Gas (Comp.);Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H224:39;H335:39;H315:39;H280:39
126850,Calcium hydrogen triacetate,266-516-5,66905-25-7,Not Classified,Notified C&L,1,Not classified:1
126851,4'-(1-hydroxy-2-isopropylaminoethyl)methanesulphonanilide hydrochloride,213-496-0,959-24-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,72,H319:68;H335:68;H315:68;H362:1;H361:2;H332:1;H302:1;H372:1;Not classified:1
126853,"3-Octanol, 3,7-dimethyl-, sodium salt",607-911-8,263148-59-0,Skin Corr. 1A,Notified C&L,83,H314:83
126859,"9-chloro-6α-fluoro-11β,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-pivalate",251-826-5,34097-16-0,Repr. 1A;STOT RE 1,Notified C&L,25,H360:24;H372:24;H361:1
126862,"2,2-Difluoro-1,3-benzodioxole-5-carboxylic acid",613-828-8,656-46-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,162,H319:162;H335:162;H315:162
126864,"2-(4-biphenylyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole",239-135-7,15082-28-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
126865,"2,5-di(1-naphthyl)-1,3,4-oxadiazole",212-995-0,905-62-4,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
126868,Benzyldocosyldimethylammonium chloride,240-865-3,16841-14-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,21,H319:21;H315:21
126869,"Azacyclotridecan-2-one, homopolymer",607-508-7,25038-74-8,Not Classified,Notified C&L,43,Not classified:43
126870,Dimethyl(tetradecyl)amine,204-002-4,112-75-4,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,475,H410:216;H400:368;H314:407;H302:406;Not classified:67;H318:238;H411:33;H319:1;H335:1;H315:1
126875,"Sulfuric acid, monococo alkyl esters, sodium salts",306-683-4,97375-27-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H315:2;H318:2;H302:2
126876,"Oxirane, 2-methyl-, polymer with oxirane, monooctyl ether",609-401-0,37311-02-7,Not Classified,Notified C&L,37,Not classified:37
126877,3-hydroxy-3'-nitro-2-naphthanilide,205-209-2,135-65-9,Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,125,H319:41;H317:2;Not classified:84;H400:38
126880,"4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridinium chloride",257-126-6,51304-61-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Notified C&L,41,H351:41;H331:39;H311:41;H301:41;H319:2;H315:2;H335:2
126881,"2,3,4-trichlorophenol",240-083-2,15950-66-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,43,H335:39;H315:42;H318:39;H302:42;H319:3;Not classified:1
126888,4-cyanophenyl acetate,235-893-8,13031-41-9,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1,H319:1;H312:1;H317:1;H302:1
126891,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (CAS: 101-68-8) and Hexamethylenediamine (124-09-4)",929-038-4,,Not Classified,Notified C&L,1,Not classified:1
126893,"1,3-Butadiene, homopolymer, oligomeric",614-501-2,68441-52-1,Not Classified,Notified C&L,76,Not classified:76
126896,"N,N'-diethyl-N,N'-dimethylethylenediamine",203-420-4,106-66-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38;H302:38
126897,3-iodo-p-toluidine,252-803-2,35944-64-0,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,Notified C&L,44,H318:38;H301:40;H317:38;H319:5;H332:4;H302:4;H312:4;H315:5;H335:4;H331:1;H311:1
126898,"Mango, ext.",290-045-4,90063-86-8,Not Classified,Notified C&L,206,Not classified:104;H226:51;H224:25;H411:25;H317:25;H319:2;H335:1;H315:1
126902,N-(2-ethoxy-4-nitrophenyl)dibenzylamine,288-786-3,85896-09-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H400:38;H335:38;H315:38;H410:38
126903,"Nickelate(6-), [22-[[[3-[[4,5-dihydro-3-methyl-5-oxo-1-[3-sulfo-4-[2-[2-sulfo-4-[(2,5,6-trichloro-4-pyrimidinyl)amino]phenyl]ethenyl]phenyl]-1H-pyrazol-4-yl]azo]-4-sulfophenyl]amino]sulfonyl]-29H,31H-phthalocyanine-1,8,15-trisulfonato(8-)-N29,N30,N31,N32]-, hexasodium, (SP-4-2)-",276-399-2,72152-45-5,Not Classified,Notified C&L,2040,Not classified:2039;H350:1
126913,"4''-Ethyl-2'-fluor-4-pentyl-1,1':4',1''-terphenyl",619-172-9,95759-59-4,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
126915,Isopropyl cinnamate,231-949-0,7780-06-5,Not Classified,Notified C&L,234,Not classified:234
126918,salts of benzidine [,244-236-4,21136-70-9,Acute Tox. 4;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H350:0;H302:0
126921,Alkali salt of (sulfonato oxyethane sulfonyl) arylamino triazinylamino sulfonato (sulfonato arylazo) aryl sulfonate,473-130-2,,Not Classified,REACH registration C&L,1,Not classified:1
126926,"2,2,4-trimethylcyclopentan-1-one",248-802-1,28056-54-4,Flam. Liq. 3,Notified C&L,1,H226:1
126927,"Zinc, C5-23-branched carboxylate naphthenate octanoate complexes",280-550-8,83711-53-9,Not Classified,Notified C&L,8,Not classified:8
126933,"Petrolatum (petroleum), silicic acid-treated;[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C",308-150-1,97862-98-1,Carc. 1B,Harmonised C&L,0,H350:0
126936,Oligomycin A,209-437-3,579-13-5,Acute Tox. 4,Notified C&L,128,H302:128
126938,Titanium trifluoride,236-732-4,13470-08-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43,H314:43;H318:38;H312:4;H332:4;H302:4
126945,"Fatty acids, C8-18 and C18-unsatd., sodium salts",266-934-8,67701-10-4,Not Classified,Notified C&L,15,Not classified:15
126950,"Glycerides, soya mono-, hydrogenated",263-030-5,61789-08-0,Not Classified,Notified C&L,1,Not classified:1
126952,"4-(1,3-benzodioxol-5-yl)butan-2-one",259-630-1,55418-52-5,Not Classified,Notified C&L,128,Not classified:127;H319:1;H315:1
126954,Methyl 5-(ethylsulphonyl)-o-anisate,263-429-4,62140-67-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,158,H319:158;H335:158;H315:158
126961,"1-benzylimidazolidine-2,4-dione",421-340-1,6777-05-5,Acute Tox. 4,Harmonised C&L,0,H302:0
126963,3-pentyloxypyridine,245-991-2,24027-10-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38;H302:38
126965,"9,10-dibenzylanthracene",222-785-0,3613-42-1,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
126970,"3,5-dibromo-2-pyridylamine",252-590-6,35486-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46
126971,"Ethanol, 2,2',2''-nitrilotris-, homopolymer, acetate (salt)",614-176-7,67924-03-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,59,H319:59;H315:59
126972,"Octahydro-7-methyl-1,4-methanonaphthalen-6(2H)-one",255-517-6,41724-19-0,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 3,Notified C&L,1648,H312:1335;H412:1339;H317:1335;H302:1648;H400:24
126975,"Urea, phosphate (1:2)",610-818-5,52279-68-2,Not Classified,Notified C&L,1,Not classified:1
126976,"2,2-diphenylethylamine",223-565-7,3963-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H335:39;H315:40;H332:1;H302:1;H312:1;Not classified:1
126982,"Resin acids and Rosin acids, copper salts",232-699-5,9007-39-0,Not Classified,Notified C&L,24,Not classified:22;H413:2
126985,Erythromycin thiocyanate,231-723-1,7704-67-8,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 2,REACH registration C&L,51,H411:1;H317:1;H334:1;H319:49;Not classified:1
126986,4-methyl-2-pyridylamine,211-780-9,695-34-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,120,H319:75;H315:79;H301:119;H335:78;H311:56;H331:39;H373:40;H318:4;Not classified:1
126987,"Oils, palm kernel, stearins, hydrogenated",297-113-2,93334-38-4,Not Classified,Notified C&L,1,Not classified:1
126992,"4,7-dichloro-2-(4,7-dichloro-3-oxobenzo[b]thien-2(3H)-ylidene)benzo[b]thiophene-3(2H)-one",238-222-7,14295-43-3,Not Classified,Notified C&L,8,Not classified:8
126994,(Z)-6-(3-hexenyl)tetrahydro-2H-pyran-2-one,273-411-8,68959-28-4,Not Classified,Notified C&L,88,Not classified:88
126997,"Proteinase, Bacillus alcalophilus serine",306-090-0,95979-76-3,Not Classified,Notified C&L,1,Not classified:1
127000,N-acetyl-N-phenylglycine,209-449-9,579-98-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
127001,Oxprenolol,229-257-9,6452-71-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
127006,2-[(carboxymethyl)thio]benzoic acid,205-178-5,135-13-7,,Notified C&L,1,H331:1;H311:1;H301:1
127007,Triethoxy(ethyl)silane,201-080-1,78-07-9,Flam. Liq. 3,Notified C&L,54,H226:44;Not classified:10;H319:2;H315:1;H335:1
127020,"1-Butanaminium, N,N,N-tributyl-, 2-hydroxybenzoate (1:1)",606-975-4,22307-72-8,Acute Tox. 4,Notified C&L,25,H302:25
127021,"11-[3-(dimethylamino)propyl]-6,11-dihydrodibenz[b,e]oxepin-11-ol",224-821-0,4504-88-5,Not Classified,REACH registration C&L,2,Not classified:1;H302:1
127022,C.I. Disperse Orange 38,611-917-6,59948-52-6,Not Classified,Notified C&L,2,Not classified:2
127028,"3-Methylbutane-1,3-diol",607-773-9,2568-33-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
127029,Lamotrigine,281-901-8,84057-84-1,,Notified C&L,220,H301:220;H412:13
127032,Metildigoxin,250-292-0,30685-43-9,Acute Tox. 2;Eye Irrit. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H319:2;H400:1;H331:1;H300:2;H410:1;H372:1;H330:1;H412:1
127035,Vinyl isocyanate,222-616-0,3555-94-0,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H330:38;H312:38;H315:38;H301:38;H335:38;H334:38;H317:38;H318:38;H225:38
127036,2-amino-1-(2-chlorophenyl)ethan-1-one hydrochloride,240-495-2,16442-79-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
127037,Ethylenebis(oxyethylene) bis[3-(5-tert-butyl-4-hydroxy-m-tolyl)propionate],253-039-2,36443-68-2,Not Classified,REACH registration C&L,693,Not classified:439;H413:186;H412:94
127038,Tetra-O-acetyl-α-D-galactopyranosyl bromide,221-324-0,3068-32-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
127045,"1,5,5-trimethylimidazolidine-2,4-dione",229-945-9,6851-81-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
127047,"3,7-dimethylocta-2,6-dienenitrile",225-918-0,5146-66-7,Muta. 1B,Harmonised C&L,0,H340:0
127049,3-(dimethoxymethylsilyl)propyl methacrylate,238-518-6,14513-34-9,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,477,H400:6;H410:6;Not classified:469;H319:2;H315:2;H332:1;H302:1;H312:1;H335:1
127050,"Zinc [6R-[6α,7β(R*)]]-3-(acetoxymethyl)-7-[(5-amino-5-carboxylato-1-oxopentyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",261-624-9,59143-60-1,Skin Sens. 1,Notified C&L,39,H317:39
127054,"1,2-bis(dichloromethyl)benzene",247-159-4,25641-99-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H302:1;H335:1;H317:1;H314:2;H318:1
127060,"1,1,2-trichloroethane",201-166-9,79-00-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Harmonised C&L,0,H351:0;H312:0;H332:0;H302:0
127062,Piperonylic acid,202-342-8,94-53-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,44,H319:6;H312:1;H332:1;H302:39;H335:42;H315:43;H318:38
127065,Chlorotrihexylsilane,222-851-9,3634-67-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H314:39;H318:39;H290:1
127068,Indol-3-yl butyrate,224-404-3,4346-15-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38
127069,Logwood (Haematoxylon campechianum) extract,232-337-6,8005-33-2,Not Classified,Notified C&L,1,Not classified:1
127078,"2-Methyl-4,6-dichloro-5-aminopyrimidine",609-751-4,39906-04-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,53,H319:51;H335:50;H315:51;H301:1;H317:1;Not classified:1
127079,Methyl hexacosanoate,227-355-6,5802-82-4,Not Classified,Notified C&L,4,Not classified:4
127082,(E)-4-methylpent-2-ene,211-616-6,674-76-0,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H304:39;H335:38;H315:38;H225:39
127084,2-chloro-3-oxopentyl acetate,235-930-8,13051-49-5,Met. Corr. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,1,H319:1;H315:1;H335:1;H290:1;H412:1
127085,Methyl hydrogen 2-dodecenylsuccinate,264-683-9,64129-91-5,Not Classified,Notified C&L,5,Not classified:5
127086,"Methyl [1S-(1α,4aα,6α,7α,7aα)]-1-(β-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methylcyclopenta[c]pyran-4-carboxylate",242-398-0,18524-94-2,Not Classified,Notified C&L,1,Not classified:1
127089,"2,3,4,5,6-pentafluorobenzophenone",216-258-4,1536-23-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
127091,5-nitroindoline,251-158-4,32692-19-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H335:45;H315:45
127096,"3',6'-bis(diethylamino)spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",208-096-8,509-34-2,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,351,H319:220;H411:136;H302:339;H335:137;H315:128;H318:119;H332:30;H413:23;H341:14;H412:21;Not classified:11;H351:4;H373:1
127097,"Titanium, Bu alc. iso-Pr alc. complexes",273-260-8,68955-22-6,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,233,H226:230;H315:233;H318:214;H319:19;H332:6;H335:6;H336:2
127099,"Isoeicosane (Hydrocarbons, C4, 1,3-butadiene-free, polymd., pentaisobutylene fraction, hydrogenated)",297-627-7,93685-79-1,Asp. Tox. 1,REACH registration C&L,355,H304:76;Not classified:279;H315:1
127101,1-(3-fluoro-4-methoxyphenyl)ethan-1-one,207-253-8,455-91-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,101,H319:101;H335:99;H315:101
127105,"N-ethyl-N-(2-phenoxyethyl)aniline, hydrochloride",279-054-4,79084-84-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
127106,p-(aminomethyl)benzoic acid,200-297-9,56-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H335:44;H315:45;H302:1
127107,"(1S,4R,6R)-1-[(3E)-5-hydroxy-3-methylpent-3-en-1-yn-1-yl]-2,2,6-trimethylcyclohexane-1,4-diol",700-054-1,70905-68-9,Not Classified,Notified C&L,1,Not classified:1
127108,"1,2-Ethanediamine, N-(2-aminoethyl)-, reaction products with glycidyl tolyl ether",282-199-6,84144-79-6,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,35,H400:3;H302:3;H410:3;H318:3;H317:4;H314:4;H319:22;H315:22;Not classified:9;H411:1
127111,Dibutylbis[(1-oxoisooctyl)oxy]stannane,288-265-0,85702-74-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,7,H319:7;H331:7;H315:7;H301:7;H311:7
127112,"4,6-dichloro-5-methoxypyrimidine",225-699-1,5018-38-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,43,H318:42;H302:42;H332:2;H312:2;H315:3;H335:2;H319:1;H412:1
127114,"etacelasil (ISO);6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane",253-704-7,37894-46-5,Acute Tox. 4;STOT RE 2;Repr. 1B,Harmonised C&L,0,H360:0;H373:0;H302:0
127115,Disodium tetrasulphide,234-805-5,12034-39-8,Flam. Sol. 2;Skin Corr. 1B,Notified C&L,48,H228:38;H314:48;H400:10;H301:6;H302:4;H252:4;H311:5;H290:1
127117,"1,3a,4,6,7,7a-hexahydro-4,7-methano-5H-inden-5-one",228-649-7,6316-16-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
127121,"Alcohols, C10-16 ethoxylated propoxylated",614-942-0,69227-22-1,Eye Irrit. 2,Notified C&L,282,H319:219;H318:57;H302:56;H400:21;H315:22;H411:20;Not classified:5;H332:1
127126,"Aluminum, dross",273-708-2,69011-71-8,Not Classified,Notified C&L,3,Not classified:2;H261:1
127132,"2,4-diethylhepta-2,6-dienal",285-729-4,85136-07-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
127138,"reaction product of 2-aminoethanol, tall oil and boric acid",918-499-7,,Not Classified,Notified C&L,1,Not classified:1
127142,Isopentyl salicylate,201-730-4,87-20-7,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,594,H411:592;H302:65;H319:3;H315:4;H335:1;H303:1;H401:1;H400:1;H410:1;Not classified:1
127144,4-amino-o-anisic acid,219-632-5,2486-80-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
127147,"2,4-dinitrophenylhydrazine",204-309-3,119-26-6,Flam. Sol. 1;Acute Tox. 4,Notified C&L,47,H228:44;H302:47;H319:5;H315:3
127148,3-methylindole,201-471-7,83-34-1,Not Classified,Notified C&L,456,Not classified:303;H411:129;H319:150;H335:137;H315:138;H312:3;H332:3;H370:1;H400:1;H302:1;H317:1
127151,3-(hexyloxy)propiononitrile,226-208-3,5327-02-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,22,H319:22;H332:22;H302:22;H312:22;H315:22;H335:22
127156,Etretinate,259-119-3,54350-48-0,Skin Irrit. 2;Eye Irrit. 2;Repr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H319:2;H400:4;H341:1;H315:4;H410:4;H360:4;H335:2
127163,Dimethyl tetrasulphide,227-278-8,5756-24-1,Acute Tox. 4,Notified C&L,1374,H302:1374;H319:477;H335:389;H315:477
127164,Indan-1-ol,228-755-3,6351-10-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H335:45;H315:46;H302:42
127168,"3,4-dimethylhexane",209-504-7,583-48-2,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H304:0;H315:0;H336:0;H410:0;H225:0
127170,"1,3:2,4-bis-O-(3,4-dimethyl bezylidene)-D-sorbitol",603-934-2,135861-56-2,Not Classified,Notified C&L,18,Not classified:17;H319:1
127171,Alpha-methyl-γ-butyrolactone,216-846-0,1679-47-6,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1;H227:1
127178,Diisobutylnitrosoamine,213-644-4,997-95-5,Acute Tox. 4;Acute Tox. 4;Carc. 1A,Notified C&L,2,H350:2;H332:2;H302:2
127180,"Oxirane, (chloromethyl)-, polymer with .alpha.-hydro-.omega.-hydroxypoly(oxy-1,2-ethanediyl)",609-683-5,39443-66-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,11,H319:10;H315:10;H317:10;Not classified:1
127182,"1-Penten-4-yne, 3-(1-ethoxyethoxy)-3-methyl-",615-703-3,72008-25-4,Flam. Liq. 3;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,84,H226:84;H412:83;H302:83;H319:1;H315:1;H335:1
127184,"1,3-[bis(3-pyridylmethyl)]thiourea",230-168-2,6965-01-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
127190,C.I. Direct Brown 116,612-300-4,61724-81-0,Not Classified,Notified C&L,5,Not classified:5
127198,"Bis[2-[2-(1-methylethyl)-3-oxazolidinyl]ethyl] hexan-1,2-diylbiscarbamate",261-879-6,59719-67-4,Not Classified,Notified C&L,149,Not classified:132;H319:15;H411:15;H317:17;H413:2;H315:2;H334:2
127199,"1,1'-(chlorophenylmethylene)bis[4-methoxybenzene]",255-002-6,40615-36-9,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,11,H335:8;H411:1;H318:1;H317:1;H314:1;H319:10;H315:10
127201,"2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)glutaric acid",228-754-8,6349-98-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H319:38;H335:38;H315:38
127204,"(E)-1-ethoxy-3,7-dimethylocta-2,6-diene",245-288-0,22882-91-3,Not Classified,Notified C&L,88,Not classified:88
127205,"Urea, N,N'-dimethyl-, polymer with ethanedial",601-396-3,115926-96-0,Not Classified,Notified C&L,1,Not classified:1
127207,"Phosphorodithioic acid, O,O-diester with phenol C10-80-alkyl derivs., zinc salts",308-565-8,98073-07-5,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,472,H319:447;H412:472
127209,6-nitroquinoline,210-346-6,613-50-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,43,H351:38;H312:39;H332:39;H302:39;H341:4
127213,"Fatty acids, castor-oil, hydrogenated, calcium salts",286-485-1,85251-72-5,Not Classified,Notified C&L,3,Not classified:3
127215,(3R-trans)-3-methyl-6-(1-methylvinyl)cyclohexene,225-843-3,5113-87-1,Flam. Liq. 3;Acute Tox. 4,Notified C&L,38,H226:38;H302:38
127221,Dichlorosilane,223-888-3,4109-96-0,Flam. Gas 1;Press. Gas (Liq.);Skin Corr. 1A;Eye Dam. 1;Acute Tox. 2,REACH registration C&L,159,H330:121;H220:159;H318:17;H280:155;H314:159;H331:38;H261:26
127233,4-amino-6-chloropyrimidine-5-carbaldehyde,238-005-7,14160-93-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
127234,Octan-3-one,203-423-0,106-68-3,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,1775,H226:1770;H315:105;H319:57;H335:51;Not classified:5;H332:1
127235,"Propanedioic acid, 2-(2,4,6-trifluorophenyl)-, 1,3-diethyl ester",607-899-4,262609-07-4,,Notified C&L,4,H319:4;H315:4
127236,6-methylpiperidin-2-one,225-321-5,4775-98-8,,Notified C&L,2,H319:2;H335:2;H315:2
127237,2-methylbut-3-yn-2-ol,204-070-5,115-19-5,Flam. Liq. 2;Acute Tox. 4;Eye Dam. 1,REACH registration C&L,429,H225:189;H318:263;H302:400;H336:18;H361:99;H335:144;H226:151;H319:83;H315:60;Not classified:24;H300:4;H332:1;H351:1
127244,Amphetamine sulphate,200-457-8,60-13-9,Acute Tox. 3,Notified C&L,40,H301:40;H331:1;H311:1;H228:1;H412:1
127245,Nonan-2-one,212-480-0,821-55-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1662,H319:1257;H315:1653;H320:3;H412:3;H335:39;Not classified:9
127248,Tungsten Blue Oxide,,,Not Classified,REACH registration C&L,1,Not classified:1
127249,2-chloroaniline,202-426-4,95-51-2,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;Muta. 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,109,H319:90;H341:50;H331:104;H301:106;H410:108;H311:108;H318:5;H373:101;H372:6;H317:4;H350:4;H400:60;Not classified:31;H330:2;H370:2;H332:2;H302:2;H361:2
127251,Tridecanedioic acid,208-011-4,505-52-2,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,49,H319:49;H412:4;H335:42;H315:43
127252,(methylthio)methyl hexanoate,277-988-7,74758-91-1,Not Classified,Notified C&L,89,Not classified:89
127254,"dinoseb (ISO);6-sec-butyl-2,4-dinitrophenol",201-861-7,88-85-7,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H319:0;H400:0;H301:0;H410:0;H311:0;H360:0
127258,"Fatty acids, C16-18 and C18-unsatd., potassium salts",270-283-5,68424-23-7,Not Classified,Notified C&L,10,Not classified:10
127260,Thiamine nitrate,208-537-4,532-43-4,Not Classified,Notified C&L,67,Not classified:67
127263,N-(triphenylphosphoranylidene)aniline,219-039-1,2325-27-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
127268,"2,6,8-trimethylnonan-4-ol",204-606-8,123-17-1,Not Classified,REACH registration C&L,223,Not classified:205;H411:18
127269,Morpholine--borane,225-450-7,4856-95-5,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,178,H228:139;H312:135;H314:178;H302:140;H318:1
127272,[3-(triethoxysilyl)propyl]urea,245-876-7,23779-32-0,Not Classified,REACH registration C&L,60,Not classified:32;H319:20;H315:28;H318:8
127277,"Siloxanes and Silicones, di-Me, 3-hydroxypropyl group-terminated, ethoxylated",600-355-7,102783-01-7,Not Classified,Notified C&L,83,Not classified:82;H319:1;H315:1
127278,α-cyclopropyl-4-fluorobenzyl alcohol,212-576-2,827-88-3,Eye Irrit. 2,Notified C&L,38,H319:38
127280,9-(4-Acetoxy-3-acetoxymethylbut-1-yl)-2-amino-6-chloropurine,619-293-7,97845-60-8,,Notified C&L,2,H302:1;H341:1
127283,1-(4-methoxyphenyl)piperazine,253-829-7,38212-30-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40;H332:1;H302:2;H312:1
127287,"4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane",418-770-5,151882-81-4,Carc. 2,Harmonised C&L,0,H351:0
127290,Bamifylline hydrochloride,243-967-6,20684-06-4,Acute Tox. 4,Notified C&L,2,H302:2;H317:1
127292,Chromium tris(dihydrogen phosphate),248-221-3,27096-04-4,Skin Corr. 1;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,50,H314:23;H318:22;H317:21;H319:25;H315:25;H302:4;H335:1
127293,"(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride",426-210-6,120086-58-0,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H314:0;H410:0
127295,"Phosphoric acid, mono-C12-14-alkyl esters, dipotassium salts",291-951-2,90506-85-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H315:2;H318:2
127297,"Fatty acids, corn-oil",269-654-4,68308-50-9,Not Classified,Notified C&L,1,Not classified:1
127298,Copper compound,452-220-5,,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H318:2;H412:2
127300,"5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]cyclohepten-5-ol",241-944-5,18029-54-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,3,H312:3;H332:3;H302:3
127302,"diphenylmethyl (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide",618-304-2,89789-07-1,Not Classified,REACH registration C&L,1,Not classified:1
127304,"1,4-bis(chloromethyl)-2,3,5,6-tetramethylbenzene",221-173-0,3022-16-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H314:39;H318:39;H290:1
127305,"2-[2-[4-(dimethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate",276-486-5,72214-25-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,2,H318:2;H302:2
127306,Azure II,609-371-9,37247-10-2,,Notified C&L,6,H319:4;H335:4;H315:5;H302:2;H332:1
127307,no defined IUPAC name,612-381-6,61789-91-1,Acute Tox. 4,REACH registration C&L,126,H332:3;Not classified:122;H413:1;H319:1
127309,Ethyl 5-Fluoroindole-2-carboxylate,609-032-5,348-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
127314,Disodium tetrafluoroberyllate,237-630-2,13871-27-7,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 1B;STOT RE 1;Aquatic Chronic 2,Notified C&L,38,H319:38;H372:38;H330:38;H315:38;H301:38;H335:38;H411:38;H317:38;H350:38
127315,"2,5-dichlorobenzenesulphonyl chloride",226-453-6,5402-73-3,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,46,H335:39;H314:46;H318:40;H290:1
127316,"4,4'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[2,4-dihydro-5-methyl-2-(p-tolyl)-3H-pyrazol-3-one]",239-898-6,15793-73-4,Not Classified,REACH registration C&L,698,Not classified:697;H412:1
127319,3-bromo-2-[[4-(diethylamino)-o-tolyl]azo]-5-methylbenzonitrile,280-319-1,83249-49-4,,Notified C&L,33,Not classified:33
127322,[No public or meaningful name is available],448-070-5,,Not Classified,Notified C&L,1,Not classified:1
127323,sodium 4-chloro-1-hydroxybutane-1-sulfonate,406-190-5,54322-20-2,Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0;H302:0
127324,Allyl 2-butenoate,243-845-2,20474-93-5,Not Classified,Notified C&L,130,Not classified:88;H400:38;H302:38;H226:4;H319:4;H315:4;H335:4
127326,2-propylaniline,217-346-5,1821-39-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40;H332:2;H302:2;H312:2
127332,"2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)",403-800-1,103597-45-1,Aquatic Chronic 4,Harmonised C&L,0,H413:0
127335,"Pine, Pinus cembra, ext.",296-036-1,92202-04-5,Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,87,H304:87;H400:85;H317:87;H410:86;H315:24;H226:26;H319:1;H411:1
127336,3-iodobenzyl alcohol,260-744-9,57455-06-8,,Notified C&L,5,H319:5;H315:5
127341,"Benzeneacetonitrile, 2-methyl-.alpha.-[2-[[[(4-methylphenyl)sulfonyl]oxy]imino]-3(2H)-thienylidene]-",457-530-4,852246-52-7,Flam. Sol. 1;Skin Sens. 1,Notified C&L,83,H228:83;H317:83
127342,3-bromobornan-2-one,200-950-8,76-29-9,Not Classified,Notified C&L,126,Not classified:88;H319:38;H335:38;H315:38
127343,Nitro(2H3)methane,235-892-2,13031-32-8,Flam. Liq. 3;Acute Tox. 4,Notified C&L,45,H226:45;H302:45
127344,2-methylquinoline-4-carboxamide,239-917-8,15821-13-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,39,H319:39;H302:39;H312:1;H315:1;H411:1
127345,Zinc bis(N-ethyl-N-phenyldithiocarbamate),238-677-1,14634-93-6,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,12,H400:4;H410:4;H413:4;H319:7;Not classified:2;H317:2;H302:1;H315:1
127347,"1-phenyl-1,3,8-triazaspiro(4,5)decan-4-one",213-819-5,1021-25-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
127352,N-3-thienylacetamide,255-907-6,42602-67-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
127355,Bis(hydroxyethyl) terephthalate,213-497-6,959-26-2,Not Classified,Notified C&L,1,Not classified:1
127357,Triacont-1-ene,242-314-2,18435-53-5,Not Classified,Notified C&L,13,Not classified:13
127358,"4-amino-3,5-xylenol",221-448-5,3096-70-6,Aquatic Acute 1,Notified C&L,42,H400:39;H319:4;H332:3;H302:4;H312:3;H315:4;H335:1
127362,4-[(5-chloro-2-oxo-2H-benzothiazol-3-yl)acetyl]piperazine-1-ethanol monohydrochloride,252-802-7,35941-71-0,Eye Irrit. 2,Notified C&L,1,Not classified:1;H319:1
127363,Sodium decyl sulphate,205-568-5,142-87-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,784,H315:748;H412:674;H318:733;H302:323;H228:122;H332:100;H335:130;H319:15;Not classified:1
127366,Zinc bis(pentachlorothiophenolate),204-224-1,117-97-5,Skin Corr. 1B,Notified C&L,38,H314:38
127372,"Fatty acids, lanolin, esters with pentaerythritol",270-434-5,68440-09-5,Not Classified,REACH registration C&L,5,Not classified:5
127374,triethylamine,204-469-4,121-44-8,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0;H312:0;H314:0;H225:0
127375,Oct-1-yne,211-069-3,629-05-0,Flam. Liq. 2;Asp. Tox. 1;Skin Mild Irrit. 3,REACH registration C&L,46,H304:46;H316:1;H225:46
127377,"(3,5-dimethylphenyl)acetonitrile",254-292-1,39101-54-7,,Notified C&L,6,H312:5;H332:5;H302:5;H319:2;H335:2;H315:2
127381,"2-Propanone, 1,3-difluoro-",610-242-4,453-14-5,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45,H331:43;H226:44;H311:43;H301:43;H319:1;H315:1;H335:1;Not classified:1
127382,4-nitrobenzophenone,214-542-2,1144-74-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
127387,"3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-6,7-dimethoxy-, (3S)-",600-480-7,103733-66-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
127388,Trihydro(trimethylamine)aluminium,240-866-9,16842-00-5,Pyr. Sol. 1;Water-react. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H250:38;H318:38;H261:38
127390,benzene,200-753-7,71-43-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;Asp. Tox. 1;Muta. 1B;Carc. 1A;STOT RE 1,Harmonised C&L,0,H319:0;H372:0;H304:0;H315:0;H340:0;H225:0;H350:0
127394,3-chlorobiphenyl-4-ol,202-120-0,92-04-6,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,39,H411:38;H318:39
127396,4-(4-hydroxy-3-methoxyphenyl)butan-2-ol,254-607-2,39728-80-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
127398,2-(2H-benzotriazol-2-yl)-6-dodecyl-4-methylphenol,603-051-2,125304-04-3,Aquatic Chronic 2,Notified C&L,297,H411:198;Not classified:99
127403,10-chlorodecan-1-ol,257-129-2,51309-10-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
127404,"Ginger, Zingiber amaricans, ext.",294-878-4,91770-91-1,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1,Notified C&L,75,H304:75;H226:50;H317:75;H412:50;H315:25
127407,Polyquaternium 47,606-383-6,197969-51-0,Skin Sens. 1,Notified C&L,1,H317:1
127410,"Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-[(9Z)-9-octadecenyloxy]-, sodium salt",609-586-8,38816-48-7,Not Classified,Notified C&L,67,Not classified:44;H319:23;H315:23
127414,8-p-menthyl hydroperoxide;p-menthane hydroperoxide,201-281-4,80-47-7,Org. Perox. D;Skin Corr. 1B;Acute Tox. 4,Harmonised C&L,0,H242:0;H314:0;H332:0
127415,"1,6-Hexanediamine, polymer with 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane], acetate (ester)",615-883-3,73018-28-7,Not Classified,Notified C&L,1,Not classified:1
127417,1-[[2-[(2-aminoethyl)amino]ethyl]amino]-3-phenoxypropan-2-ol,279-873-7,82001-48-7,Not Classified,Notified C&L,30,Not classified:30
127418,Ethyl 3-(furfurylthio)propionate,304-716-7,94278-27-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1376,H319:1375;H315:1375;Not classified:1
127419,Tripotassium propylsilanetriolate,299-135-8,93857-00-2,Skin Corr. 1A,REACH registration C&L,2,H314:2
127424,"Paraffin waxes (Fischer-Tropsch), full range, C15-50 - branched and linear",482-130-1,,Not Classified,REACH registration C&L,2,Not classified:1;H304:1
127425,"Disodium 4,4'-[(4,6-dihydroxy-1,3-phenylene)bis(azo)]bis(benzenesulphonate)",280-483-4,83562-73-6,Not Classified,Notified C&L,7,Not classified:7
127428,"tri-allate (ISO);S-2,3,3-trichloroallyl diisopropylthiocarbamate",218-962-7,2303-17-5,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H302:0;H410:0;H317:0;H373:0
127431,2-(methylthio)aniline,221-055-9,2987-53-3,Acute Tox. 3,Notified C&L,48,H301:42;H319:10;H332:5;H302:5;H315:10;H311:8;H331:4;H335:5;H312:1
127433,2-(1-hydroxypentyl)cyclopentan-1-one,255-882-1,42558-01-0,Not Classified,Notified C&L,25,Not classified:25
127434,sulfur,231-722-6,7704-34-9,Skin Irrit. 2,Harmonised C&L,0,H315:0
127438,"[hydroxyacetato(2-)-O1,O2]bis[4-(1-methyl-1-phenylethyl)phenolato]titanium",270-509-2,68443-32-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H315:1
127439,Dimethadione,211-781-4,695-53-4,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,288,H319:209;H312:251;H332:251;H302:251;H351:39;Not classified:33;H361:4
127440,2-phenoxypropionyl chloride,204-536-8,122-35-0,Met. Corr. 1;Skin Corr. 1C,REACH registration C&L,46,H314:46;H290:3;H318:39
127441,"2,5-dimethoxy-α-methylphenethylamine",220-540-2,2801-68-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 1,Notified C&L,38,H311:38;H301:38;H330:38
127443,Perbromophenyl methacrylate,242-705-8,18967-31-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
127444,N-(bromomethylene)-N-methyl-methanaminium bromide; (Bromomethylene)dimethylammonium bromide,457-720-7,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,1,H332:1;H302:1;H312:1;H318:1;H314:1
127446,Hexacalcium hexaoxotris[sulphato(2-)]dialuminate(12-),234-448-5,12004-14-7,Not Classified,REACH registration C&L,85,Not classified:1;H335:84;H315:84;H318:1
127453,Uridine(5')disodiodiphospho(1)-α-D-glucose,248-801-6,28053-08-9,Not Classified,Notified C&L,1,Not classified:1
127455,Cilastatin,279-875-8,82009-34-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
127458,N-methylacetanilide,209-436-8,579-10-2,Acute Tox. 3,Notified C&L,39,H301:39
127464,Ethyl (E)-oct-3-enoate,247-799-4,26553-47-9,Not Classified,Notified C&L,1,Not classified:1
127465,"(4,5-dibromo-1H-pyrrol-2-yl)(phenyl)methanone",700-338-5,50372-61-7,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,4,H317:4;H334:4
127466,Amrinone,262-390-0,60719-84-8,Acute Tox. 3,Notified C&L,39,H301:39
127470,"Fatty acids, C14-18 and C16-18-unsatd., sodium salts",266-935-3,67701-11-5,Not Classified,REACH registration C&L,49,Not classified:49
127473,2-pentylanthraquinone,237-711-2,13936-21-5,Not Classified,Notified C&L,6,Not classified:3;H373:2;H302:2;H413:1
127478,Melittin,253-417-7,37231-28-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H302:38
127481,"7-methoxy-3,7-dimethyloctanal",222-784-5,3613-30-7,Not Classified,REACH registration C&L,127,Not classified:126;H411:1;H315:1;H317:1
127484,"S,S'-dimethyl 2-difluoromethyl-4-isobutyl-6-trifluoromethylpyridine-3,5-dicarbothioate",619-297-9,97886-45-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,58,H400:55;H410:55;Not classified:3
127488,Tetrairon tris(pyrophosphate),233-190-0,10058-44-3,Not Classified,REACH registration C&L,5,Not classified:5
127490,tert-pentyl peroxyneodecanoate,269-597-5,68299-16-1,Org. Perox. C;Skin Irrit. 2,Notified C&L,6,H242:6;H315:6
127491,"Butane-1,2,4-triol",221-323-5,3068-00-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,92,H319:91;H335:91;H315:91;Not classified:1
127493,2-(tricylcoxy) ethyl dihydrogen phosphate,618-558-4,9046-01-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1201,H315:1006;H318:1075;H411:195;H412:119;H314:74;Not classified:65;H311:56;H302:56
127497,(2-hydroxyethyl)[2-(stearoyloxy)ethyl]ammonium acetate,273-410-2,68959-26-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6,H319:6;H315:6
127507,4-{(E)-[1-(anilinocarbonyl)-2-oxopropyl]diazenyl}benzoic acid,603-014-0,124772-04-9,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1
127508,"5,7-dihydroxy-8-[5-(5-hydroxy-7-methoxy-4-oxo-4H-1-benzopyran-2-yl)-2-methoxyphenyl]-2-(4-methoxyphenyl)-4-benzopyrone",208-311-5,521-34-6,Not Classified,Notified C&L,2,Not classified:2
127509,6-aminophthalide,260-675-4,57319-65-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43;H301:38;H332:1;H302:1;H312:1
127511,"2-Propenoic acid, 2-methyl-, (trimethoxysilyl)methyl ester",611-170-6,54586-78-6,Not Classified,Notified C&L,6,Not classified:6
127512,"Benzene-1,2,4,5-tetrayltetraamine tetrahydrochloride",224-822-6,4506-66-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
127513,Lead diiodide,233-256-9,10101-63-0,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H400:46;H332:44;H302:44;H410:46;H360:46;H373:46;H372:2;H370:2;H331:2;H301:2;H350:2
127514,2-[2-(Methoxycarbonyl-phenyl-amino)-phenyl]-acetic acid,439-530-6,,Skin Sens. 1,REACH registration C&L,3,H317:3;H313:1;H303:1
127518,Disperse orange 080,611-916-0,59948-51-5,Acute Tox. 4,Notified C&L,3,H302:3
127524,"Fatty acids, C14-18 and C16-18-unsatd., dodecyl esters",295-648-6,92113-43-4,Not Classified,Notified C&L,1,Not classified:1
127526,"N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide",412-340-0,147741-93-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
127527,α-tocopheryl hydrogen succinate,224-403-8,4345-03-3,Not Classified,REACH registration C&L,33,Not classified:33
127533,"Adipic acid, sodium salt",245-577-1,23311-84-4,Not Classified,Notified C&L,2,Not classified:2
127534,"6,6'-methylenebis[3,4-dihydro-3-phenyl-2H-1,3-benzoxazine",604-043-1,137836-80-7,Aquatic Chronic 3,Notified C&L,9,H412:9
127535,6-[[(phenylmethoxy)carbonyl]amino]hexanoic acid,217-748-0,1947-00-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:39;H315:41;Not classified:2;H412:1
127536,diketene,211-617-1,674-82-8,Flam. Liq. 3;Acute Tox. 4,Harmonised C&L,0,H226:0;H332:0
127537,"methyl 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylate",610-904-2,528560-93-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
127540,"1,6-Bis-[(2,2-dimethyl-3-lauroyloxy-propylidene)-amino]hexane",479-930-8,613222-52-9,Skin Sens. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,6,H335:6;H318:6;H317:6
127542,2-(PERFLUOROALKYL)ETHANOL,613-817-8,65545-80-4,Aquatic Chronic 2,Notified C&L,508,H411:434;Not classified:59;H319:53;H335:44;H315:45;H302:14
127543,"Bis(2,6-dichlorobenzoic) anhydride",240-494-7,16442-10-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H400:38;H335:38;H315:38;H410:38
127546,Ammonium xylenesulphonate,247-710-9,26447-10-9,Not Classified,Notified C&L,47,Not classified:45;H319:2
127550,Triethoxy(vinyl)silane,201-081-7,78-08-0,Flam. Liq. 3,REACH registration C&L,233,H226:170;Not classified:79;H319:96;H335:94;H315:2
127553,"3-(2,6,6-trimethyl-1-cyclohexen-1-yl)acrylonitrile",276-488-6,72214-33-6,Eye Irrit. 2,Notified C&L,1374,H319:1286;Not classified:88
127554,"Coal liquids, liq. solvent extn.;[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]",302-683-3,94114-48-4,Carc. 1B,Harmonised C&L,0,H350:0
127568,PIGMENT 11990,404-460-7,,Not Classified,Notified C&L,31,Not classified:31
127569,"2-ethyl-4,5-dihydro-4,4-dimethyloxazole",225-919-6,5146-88-3,,Notified C&L,4,H226:4
127571,"Bicyclo[2.2.1]heptane, 7,7-dimethyl-2-methylene-",610-330-2,471-84-1,Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,14,H304:14;H411:13;H319:1;H315:1;H317:1;H226:1
127573,"2,4,6-trimethylphenylacetonitrile",252-151-9,34688-71-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H312:43;H332:42;H302:43;H319:4;H315:4;H335:4;H331:1;H311:1;H301:1
127574,"Phosphoric acid, dodecyl ester, compd. with 2,2',2''-nitrilotris[ethanol]",261-625-4,59146-94-0,Not Classified,Notified C&L,2,Not classified:1;H319:1
127576,Nafcillin,205-690-9,147-52-4,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,3,H317:3;H334:3
127578,"1,1-dichloropropane",201-165-3,78-99-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,41,H319:41;H332:41;H335:41;H315:41;H351:41;H225:38;H224:3;H302:3;H312:3
127579,"1-(3-chloropropyl)-1,3-dihydro-2H-benzimidazol-2-one",263-731-6,62780-89-6,Acute Tox. 4;Skin Sens. 1B;Muta. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,6,H341:4;H302:6;H317:4;H373:4;H412:4
127585,"Oils, palm, stearins, hydrogenated",297-112-7,93334-37-3,Not Classified,Notified C&L,32,Not classified:32
127588,"Ester reaction products of 1,4-Benzenedicarboxylic acid with C11-14 iso-alcohols, C13-rich",416-740-6,,Not Classified,REACH registration C&L,1,Not classified:1
127590,"4,5-dibromoveratrole",253-705-2,37895-73-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
127594,Rubidium tetrafluoroborate(1-),242-660-4,18909-68-7,,Notified C&L,4,H319:4;H335:4;H315:4
127596,5-Bromo-2-methoxyphenol,609-492-7,37942-01-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:4;H315:4;H302:1;H335:2
127597,Rot K16DR254,600-201-9,101380-00-1,Acute Tox. 4,Notified C&L,1,H302:1
127598,"1,3-bis(isocyanatomethyl)benzene",222-852-4,3634-83-1,Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;STOT SE 1;STOT RE 1;Aquatic Chronic 3,REACH registration C&L,83,H372:14;H330:17;H370:15;H315:35;H334:82;H318:14;H317:44;H412:4;H226:48;H314:48;H319:31;H331:28;H335:30
127600,Potassium picrate,209-361-0,573-83-1,Unst. Expl.;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H200:1;H301:1
127601,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, isodecyl ester",292-416-6,90605-17-7,Not Classified,Notified C&L,1,Not classified:1
127604,3-methylbutyl chloroacetate,226-207-8,5326-92-1,Eye Irrit. 2,Notified C&L,38,H319:38
127605,"Sodium hydrogen 2-aminonaphthalene-1,5-disulphonate",243-138-9,19532-03-7,Not Classified,Notified C&L,12,Not classified:11;H319:1;H317:1
127606,"4-chloro-2,6-dinitrophenol",201-863-8,88-87-9,Acute Tox. 4,Notified C&L,38,H302:38
127609,MDI/CHA/PTL,451-130-3,,Not Classified,Notified C&L,1,Not classified:1
127610,5-methoxybenzothiazol-2-amine,259-118-8,54346-87-1,,Notified C&L,2,H319:2;H335:2;H315:2
127611,2-ethylacrylaldehyde,213-079-3,922-63-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 2,Notified C&L,43,H312:39;H225:43;H330:43;H302:39;H319:4;H341:4;H315:4;H335:4
127614,3-(2-ammonioethyl)-5-hydroxy-1H-indolium maleate,242-399-6,18525-25-2,Acute Tox. 4,Notified C&L,39,H302:39
127620,Pipazetate hydrochloride,227-980-4,6056-11-7,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H315:1;H302:1
127623,"2,2'-dihydroxy-4-octyloxybenzophenone",201-594-6,85-24-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
127625,Ethyl 4-fluoro-3-nitrobenzoate,609-290-9,367-80-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H302:1;H312:1;H315:1;H335:1
127626,1-butylbiguanide monohydrochloride,214-723-6,1190-53-0,,Notified C&L,3,H319:3;H315:3;H332:1;H302:3;H335:1
127629,"Amides, coco, N-[3-(dimethylamino)propyl], N-oxides",268-938-5,68155-09-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2,REACH registration C&L,849,H315:844;H373:98;H318:799;H302:551;H319:48;H301:47;H411:39;H400:19;H410:5;Not classified:2
127630,(p-chlorophenyl)metaboric acid,216-845-5,1679-18-1,Not Classified,REACH registration C&L,60,Not classified:4;H312:44;H332:44;H302:48;H319:12;H335:11;H315:12
127631,Diethyl[2-(3-pyridiniocarbonyloxy)ethyl]ammonium hydrogen citrate,216-694-5,1641-74-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
127633,2-chloro-6-fluorophenylacetic acid,253-661-4,37777-76-7,,Notified C&L,7,H319:7;H335:6;H315:7
127642,Norfenefrine hydrochloride,225-323-6,4779-94-6,Acute Tox. 4,Notified C&L,39,H302:38;H301:1
127649,"11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride",448-720-8,363138-44-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0;H302:0
127650,"1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione",240-230-0,16079-88-2,Ox. Sol. 2;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,56,H400:56;H272:45;H314:56;H302:56;H317:12;H410:1;H318:1
127651,Ethynylenebis[diphenylphosphine],225-842-8,5112-95-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
127652,"(2S)-(+)-3-Chloro-1,2-propanediol",612-041-7,60827-45-4,Acute Tox. 3;Acute Tox. 4;Eye Dam. 1,Notified C&L,45,H312:43;H301:44;H318:45;H341:4;H330:5;H315:6;H335:4;H360:5;H372:1;H370:1;H351:1;H290:1;H300:1;H332:1;H311:1;H361:1
127657,"3,4-diaminobenzenesulphonic acid",231-274-1,7474-78-4,Aquatic Chronic 3,REACH registration C&L,37,H412:2;H315:35;H318:34;H319:1;H317:2;H335:1
127660,"Disodium 2-(2,3-dihydro-1,3-dioxosulphonato-1H-inden-2-yl)quinolinesulphonate",284-497-1,84924-83-4,Not Classified,REACH registration C&L,6,Not classified:6
127661,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl β-D-glucopyranoside (4:1)",614-384-8,68239-42-9,Not Classified,Notified C&L,41,Not classified:41
127665,caffeine,200-362-1,58-08-2,Acute Tox. 4,Harmonised C&L,0,H302:0
127666,[No public or meaningful name is available],484-670-3,,Not Classified,Notified C&L,83,Not classified:83
127667,"orthoboric acid, sodium salt",237-560-2,13840-56-7,Repr. 1B,Harmonised C&L,0,H360:0
127669,methyl N-(phenoxycarbonyl)-L-valinate,414-500-5,153441-77-1,Aquatic Chronic 3,Harmonised C&L,0,H412:0
127671,Perflunafene,206-192-4,306-94-5,Not Classified,REACH registration C&L,45,Not classified:41;H319:3;H335:3;H315:3;H226:2
127674,Indan-1-one,201-470-1,83-33-0,Not Classified,REACH registration C&L,20,Not classified:4;H302:14;H319:2;H335:2;H315:2
127676,"N-(6-oxo-6H-anthra[9,1-cd]isothiazol-7-yl)propionamide",256-897-6,50988-02-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
127679,p-methoxytrityl alcohol,212-693-9,847-83-6,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,38,H413:38;H318:38;H302:38
127682,2-(trifluoromethoxy)aniline,216-257-9,1535-75-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47,H319:47;H332:47;H302:47;H312:47;H315:47;H335:41;H226:42;H373:5
127687,"Hydrocarbons, C6",300-229-9,93924-36-8,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,46,H304:46;H315:46;H336:46;H373:46;H411:46;H361:46;H225:46
127688,"α,α,β,β-tetrafluoro-p-nitrophenetole",248-899-0,28202-32-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
127690,N-acetyl-L-aspartic acid,213-643-9,997-55-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
127693,"1,3-dimethylbutyl 2-butenoate",252-438-9,35206-51-0,Skin Irrit. 2,Notified C&L,1559,H315:1559
127694,"Disodium 4-amino-5-hydroxynaphthalene-2,7-disulphonate",223-566-2,3963-80-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:38;H332:38;H302:38;H312:38;H315:38;H335:38;Not classified:1
127698,3-ethoxypropyl acetate,619-360-0,98516-30-4,Flam. Liq. 3,Notified C&L,207,H226:207;H336:17
127701,"Distillates (petroleum), steam-cracked, polymerized",614-301-5,68131-77-1,Not Classified,Notified C&L,78,Not classified:58;H317:20;H412:20
127702,"1,3-dioxolane-2-ethylamine",227-277-2,5754-35-8,Flam. Liq. 3;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H226:1;H314:1;H318:1
127704,2-imidazol-4-ylethylamine dihydrochloride,200-298-4,56-92-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,REACH registration C&L,219,H319:218;H335:217;H315:218;H334:216;H317:216;H332:1;H302:1;H370:1;Not classified:1
127711,"N,N'-(5,6,12,17,18,24-hexahydro-5,12,17,24-tetraoxodinaphth[2,3-i:2',3'-i']indeno[4,3-ab:2,1-c']dicarbazole-11,23-diyl)bis(benzamide)",274-412-6,70210-15-0,Not Classified,Notified C&L,1,Not classified:1
127714,"D-Glucitol, reaction products with epichlorohydrin",270-160-6,68412-01-1,Not Classified,Notified C&L,30,Not classified:26;H341:3;H315:4;H351:1
127715,Nitrilase,618-514-4,9024-90-2,Skin Sens. 1;Resp. Sens. 1,Notified C&L,40,Not classified:38;H317:38;H334:40
127718,4-isopropyl-1-methylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde,267-559-2,67890-79-3,Skin Sens. 1,Notified C&L,233,H317:233
127719,"Alkanes, middle distillate-range, hydrotreated",310-009-4,102110-12-3,Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,1,H304:1;H411:1
127726,methyl 3-sulfamoylthiophene-2-carboxylate,611-820-9,59337-93-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
127728,"Cupro, copper processing",919-583-6,,Skin Sens. 1;Carc. 2;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2,H400:2;H372:2;H351:2;H411:2;H317:2;H360:2
127729,Potassium sodium tartrate,613-385-0,6381-59-5,,Notified C&L,42,Not classified:42
127730,"2,6,8-trimethylnonan-4-one",204-607-3,123-18-2,Not Classified,Notified C&L,170,Not classified:83;H411:65;H412:22
127731,3-amino-3-phenylpropanoic acid,604-118-9,13921-90-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H228:1;H252:1
127737,"Formaldehyde, reaction products with oleylamine",295-051-0,91782-77-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,46,H314:46;H302:26;H301:20
127739,2-{2-[(2-ethylhexyl)oxy]ethoxy}ethanol,437-540-5,1559-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,179,H319:177;H335:177;H315:177;Not classified:2
127742,"Naphthalene-1,2,4-triyl triacetate",217-239-3,1785-67-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H335:38;H315:38;H318:38
127746,3-diethylaminophenol,202-090-9,91-68-9,Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,138,H411:95;H301:94;H302:3;H319:42;H335:40;H315:42;H332:1
127750,"Amides, from diethylenetriamine and soya fatty acids",269-653-9,68308-46-3,Not Classified,Notified C&L,72,Not classified:71;H411:1;H314:1
127753,"(1S,2S,5R,7S,9S,10S,14R,19S)-15-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione;(1S,2R,5S,7R,9R,10S,14R,19S)-15-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione",605-513-9,168316-95-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,211,H400:211;H410:211
127755,4-methoxy-α-pyridylbenzyl alcohol,248-664-2,27805-39-6,Acute Tox. 4,Notified C&L,38,H302:38
127757,"3-chloro-1,1,1-trifluoropropane",207-307-0,460-35-5,Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1
127761,2-methyl-5-(methylthio)furan,237-170-2,13678-59-6,Flam. Liq. 3,Notified C&L,120,H226:120;H319:1;H315:1;H335:1
127762,Suberic acid,208-010-9,505-48-6,Eye Irrit. 2,REACH registration C&L,149,H319:142;Not classified:9;H335:5;H315:6
127766,"4H-Dinaphtho[2,1-f:1',2'-h][1,5]dioxonin-5-ol, 5,6-dihydro-, (13bS)-",610-376-3,477327-67-6,Not Classified,Notified C&L,1,Not classified:1
127767,"β-D-Glucopyranosiduronic acid, 5-bromo-4-chloro-1H-indol-3-yl, compd. with cyclohexanamine (1:1)",601-302-0,114162-64-0,Not Classified,Notified C&L,3,Not classified:2;H312:1;H332:1;H302:1
127768,Methyl 4-[(chlorocarbonyl)oxy]benzoate,250-483-9,31140-40-6,Skin Corr. 1B,Notified C&L,39,H314:39
127769,(methylthio)methyl butyrate,277-989-2,74758-93-3,Acute Tox. 4,Notified C&L,1377,H302:1376;H319:1;H335:1;H315:1
127772,"Fatty acids, C14-18 and C16-26-unsatd., sodium salts",270-284-0,68424-24-8,Not Classified,Notified C&L,6,Not classified:6
127773,"N,N-diethyl-p-toluidine",210-345-0,613-48-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,281,H319:203;H315:165;H302:200;H331:78;H301:78;H311:78;H373:77;H412:77;H332:2;H411:1
127775,"2,5-dichloro-3-nitrobenzoic acid",201-862-2,88-86-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43
127777,Disodium sulfate decahydrate (Na2SO4.10H2O),616-445-4,7727-73-3,,Notified C&L,39,Not classified:39
127782,2-(hydroxymethyl)-1H-benzimidazole,225-451-2,4856-97-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H319:43;H332:40;H302:40;H312:40;H315:43;H335:42
127783,2-methyl-4-nitroanisole,256-748-5,50741-92-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
127786,"Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, bromides",293-522-5,91080-29-4,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,6,H400:3;H312:3;H314:3;H301:3;Not classified:3
127787,N-DL-alanyl-DL-norvaline,219-038-6,2325-18-0,Not Classified,Notified C&L,3,Not classified:3
127788,"PHENYL SILSESQUIOXANE, HYDROXY TERMINATED",605-918-0,181186-39-0,Acute Tox. 4,Notified C&L,18,H332:17;Not classified:1
127791,"Maple, Acer campestre, ext.",290-047-5,90063-87-9,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1
127795,Methyl 4-pyridylacetate,249-856-9,29800-89-3,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
127801,Diphenyliodonium hexafluorophosphate,261-134-5,58109-40-3,Skin Corr. 1B,Notified C&L,52,H314:40;H300:7;H319:5;H335:4;H315:5;H301:4
127802,"3,5-dinitrobenzonitrile",223-889-9,4110-35-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H319:45;H332:44;H302:40;H312:44;H315:45;H335:40;H301:5;H373:4;H331:1;H311:1
127805,"Dihydro-4,4-dimethylfuran-2,3-dione",235-891-7,13031-04-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
127807,"3-[2-(3,4-dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-one",239-479-8,15462-91-6,Not Classified,REACH registration C&L,4,Not classified:4
127809,2-phenylbutyric anhydride,216-180-0,1519-21-7,Skin Corr. 1B,Notified C&L,38,H314:38
127810,Ethacridine,207-130-9,442-16-0,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H335:1;H315:1
127811,"Rape oil, sulfonated, sodium salt",293-618-7,91081-16-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,88,H319:83;H315:83;Not classified:5
127817,"1-Propene, hydroformylation products, high-boiling",271-363-2,68551-11-1,Eye Dam. 1,Notified C&L,156,H318:85;H400:71;H410:71;H360:1;H332:1;H315:1;H335:1;H317:1;H226:1;H361:1
127820,Nonadec-1-ene,242-313-7,18435-45-5,Not Classified,Notified C&L,4,Not classified:3;H304:1
127821,2-(3-oxazolidinyl)ethyl methacrylate,256-260-2,46235-93-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,60,H400:4;H302:4;H312:4;H318:4;H314:4;H412:4;Not classified:56
127822,"3,5-diacetamido-2,4,6-triiodobenzoic acid",204-223-6,117-96-4,Not Classified,REACH registration C&L,10,Not classified:1;H317:9;H334:9
127827,Piperazine adipate,205-569-0,142-88-1,Not Classified,REACH registration C&L,4,Not classified:2;H314:1;H412:1;H317:1;H334:1;H319:1;H335:1;H315:1
127828,5-ethoxysalicylic acid,238-004-1,14160-71-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
127833,"Manganese, [[2,2',2''-[nitrilotris[2,1-ethanediyl(nitrilo-.kappa.N)methylidyne]]tris[phenolato-.kappa.O]](3-)]-, (OC-6-22)-",479-540-8,61007-89-4,Skin Sens. 1B;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,85,H402:2;H317:85;H412:85
127834,Oligomerisation reaction products of glyoxal and urea.,610-945-6,53037-34-6,Skin Sens. 1B;Muta. 2,REACH registration C&L,8,H341:2;H317:2;Not classified:6;H319:1;H332:1;H315:1
127836,"Coal liquids, liq. solvent extn. soln.;[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]",302-682-8,94114-47-3,Carc. 1B,Harmonised C&L,0,H350:0
127837,2'-deoxycytidine hydrochloride,223-639-9,3992-42-5,Not Classified,Notified C&L,1,Not classified:1
127840,"4,9-diazadodecamethylenediamine",200-754-2,71-44-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,135,H314:135;H318:90
127842,"1,2-dichlorobenzene;o-dichlorobenzene",202-425-9,95-50-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H400:0;H302:0;H335:0;H315:0;H410:0
127848,4-Bromo-2-ethylaniline,610-270-7,45762-41-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H226:41;H319:45;H315:45;H335:41;H332:4;H302:4;H312:4
127849,2-quinolylhydrazine,239-899-1,15793-77-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,44,H318:38;H302:40;H319:6;H335:5;H315:6;H332:2;H312:1
127861,"2-[6-dodecoxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",614-943-6,69227-93-6,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
127864,"2,6-dibromo-4-nitroaniline",212-577-8,827-94-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H312:44;H332:44;H302:44;H319:5;H315:5;H335:4;H373:4
127868,"Methyl 4-[[(2,5-dichlorophenyl)amino]carbonyl]-2-nitrobenzoate",281-339-3,83929-47-9,Not Classified,REACH registration C&L,34,Not classified:32;H413:2
127870,Copper dinitrate,221-838-5,3251-23-8,Ox. Sol. 2;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1171,H400:910;H411:311;H318:300;H272:548;H314:507;H319:560;H315:596;H301:443;H270:176;H302:418;H410:247;H271:22;Not classified:22;H332:6;H312:6;H350:6;H335:2
127874,1-methyl-1H-pyrrole-2-ethylamine,280-626-0,83732-75-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38
127876,Methyl 3-(furfurylthio)propionate,304-715-1,94278-26-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,11,H319:10;H335:10;H315:10;Not classified:1
127877,(methoxymethoxy)cyclododecane,255-908-1,42604-12-6,Not Classified,Notified C&L,88,Not classified:88
127879,"7-[3-(benzylamino)propyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione",246-518-2,24890-70-8,,Notified C&L,2,Not classified:2
127880,4-mesylaniline,226-803-8,5470-49-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:4;H315:4;H335:3
127884,"Phosphonic acid, [2-(hydroxyphosphinyl) ethylidene] bis-, pentasodium salt",618-709-4,912335-51-4,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,0,No data
127887,"Phosphonic acid, diammonium salt, monohydrate",610-672-2,51503-61-8,Eye Irrit. 2,REACH registration C&L,94,H319:93;Not classified:1
127888,1-bromoheptane,211-068-8,629-04-9,Flam. Liq. 3,Notified C&L,59,H226:59;H319:6;H332:5;H315:6;H335:5;H411:1
127897,3-morpholino-1-(2-thienyl)propan-1-one hydrochloride,299-122-7,93856-88-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
127898,"3,4,4a,5,8,8a-hexahydro-3',6-dimethylspiro[1,4-methanonaphthalene-2(1H),2'-oxirane]",255-515-5,41723-98-2,Not Classified,Notified C&L,88,Not classified:88
127899,2-(octadec-9-en-1-yloxy)ethan-1-ol; phosphoric acid,609-690-3,39464-69-2,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1310,H314:1064;H318:1302;H315:246;H413:125;H319:3;H302:2;H400:2;H412:2
127900,"2,5,8,11-tetramethyldodec-6-yne-5,8-diol",269-348-0,68227-33-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,663,H411:46;H319:656;H315:658;H302:441;H412:13;Not classified:5;H318:1
127902,Lithium p-toluenesulphinate,240-867-4,16844-27-2,Acute Tox. 3;Acute Tox. 3,Notified C&L,25,H311:25;H301:25
127905,"Bis(8-hydroxyquinolyl) sulphate, monopotassium salt",239-133-6,15077-57-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
127906,"5'-O-(p,p'-dimethoxytrityl)thymidine",255-003-1,40615-39-2,Aquatic Chronic 4,REACH registration C&L,46,H413:2;H319:44;H335:43;H315:44
127909,α-methoxyacetophenone,223-802-4,4079-52-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
127912,"Cuprate(6-), [μ-[[2,2'-[(1,4-dioxo-2-butene-1,4-diyl)bis[imino(2-sulfo-4,1-phenylene)-2,1-ethenediyl(3-sulfo-4,1-phenylene)(4,5-dihydro-3-methyl-5-oxo-1H-pyrazole-4,1-diyl)azo]]bis[5-sulfobenzoato]](10-)]]di-, hexasodium",276-162-3,71889-03-7,Aquatic Chronic 4,Notified C&L,31,H413:31
127913,"Hydrogen [4-[[4-(diethylamino)phenyl][4-[ethyl(sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(sulphonatobenzyl)ammonium, sodium salt",306-565-2,97334-73-1,,Notified C&L,33,Not classified:33
127916,"Oxirane, methyl-, polymer with oxirane, monododecyl ether",609-400-5,37311-00-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,8,H412:6;H318:7;H302:7;H400:1
127917,Thiophen-2-ethanol,226-452-0,5402-55-1,Not Classified,REACH registration C&L,15,Not classified:13;H319:2;H315:2;H302:2;H335:1
127919,"3,5-diphenyl-1H-pyrazole",214-543-8,1145-01-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38;H335:38;H315:38;H318:38
127920,DIOXAZINBLAU-ETHYL,447-220-7,,Not Classified,Notified C&L,31,Not classified:31
127921,"Biphenyl-3,4-diol",202-121-6,92-05-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,39,H411:39;H318:39;H302:39
127924,"Endo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl valerate",231-435-6,7549-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
127925,"8-[4-(3,4-Difluorophenyl)-3-cyclohexene-1-yl)-1,4-dioxaspiro[4.5]decane",604-591-1,147622-83-1,Not Classified,REACH registration C&L,2,Not classified:2
127931,"2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-one",238-909-1,14847-56-4,Not Classified,REACH registration C&L,2155,Not classified:2122;H228:33;H412:33
127932,"Propanenitrile, 3-(C8-10-alkyloxy) derivs.",272-243-2,68784-39-4,Not Classified,Notified C&L,1,Not classified:1
127934,Nequinate,237-796-6,13997-19-8,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
127936,"3,5-dimethylbenzoyl chloride",413-010-9,6613-44-1,Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0,H314:0;H317:0
127937,"Zanthoxylum alatum, ext.",294-877-9,91770-90-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,7,H304:7;H315:7;H410:4;H317:7;H226:6;H319:2;H411:3;H400:1
127938,Tris(2-hydroxyethyl)ammonium lactate,243-846-8,20475-12-1,Not Classified,Notified C&L,103,Not classified:63;H315:40;H318:40
127939,"Cadmium sulfide (CdS), solid soln. with zinc sulfide, silver chloride-doped",271-513-7,68583-45-9,Acute Tox. 4;Muta. 2;Carc. 1B;Repr. 2;STOT RE 1;Aquatic Acute 1,Notified C&L,1,H341:1;H372:1;H400:1;H302:1;H410:1;H361:1;H350:1
127947,Undecan-2-ol,216-722-6,1653-30-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,126,H411:126;H319:126;H335:126;H315:126
127948,"3,4-dichloro-1-methylpyrrole-2,5-dione",601-181-4,1123-61-1,Acute Tox. 2,Notified C&L,1,H300:1
127950,"p-(1,1-dimethylpropyl)phenol",201-280-9,80-46-6,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 1,REACH registration C&L,677,H314:669;H318:560;H317:529;H410:484;H312:93;H302:112;H411:119;H400:16;Not classified:5;H332:1;H335:1
127951,Cacao butter,616-793-7,8002-31-1,Not Classified,Notified C&L,254,Not classified:254
127952,"Ethanethioamide, 2-(dimethylamino)-, hydrochloride (1:1)",608-090-9,27366-72-9,,Notified C&L,1,H302:1
127954,"di-allate (ISO);S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate",218-961-1,2303-16-4,Acute Tox. 4;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H351:0;H400:0;H410:0;H302:0
127956,"2,2'-[1,3-phenylenebis(oxy)]bisethanol",203-028-3,102-40-9,Not Classified,REACH registration C&L,20,Not classified:5;H318:15;H319:2;H315:2
127959,"1,2-Bis(2-aminophenoxy)ethane",459-990-1,,Aquatic Chronic 2,REACH registration C&L,35,H411:35
127961,2-ethyl-4-methylpentan-1-ol,203-422-5,106-67-2,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H332:1
127965,1-chlorononane,219-595-5,2473-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
127970,4-isopropoxybenzoic acid,236-169-4,13205-46-4,,Notified C&L,5,H319:5;H335:4;H315:5
127972,o-ethylbenzenethiol,224-811-6,4500-58-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1421,H319:1420;H302:1381;H335:42;H315:43;H332:5;H312:5;Not classified:1
127973,"2,2-dibutyldihydro-6H-1,3,2-oxathiastannin-6-one",201-079-6,78-06-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H332:1;H302:1;H312:1;H315:1
127974,Disodium 1-[2-[(1-oxododecyl)amino]ethyl] 2-sulphonatosuccinate,247-310-4,25882-44-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,16,H319:8;H315:8;Not classified:6;H318:2
127975,2-octyldodecyl 2-ethylhexanoate,273-943-0,69275-04-3,Not Classified,Notified C&L,3,Not classified:3
127977,"(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate",406-960-0,77497-97-3,Aquatic Chronic 2,Harmonised C&L,0,H411:0
127980,"8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione",922-028-0,,Not Classified,REACH registration C&L,4,Not classified:4
127994,"Tris(1,10-phenanthroline-N1,N10)iron sulphate",238-676-6,14634-91-4,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,2,H412:1;H302:1;Not classified:1
127995,Chlorphentermine,207-314-9,461-78-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
127997,Sodium palmitate,206-988-1,408-35-5,Eye Irrit. 2,Notified C&L,59,H319:38;Not classified:21
127998,1-[4-(5-oxo-1-phenyl-2-thioxoimidazolidin-4-yl)butyl]-3-phenylthiourea,227-106-1,5657-26-1,Acute Tox. 3,Notified C&L,38,H301:38
127999,nickel chromate,238-766-5,14721-18-7,Skin Sens. 1;Resp. Sens. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0,H400:0;H372:0;H410:0;H334:0;H317:0;H350:0
128003,"(4-trans-Propyl-[1,1-bicyclohexyl]-4-trans-carbonic acid)-[4-(4-trans-butylcyclohexyl)-phenylester]",601-406-6,115978-59-1,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
128006,NEODYMIUM DEHP 45,482-670-8,,Not Classified,Notified C&L,1,Not classified:1
128008,"Cuprate(3-), [2-[[[[3-amino-2-(hydroxy-κO)-5-sulfophenyl]azo-κN2]phenylmethyl]azo-κN1]-4-sulfobenzoato(5-)-κO]-, trihydrogen",616-519-6,77840-01-8,Not Classified,Notified C&L,31,Not classified:31
128011,"1,3-Butanedithiol, 1-acetate",618-280-3,89534-38-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H319:90;H335:90;H315:90;H302:90;Not classified:1
128012,"2,4-Imidazolidinedione, (hydroxymethyl)-5,5-dimethyl-",608-120-0,27636-82-4,,Notified C&L,34,Not classified:34
128018,"1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione",223-109-7,3736-92-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H410:2;H400:2;H302:5
128019,"1-Propanaminium, N-(3-aminopropyl)-2-hydroxy-N,N-dimethyl-3-sulfo-, N-coco acyl derivs., hydroxides, inner salts",268-761-3,68139-30-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,665,H411:24;H319:611;H400:2;H410:2;H315:141;Not classified:51;H318:3;H302:1
128021,n-Butyoxycarbonyl-O-n-butyl thionocarbamate,476-230-4,,Acute Tox. 4;Skin Sens. 1;Muta. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,1,H341:1;H372:1;H302:1;H411:1;H317:1
128022,"4,4'-thiodi-o-cresol",403-330-7,24197-34-0,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H318:0;H410:0
128023,"2-Propenoic acid, 2-methyl-, C16-18-alkyl esters",292-101-3,90551-83-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,62,H319:62;H335:62;H315:62
128026,(S)-3-[1-(Dimethylamino)ethyl]-phenol,478-670-2,,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2A;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H317:1;H302:1
128027,"Phosphorodithioic acid, mixed O,O-bis(hexyl and iso-Bu) esters, zinc salts",272-241-1,68784-34-9,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,4,H411:4;H318:4
128028,C.I. Reactive Blue 140,615-668-4,71872-74-7,Not Classified,Notified C&L,1,Not classified:1
128031,1-tert-butoxypropan-2-ol,406-180-0,57018-52-7,Flam. Liq. 3;Eye Dam. 1,Harmonised C&L,0,H226:0;H318:0
128037,1-Methylsulfanylpropan-2-one,604-217-7,14109-72-9,Flam. Liq. 3,Notified C&L,1381,H226:1381;H319:90;H315:90;H335:90
128045,"Sulfuric acid, iron(3+) salt (3:2), hydrate",604-849-3,15244-10-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,43,H315:43;H318:39;H302:39;H319:4
128048,1H-indole-3-acetamide,212-904-4,879-37-8,,Notified C&L,33,Not classified:33
128049,"3-methylcyclopentane-1,2-dione",212-154-8,765-70-8,Not Classified,Notified C&L,208,Not classified:206;H224:1;H302:1
128050,Ethyl L-ornithine dihydrochloride,283-859-6,84772-29-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
128051,Allylcyclohexane,218-316-4,2114-42-3,Flam. Liq. 3;Acute Tox. 3;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,43,H413:38;H226:43;H301:38;H318:42;H304:5
128054,"Fatty acids, C16-18, C12-18-alkyl esters",306-083-2,95912-87-1,Not Classified,REACH registration C&L,195,Not classified:195
128056,Trisilane,616-514-9,7783-26-8,Pyr. Liq. 1,Notified C&L,79,H250:79;H319:38;H335:38;H315:38;H261:38;H224:1
128058,"Fennel, Foeniculum vulgare piperitum, ext.",297-620-9,93685-73-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:2;H304:2;H315:2;H410:2;H317:2;H226:2
128060,But-3-enoic acid,210-892-5,625-38-7,Acute Tox. 4;Skin Corr. 1B,Notified C&L,47,H314:47;H302:39;H335:2;H290:1;H318:2;H341:1;H351:1;H411:1;H317:1;H227:1
128061,Iodomethyl pivalate,258-339-7,53064-79-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H335:39;H315:39;H318:40;H341:1;H314:1
128062,"Alkanes, C13-16-iso-",271-370-0,68551-20-2,Not Classified,Notified C&L,126,Not classified:50;H304:57;H336:24;H411:19;H319:19;H335:19;H315:19;H320:4
128065,"Benzenesulfonic acid, 4-[2-[2,4-dihydroxy-5-[2-(4-nitrophenyl)diazenyl]phenyl]diazenyl]-",606-313-4,194595-35-2,Not Classified,Notified C&L,1,Not classified:1
128067,Sodium 2-(dodecyloxy)ethyl sulphate,239-925-1,15826-16-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,51,H315:50;H318:50;H302:1
128068,Ethyl isovalerate,203-602-3,108-64-5,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,1700,H226:1698;H315:1651;H335:1;H318:1;H411:1;H225:1
128069,"Buta-1,2-diene",209-674-2,590-19-2,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,235,H280:235;H220:202;H411:33;H224:33
128074,5-acetylsalicylic acid,236-037-6,13110-96-8,,Notified C&L,6,H319:6;H335:4;H315:6
128075,"Melon (plant), ext.",290-054-3,90063-94-8,Flam. Liq. 3,Notified C&L,29,H226:28;Not classified:1
128077,1-methyl-5-oxopyrrolidine-3-carboxylic acid,255-765-5,42346-68-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3;H332:1;H302:1;H312:1
128082,"1,2,3-Propanetriol, homopolymer, 2-oxiranylmethyl ether",601-532-1,118549-88-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,27,H319:26;H315:15;H317:23;H302:11;H332:1;H312:1
128083,Cyclopent-2-en-1-one-ethyleneacetal,211-783-5,695-56-7,Flam. Liq. 3,Notified C&L,39,H226:39
128084,Ammonium tetrachloroaurate,250-476-0,31113-23-2,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H302:1;H318:1;H314:1;H290:1;H412:1
128085,"Fatty acids, C16-18-unsatd., reaction products with ethanolamine",287-647-4,85566-36-5,Not Classified,Notified C&L,442,Not classified:442
128086,"Oxidase, cholesterol",232-842-1,9028-76-6,Resp. Sens. 1,Notified C&L,13,H334:11;Not classified:2
128089,"Poly [oxy(methyl-1,2-ethanediyl)] , a -hydro-w -hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1), 3-[[3-dimethylamino) propyl]imino]butanoate",613-645-3,646505-36-4,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,Notified C&L,1,H315:1;H318:1;H317:1
128090,3-amino-4-methoxybenzamide,241-497-6,17481-27-5,,Notified C&L,6,H319:6;H335:5;H315:6
128091,N-(Cyclopentyloxycarbonyloxy)succinimide,603-287-6,128595-07-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
128097,"Poly(oxy-1,2-ethanediyl), a,a',a'',a'''-[1,2-ethanediylbis(nitrilodi-2,1-ethanediyl)]tetrakis[w-hydroxy-",608-035-9,27014-42-2,Eye Irrit. 2,REACH registration C&L,40,H319:39;H314:1;H302:1
128102,N-chlorophthalimide,222-459-8,3481-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H314:1;H318:1
128109,"4-[bis[4-(ethylamino)-3-methylphenyl]methyl]benzene-1,3-disulphonic acid",303-373-0,94166-75-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
128112,Sodium 6-hydroxynaphthalene-2-sulphonate,205-218-1,135-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,92,H319:90;H335:45;H315:45;H332:5;H302:5;H312:5;Not classified:2
128116,Dioctylamine,214-311-6,1120-48-5,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,82,H410:76;H400:76;H314:82;H302:77;Not classified:2;H312:1;H332:1;H318:1;H341:1;H350:1
128122,2-[(1-methylethyl)thio]ethanol,255-090-6,40811-49-2,,Notified C&L,4,H314:4
128124,"reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)",408-240-1,,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
128126,Calcium lactate pentahydrate,611-530-2,5743-47-5,Not Classified,Notified C&L,1,Not classified:1
128127,3-chloro-4-methylbenzyl alcohol,254-566-0,39652-32-9,,Notified C&L,4,H319:4;H335:4;H315:4
128130,"Fatty acids, C18-unsatd., dimers, oligomeric reaction products with tall-oil fatty acids, tetraethylenepentamine and triethylenetetramine",500-187-3,68071-65-8,Eye Dam. 1,Notified C&L,65,H318:39;Not classified:22;H411:5;H317:11;H314:6;H290:5;H315:5;H412:3;H319:3;H332:1;H302:1;H312:2
128131,"METHYL 4-(ACETYLAMINO)-5-CHLORO-2,3-DIHYDRO-1-BENZOFURAN-7-CARBOXYLATE",604-385-1,143878-29-9,Skin Sens. 1,Notified C&L,1,H317:1
128133,"Acetic acid, 2-(1-oxopropoxy)-, 1-(3,3-dimethylcyclohexyl)ethyl ester",607-255-2,236391-76-7,Aquatic Chronic 2,Notified C&L,169,H411:169
128135,"Butanamide, 2,2'-[(2,2'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(2,1-diazenediyl)]bis[N-(4-ethoxyphenyl)-3-oxo-",606-443-1,20139-66-6,Not Classified,Notified C&L,5,Not classified:5
128136,"Slack wax (petroleum), low-melting, silicic acid-treated;[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C",308-158-5,97863-06-4,Carc. 1B,Harmonised C&L,0,H350:0
128137,"Disodium 4-amino-5-hydroxy-6-[[4'-[(4-hydroxyphenyl)azo][1,1'-biphenyl]-4-yl]azo]-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonate",224-376-2,4335-09-5,Acute Tox. 4;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H410:38;H400:38;H350:38;H302:38;Not classified:1
128139,Tosylamide/Formaldehyde Resin,607-493-7,25035-71-6,Not Classified,Notified C&L,6,Not classified:5;H319:1;H315:1
128141,"1,4-bis(4-methyl-alpha-styryl)benzene",236-285-5,13280-61-0,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,46,H413:43;H319:45;H302:44;H335:5;H412:1;H315:1;Not classified:1
128144,1-methylcyclohexene,209-718-0,591-49-1,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:38;H304:42;H335:38;H315:38;H225:47
128145,3-(3-Pyridyl)-D-alanine,615-146-6,70702-47-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
128147,4-quinolylmethanol,228-489-8,6281-32-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
128149,"Propanoic acid, 2,2-dimethyl-, 2-octyldodecyl ester",603-076-9,125496-22-2,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H315:1;H317:1
128150,Alkyl phosphites,424-820-7,,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,188,H400:115;H312:51;H314:51;H410:187;H318:43
128153,"(1S-cis)-1,2,3,4,5,6,7,8-octahydro-7-isopropylidene-1,4-dimethylazulene",201-860-1,88-84-6,Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,314,H304:314;H319:306;H315:314
128156,"reaction product of: 2,3,4,2',3',4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride",421-520-8,,Aquatic Chronic 4,Harmonised C&L,0,H413:0;Not classified:0
128163,Deuterium,231-952-7,7782-39-0,Flam. Gas 1;Press. Gas (Comp.),REACH registration C&L,121,H280:121;H220:121
128165,"Dichloromethyl(3,3,3-trifluoropropyl)silane",211-623-4,675-62-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,481,H302:26;H318:4;H226:25;H314:32;H412:25;Not classified:449;H225:7;H332:4;H335:1;H290:1
128166,2-isopropyl-m-cresol,221-760-1,3228-01-1,Not Classified,Notified C&L,33,Not classified:33
128167,"Fatty acids, tall-oil, Me esters",277-893-0,74499-22-2,Not Classified,Notified C&L,6,Not classified:6
128171,Dimantine,204-694-8,124-28-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,712,H410:110;H400:670;H314:712;H302:687;H318:572;H226:449;H312:39;H332:39;H317:3
128172,Sodium m-cresolate,221-167-8,3019-89-4,,Notified C&L,33,Not classified:33
128175,"2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane",222-217-1,3388-04-3,Skin Sens. 1B;Muta. 2;Carc. 2;Aquatic Chronic 3,REACH registration C&L,220,H351:126;H341:91;H317:59;H412:91;H350:55;Not classified:32;H340:17;H413:2;H319:1
128180,Bis(2-hydroxyethyl)(stearoyl)ammonium acetate,302-134-8,94094-33-4,Not Classified,Notified C&L,1,Not classified:1
128187,trans-4-isopropylcyclohexanecarboxylic acid,230-375-8,7077-05-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:39;H315:39;Not classified:1
128192,4-(2-methoxyethyl)aniline,284-182-9,84803-56-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H302:1;H312:1;H315:1;H335:1;H318:1
128196,(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride,406-010-5,88918-84-7,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0;H318:0
128199,"Solvent naphtha (coal), light;Light Oil Redistillate, low boiling",287-498-5,85536-17-0,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
128200,p-chlorostyrene,214-028-8,1073-67-2,,Notified C&L,8,H319:7;H335:6;H315:7;H226:1;H332:1;H302:1;H312:1;H400:1;H410:1
128201,N-(4-nitrobenzoyl)-L-glutamic acid hemihydrate,229-820-9,6758-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2
128203,sodium 2-(4-methoxybiphenyl-3-yl)hydrazinesulfonate,923-192-6,,Not Classified,REACH registration C&L,1,Not classified:1
128204,(4-methylphenoxy)acetaldehyde,267-317-6,67845-46-9,Flam. Liq. 3;Skin Sens. 1,Notified C&L,122,H226:86;H317:120;H315:34;H319:1;Not classified:1
128205,"Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester",606-850-4,218600-53-4,,Notified C&L,2,H371:1;Not classified:1
128206,"Butanedioic acid, sulfo-, 4-C12-18-alkyl esters, disodium salts",290-839-0,90268-38-5,Eye Dam. 1,Notified C&L,19,H318:18;H315:5;Not classified:1
128207,"Saccharomyces cerevisiae, lysate",305-230-8,94350-12-6,Not Classified,REACH registration C&L,6,Not classified:6
128210,"Propane, 2-bromo-1,1,1,2,3,3,3-heptafluoro-",610-009-7,422-77-5,Press. Gas (Comp.),Notified C&L,33,H280:33
128213,"2-ethylpropane-1,3-diol",220-038-3,2612-29-5,Eye Dam. 1,REACH registration C&L,44,H318:4;Not classified:38;H225:2;H319:1;H335:1;H315:1
128215,"Formaldehyde, polymer with 4-(1,1-dimethylpropyl)phenol, 2-methyloxirane and oxirane",613-220-2,63428-91-1,Not Classified,Notified C&L,59,Not classified:59
128217,potassium hydroxide;caustic potash,215-181-3,1310-58-3,Acute Tox. 4;Skin Corr. 1A,Harmonised C&L,0,H314:0;H302:0
128219,"Hex-3-yne-2,5-diol",221-209-5,3031-66-1,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,208,H315:86;H301:182;H411:85;H318:123;H317:85;H373:85;H319:85;H300:25
128220,"N,N-diphenylhydrazinium(1+) chloride",208-481-0,530-47-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,46,H312:39;H314:41;H332:39;H302:43;H319:8;H335:7;H315:5
128221,Pyridoxal 5'-(dihydrogen phosphate),200-208-3,54-47-7,Not Classified,Notified C&L,4,Not classified:4
128226,"3-(2,4,6-trimethoxyphenyl)propionic acid",277-978-2,74737-05-6,,Notified C&L,4,H319:4;H335:4;H315:4
128227,C.I. Solvent Black 28,602-673-1,12237-23-9,Not Classified,Notified C&L,2122,Not classified:2039;H360:83
128228,"4-nitro-1,2,3-trichlorobenzene",241-705-5,17700-09-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,76,H319:42;H332:42;H302:43;H312:42;H315:42;H335:42;Not classified:33
128229,Fenbufen,252-979-0,36330-85-5,Acute Tox. 3,Notified C&L,40,H301:40
128234,"Black copper, copper smelting",918-452-0,,Skin Sens. 1;Resp. Sens. 1;Carc. 1B;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,18,H362:18;H372:18;H400:18;H334:18;H411:18;H317:18;H360:18;H350:18
128235,Ammonium carbonate,233-786-0,10361-29-2,Acute Tox. 4,REACH registration C&L,1568,H302:1418;H319:151;H335:25;H315:24
128237,"Fatty acids, tall-oil, compds. with 1,1'-[[3-[(2-hydroxypropyl)tallow alkylamino]propyl]imino]bis[2-propanol] (2:1)",296-273-0,92456-94-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H400:1;H315:1;H318:1
128239,"Stearic acid, compound with 2,2'-iminodiethanol (1:1)",220-312-2,2717-16-0,Not Classified,Notified C&L,36,Not classified:33;H315:2;H318:1;H319:2
128242,1-phenylcyclohexanol,216-456-0,1589-60-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38;H302:38
128251,Dimethyl glutarate,214-277-2,1119-40-0,Not Classified,REACH registration C&L,1016,Not classified:918;H302:58;H319:40;H315:23;H331:20;H373:16;H312:3;H332:3;H335:3;H413:1
128254,Piperazine-2-carboxamide,282-984-3,84501-64-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
128256,"calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate",400-710-4,,Acute Tox. 4,Harmonised C&L,0,H332:0
128257,4-Bromo-3-chlorophenol,603-955-7,13631-21-5,,Notified C&L,71,H319:71;H302:69;H312:68;H315:71;H335:70;H332:1
128264,"1-(4-Methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione",610-422-2,484-33-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
128269,"1,1'-(methylenedi-p-phenylene)bismaleimide",237-163-4,13676-54-5,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,632,H319:493;H335:492;H315:508;H330:517;H317:114;H332:41;H331:14;H341:6;H312:1;H302:1;H400:1;H410:1
128273,"Disodium [4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonato(3-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-)",283-610-1,84682-46-2,Not Classified,Notified C&L,1,Not classified:1
128274,Butyramide,208-776-4,541-35-5,Acute Tox. 4,Notified C&L,39,H302:39
128276,(S)-(+)-Glycidyl butyrate,613-736-8,65031-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44;H302:6;H312:6;H332:1
128277,"Phosphoric acid, mixed cetyl and oleyl esters, potassium salts",292-405-6,90605-07-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
128281,"N-[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid",200-209-9,54-62-6,Acute Tox. 2;Repr. 1B,Notified C&L,43,H360:43;H300:43;H351:1;H340:1
128283,"Decyl dihydrogen phosphate, compound with 2,2'-iminodiethanol (1:1)",265-463-5,65121-81-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:2
128285,Anhydro-D-glucitol trioleate,247-569-3,26266-58-0,Not Classified,REACH registration C&L,626,Not classified:383;H319:183;H315:223
128287,Riboflavin,201-507-1,83-88-5,Not Classified,REACH registration C&L,120,Not classified:119;H302:1
128291,Ethyltrimethoxysilane,226-172-9,5314-55-6,Not Classified,Notified C&L,183,Not classified:125;H226:57;H319:57;H315:19;H335:17;H225:1
128294,Acid5-methoxysalicylic,220-037-8,2612-02-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
128295,"Phenol, 2-ethoxy-4-methyl-",432-030-9,2563-07-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,85,H315:75;H318:85;H317:85;H302:85
128298,5-fluoro-2-nitrobenzaldehyde,206-903-8,395-81-3,,Notified C&L,8,H319:8;H335:7;H315:8
128299,Cesium diiodide,260-365-9,56749-51-0,Not Classified,Notified C&L,25,Not classified:25
128301,"Nonene, hydroformylation products, high-boiling",271-238-2,68526-90-9,Eye Irrit. 2,Notified C&L,1,H319:1
128304,Phenyl butyrate,224-405-9,4346-18-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2
128315,Tetrabutylammonium cyanide,233-926-0,10442-39-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H310:38;H400:38;H330:38;H300:38;H410:38
128322,6-Chloronicotinoyl Chloride,611-746-7,58757-38-3,,Notified C&L,7,H314:6;H319:1;H315:1;H301:1;H335:1;H311:1;H290:1;H318:1
128323,4'-methyldodecane-1-sulfonanilide,435-490-9,17417-32-2,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
128325,"5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one",428-410-9,67014-36-2,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H317:0;H302:0
128327,"Fatty acids, tallow, calcium salts",265-228-7,64755-01-7,Not Classified,REACH registration C&L,51,Not classified:51
128328,"ethoxysulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea",603-166-8,126801-58-9,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
128329,"1-Bromo-2-(2,4-difluoro-phenyl)-3-[1,2,4]-triazol-1-yl-propan-2-ol",604-726-4,150194-52-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
128331,Cyclohex-3-ene-1-methanol,216-847-6,1679-51-2,Not Classified,Notified C&L,1,Not classified:1
128332,Cadmium bis(2-ethylhexanoate),219-346-0,2420-98-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2;Aquatic Chronic 1,Notified C&L,2,H332:1;H302:1;H312:2;H410:2;H361:1;H372:1;H330:1;H400:1;H301:1;H340:1;H360:1;H350:1
128333,"3,4-xylylacetonitrile",221-168-3,3020-06-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H332:1;H302:1;H312:1
128335,4-Butylcyclohexylacetaldehyde,921-863-8,,Not Classified,Notified C&L,1,Not classified:1
128336,(E)-oct-3-ene,238-990-3,14919-01-8,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,44,H304:39;H225:44
128339,2-aminonicotinic acid,226-296-3,5345-47-1,,Notified C&L,8,H319:8;H335:7;H315:8
128348,α-carboline,205-960-6,244-76-8,Acute Tox. 4;Skin Sens. 1,Notified C&L,1,H317:1;H302:1
128350,"Fatty acids, C16-18 and C18-unsatd., zinc salts",266-937-4,67701-13-7,Not Classified,Notified C&L,118,Not classified:118
128351,"1,5,6,7-Tetrahydro-4H-indol-4-one",604-023-2,13754-86-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
128359,polychlorobiphenyls;PCB,215-648-1,1336-36-3,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H373:0;H410:0
128361,6-hydroxy-2-phenyl-4-benzopyrone,229-704-8,6665-83-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
128363,"1-(4'-bromo[1,1'-biphenyl]-4-yl)-3-phenyl-2-propen-1-one",285-441-9,85098-88-0,Not Classified,Notified C&L,1,Not classified:1
128365,"2-Phenyl-1,2-benzisoselenazol-3(2H)-one",612-054-8,60940-34-3,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H400:42;H331:41;H301:41;H410:42;H373:42
128370,"Alcohols, C>14, ethoxylated",607-574-7,251553-55-6,Aquatic Chronic 2,Notified C&L,644,H411:548;Not classified:96
128371,o-tolyl salicylate,210-500-2,617-01-6,Not Classified,Notified C&L,89,Not classified:89
128374,"Sodium N-[5-chloro-4-[(4-chlorophenyl)cyanomethyl]-o-tolyl]-2-hydroxy-3,5-diiodobenzamidate",262-794-7,61438-64-0,Acute Tox. 4,Notified C&L,13,H302:9;H301:4;H400:1;H410:1
128375,"2,2'-(4,4'-biphenylene)bis(2-hydroxy-4,4-dimethylmorpholinium) dibromide",206-227-3,312-45-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38,H319:38;H331:38;H315:38;H301:38;H335:38;H311:38
128377,"Glycerides, C16-18 mono-, di- and tri-, hydrogenated, citrates, sodium salts",294-601-7,91744-39-7,Not Classified,REACH registration C&L,88,Not classified:88
128379,Tris(2-thienyl)phosphine,246-059-8,24171-89-9,,Notified C&L,5,H319:5;H335:4;H315:5
128380,[No public or meaningful name is available],469-080-6,921213-47-0,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2,H400:2;H317:2;H410:2;H319:1
128382,Guanethidine sulphate,200-452-0,60-02-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H302:39
128383,"4,4'-bis[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulphophenyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonic acid, lithium sodium salt",274-978-4,70880-04-5,Not Classified,Notified C&L,1,Not classified:1
128384,Bis(p-tolyl)iodonium hexafluorophosphate,262-301-5,60565-88-0,Skin Corr. 1B,Notified C&L,44,H314:44
128385,methyl 10α-methoxydihydrolysergate,921-546-4,,Not Classified,REACH registration C&L,1,Not classified:1
128386,"Tricyclo[3.3.1.13,7]decan-2-one",211-847-2,700-58-3,,Notified C&L,4,H400:3;H410:3;Not classified:1;H315:1;H301:1;H318:1
128388,"(2E,4E)-2-methyl-5-phenyl-penta-2,4-dienal",919-772-3,,Skin Sens. 1,Notified C&L,1,H317:1
128390,1-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio] methyl]cyclopropaneacetic Acid Sodium Salt,604-813-7,151767-02-1,Eye Dam. 1,Notified C&L,140,H318:99;H361:41;H319:37;H315:11;Not classified:3;H302:2;H411:1
128391,"N,N-dibutylformamide",212-090-0,761-65-9,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,131,H302:91;H311:3;H318:85;H314:85;H412:90;H317:39;H319:6;H315:6;H335:1
128392,thiabendazole (ISO); 2-(thiazol-4-yl)benzimidazole;thiabendazol (ISO);2-(thiazole-4-yl)benzimidazole,205-725-8,148-79-8,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
128393,Phenothiazine-2-carbonitrile,254-057-3,38642-74-9,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,6,H411:6;H317:6
128394,"N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane",445-890-5,201290-01-9,Acute Tox. 4;Skin Sens. 1,Harmonised C&L,0,H317:0;H302:0
128399,3-(trifluoromethyl)pyridine,223-268-2,3796-23-4,Flam. Liq. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:46;H300:38;H315:46;H335:45;H226:42;H225:5;H301:3;H331:1;H311:1
128404,Nicotinic anhydride,240-860-6,16837-38-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
128409,Berberine hydrochloride,211-195-9,633-65-8,Not Classified,Notified C&L,4,Not classified:4
128412,Fluocinonide,206-597-6,356-12-7,Acute Tox. 2;Repr. 2,Notified C&L,42,H361:41;H300:42;H362:1;H373:2;H319:1;H372:1
128413,Aztreonam,278-839-9,78110-38-0,Not Classified,Notified C&L,4,Not classified:2;H317:1;H334:2;H400:1
128416,"Naphtha (petroleum), light heat-soaked, steam-cracked;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C",296-028-8,92201-97-3,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
128417,"2-Propenoic acid, 2-methyl-, homopolymer, sodium salt",611-109-3,54193-36-1,Not Classified,Notified C&L,56,Not classified:56
128418,"Acacia mearnsi, ext.",272-777-6,68911-60-4,Not Classified,Notified C&L,86,Not classified:86
128419,4-chlorobenzothiazol-2-amine monohydrobromide,248-194-8,27058-83-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H335:42;H315:42
128420,"Tetrasodium 3-[[8-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-1-hydroxy-3,6-disulphonato-2-naphthyl]azo]-4-hydroxynaphthalene-1,5-disulphonate",300-471-5,93940-72-8,,Notified C&L,8,Not classified:8
128422,2-Bromo-4-methoxy-5-nitrophenol,601-397-9,115929-59-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
128424,Dianilinium sulphate,208-805-0,542-16-5,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H341:42;H331:42;H372:42;H400:42;H301:42;H410:38;H351:42;H311:42;H318:42;H317:42
128427,"Alkenes, C>10 α-, oxidized, reaction products with ethanolamine and 2,4-TDI",267-562-9,67891-76-3,Not Classified,Notified C&L,61,Not classified:61
128433,O-α-D-glucopyranosyl-(1→6)-O-α-D-glucopyranosyl-(1→6)-D-glucose,222-149-2,3371-50-4,Not Classified,Notified C&L,1,Not classified:1
128435,6-[(1-oxomethyloctyl)amino]hexanoic acid,276-173-3,71902-23-3,Not Classified,REACH registration C&L,35,Not classified:35
128439,Isoundecyl undecyl phthalate,306-157-4,96507-79-8,Not Classified,Notified C&L,1,Not classified:1
128440,"methyl (7R,8S,9S,10R,11R,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylate",606-281-1,192704-56-6,Not Classified,REACH registration C&L,2,Not classified:2
128447,"Fatty acids, C8-10, C12-18-alkyl esters",306-082-7,95912-86-0,Not Classified,REACH registration C&L,109,Not classified:109
128453,"Silicic acid, aluminum sodium salt, sulfurized",309-928-3,101357-30-6,Not Classified,REACH registration C&L,359,Not classified:359
128454,"2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate",248-227-6,27107-89-7,Repr. 1B;Aquatic Chronic 3,REACH registration C&L,73,H360:20;H412:12;H411:8;H373:43;H413:4;H372:8;H400:53;H410:53;H315:35;H361:34
128457,"Eucalyptus maculata citriodora, ext.",286-249-8,85203-56-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,210,H411:154;H319:88;H315:194;H317:156;H226:75;H304:52;H412:2
128464,Oleamide,206-103-9,301-02-0,Not Classified,Notified C&L,1140,Not classified:567;H413:441;H319:132;H335:132;H315:132;H317:92
128467,1-(cyclohexylaminoanthraquinone),214-143-3,1096-48-6,Not Classified,Notified C&L,1,Not classified:1
128469,4-[(dichloroacetyl)methylamino]phenyl 2-furoate,223-108-1,3736-81-0,Acute Tox. 4,Notified C&L,40,H302:40
128470,(acetylthio)acetic acid,214-725-7,1190-93-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:38;H315:1
128480,"Chromate(2-), [2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-1-naphthalenesulfonato(3-)]-, dihydrogen",277-197-7,73003-33-5,Aquatic Chronic 3,Notified C&L,1,H412:1
128484,Dihydroxymalonic acid,209-208-8,560-27-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
128486,"Hydrogen [4-[(2-chlorophenyl)[4-[ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt",225-458-0,4857-81-2,Not Classified,Notified C&L,14,Not classified:13;H319:1;H335:1;H315:1
128489,Clonidine,224-119-4,4205-90-7,Acute Tox. 3;Acute Tox. 1;Acute Tox. 1,Notified C&L,94,H310:53;H330:54;H301:94;H331:1;H370:1;H410:1;H311:1;H315:1
128494,"Cycloocta-1,5-diene",203-907-1,111-78-4,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,138,H332:123;H302:123;H304:2;H411:2;H226:138;H400:83;H410:83;H319:50;H315:50;H317:50;H311:3;H330:3
128495,Rhodium octanoate dimer,615-980-0,73482-96-9,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,123,H413:83;H302:83;H319:39;H335:39;H315:40;H312:1;H332:1
128496,"Zinc sulfide (ZnS), silver chloride-doped",271-905-8,68611-71-2,Not Classified,REACH registration C&L,9,Not classified:7;H413:1;H319:1;H335:1;H315:1;H317:2;H410:1;H400:1;H334:1
128499,4-(p-nitrophenylthio)aniline,202-957-1,101-59-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48,H319:48;H335:47;H315:48
128500,"Pepper (Piper), P. methysticum, ext.",283-648-9,84696-40-2,,Notified C&L,8,Not classified:8;H400:8;H331:8;H332:8;H302:8;H315:8;H311:8
128502,"2',4'-dichloroacetoacetanilide",241-262-8,17223-66-4,Acute Tox. 4,Notified C&L,38,H302:38
128506,"2,6-dimethylheptan-3-one",243-149-9,19549-83-8,Flam. Liq. 3;STOT SE 3,Notified C&L,38,H226:38;H335:38
128508,"1,1-dichloro-2,2,3,3,3-pentafluoropropane",207-016-9,422-56-0,Not Classified,Notified C&L,32,Not classified:29;H319:3;H315:3;H332:3
128509,Phenol red,205-609-7,143-74-8,Skin Irrit. 2;STOT SE 3,Notified C&L,205,H335:180;H315:201;H319:84;Not classified:3;H302:2
128511,acetalization product between glucose and C20-22(even numbered)- alcohol,923-835-0,,Not Classified,Notified C&L,1,Not classified:1
128516,"Residues (petroleum), butane splitter bottoms;Low boiling point naphtha - unspecified;[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]",270-791-7,68478-12-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
128518,N-methylmethanaminium (4-chloro-2-methylphenoxy)acetate,218-014-2,2039-46-5,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,Notified C&L,147,H332:146;H312:145;H318:146;H302:147;H400:57;H410:57
128519,"4,4'-diaminobenzanilide",212-321-5,785-30-8,Not Classified,REACH registration C&L,53,Not classified:8;H319:44;H335:43;H315:44;H302:6;H332:2;H312:2
128521,m-terphenyl-2'-ol,219-401-9,2432-11-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,130,H400:85;H410:85;H319:45;H335:44;H315:45
128522,"Pentene, 2,4,4-trimethyl-, sulfurized",271-114-8,68515-88-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1166,H400:2;H315:17;H317:860;H410:2;H413:871;Not classified:286;H332:14;H319:7
128533,"1,1,3,3-tetramethylbutyl 2-ethylperoxyhexanoate",244-894-2,22288-43-3,Org. Perox. D;Skin Sens. 1B,REACH registration C&L,7,H242:7;H317:7;H319:5;H315:5
128535,Triphenylsulphonium chloride,224-259-6,4270-70-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:44;H315:44
128539,2-hexyldecyl palmitate,273-942-5,69275-02-1,Not Classified,Notified C&L,7,Not classified:7
128540,p-vinylphenetole,226-729-6,5459-40-5,Acute Tox. 4,Notified C&L,38,H302:38
128542,"4-(1,1-dimethylethyl)cyclohexyl acrylate",282-104-8,84100-23-2,Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,177,H411:176;H400:103;H317:137;H319:172;H335:172;H315:172;H410:97;H361:1
128544,"2,2-bis[[(2-ethyl-1-oxohexyl)oxy]methyl]propane-1,3-diyl bis(2-ethylhexanoate)",230-743-8,7299-99-2,Not Classified,Notified C&L,159,Not classified:159
128547,Calcium magnesium oxide,253-425-0,37247-91-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,172,H335:169;H315:170;H318:171;Not classified:1;H373:1
128548,Trisodium 4-[[1-hydroxy-6-[[[[5-hydroxy-6-(phenylazo)-7-sulphonato-2-naphthyl]amino]carbonyl]amino]-3-sulphonato-2-naphthyl]azo]benzoate,229-539-1,6598-63-6,Not Classified,REACH registration C&L,52,Not classified:52
128557,oxydiethylene bis(chloroformate),203-430-9,106-75-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0;H318:0;H302:0
128562,Eugenol,202-589-1,97-53-0,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,2854,H319:2216;H317:2764;H304:58;H315:577;H302:488;Not classified:88;H335:8;H334:9;H303:1;H227:1;H316:1;H401:1
128563,"N-(2,6-dichlorophenyl)acetamide",241-706-0,17700-54-8,Acute Tox. 4,Notified C&L,42,H302:42;H319:4;H335:4;H315:4
128566,2-iminocyclopentanecarbonitrile,219-033-9,2321-76-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H302:38
128567,Sulphur trioxide--pyridine (1:1),247-683-3,26412-87-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,103,H319:44;H315:44;H302:103;H314:59;H290:1;H318:1;Not classified:1
128571,"(4-tert-butyl-2,6-dimethylphenyl)acetonitrile",284-183-4,84803-57-6,Aquatic Chronic 3,REACH registration C&L,3,H412:2;H302:2;H319:1;H332:1;H312:1;H315:1;H335:1
128573,"reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide",422-500-1,,STOT RE 2,Harmonised C&L,0,H373:0
128575,O-allylhydroxylamine hydrochloride,254-203-6,38945-21-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
128576,"Bicyclo[[]3.1.1]heptane, 6,6-dimethyl-2-methylene-, homopolymer",607-785-4,25719-60-2,Not Classified,Notified C&L,9,Not classified:8;H413:1
128578,methyl acrylate;methyl propenoate,202-500-6,96-33-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3,Harmonised C&L,0,H319:0;H332:0;H302:0;H312:0;H315:0;H335:0;H317:0;H225:0
128586,m-phenylenedioxydi(acetic acid),203-027-8,102-39-6,Acute Tox. 4,Notified C&L,42,H302:38;H319:4;H335:4;H315:4
128590,"Cyclohexane-1,2-dione",212-155-3,765-87-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H302:1
128591,"Poly(oxy-1,2-ethanediyl), α-(butoxyhydroxyphosphinyl)-ω-hydroxy-, C13-15-alkyl ethers, sodium salts",615-899-0,73050-07-4,Not Classified,Notified C&L,37,Not classified:37
128592,"Fatty acids, rape-oil, compds. with diethanolamine",286-247-7,85203-54-9,Not Classified,Notified C&L,1,Not classified:1
128595,"Fatty acids, C16-18, isotridecyl esters",306-084-8,95912-88-2,Not Classified,REACH registration C&L,58,Not classified:58
128598,Ethyl 2-ethylbutyrate,221-044-9,2983-38-2,,Notified C&L,6,H226:6
128600,N-methylisobutylamine,210-893-0,625-43-4,,Notified C&L,6,H314:6;H224:5;H225:1;H318:1
128602,"(S)-(+)-N-(2,3-Epoxypropyl)-Phthalimide",605-259-9,161596-47-0,Eye Dam. 1,Notified C&L,113,H318:112;H341:72;H317:70;H319:1;H335:1;H315:1;H412:1
128603,Benzyl cyanoformate,226-880-8,5532-86-5,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,38,H331:38;H311:38;H314:38;H301:38
128607,8-(isopropyl)quinoline,229-264-7,6457-30-3,Acute Tox. 4;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1287,H310:1286;H319:1287;H315:1287;H302:1286;H335:1
128608,2-methoxy-1-methylethyl acetate,203-603-9,108-65-6,Flam. Liq. 3,Harmonised C&L,0,H226:0
128611,"Cyclopentane-1,1-diacetic acid",240-761-8,16713-66-9,,Notified C&L,6,H319:6;H335:5;H315:6
128612,"Amines, coco alkyl, ethoxylated, N-oxides",500-186-8,68071-48-7,Not Classified,Notified C&L,29,Not classified:28;H400:1;H314:1;H410:1
128613,"2,9-bis(p-methoxybenzyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone",280-472-4,83524-75-8,Not Classified,REACH registration C&L,129,Not classified:91;H319:38;H335:38;H315:38
128615,1-chloro-4-(trifluoromethoxy)benzene,207-315-4,461-81-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H315:1
128616,1-chloropropene,209-675-8,590-21-6,Flam. Liq. 1;Acute Tox. 4,Notified C&L,4,H224:3;H302:4;H319:1;H315:1;H225:1
128622,"Oxygenase, lactate 2-mono-",232-841-6,9028-72-2,Resp. Sens. 1,Notified C&L,40,H334:39;Not classified:1
128624,2'-methoxyacetoacetanilide,202-131-0,92-15-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,230,H312:182;H332:171;H302:230;H319:40
128627,"Butanenitrile, 2-amino-2,3-dimethyl-",604-102-1,13893-53-3,Acute Tox. 3;Acute Tox. 1;Acute Tox. 1,REACH registration C&L,85,H310:84;H330:84;H301:85;H400:83;H410:83;H319:1;H302:1;H335:1;H315:1
128628,Calcium malate,241-498-1,17482-42-7,Eye Irrit. 2,Notified C&L,1,H319:1
128629,1-methoxy-2-propanol;monopropylene glycol methyl ether,203-539-1,107-98-2,Flam. Liq. 3;STOT SE 3,Harmonised C&L,0,H226:0;H336:0
128631,"cis-1,3-dimethylcyclopentane",219-793-1,2532-58-3,Flam. Liq. 2;Acute Tox. 4,Notified C&L,43,H225:43;H302:38
128632,N-tosyl-D-aspartic acid,256-362-7,48176-62-1,Acute Tox. 4;Skin Sens. 1,Notified C&L,11,H317:11;H302:11
128638,"2-Propenoic acid, 2-methyl-, C16-20-alkyl esters",292-102-9,90551-84-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:55;H335:55;H315:55
128643,"1,1,5-trimethylhepta-4,6-dienyl acetate",276-484-4,72214-23-4,Not Classified,Notified C&L,158,Not classified:120;H315:38
128644,Biphenyl-4-yl bromomethyl ketone,205-217-6,135-73-9,Skin Corr. 1B,Notified C&L,44,H314:44;H290:1;H318:1
128652,Reaction product of ammonium molybdate and C,412-780-3,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0;H317:0
128655,Tetraammonium hexamolybdate,235-650-6,12411-64-2,Not Classified,REACH registration C&L,11,Not classified:11
128660,"Cuprate(4-), [μ-[4-hydroxy-7-[4-[(2-hydroxyethyl)amino]-6-[[5-hydroxy-6-[(2-hydroxy-4-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]-3-[(2-hydroxy-4-sulfophenyl)azo]-2-naphthalenesulfonato(8-)]]di-, tetrasodium",277-520-1,73513-82-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H335:25;H315:25;H320:24;H412:8;Not classified:5;H319:1;H334:1;H411:1
128663,o-nitrocumene,229-415-7,6526-72-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
128669,1H-benzimidazole-pentane-2-amine,254-565-5,39650-63-0,Eye Dam. 1,Notified C&L,2,H318:2
128670,3'-trifluoromethylacetanilide,206-512-2,351-36-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,132,H319:131;H335:131;H315:131;H302:132;H312:1;H332:1
128671,(4-chlorophenyl)hydrazine,214-029-3,1073-69-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,115,H319:84;H341:84;H331:84;H372:84;H400:83;H315:84;H301:84;H410:84;H311:84;H317:84;H350:84;Not classified:31
128679,Germanium dioxide,215-180-8,1310-53-8,Repr. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,226,H361:8;H400:8;H373:40;H412:8;Not classified:133;H302:85;H332:8
128681,3-methylcyclohexene,209-717-5,591-48-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H225:39
128682,"1H-Indene-5-carboxamide, 2-(4-bromo-3-hydroxy-2-quinolinyl)-2,3-dihydro-1,3-dioxo-N,N-dipropyl-",417-500-3,78334-00-6,Skin Sens. 1,Notified C&L,8,H317:8
128683,"(6S)-6-methyl-5,6-Dihydro-4H-thieno[2,3-b]thiopyran4-one-7,7-dioxide",431-140-4,,Not Classified,REACH registration C&L,2,Not classified:2
128684,Benzyltriethylammonium iodide,226-446-8,5400-94-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H319:39;H315:39
128685,Tetrasodium (1-hydroxyethylidene)bisphosphonate,223-267-7,3794-83-0,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,565,H319:468;H302:390;H315:127;H413:36;Not classified:6;H314:1
128686,Solvent Blue 70,602-674-7,12237-24-0,Aquatic Chronic 3,Notified C&L,264,H412:178;Not classified:86
128687,"Reaction product of 2-Propenoic acid and Oxirane, mono[(C12-16-alkyloxy)methyl] derivs.",614-257-7,68071-40-9,Skin Sens. 1A,REACH registration C&L,4,H317:4
128690,2-piperidone,211-622-9,675-20-7,Not Classified,Notified C&L,7,Not classified:2;H319:5;H335:4;H315:3
128691,3-iodo-2-propynyl butylcarbamate;3-iodoprop-2-yn-1-yl butylcarbamate,259-627-5,55406-53-6,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H372:0;H331:0;H400:0;H302:0;H410:0;H317:0;H318:0
128693,octadecylamine,204-695-3,124-30-1,Skin Irrit. 2;Eye Dam. 1;Asp. Tox. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H304:0;H315:0;H410:0;H318:0;H373:0
128695,Ovalbumins,232-692-7,9006-59-1,Resp. Sens. 1,Notified C&L,39,H334:38;Not classified:1
128696,"5-Isobenzofurancarboxylic acid, 1,3-dihydro-1,3-dioxo-, reaction products with 1,2-propanediol",613-407-9,63948-88-9,Skin Sens. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,72,H335:58;H317:58;H334:58;Not classified:14
128704,Didecylamine,214-312-1,1120-49-6,Acute Tox. 4;Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,98,H410:53;H400:55;H314:55;H302:35;H319:43;H335:62;H315:43;H318:20
128706,Dimethoxysilane,226-171-3,5314-52-3,Org. Perox. D;Aquatic Chronic 4,Notified C&L,2,H242:1;H412:1;H241:1;H400:1;H410:1
128707,"(-)-CIS-5-(4-AMINO-1,2-DIHYDRO-2-OXO-1-PYRIMIDINYL)-1,3-OXATHIOLANE-2-METHANOL",603-844-3,134678-17-4,Repr. 2,Notified C&L,129,H361:88;H319:39;H335:39;H315:39;H373:36;H372:3;Not classified:1
128709,"4-(acetylamino)-5-hydroxynaphthalene-1,7-disulphonic acid",229-080-7,6409-21-8,Not Classified,Notified C&L,1,Not classified:1
128710,"2-(heptadec-8-enyl)-4,5-dihydro-1-(2-hydroxyethyl)-1H-imidazolium acetate",222-218-7,3388-72-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,11,H319:9;H400:9;H315:11;H410:9;H318:10;H314:9;H411:1;H317:1;H302:1
128713,2-hydroxy-1-[4-[4-(2-hydroxy-2-methylpropanoyl)phenoxy]phenyl]-2-methylpropan-1-one,472-110-0,,Aquatic Chronic 2,REACH registration C&L,19,H411:19
128714,"N-(α,α-dimethylphenethyl)formamide",257-667-8,52117-13-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H302:1
128730,Bromocyclopropane,224-375-7,4333-56-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50,H319:50;H335:49;H315:50;H225:50
128733,Tetradecyl dihydrogen phosphate,233-184-8,10054-29-2,,Notified C&L,1,Not classified:1
128742,"Thiodiethane-1,2-diyl bis(3-aminobut-2-enoate)",236-946-8,13560-49-1,Aquatic Chronic 2,Notified C&L,12,H411:11;Not classified:1
128743,1-(2-ethoxyphenyl)piperazine,236-389-0,13339-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
128745,1-methyl-3-phenylpropylamine,244-942-2,22374-89-6,Skin Corr. 1B,REACH registration C&L,53,H314:51;H318:5;H317:4;H412:10;H311:5;H301:5;Not classified:2;H302:2;H335:1
128746,"1,1-diphenylethylene",208-482-6,530-48-3,Aquatic Chronic 2,REACH registration C&L,3,H411:2;H317:1;Not classified:1
128748,Disodium 4-(2-ethylhexyl) 2-sulphonatosuccinate,306-315-2,96954-01-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H315:2;H318:1;H319:1;H332:1;H302:1;H312:1
128751,"2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl",617-533-5,841290-80-0,Acute Tox. 3;Repr. 2,Notified C&L,3,H361:3;H301:3
128757,"Oleic acid, compound with 2,2',2''-nitrilotriethanol (1:1)",220-311-7,2717-15-9,Not Classified,Notified C&L,145,Not classified:104;H319:38;H315:38;H318:3;H302:2
128758,"thifensulfuron-methyl (ISO); methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate",616-673-4,79277-27-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
128759,"Distillates (petroleum), hydrocracked solvent-refined light;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",307-010-7,97488-73-8,Carc. 1B,Harmonised C&L,0,H350:0
128773,"4,4'-[hexane-1,6-diylbis(oxy)]bisbenzonitrile",304-886-2,94291-61-9,Not Classified,REACH registration C&L,2,Not classified:1;H351:1;H411:1
128774,"N-ethyl 1,2 dimethyl propylamine",608-094-0,2738-06-9,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1B,Notified C&L,24,H301:23;H314:24;H225:23;H318:1;H302:1
128783,Hexadecyl stearate,214-724-1,1190-63-2,Not Classified,Notified C&L,24,Not classified:24
128784,"4,4'-diamino-2-methylazobenzene",407-590-2,43151-99-1,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H301:0;H410:0;H317:0;H373:0
128786,1-ALLYLOXY-3-CHLORO-2-PROPANOL,610-296-9,4638-03-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H315:38;H318:38;H302:38
128790,"1,4,7,10-Tetrabenzyl-1,4,7,10-tetraazacyclododecane",449-410-5,,Acute Tox. 4;STOT RE 2,REACH registration C&L,3,H373:3;H302:3
128793,"Spiro[isobenzofuran-1(3H),9'(8'aH)-xanthylium], 3',6'-bis(diethylamino)-3-oxo-, chloride, compd. with [4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-1-naphthalenesulfonato(3-)]chromium (1:1)",276-631-2,72391-06-1,Not Classified,Notified C&L,5,Not classified:5
128806,"Indeno[1,2,3-cd]pyrene",205-893-2,193-39-5,Carc. 2,Notified C&L,10,H351:7;Not classified:3
128809,"Trisodium 1-(1-naphthylazo)-2-hydroxynaphthalene-4',6,8-trisulphonate",220-036-2,2611-82-7,Not Classified,REACH registration C&L,2319,Not classified:2314;H341:5
128810,Calcium bis(hydroxymethanesulphinate),244-943-8,22374-97-6,Not Classified,Notified C&L,83,Not classified:83
128812,Fytic acid,201-506-6,83-86-3,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,194,H314:138;H290:52;H318:97;H302:99;Not classified:39;H335:58;H319:17;H315:18
128817,p-(benzyloxy)phenethyl alcohol,262-795-2,61439-59-6,Not Classified,REACH registration C&L,37,Not classified:36;H319:1;H317:1;H412:1
128819,"nickel carbonate;basic nickel carbonate;carbonic acid, nickel (2+) salt",222-068-2,3333-67-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H341:0;H372:0;H332:0;H302:0;H400:0;H315:0;H334:0;H410:0;H317:0;H360:0;H350:0
128820,"medinoterb acetate (ISO);6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate",219-634-6,2487-01-6,Acute Tox. 3;Acute Tox. 4,Harmonised C&L,0,H312:0;H301:0
128821,2-phenoxyisobutyric acid,213-402-8,943-45-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,5,H319:4;H335:3;H315:4;Not classified:1
128822,Glycerol tributyrate,200-451-5,60-01-5,Not Classified,Notified C&L,118,Not classified:118
128827,2-methoxypropanol,216-455-5,1589-47-5,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Repr. 1B,Harmonised C&L,0,H335:0;H315:0;H318:0;H360:0;H226:0
128829,1-benzylpyrrole,218-137-1,2051-97-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H226:1
128830,"4,4-dimethylpiperidinium chloride",254-058-9,38646-68-3,,Notified C&L,2,H330:1;H319:1;H335:1;H315:1;H302:1
128834,3-ethylpentan-2-one,228-112-7,6137-03-7,Acute Tox. 3;STOT RE 2;Aquatic Chronic 3,Notified C&L,16,H311:16;H373:16;H412:16
128835,"N,N-diethylphenylacetamide",219-400-3,2431-96-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 2,Notified C&L,38,H312:38;H330:38;H302:38
128837,"3,3'-((2-chloro-5-methylbenzene-1,4-diyl)bis(imino(1,3-dioxobutane-1,2-diyl)diazene-2,1-diyl))bis(4-chlorobenzoic acid)",612-012-9,60728-43-0,Aquatic Chronic 4,REACH registration C&L,87,H413:87
128838,haloxyfop-etotyl (ISO);2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;haloxyfop-(2-ethoxyethyl),402-560-5,87237-48-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H400:0;H302:0
128839,Iopromide,277-385-9,73334-07-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:38;H410:38;Not classified:1
128846,Pyridine-2-carboxamide,215-921-5,1452-77-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,132,H319:132;H335:131;H315:132
128848,"2,5-Diiodobenzoic acid",604-262-2,14192-12-2,Acute Tox. 4,Notified C&L,40,H302:39;H312:1;H332:1;H319:1;H335:1;H315:1
128852,Reaction products of 4-methyl-m-phenylene diisocyanate with octylamine and p-toluidine,922-435-3,,Flam. Sol. 1,REACH registration C&L,2,H228:2
128854,"Nitric acid, cerium salt",241-339-6,17309-53-4,Met. Corr. 1;Skin Corr. 1A,Notified C&L,1,H314:1;H290:1
128855,3-methyl-2-nitroanisole,226-295-8,5345-42-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,44,H319:39;H302:44;H335:1;H315:1
128857,tert-butyl α-cyanobenzylaminyl carbonate,261-370-9,58632-95-4,,Notified C&L,6,H319:6;H332:5;H302:5;H312:5;H315:6;H335:5;H301:1
128859,"Fatty acids, C14-18 and C16-18-unsatd., zinc salts",266-936-9,67701-12-6,Not Classified,REACH registration C&L,18,Not classified:18
128860,2-chloro-6-methoxyquinoline,237-162-9,13676-02-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
128861,Tetrachloro-o-benzoquinone,219-424-4,2435-53-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:38;H315:39;H331:1;H311:1;H301:1
128862,"Juniper, Juniperus, ext., acetylated",281-604-3,83984-78-5,Not Classified,Notified C&L,72,Not classified:72
128864,"Sulfonic acids, petroleum, sodium salts",271-781-5,68608-26-4,Eye Irrit. 2,REACH registration C&L,2197,H319:300;H318:1667;H315:1156;Not classified:175;H413:127;H317:115;H400:58;H410:58;H411:31;H412:3;H314:1;H302:1;H332:1
128866,"Benzene, C10-16-alkyl derivs.",272-008-4,68648-87-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1031,H400:888;H410:887;Not classified:87;H361:32;H304:13;H315:11;H319:5
128867,Perhydrophenanthrene,227-267-8,5743-97-5,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
128868,1-methylpiperidin-3-ol,222-609-2,3554-74-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
128870,ammonia ....%,215-647-6,1336-21-6,Skin Corr. 1B;Aquatic Acute 1,Harmonised C&L,0,H400:0;H314:0
128871,"Alcohols, C18-32",272-778-1,68911-61-5,Not Classified,Notified C&L,107,Not classified:87;H315:20
128874,Methylnaphthalene,215-329-7,1321-94-4,Acute Tox. 4;Eye Irrit. 2;STOT SE 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,2,H319:2;H302:2;H335:2;H336:1;H411:2;H373:1;H315:1
128880,"Dodecene, hydroformylation products, high-boiling",271-239-8,68526-91-0,Skin Sens. 1B;Eye Irrit. 2,Notified C&L,120,H319:84;H317:84;H411:36
128882,"Glycerides, C16-18 mono-, di- and tri-, hydrogenated, citrates, potassium salts",294-600-1,91744-38-6,Not Classified,REACH registration C&L,8,Not classified:8
128883,Ethyl 3-hydroxybenzoate,231-951-1,7781-98-8,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,43,H335:42;H315:43;H302:38;H319:5
128884,o-(trifluoromethyl)styrene,206-902-2,395-45-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H226:39;H319:39;H315:39;H335:39
128889,Butylammonium 4-[(2-hydroxy-1-naphthyl)azo]-3-methylbenzenesulphonate,284-409-1,84878-19-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,83,H335:83;H315:83;H318:83;H412:83
128893,"(α,α,α-trifluoro-3-tolyl)acetic acid",206-511-7,351-35-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H335:48;H315:49
128894,"potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)",425-830-4,,Eye Dam. 1,Harmonised C&L,0,H318:0
128896,Melphalan,205-726-3,148-82-3,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;Carc. 1B;Repr. 2,Notified C&L,42,H310:38;H330:38;H300:42;H361:39;H350:42;H372:1;H340:4;H318:1;H360:3;H373:2;H317:1
128897,"N-phenyl-1H-1,2,4-triazole-3,5-diamine",221-994-4,3310-68-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
128898,"Fatty acids, tallow, barium salts",265-227-1,64755-00-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:3;H302:3
128902,1-methyl-4-(isopropyl)cyclohexan-1-ol,244-230-1,21129-27-1,Not Classified,Notified C&L,1374,Not classified:1374
128916,"Pitch, vegetable-oil",272-840-8,68917-42-0,Not Classified,Notified C&L,1,Not classified:1
128917,"2,2,3,3,4,4,5,5-octafluoropentyl methacrylate",206-596-0,355-93-1,Not Classified,REACH registration C&L,60,Not classified:2;H319:57;H335:56;H315:57;H311:1;H301:1;H330:1
128918,"Estra-5(10),9(11)-dien-3-one, 17-methyl-17-(1-oxopropyl)-, cyclic 3-(1,2-ethanediyl acetal), (17β)-",610-095-6,42982-45-6,Repr. 1B;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H360:1;H411:1;H373:1
128919,mannitol hexanitrate;nitromannite;[>40 % phlegmatiser],239-924-6,15825-70-4,,,0,H201:0
128925,10-hydroxydecanoic acid,216-848-1,1679-53-4,Not Classified,Notified C&L,24,Not classified:21;H319:3;H335:3;H315:3
128927,"Tris(2-ethylhexyl) 2-hydroxypropane-1,2,3-tricarboxylate",230-457-3,7147-34-4,Not Classified,Notified C&L,7,Not classified:4;H319:3;H315:3
128929,"Benzenecarbothioamide, 2-amino-",607-399-6,2454-39-9,,Notified C&L,4,H319:4;H335:4;H315:4;H302:4
128930,3-chloro-2-toluonitrile,229-499-5,6575-09-3,,Notified C&L,5,H319:4;H332:4;H302:4;H315:5;H311:5;H331:1;H301:1;H335:1;H318:1
128931,Chlorocyclohexane,208-806-6,542-18-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,53,H226:53;H319:49;H315:49;H335:49;Not classified:1;H411:2
128932,3-Butynoic Acid,607-235-3,2345-51-9,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,40,H311:39;H314:40;H301:39;H290:1;H318:1
128940,"2,3,3-trimethylpentane",209-207-2,560-21-4,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H304:0;H315:0;H336:0;H410:0;H225:0
128941,Methyl non-2-enoate,203-908-7,111-79-5,Not Classified,REACH registration C&L,1667,Not classified:1602;H411:64;H319:40;H315:40;H400:25;H410:25;H335:1
128946,"1-(3,5-dihydroxyphenyl)-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethan-1-one hydrobromide",222-148-7,3371-33-3,Not Classified,REACH registration C&L,2,Not classified:1;H400:1;H341:1;H410:1;H318:1;H317:1
128947,"furmecyclox (ISO);N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide",262-302-0,60568-05-0,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H351:0;H400:0;H410:0
128950,Khelloside,241-263-3,17226-75-4,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H400:38;H302:38
128957,"3,6-Dimethyl-1-heptyn-3-ol",606-338-0,19549-98-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,23,H226:23;H319:22;H315:22;H335:22
128958,butylamine,203-699-2,109-73-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Harmonised C&L,0,H332:0;H302:0;H312:0;H314:0;H225:0
128959,"2',3,5-Trifluoro-4''-(trans-4-propylcyclohexyl)-4-trifluoromethoxy-[1,1';4',1'']terphenyl",610-847-3,524709-77-1,Not Classified,REACH registration C&L,1,Not classified:1
128961,GASIR1,455-790-3,,Not Classified,Notified C&L,1,Not classified:1
128962,Calcium dihydrogen di-L-aspartate,254-327-0,39162-75-9,Not Classified,Notified C&L,1,Not classified:1
128966,"3,4-dichlorophenyl isocyanate",203-026-2,102-36-3,Acute Tox. 3;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,53,H400:4;H331:2;H330:4;H335:52;H301:53;H410:4;H318:4;H317:44;H334:48;H319:48;H332:45;H315:49
128973,Ethyl propyl sulphide,223-890-4,4110-50-3,,Notified C&L,5,H319:5;H335:4;H315:5;H225:5
128974,"dichlorprop (ISO);2-(2,4-dichlorophenoxy) propionic acid",204-390-5,120-36-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Harmonised C&L,0,H312:0;H315:0;H318:0;H302:0
128975,lead di(acetate),206-104-4,301-04-2,STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0,H360:0;H400:0;H373:0;H410:0
128979,"[2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one",223-107-6,3736-77-4,Not Classified,Notified C&L,2,Not classified:1;H302:1
128982,"Carbonic acid, praseodymium salt",604-443-6,14475-17-3,Not Classified,Notified C&L,1,Not classified:1
128990,Chlorotriisopropylsilane,603-492-0,13154-24-0,Skin Corr. 1B,Notified C&L,51,H314:50;H318:3;H335:1;H290:1;Not classified:1;H315:1
128992,"Naphtha (petroleum), light steam-cracked, debenzenized, C8-16-cycloalkadiene conc.",270-790-1,68478-10-4,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,56,H319:54;H372:40;H400:40;H332:40;H302:40;H304:55;H315:54;H335:40;H336:40;H410:40;H351:38;H340:40;H226:54;H361:40;H350:40;H373:8;H411:14;Not classified:1
128995,mono-methylamine;mono-methylamine ... %,200-820-0,74-89-5,,,0,Not classified:0;H332:0;H220:0;H315:0;H335:0;H318:0
128997,Bis(2-ethylhexyl) malate,260-070-5,56235-92-8,Not Classified,REACH registration C&L,5,Not classified:4;H400:1;H410:1
128999,Sorbitan palmitate,247-568-8,26266-57-9,Not Classified,REACH registration C&L,177,Not classified:131;H319:41;H335:39;H315:41;H413:3;H411:2
129000,"Zinc 3,5-di-tert-butylsalicylate",610-025-4,42405-40-3,Flam. Sol. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H228:42;H400:42;H410:42;H302:43;H411:1
129001,"Superphosphates, concd.",266-030-3,65996-95-4,Eye Dam. 1,REACH registration C&L,35,H318:34;Not classified:1
129005,"1,1-diethoxy-3-methylbutane",223-335-6,3842-03-3,Flam. Liq. 3,Notified C&L,1374,H226:1374;H319:88
129007,"Zinc sulfide (ZnS), copper chloride-doped",271-904-2,68611-70-1,Not Classified,REACH registration C&L,64,Not classified:61;H410:1;H400:1;H317:2;H334:1;H413:1;H319:1;H335:1;H315:1;H412:1
129008,4-nitro-o-anisidine,202-588-6,97-52-9,Acute Tox. 4;Carc. 2;Aquatic Chronic 2,REACH registration C&L,214,H351:127;H411:131;H302:212;H319:41;H335:40;H315:41;H312:5;H341:6;H332:5;H412:3;Not classified:1
129012,"4,5-bis(1-phenylethyl)-o-xylene",257-296-1,51580-93-9,Not Classified,Notified C&L,12,Not classified:12
129015,"3-Hydroxy-2-[(2E)-2-(6-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethyl]-2-methylcyclopentanone",613-827-2,6563-82-2,STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H373:1;H401:1
129016,"1,5-Naphthalenedisulfonicacid,2-[[6-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]-,tetrasodium salt (9CI);",602-042-0,12220-12-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,16,H317:16;H334:16
129017,"2-Propenoic acid, polymer with ethenylbenzene",607-532-8,25085-34-1,Not Classified,Notified C&L,145,Not classified:145
129019,"Bis(4-(1,1,3,3-tetramethylbutyl)phenyl) ether",202-956-6,101-58-6,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H317:1
129021,"2-Propenoic acid, reaction products with 4,5-dihydro-2-norcoco alkyl-1H-imidazole-1-ethanol, sodium salts",309-317-1,100209-10-7,Not Classified,Notified C&L,1,Not classified:1
129024,"Fatty acids, rape-oil, sodium salts",270-440-8,68440-17-5,Not Classified,Notified C&L,1,Not classified:1
129027,[(benzoylamino)oxy]acetic acid,226-053-1,5251-93-4,Acute Tox. 4,Notified C&L,38,H302:38
129030,1-(4-hydroxy-3-methoxyphenyl)decan-5-one,248-228-1,27113-22-0,Not Classified,Notified C&L,113,Not classified:88;H317:25
129032,"(N,N-diethylaniline)trihydroboron",236-305-2,13289-97-9,Flam. Liq. 2;Water-react. 2,REACH registration C&L,188,H226:1;H261:43;H330:136;H301:145;H373:145;H311:145;H411:145;H260:136;H225:51;H331:9;H319:2;H332:2;H302:2;H312:2;H315:1
129034,"3,5-bis(trifluoromethyl)benzoyl chloride",212-322-0,785-56-8,Skin Corr. 1B,Notified C&L,45,H314:45;H290:1;H318:1
129036,"Barium, carbonate nonylphenol complexes",271-115-3,68515-89-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,62,H332:62;H302:62
129042,Adipamide,211-062-5,628-94-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:42;H315:43
129043,6-chlorouracil,224-258-0,4270-27-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H335:47;H315:48;H302:1
129044,"2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride",424-120-1,174514-06-8,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H318:0;H410:0
129049,[2H3]methyltriphenylphosphonium bromide,217-248-2,1787-44-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
129050,"2,2'-[(3-acetamidophenyl)imino]diethyl diacetate",248-196-9,27059-08-1,Not Classified,REACH registration C&L,2,Not classified:2
129052,"Chromium, diazotized 2-amino-4,6-dinitrophenol-diazotized 6(or 7)-amino-4-hydroxy-2-naphthalenesulfonic acid-formaldehyde-resorcinol reaction product coupling products complexes",305-466-1,94552-20-2,Not Classified,Notified C&L,1,Not classified:1
129057,2-methoxyethyl acetoacetate,245-043-8,22502-03-0,Repr. 1B,REACH registration C&L,78,H360:35;H319:44;H335:39;H315:44
129063,"Alcohols, C12- 15, ethoxylated, phosphates",500-185-2,68071-35-2,Skin Corr. 1C;Eye Dam. 1,Notified C&L,485,H314:447;H318:459;H319:14;H315:29;Not classified:6;H400:3;H412:1
129065,Calcium (±)-3-methyl-2-oxovalerate,266-505-5,66872-75-1,Not Classified,Notified C&L,1,Not classified:1
129066,"2,3,4,4,5-pentachlorocyclopent-2-en-1-one",227-108-2,5659-47-2,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,38,H335:38;H315:38;H302:38
129070,(E)-hex-2-enyl valerate,260-439-0,56922-74-8,Not Classified,Notified C&L,88,Not classified:88
129071,Perfluoropropionyl fluoride,207-019-5,422-61-7,Press. Gas (Liq.);Acute Tox. 2,REACH registration C&L,2,H330:2;H280:2
129072,"1-[2-(4-trans-Pentyl-[1,1-bicyclohexyl]-4-trans-yl)-ethyl] -4-trifluormethoxybenzene",603-779-0,133914-50-8,Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1
129074,"13-β-ethyl-3-methoxygona-2,5(10)-dien-17-one",219-034-4,2322-77-2,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H400:3;H410:3
129078,C.I. Vat Black 16,603-667-1,1328-19-4,Not Classified,Notified C&L,3,Not classified:3
129079,2-(1-oxa-4-azaspiro[4.5]dec-4-yl)ethyl methacrylate,224-116-8,4203-89-8,Skin Corr. 1;Skin Sens. 1,REACH registration C&L,2,H314:2;H317:2
129083,"Octadecanoic acid, 12-hydroxy-, homopolymer, reaction products with N1,N1-dimethyl-1,3-propanediamine",619-275-9,97553-92-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,453,H319:446;H315:446;Not classified:7
129086,"5-Brom-2-[(3,4,5-trifluorphenoxy)-difluormethyl]-1,3-difluorbenzene",610-623-5,511540-64-0,Not Classified,REACH registration C&L,2,Not classified:2
129092,Sodium dichromate,616-541-6,7789-12-0,Skin Sens. 1;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2128,H350:2128;H400:2128;H317:2128;H410:2128;H372:90;H330:90;H312:90;H301:90;H334:90;H340:90;H360:90;H272:90;H314:90
129100,"alpha.-[2-[bis(1-methylethyl)amino]ethyl]-.alpha.-phenyl-, 4-methylbenzenesulfonate",616-190-9,75157-06-1,Acute Tox. 4,REACH registration C&L,2,H302:2
129103,"2,3,4,5-tetrachloronitrobenzene",212-906-5,879-39-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H319:39;H332:39;H302:39;H312:39;H315:39;H335:38;Not classified:3
129110,"9,12-Octadecadienoic acid (9Z,12Z)-, dimer, reaction products with N,N-dimethyl-1,3-propanediamine",604-073-5,138337-31-2,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,441,H400:441;H318:441;H317:441;H410:441
129112,"Silane, trimethoxyoctyl-, reaction products with titanium oxide (TiO2)",309-319-2,100209-12-9,,Notified C&L,2,Not classified:2
129118,methoxyacetic acid,210-894-6,625-45-6,Acute Tox. 4;Skin Corr. 1B;Repr. 1B,Harmonised C&L,0,H360:0;H314:0;H302:0
129121,"Acetamide, N-(4-bromo-2-nitrophenyl)-",618-120-2,881-50-5,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
129123,Dimethyl sebacate,203-431-4,106-79-6,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,182,H318:9;H412:9;Not classified:173
129125,"Manganese chloride (MnCl2), monohydrate",613-575-3,64333-01-3,Acute Tox. 4,Notified C&L,91,H302:91
129128,N-acetyl-4-fluoro-3-phenyl-DL-alanine,241-495-5,17481-06-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
129134,2-bromo-4-chlorophenol,211-785-6,695-96-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H335:42;H315:43;H302:4;H312:4;H314:1
129136,N-[(benzyloxy)carbonyl]-L-tyrosine,214-609-6,1164-16-5,Not Classified,Notified C&L,1,Not classified:1
129137,"Oxidase, choline",232-840-0,9028-67-5,Resp. Sens. 1,Notified C&L,117,H334:117
129140,(S)-2-[(tert-Butoxycarbonyl)amino]-2-(cyclohexyl)acetic acid,600-901-4,109183-71-3,Not Classified,Notified C&L,5,Not classified:2;H319:2;H335:2;H315:2;H228:1
129142,Coelenterazine H,610-584-4,50909-86-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
129148,barium chloride,233-788-1,10361-37-2,Acute Tox. 3;Acute Tox. 4,Harmonised C&L,0,H301:0;H332:0
129152,"Fatty acids, C16-18 and C16-18-unsatd., Me esters",310-005-2,102047-28-9,Not Classified,Notified C&L,2,Not classified:2
129154,"Phosphoric acid, mono- and di-iso-Bu esters",291-941-8,90506-76-6,Skin Corr. 1B,Notified C&L,1,H314:1
129157,"5-methyl-1,3-benzodioxole",230-453-1,7145-99-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
129159,"N,N-dimethyltridecylamine",241-410-1,17373-29-4,Skin Irrit. 2,Notified C&L,38,H315:38
129160,Methylenecyclobutane,214-313-7,1120-56-5,Flam. Liq. 2,Notified C&L,40,H225:40
129161,"Phosphoric acid, isotridecyl ester, potassium salt",292-407-7,90605-09-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H315:3;H318:3
129163,HAA299,485-100-6,,Not Classified,Notified C&L,1,Not classified:1
129171,(Z)-dodec-9-en-1-ol,609-079-1,35148-18-6,Not Classified,Notified C&L,2,Not classified:1;H413:1
129177,Orphenadrine,201-509-2,83-98-7,Acute Tox. 3,REACH registration C&L,39,H301:39
129180,SYNTHOESTER DRS 94-848,432-650-1,,Not Classified,Notified C&L,1,Not classified:1
129182,3-Acetylpyridine N-Oxide,604-259-6,14188-94-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
129184,"Fatty acids, C16-18, 2-hydroxyethyl esters",306-522-8,97281-23-7,Not Classified,Notified C&L,12,Not classified:12
129187,"Slack wax (petroleum), low-melting, clay-treated;[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C",308-156-4,97863-05-3,Carc. 1B,Harmonised C&L,0,H350:0
129188,Ethyltoluene,247-093-6,25550-14-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;Aquatic Chronic 2,Notified C&L,49,H319:20;H304:38;H315:20;H335:20;H336:20;H411:38;H226:38;Not classified:11
129190,potassium,231-119-8,7440-09-7,Water-react. 1;Skin Corr. 1B,Harmonised C&L,0,H314:0;H260:0
129195,2-bromoacrylic acid,233-928-1,10443-65-9,Skin Corr. 1B;STOT SE 3,Notified C&L,43,H335:39;H314:43;H317:5
129196,"3,3'-[(2,5-dichloro-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-(5-chloro-o-tolyl)benzamide]",226-971-2,5580-58-5,Not Classified,REACH registration C&L,4,Not classified:4
129197,"Disodium 5-[[2,4-dihydroxy-5-[(4-nitrophenyl)azo]phenyl]azo]-4-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonate",274-421-5,70210-24-1,Not Classified,Notified C&L,9,Not classified:9
129202,"Monensin, monosodium salt",244-941-7,22373-78-0,Acute Tox. 2,Notified C&L,198,H300:196;H301:2;H411:1;H318:1;H373:1
129208,"[hexane-1,6-diylbis[nitrilobis(methylene)]]tetrakisphosphonic acid, sodium salt",260-362-2,56744-47-9,Not Classified,Notified C&L,4,Not classified:3;H315:1;H290:1;H318:1
129212,"Reaction product of Polymethylene Polyphenyl Polyisocyanate (CAS 9016-87-9) and octadecylamine and amines, coco alkyl (EC 262-977-1)",926-604-2,,,Notified C&L,1,H413:1
129213,3-methylpyrazole,215-925-7,1453-58-3,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Repr. 2,REACH registration C&L,54,H361:4;H314:3;H318:3;H302:54;H319:51;H335:44;H315:51;H331:1;H373:1;H332:1;H312:1
129214,Trichloroacetyl isocyanate,221-165-7,3019-71-4,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Resp. Sens. 1,Notified C&L,46,H311:40;H314:45;H331:41;H334:46;H330:4;H301:1;H318:1;Not classified:1;H319:1;H335:1;H315:1
129217,"Oxirane, methyl-, polymer with oxirane, ether with 2,2'-[[3-[(2-hydroxyethyl)amino]propyl]imino]bis[ethanol] (3:1), N-tallow alkyl derivs.",614-898-2,69011-89-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,31,H411:31;H319:31;H315:31;H302:31
129219,"Amines, polyethylenepoly-, triethylenetetramine fraction",292-588-2,90640-67-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,524,H302:500;H312:524;H318:486;H317:524;H314:524;H412:524
129220,"4,7,7-trimethyl-2-(3-methyl-2-butenyl)bicyclo[4.1.0]heptan-3-one",277-895-1,74499-58-4,Not Classified,Notified C&L,985,Not classified:985
129221,Bicozamycin,253-795-3,38129-37-2,Acute Tox. 1,Notified C&L,38,H300:38
129225,1-hydroxy-cyclopentane carbonitrile,610-627-7,5117-85-1,Acute Tox. 1;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,57,H310:55;H319:55;H400:55;H300:55;H330:55;H315:55;H410:57;H318:55;H331:2;H311:2;H301:2
129227,C.I. Solvent Yellow 162,600-546-5,104244-10-2,Not Classified,Notified C&L,10,Not classified:10
129230,Tetradecanal,204-692-7,124-25-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1461,H319:1449;H315:1449;H335:38;Not classified:12
129232,"α-D-Arabinofuranose, 2-deoxy-2-fluoro-, 1,3,5-tribenzoate",619-281-1,97614-43-2,Not Classified,Notified C&L,1,Not classified:1
129233,"Disodium [(9,10-dihydro-9,10-dioxo-1,4-anthrylene)diimino]bis[ethyltoluenesulphonate]",280-163-4,83027-61-6,Skin Sens. 1,REACH registration C&L,3,H317:1;H412:2
129236,Thiopental sodium,200-763-1,71-73-8,Acute Tox. 3,Notified C&L,42,H301:42;H361:2;H312:1;H332:1
129237,"Residues, niobium oxide-tantalum oxide manufg., lime-neutralized",309-639-2,100656-50-6,Not Classified,Notified C&L,1,Not classified:1
129245,methyl chloroacetate,202-501-1,96-34-4,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;STOT SE 3,Harmonised C&L,0,H331:0;H315:0;H301:0;H335:0;H318:0;H226:0
129254,5-ethyl-2-methylnonan-1-al,268-836-0,68141-14-0,Not Classified,Notified C&L,88,Not classified:88
129255,2-(2-phenylethyl)pyridine,218-318-5,2116-62-3,Not Classified,Notified C&L,88,Not classified:88
129256,"Phenol, 2-fluoro-4-propyl-",617-010-1,80222-25-9,Not Classified,Notified C&L,1,Not classified:1
129257,Sodium permanganate,233-251-1,10101-50-5,Ox. Sol. 2;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,REACH registration C&L,70,H400:60;H302:65;H410:60;H272:67;H314:62;H318:14;Not classified:3
129260,"methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine",236-035-5,13108-52-6,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H312:0;H317:0;H302:0
129262,Bromoacetonitrile,209-672-1,590-17-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,50,H319:42;H331:43;H315:41;H301:50;H335:41;H311:50;H314:6;H330:7;H318:1
129265,"mesitylene;1,3,5-trimethylbenzene",203-604-4,108-67-8,Flam. Liq. 3;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H226:0;H335:0
129266,"reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate",604-398-2,144171-61-9,Acute Tox. 3;Skin Sens. 1B;Acute Tox. 4;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H372:0;H332:0;H301:0;H410:0;H317:0
129268,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with acrylic acid and fatty acids, coco",500-489-5,161074-56-2,Not Classified,Notified C&L,11,Not classified:11
129270,"Amines, hydrogenated tallow alkyl, stearates",271-372-1,68551-29-1,Not Classified,Notified C&L,2,Not classified:2
129271,"2-(3-chloropropyl)-2-(p-fluorophenyl)-1,3-dioxolane",221-993-9,3308-94-9,Acute Tox. 4,REACH registration C&L,42,H302:42;H312:1;H332:1
129274,4-hexyloxybenzoic acid,214-534-9,1142-39-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
129276,"3-methyl-4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one",267-149-3,67801-29-0,Not Classified,Notified C&L,88,Not classified:88
129278,Trimethoxy(2-phenylethyl)silane,256-363-2,49539-88-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
129279,Metyrapone,200-206-2,54-36-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:38;H335:38;H315:38;H302:41;H361:1
129280,1-cinnamylpiperazine,242-652-0,18903-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
129283,Silver heptafluorobutyrate,223-266-1,3794-64-7,Eye Dam. 1,Notified C&L,42,H318:42
129286,3-[(2-hydroxyethyl)[4-[[6-(methylsulphonyl)benzothiazol-2-yl]azo]phenyl]amino]propiononitrile,246-057-7,24170-48-7,Not Classified,Notified C&L,18,Not classified:18
129288,Hydrogen bis[1-[(2-hydroxy-4-nitrophenyl)azo]naphthalen-2-olato(2-)]cobaltate(1-),251-080-0,32517-38-7,Not Classified,Notified C&L,1,Not classified:1
129290,"Fatty acids, C12-20, reaction products with triethanolamine, di-Me sulfate-quaternized",293-018-5,91032-11-0,Not Classified,Notified C&L,250,Not classified:228;H400:22
129291,2-aminoethyl methacrylate hydrochloride,219-343-4,2420-94-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:40;H315:40;H335:1
129293,C.I. Disperse Red 362,605-131-2,158129-94-3,Not Classified,Notified C&L,2,Not classified:2
129295,(4-amino-2-chloro-5-methylphenyl)(4-chlorophenyl)acetonitrile,262-792-6,61437-85-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,161,H319:161;H332:161;H302:161;H312:161;H315:161;H335:161
129298,"1,5-diphenyl-3-thiocarbazone",200-454-1,60-10-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,106,H319:106;H335:102;H315:106;H332:1;H302:2;H312:1;H371:1
129301,"4,4'-dimethoxythiobenzophenone",213-489-2,958-80-5,Skin Irrit. 2;Eye Dam. 1;Resp. Sens. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H335:38;H315:38;H334:38;H318:38
129306,"Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;Baseoil - unspecified;[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",292-618-4,90640-96-3,Carc. 1B,Harmonised C&L,0,H350:0
129307,"Resin acids and Rosin acids, calcium salts",232-694-8,9007-13-0,Not Classified,REACH registration C&L,387,Not classified:360;H228:25;H319:24;H315:25;H332:1;H317:2;H316:1;H320:1;H252:1;H312:1;H302:1
129316,5-amino-2-nitrobenzoic acid,236-283-4,13280-60-9,,Notified C&L,9,H319:9;H335:8;H315:9
129320,"Disodium 4-[(2,7-dihydro-3-methyl-2,7-dioxo-3H-dibenz[f,ij]isoquinolin-6-yl)amino]-benzene-1,3-disulphonate",220-035-7,2611-80-5,,Notified C&L,34,Not classified:34
129322,1-methylpyrrolidine-2-methanol,222-608-7,3554-65-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:1;H335:2;H315:2;H302:2;H318:1;H227:1
129329,"Benzene, C4-16-alkyl derivs.",272-007-9,68648-86-2,Not Classified,Notified C&L,1,Not classified:1
129330,Benzo[c]phenanthrene,205-896-9,195-19-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,53,H319:41;H332:41;H302:41;H312:41;H315:41;H335:41;H351:12;H341:12
129332,Methyl 5-[(4-aminophenyl)methyl]anthranilate,257-541-2,51947-52-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT RE 2,Notified C&L,21,H319:21;H302:21;H335:21;H315:21;H373:21
129333,"Trisodium 5-[[4-chloro-6-(ethylphenylamino)-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",276-911-4,72829-25-5,Skin Sens. 1B,REACH registration C&L,144,H317:97;H412:37;Not classified:9;H319:1;H315:1
129334,Acetylclonidin,611-188-4,54707-71-0,Acute Tox. 4,Notified C&L,2,H302:2
129335,N-methyldidecylamine,230-990-1,7396-58-9,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,174,H410:67;H400:142;H315:99;H302:166;H314:74;H318:44;H319:20;H411:13
129339,"(R)-3,7-dimethyloct-6-enal",219-194-5,2385-77-5,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,124,H319:123;H315:124;H317:86;H335:38;H411:1
129340,Zirconium orthosilicate,233-252-7,10101-52-7,Not Classified,Notified C&L,119,Not classified:81;H319:38;H335:38;H315:38;H332:38
129341,1-(p-iodophenyl)-5-(p-nitrophenyl)-3-phenylformazan,231-950-6,7781-49-9,Resp. Sens. 1,Notified C&L,38,H334:38
129342,1-(bromomethyl)-2-(trifluoromethyl)benzene,206-901-7,395-44-8,Skin Corr. 1B,Notified C&L,46,H314:46;H319:2;H335:1;H290:1;H318:1
129350,"Lup-20(29)-ene-3,28-diol, (3β)-",207-475-5,473-98-3,Not Classified,Notified C&L,30,Not classified:27;H319:1;H335:1;H315:1;H312:1;H332:1;H302:1;H371:1
129357,N-Benzoylmeroquinene tert-Butyl Ester,610-829-5,52346-13-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
129363,Neodymium phosphate,238-232-1,14298-32-9,Not Classified,Notified C&L,1,Not classified:1
129371,"Dinaphtho[1,2,3-cd:3',2',1'-lm]perylene-5,10-dione, (9,10-dihydro-9,10-dioxo-1-anthracenyl)amino derivs.",291-174-9,90342-37-3,Not Classified,REACH registration C&L,1,Not classified:1
129372,"Amines, polyethylenepoly-, tetraethylenepentamine fraction",292-587-7,90640-66-7,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,582,H312:582;H411:559;H318:28;H317:582;H314:582;H302:570;H400:23;H410:23
129374,"(1E,5E,9E)-cyclododeca-1,5,9-triene",211-626-0,676-22-2,Skin Corr. 1B,Notified C&L,42,H314:42;H411:4;H317:4
129377,"[2-(diphenylmethoxy)ethyl]dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate",289-432-0,88637-37-0,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,26,H332:24;H302:26;H312:24;H334:24;H317:24;H319:1;H335:2;H315:1
129378,"Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate",917-714-1,,Not Classified,Notified C&L,1,Not classified:1
129380,5-diazouracil,219-427-0,2435-76-9,Self-react. C;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H242:1;H332:1;H302:1
129381,2-butoxyethanol;2-butoxyethanol; ethylene glycol monobutyl ether;butyl cellosolve,203-905-0,111-76-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Harmonised C&L,0,H319:0;H315:0;H332:0;H302:0
129386,3-pyridyl dimethylcarbamate,257-297-7,51581-32-9,Acute Tox. 3;Eye Dam. 1,REACH registration C&L,6,H301:4;H318:4;Not classified:2;H310:1;H330:1;H300:1;H317:1
129387,"1H-Indeno[5,4-f]quinoline-7-carboxylic acid, hexadecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-",600-424-1,103335-55-3,,Notified C&L,1,H341:1;H302:1
129388,"Fatty acids, C14-26, sodium salts",266-939-5,67701-14-8,Not Classified,Notified C&L,6,Not classified:6
129389,(3-chloropropyl)cyclohexane,214-399-6,1124-62-5,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,38,H413:38;H301:38
129391,Methyl 4-bromo-2-methoxybenzoate,604-108-4,139102-34-4,Acute Tox. 3,Notified C&L,43,H301:39;H319:4;H335:4;H315:4
129392,Diethyl (2-cyanoethyl)malonate,241-260-7,17216-62-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43,H312:43;H332:43;H302:43;H319:1;H315:1
129393,"Slack wax (petroleum), low-melting, carbon-treated;[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C",308-155-9,97863-04-2,Carc. 1B,Harmonised C&L,0,H350:0
129397,"N,N,N',N'-tetramethyl-4,4'-methylendianiline",202-959-2,101-61-1,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H350:0;H410:0
129398,D-serine,206-229-4,312-84-5,Not Classified,REACH registration C&L,20,Not classified:18;H319:2;H335:2;H315:2
129400,"2,6-dimethylpyridine 1-oxide",214-025-1,1073-23-0,,Notified C&L,5,H319:5;H315:5;H302:5
129402,Ditantalum monocarbide,235-119-9,12070-07-4,Not Classified,Notified C&L,1,Not classified:1
129404,"2-Naphthalenesulfonic acid, 4-hydroxy-3-[2-(2-methoxy-4-nitrophenyl)diazenyl]-6-[(3-sulfophenyl)amino]-, sodium salt (1:2)",608-521-0,30748-35-7,Not Classified,REACH registration C&L,2,Not classified:2
129406,2-(2-aminoethyl)phenol,218-016-3,2039-66-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:2
129411,"Phosphoric acid, 2-ethylhexyl ester, zinc salt",257-665-7,52108-54-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;Not classified:1
129412,2-hexylidenecyclopentanone,241-411-7,17373-89-6,Skin Sens. 1,Notified C&L,310,H317:272;H319:38;H302:38
129413,Bisdecanoyl peroxide,212-092-1,762-12-9,Org. Perox. C,REACH registration C&L,7,H242:7;H319:5;H315:5
129414,Triisooctylamine,247-092-0,25549-16-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,216,H302:192;H315:214;H411:215;H317:118;H361:118;H373:118;H319:62;H335:39;H314:1;H318:1;H401:1
129417,1-[4-(2-phenylethyl)phenyl]ethan-1-one,212-323-6,785-78-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
129422,Cyanocyclohexylideneacetic acid,253-351-9,37107-50-9,Acute Tox. 4,Notified C&L,42,H302:42;H319:4;H332:4;H312:4;H315:4;H335:4
129428,"1,2-dichlorohexafluorocyclobutane",206-599-7,356-18-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
129429,"2-Butyne-1,4-diol, polymer with 2-(chloromethyl)oxirane, brominated, dehydrochlorinated, methoxylated",614-503-3,68441-62-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,184,H319:184;H302:184
129430,(+)-L-arginine hydrochloride,214-275-1,1119-34-2,Not Classified,REACH registration C&L,332,Not classified:204;H319:128;H315:126;H335:1
129436,"1,3-dipiperidinourea",238-674-5,14631-68-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H302:38
129437,"Pyrrolo[3,4-c]pyrrole-1,4-dione, 2,5-dihydro-3,6-diphenyl-",601-713-5,120500-90-5,Not Classified,Notified C&L,2,Not classified:2
129440,3-methylbutane-1-thiol,208-774-3,541-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1419,H319:1414;H335:1414;H315:1414;H225:133;H332:4;H302:4
129441,Heptadecene,247-567-2,26266-05-7,Asp. Tox. 1,Notified C&L,1,H304:1
129443,"Rosin, sapond.",309-610-4,100403-64-3,Not Classified,Notified C&L,3,Not classified:3
129444,5-nitrosalicylaldehyde,202-587-0,97-51-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,51,H411:2;H319:51;H315:51;H302:51;H335:9;Not classified:1
129445,2-(ethylthio)ethylamine hydrochloride,259-081-8,54303-30-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
129449,δ-valerolactone,208-807-1,542-28-9,Eye Dam. 1,REACH registration C&L,657,H318:653;H319:4
129450,"Amines, C12-14 (even numbered) -alkyldimethyl, N-oxides",608-528-9,308062-28-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,116,H400:116;H302:103;H315:116;H411:105;H318:116;H410:14;H319:1
129453,"Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;Refinery gas;[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]",272-775-5,68911-58-0,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,Not classified:0;H340:0;H350:0;H220:0
129458,"Fatty acids, C20-22 and C20-22-unsatd.",306-080-6,95912-84-8,Not Classified,Notified C&L,1,Not classified:1
129461,"4-aminopyrazolo[3,4-d]pyrimidin-6-ol",226-811-1,5472-41-3,Acute Tox. 3,Notified C&L,39,H301:38;H319:1;H315:1
129467,"Esterification product of castor oil and tetrahydromethyl-1,3-isobenzofuranedione",700-064-6,2105830-60-0,Skin Sens. 1B;Resp. Sens. 1,REACH registration C&L,14,H413:14;H317:14;H334:1
129468,ethylene dinitrate;ethylene glycol dinitrate,211-063-0,628-96-6,Unst. Expl.;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2,Harmonised C&L,0,H310:0;H330:0;H300:0;H200:0;H373:0
129471,"Trisodium 4-amino-3-[[4-[[4-[(2,4-dihydroxyphenyl)azo]phenyl]amino]-3-sulphonatophenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate",301-253-2,93982-64-0,Aquatic Chronic 2,Notified C&L,1,H411:1
129475,8-quinolylamine,209-427-9,578-66-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,49,H319:49;H315:49;H335:8;H341:6;H332:2;H302:2;H312:2
129480,Benzamidine HCl hydrate,606-598-5,206752-36-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H335:47;H315:47
129481,o-phenylene phosphorochloridite,216-690-3,1641-40-3,Skin Corr. 1B,Notified C&L,42,H314:42
129484,Dipropetryn,223-973-5,4147-51-7,Aquatic Chronic 2,Notified C&L,3,H411:3
129487,"tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate",429-170-8,134575-17-0,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;STOT RE 2,Harmonised C&L,0,H317:0;H373:0;H318:0;H302:0
129488,"Amides, C12-18, N,N-bis(hydroxyethyl)",268-934-3,68155-06-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,33,H315:32;H318:33;H317:1
129489,Methyl hydrogen terephthalate,216-849-7,1679-64-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:40;H315:41
129490,"2-O-(6-deoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranoside",257-814-6,52286-59-6,Acute Tox. 4,Notified C&L,3,H302:2;Not classified:1
129493,2-phenylpropiononitrile,217-354-9,1823-91-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,49,H319:48;H332:44;H302:44;H312:44;H315:47;H335:41;H331:5;H301:5;H311:5
129495,Hex-2-enoic acid,214-727-8,1191-04-4,Skin Corr. 1B,Notified C&L,113,H314:113;H318:36
129497,avermectin B1a (purity ≥80 %),265-610-3,65195-55-3,Acute Tox. 2;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H400:0;H330:0;H372:0;H300:0;H410:0;H361:0
129498,"2-Bromo-4,6-dichloroaniline",615-011-1,697-86-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:38;H315:43;H332:5;H302:5;H312:5
129499,3-chloro-p-anisidine,226-298-4,5345-54-0,Acute Tox. 4,Notified C&L,40,H302:40
129504,"6-undecyl-1,3,5-triazine-2,4-diamine",219-795-2,2533-34-8,,Notified C&L,4,H319:4;H335:4;H315:4
129505,1-[p-(dimethylamino)phenyl]thiourea,244-891-6,22283-43-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
129506,"Metaphosphoric acid, sodium salt, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide",215-646-0,1336-20-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Notified C&L,38,H351:38;H331:38;H311:38;H301:38
129507,Aluminum zirconium chloride hydroxide,260-599-1,57158-29-9,Not Classified,REACH registration C&L,53,Not classified:53
129512,Perhydrofluorene,227-268-3,5744-03-6,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H413:38;H302:38
129518,"Fatty acids, C14-18 and C16-18-unsatd., reaction products with C14-18 and C16-18-unsatd. alkyl amines and maleic anhydride",307-653-3,97675-80-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,1,H319:1;H315:1;H317:1;H334:1
129521,"Fatty acids, rape-oil, zinc salts",270-441-3,68440-18-6,Not Classified,Notified C&L,33,Not classified:33
129524,"1-[4-(1,1-dimethylethyl)phenyl]-3-(4-methoxyphenyl)propane-1,3-dione",274-581-6,70356-09-1,Not Classified,REACH registration C&L,2052,Not classified:28;H413:1927;H400:38;H410:39;H411:36;H412:24
129527,"Fenazinium, 2-amino-8-(dimethylamino)-10-phenyl-, ar-methyl derivatives, chlorides",232-332-9,8004-94-2,Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H318:1;H317:1;H410:1
129528,"Sorbitan, isooctadecanoate",276-171-2,71902-01-7,Not Classified,REACH registration C&L,89,Not classified:89
129529,p-bromo-DL-phenylalanine,237-941-3,14091-15-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
129532,3-chlorosulphanilic acid,202-660-7,98-35-1,Skin Corr. 1B,Notified C&L,38,H314:38
129534,"Guar gum, oxidized, depolymd.",270-969-4,68512-39-0,Not Classified,Notified C&L,22,Not classified:22
129536,"Fatty acids, C16-18-unsatd., reaction products with diethylenetriamine, acetates",287-645-3,85566-34-3,Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,1,H400:1;H314:1;H410:1
129540,3-(ethylamino)-p-cresol,204-391-0,120-37-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
129541,"Reaction product of benzene-1,2:4,5-tetracarboxylic dianhydride, Octadecylamine, (Z)-Octadec-9-enylamine, Octylamine, Dodecylamine and hexamethylenediamine",925-838-2,,Not Classified,Notified C&L,2,Not classified:2
129545,"olivine, nickel green",271-112-7,68515-84-4,Skin Sens. 1;STOT RE 1;Carc. 1A,Harmonised C&L,0,H350:0;H372:0;H317:0
129546,Ammonium molybdenum oxide,234-320-9,11098-84-3,Aquatic Chronic 3,Notified C&L,34,H412:26;Not classified:8
129548,"(3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-[(benzyloxy)methyl]oxan-2-ol",609-908-7,4132-28-9,Aquatic Chronic 4,Notified C&L,2,H413:1;H319:1;H335:1;H315:1
129551,"Hydrocarbons, C13-C20, n-alkanes, isoalkanes, cyclic, aromatics (40-60%)",928-812-9,,Asp. Tox. 1;Aquatic Chronic 4,Notified C&L,112,H304:112;H413:56
129553,Cloprednol,226-052-6,5251-34-3,,Notified C&L,1,H373:1
129557,D:A-Friedooleanan-3-one,209-205-1,559-74-0,Not Classified,Notified C&L,1,Not classified:1
129559,4-amino-9H-fluoren-9-one,224-257-5,4269-15-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
129560,"Hydrocarbons, C6-C7, isoalkanes, cyclics, <5% n-hexane",926-605-8,,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,8,H304:8;H336:8;H411:8;H225:8
129565,C.I. Acid Orange 116,602-039-4,12220-10-9,,Notified C&L,2,H412:1;Not classified:1
129566,"3,3'-[butane-1,4-diylbis(oxy)]bispropanamine",230-745-9,7300-34-7,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,136,H332:98;H314:136;H318:85;H317:84;H311:51;H330:38
129567,Chlorododecyldimethylsilane,266-421-9,66604-31-7,Skin Corr. 1B,Notified C&L,39,H314:39;H290:1;H318:1
129568,3-Fluoro-4-pyridineboronic acid pinacol ester,610-275-4,458532-88-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H335:43;H315:43;H302:1
129569,"Disodium 5,5'-[(2-hydroxytrimethylene)bis(oxy)]bis[4-oxo-4H-1-benzopyran-2-carboxylate]",239-926-7,15826-37-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:42;H335:41;H315:42;Not classified:2;H302:1
129570,"Fats, animal",295-644-4,92113-40-1,Not Classified,Notified C&L,1,Not classified:1
129574,Dipotassium glutarate,254-563-4,39649-90-6,Not Classified,Notified C&L,85,Not classified:85
129576,(-)-Huperzine A,600-320-6,102518-79-6,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3,Notified C&L,197,H310:196;H319:195;H330:196;H315:195;H301:156;H335:195;H311:156;H300:41;H411:1
129577,Chlorohydroxyoxozirconium,242-305-3,18428-88-1,Met. Corr. 1;Skin Corr. 1B,Notified C&L,1,H314:1;H290:1
129580,"Fatty acids, tall-oil, 2-mercaptoethyl esters",270-443-4,68440-24-4,Acute Tox. 4;Skin Irrit. 2,Notified C&L,57,H312:57;H315:57;H302:1
129582,Isopentyl 3-methyl-2-butenoate,260-438-5,56922-73-7,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1;H227:1
129584,3-amino-2-naphthol,226-519-4,5417-63-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,43,H319:43;H332:39;H302:43;H312:39;H315:43;H335:42;H351:39
129585,"Poly[1,4-phenylene diisocyanate-co-poly(1,4-butanediol)] diisocyanate",618-264-6,89339-41-3,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3,Notified C&L,39,H331:38;H301:38;H311:38;H318:38;H317:38;Not classified:1
129587,"Fatty acids, C16-18-unsatd., reaction products with diethylenetriamine",287-646-9,85566-35-4,Not Classified,Notified C&L,6,Not classified:6
129588,"4-hydroxy-3,5-dimethoxybenzaldehyde azine",238-390-1,14414-32-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
129593,"1,1'-diethyl[3,3'-bianthra[1,9-cd]pyrazole]-6,6'(1H,1'H)-dione",224-115-2,4203-77-4,Not Classified,REACH registration C&L,34,Not classified:33;H412:1
129596,"Ethyl 1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate",422-380-0,98349-25-8,Not Classified,REACH registration C&L,1,Not classified:1
129597,"Siloxanes and Silicones, di-Me, 3-hydroxypropyl group-terminated, propoxylated",605-266-7,161755-53-9,Not Classified,Notified C&L,43,Not classified:43
129598,4-piperidone,255-481-1,41661-47-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
129599,Bisdemethoxycurcumin,607-464-9,24939-16-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
129603,"2-Propenoic acid, 3-[4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-, methyl ester, hydrochloride (1:1)",610-682-7,51531-46-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H312:2;H332:2;H302:2
129604,"Fatty acids, C12-18, sodium salts",293-019-0,91032-12-1,Not Classified,Notified C&L,22,Not classified:22
129606,Not known,618-624-2,9069-50-5,Resp. Sens. 1,Notified C&L,208,H334:108;Not classified:55;H319:45;H317:42;H335:20;H315:20;H332:17;H351:17;H331:17
129607,"reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)",411-600-0,143145-93-1,Aquatic Chronic 4,Harmonised C&L,0,H413:0
129608,Xylanase,253-439-7,37278-89-0,Resp. Sens. 1,Notified C&L,2,H334:2
129612,Chlorocyclobutane,214-314-2,1120-57-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H312:38;H225:45;H332:38;H302:38;H314:1;H319:2;H335:1;H315:2
129615,"Sodium 4,8-diamino-9,10-dihydro-1,5-dihydroxy-9,10-dioxoanthracene-2-sulphonate",218-435-1,2150-60-9,Not Classified,Notified C&L,2039,Not classified:2039
129618,"5-hydroxydodecanoic acid, monoester with glycerol",247-700-4,26446-32-2,Not Classified,Notified C&L,88,Not classified:88
129619,Ethylene bis(3-mercaptopropionate),245-044-3,22504-50-3,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 1,REACH registration C&L,29,H319:4;H400:2;H302:2;H312:2;H410:2;H317:2;H411:20;H301:20;Not classified:5;H335:1;H315:2
129620,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (CAS: 101-68-8), Octylamine (111-86-4) and Hexamethylenediamine (124-09-4)",924-670-7,,Flam. Sol. 1;Eye Dam. 1;Flam. Sol. 1;Eye Dam. 1,REACH registration C&L,2,H228:2;H318:2
129624,"2-Methylpropene, trimers, sulfurized",500-184-7,68037-13-8,Not Classified,Notified C&L,2,Not classified:2
129627,2-nitroethanol,210-895-1,625-48-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H335:43;H315:44
129628,"Di(hydroxyethyl)aminomethylphenol, propoxylated",614-766-4,68909-26-2,Skin Sens. 1;Eye Irrit. 2,Notified C&L,147,H319:146;H317:146;Not classified:1
129636,3-chloropropanethiol,241-496-0,17481-19-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H226:38;H319:38;H315:38;H335:38
129637,ethyl (2R)-2-{4-[[](6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoate,600-119-3,100646-51-3,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,180,H410:137;H400:134;H302:142;H413:41;H312:41;Not classified:1;H319:1
129647,"1,2,4-trimethoxybenzene",205-219-7,135-77-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
129648,2-AMINO-1-(4-HYDROXYPHENYL)ETHANONE HYDROCHLORIDE,606-368-4,19745-72-3,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,2,H312:2;H318:2;H317:2
129649,1-(bromomethyl)-2-chloro-4-nitrobenzene,255-874-8,42533-63-1,Skin Corr. 1B,Notified C&L,1,H315:1;H314:1
129651,"Phosphoric acid, mono- and di-Me esters",291-942-3,90506-77-7,Skin Corr. 1B,Notified C&L,1,H314:1
129654,Benzyl valerate,233-789-7,10361-39-4,Not Classified,Notified C&L,89,Not classified:89
129657,Methyl D-valinate hydrochloride,230-454-7,7146-15-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1;H302:1
129660,"Phosphoric acid, mixed cetyl and oleyl esters, sodium salts",292-406-1,90605-08-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
129661,"Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides",616-786-9,8001-54-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,301,H332:149;H302:227;H312:228;H318:162;H314:299;H400:150;H330:36;H301:72;H311:56;H411:49;H410:29;H315:2
129665,4-(4-nitrophenyl)morpholine,233-851-3,10389-51-2,,Notified C&L,5,H319:5;H335:4;H315:5
129668,"Acetic acid, chromium salt, basic",254-447-3,39430-51-8,Skin Sens. 1B,REACH registration C&L,2092,H317:42;Not classified:2037;H319:9;H332:13;H302:13;H312:9;H315:9;H335:9;H350:1;H400:1;H410:1
129670,"Amides, castor-oil, N-[3-(dimethylamino)propyl]",273-944-6,69278-64-4,Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,Not classified:1;H314:1;H410:1
129671,"Tribulus terrestris, ext.",290-381-1,90131-68-3,Not Classified,Notified C&L,27,Not classified:26;H351:1;H361:1;H302:1
129675,"2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate",429-610-9,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0;H302:0
129676,tetrasilane,616-515-4,7783-29-1,Pyr. Liq. 1,Notified C&L,1,H250:1
129677,"Fatty acids, C8-10, mixed esters with neopentyl glycol and trimethylolpropane",306-523-3,97281-24-8,Not Classified,REACH registration C&L,36,Not classified:36
129678,Niobium carbide,235-117-8,12069-94-2,Not Classified,REACH registration C&L,19,Not classified:15;H228:4
129680,o-(methylthio)phenol,214-027-2,1073-29-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1381,H319:1347;H315:1371;H302:1341;Not classified:10;H335:6
129682,"(1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyloxy-2,1-ethanediyl) bismethacrylate",260-363-8,56744-60-6,Not Classified,Notified C&L,1,Not classified:1
129685,"Octadecanoic acid, C16-18-alkyl esters",298-680-9,93820-97-4,Not Classified,REACH registration C&L,25,Not classified:25
129687,Barium sebacate,243-380-5,19856-32-7,Not Classified,Notified C&L,1,Not classified:1
129695,C.I. Solvent Black 27,602-672-6,12237-22-8,Skin Sens. 1B;Repr. 1B;STOT RE 2,Notified C&L,99,H360:83;H373:83;H317:83;Not classified:16
129699,Idoxuridine,200-207-8,54-42-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Repr. 2,Notified C&L,47,H319:42;H341:40;H335:40;H315:42;H361:46;H351:4;H332:1;H302:2;H312:1;H334:1;H371:2
129703,4-tert-butylcyclohexylamine,226-444-7,5400-88-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:38;H335:38;H315:38;H302:38;H314:6;H318:2
129705,"2-Propanol, 1,3-bis(2,6-dimethylphenoxy)-",617-745-8,856976-65-3,Aquatic Chronic 2,REACH registration C&L,84,H411:84
129706,"Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate",611-033-0,536759-91-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84,H400:83;H410:83;Not classified:1
129707,"3,3'-[(2-chloro-5-methyl-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-(3-chloro-o-tolyl)benzamide]",226-970-7,5580-57-4,Not Classified,REACH registration C&L,258,Not classified:258
129708,"Ethyl 7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate",252-589-0,35482-56-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
129709,"octasodium 2-{[2-anilino-5-hydroxy-6-({5-hydroxy-7-sulfonato-6-[(2-sulfonatophenyl)diazenyl]-2-naphthyl}diazenyl)-7-sulfonato-1-naphthyl]diazenyl}-5-hydroxy-6-({4-[(8-hydroxy-3,6-disulfonato-1-naphthyl)diazenyl]-5-methyl-2-(3-sulfonatopropoxy)phenyl}diazenyl)naphthalene-1,7-disulfonate",458-870-6,,Eye Dam. 1,Notified C&L,1,H318:1
129710,Trichloronitrosylruthenium,242-651-5,18902-42-6,,Notified C&L,5,H319:5;H335:4;H315:5
129712,"Acetic acid, 2-[[2-[[3-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)phenyl]amino]-2-oxoethyl]thio]-",618-725-1,91259-47-1,,Notified C&L,1,Not classified:1
129713,Amidinophosphoramidic acid,221-164-1,3019-36-1,Not Classified,Notified C&L,1,Not classified:1
129714,Dicyclopropyl ketone oxime,215-924-1,1453-52-7,Acute Tox. 4,Notified C&L,38,H302:38
129716,2'-deoxyadenosine,213-488-7,958-09-8,Not Classified,Notified C&L,3,Not classified:1;H319:1;H335:1;H315:1;H301:1
129719,"1,2,3,7-tetrahydro-2-thioxo-6H-purin-6-one",219-636-7,2487-40-3,,Notified C&L,4,H319:4;H335:4;H315:4
129726,Cyclohexanal semicarbazone,216-457-6,1589-61-3,Acute Tox. 4,Notified C&L,38,H302:38
129727,Stearamide,204-693-2,124-26-5,Not Classified,REACH registration C&L,242,Not classified:241;H319:1;H335:1;H315:1
129729,"2(2,4-DIMETHYLCYCLOHEX-1-YL)PYRIDINE",460-320-5,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1287,H319:1287;H400:1286;H315:1287;H410:1286;H317:1287;H411:1
129736,Methyl hydroxyacetate,202-502-7,96-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;Not classified:1
129741,Hydromorphone hydrochloride,200-762-6,71-68-1,Acute Tox. 4,Notified C&L,54,H302:46;H412:7;H336:9;H331:5;H361:7;H301:7;H317:6;H310:1;H330:2;H300:1;H334:1
129743,Disodium decyl(sulphonatophenoxy)benzenesulphonate,253-040-8,36445-71-3,Not Classified,Notified C&L,177,Not classified:106;H411:57;H318:49;H319:22;H315:14;H302:6
